
<html lang="en"     class="pb-page"  data-request-id="1fbc4f56-7641-4b0e-84fe-dc9389fb57cb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00926;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?" /></meta><meta name="dc.Creator" content="Paula  Morales" /></meta><meta name="dc.Creator" content="Ana  Lago-Fernandez" /></meta><meta name="dc.Creator" content="Dow P.  Hurst" /></meta><meta name="dc.Creator" content="Noori  Sotudeh" /></meta><meta name="dc.Creator" content="Eugen  Brailoiu" /></meta><meta name="dc.Creator" content="Patricia H.  Reggio" /></meta><meta name="dc.Creator" content="Mary E.  Abood" /></meta><meta name="dc.Creator" content="Nadine  Jagerovic" /></meta><meta name="dc.Description" content="GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB1R and CB2R, a growing body of research..." /></meta><meta name="Description" content="GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB1R and CB2R, a growing body of research..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 11, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00926" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00926" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00926" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00926" /></link>
        
    
    

<title>Therapeutic Exploitation of GPR18: Beyond the Cannabinoids? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00926" /></meta><meta property="og:title" content="Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0010.jpeg" /></meta><meta property="og:description" content="GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB1R and CB2R, a growing body of research suggests its relationship with the endocannabinoid system, not only because it is able to recognize cannabinoid ligands but also because of its expression and ability to heteromerize with CBRs. In this review, we aim to analyze the biological relevance, reported modulators, and structural features of GPR18. In order to guide future drug design in this field, highlights from molecular modeling of GPR18 will be provided." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00926"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00926">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00926&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00926&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00926&amp;href=/doi/10.1021/acs.jmedchem.0c00926" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 14216-14227</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00919" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00934" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?</span></h1><h2 class="article_header-subtitle"><span class="hlFld-SubTitle">Miniperspective</span></h2><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Paula Morales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paula Morales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Química Médica, CSIC, Calle Juan de la Cierva, 3, 28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paula++Morales">Paula Morales</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6209-8600" title="Orcid link">http://orcid.org/0000-0002-6209-8600</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana Lago-Fernandez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana Lago-Fernandez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Química Médica, CSIC, Calle Juan de la Cierva, 3, 28006 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Lago-Fernandez">Ana Lago-Fernandez</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dow P. Hurst</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dow P. Hurst</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, North Carolina 27412, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dow+P.++Hurst">Dow P. Hurst</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Noori Sotudeh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noori Sotudeh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, North Carolina 27412, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noori++Sotudeh">Noori Sotudeh</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eugen Brailoiu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eugen Brailoiu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, Pennsylvania 19140, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eugen++Brailoiu">Eugen Brailoiu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patricia H. Reggio</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patricia H. Reggio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemistry and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, North Carolina 27412, United States</div></div><span class="conrtib-corresp"><strong>*</strong>P.H.R.: email, <a href="/cdn-cgi/l/email-protection#1d6d756f787a7a74725d68737e7a33787968"><span class="__cf_email__" data-cfemail="8bfbe3f9eeecece2e4cbfee5e8eca5eeeffe">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patricia+H.++Reggio">Patricia H. Reggio</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mary E. Abood</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mary E. Abood</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, Pennsylvania 19140, United States</div></div><span class="conrtib-corresp"><strong>*</strong>M.E.A.: email, <a href="/cdn-cgi/l/email-protection#0a676b7873246b6865656e4a7e6f677a666f246f6e7f"><span class="__cf_email__" data-cfemail="5e333f2c27703f3c31313a1e2a3b332e323b703b3a2b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mary+E.++Abood">Mary E. Abood</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1744-2820" title="Orcid link">http://orcid.org/0000-0002-1744-2820</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nadine Jagerovic</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nadine Jagerovic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Instituto de Química Médica, CSIC, Calle Juan de la Cierva, 3, 28006 Madrid, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>N.J.: e-mail, <a href="/cdn-cgi/l/email-protection#0b656a6f62656e4b627a662568786268256e78"><span class="__cf_email__" data-cfemail="3f515e5b56515a7f564e52115c4c565c115a4c">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nadine++Jagerovic">Nadine Jagerovic</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath8">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2642-6969" title="Orcid link">http://orcid.org/0000-0003-2642-6969</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00926&amp;href=/doi/10.1021%2Facs.jmedchem.0c00926" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 14216–14227</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 11, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 May 2020</li><li><span class="item_label"><b>Published</b> online</span>11 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00926" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00926</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D14216%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPaula%2BMorales%252C%2BAna%2BLago-Fernandez%252C%2BDow%2BP.%2BHurst%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c00926%26title%3DTherapeutic%2BExploitation%2Bof%2BGPR18%253A%2BBeyond%2Bthe%2BCannabinoids%253F%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D14227%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00926"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1228</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00926" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Paula&quot;,&quot;last_name&quot;:&quot;Morales&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Lago-Fernandez&quot;},{&quot;first_name&quot;:&quot;Dow&quot;,&quot;last_name&quot;:&quot;P. Hurst&quot;},{&quot;first_name&quot;:&quot;Noori&quot;,&quot;last_name&quot;:&quot;Sotudeh&quot;},{&quot;first_name&quot;:&quot;Eugen&quot;,&quot;last_name&quot;:&quot;Brailoiu&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;H. Reggio&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;E. Abood&quot;},{&quot;first_name&quot;:&quot;Nadine&quot;,&quot;last_name&quot;:&quot;Jagerovic&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;14216-14227&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00926&quot;},&quot;abstract&quot;:&quot;GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB1R and CB2R, a growing body of research suggests its relationship with the endocannabinoid system, not only because it is able to recognize cannabinoid ligands but also because of its expression and ability to heteromerize with CBRs. In this review, we aim to analyze the biological relevance, reported modulators, and structural features of GPR18. In order to guide future drug design in this field, highlights from molecular modeling of GPR18 will be provided.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00926&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00926" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00926&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00926" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00926&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00926" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00926&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00926&amp;href=/doi/10.1021/acs.jmedchem.0c00926" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00926" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00926" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00926%26sid%3Dliteratum%253Aachs%26pmid%3D32914978%26genre%3Darticle%26aulast%3DMorales%26date%3D2020%26atitle%3DTherapeutic%2BExploitation%2Bof%2BGPR18%253A%2BBeyond%2Bthe%2BCannabinoids%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D14216%26epage%3D14227%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">GPR18 is a G-protein-coupled receptor that belongs to the orphan class A family. Even though it shares low sequence homology with the cannabinoid receptors CB<sub>1</sub>R and CB<sub>2</sub>R, a growing body of research suggests its relationship with the endocannabinoid system, not only because it is able to recognize cannabinoid ligands but also because of its expression and ability to heteromerize with CBRs. In this review, we aim to analyze the biological relevance, reported modulators, and structural features of GPR18. In order to guide future drug design in this field, highlights from molecular modeling of GPR18 will be provided.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The class A orphan G-protein-coupled receptor (GPCR) GPR18 was first cloned by Gantz and co-workers in 1997.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This receptor, which is 331 amino acids long, was initially isolated from canine gastric mucosa and human colon cancer cells and subsequently located to human chromosome 13q32.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> GPR18 shares low sequence homology with the cannabinoid receptors CB<sub>1</sub>R and CB<sub>2</sub>R (∼13% and 8%) and moderate identity with the putative cannabinoid receptor GPR55 (21%). Nonetheless, it has been related to the endocannabinoid system (ECS) since a range of endogenous, phytogenic, and synthetic cannabinoids have been shown to modulate GPR18.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a></div><div class="NLM_p">GPR18 human tissue profiling reveals high expression in spleen, thymus, peripheral blood leukocytes, lymph node, cerebellum, lung, and testis among others.<a onclick="showRef(event, 'ref1 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref5">(1,5)</a> This receptor has been shown to signal through Gα<sub>i/o</sub> and Gα<sub>q/11</sub>,<a onclick="showRef(event, 'ref3 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref6 ref7">(3,6,7)</a> while no coupling was detected through Gα<sub><i>z</i></sub> or Gα<sub>15</sub>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> One study has reported coupling through Gα<sub>s</sub>.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Different studies indicate that this orphan receptor exhibits intrinsic constitutive activity.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> However, further studies are needed to fully unravel GPR18 signaling pathways due to the current lack of selective pharmacological tools and its challenging heterologous expression.</div><div class="NLM_p">There is growing evidence demonstrating the therapeutic potential of GPR18. Modulation of GPR18 has been associated with physiopathological processes including pain, sperm physiology, immunomodulation, intraocular pressure, metabolism, or cancer.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11−15)</a></div><div class="NLM_p">Two different endogenous compounds have been proposed as putative ligands of GPR18: a carboxylic metabolite of the endocannabinoid anandamide (AEA), <i>N</i>-arachidonoylglycine<a onclick="showRef(event, 'ref6 ref14 ref16'); return false;" href="javascript:void(0);" class="ref ref6 ref14 ref16">(6,14,16)</a> (NAGly, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), and the endogenous polyunsaturated fatty acid metabolite, resolvin D2<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (RvD2, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). However, due to the lack of sufficient <i>in vivo</i> data, GPR18 is still categorized as an orphan receptor according to the International Union of Basic and Clinical Pharmacology (IUPHAR).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of lipid-like compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite its low structural homology with the cannabinoid receptors, its ability to recognize a variety of cannabinoid chemotypes<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> or form oligomers with the cannabinoid receptors<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> makes GPR18 a very attractive target. Due to the current worldwide interest in cannabinoid-based medicines, understanding GPR18-mediated cannabinoid effects is crucial to unraveling the role of this orphan receptor in the physiopathology of the ECS.</div><div class="NLM_p last">Elucidating the interactions between GPR18 and cannabinoid ligands is critical to determine the molecular basis of their activity and to help in the design of novel GPR18 selective compounds. For that purpose, we will analyze not only the structure of this orphan GPCR but also selected reported scaffolds. Molecules targeting GPR18 will be selected depending on their activity at other receptors including the related proteins CB<sub>1</sub>R, CB<sub>2</sub>R, and GPR55. With this, we aim to provide insights for further drug design and therapeutic validation of GPR18.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Biological Relevance</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">GPR18 is abundantly expressed in several immune cell types where it is involved in different biological functions. GPR18 regulates BV2 microglial cell migration and proliferation,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> neutrophil infiltration,<a onclick="showRef(event, 'ref9 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref9 ref19 ref20">(9,19,20)</a> CD8αα γδTCR positive lymphocytes maturation,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and macrophage differentiation and efferocytosis.<a onclick="showRef(event, 'ref7 ref9 ref19 ref22'); return false;" href="javascript:void(0);" class="ref ref7 ref9 ref19 ref22">(7,9,19,22)</a> GPR18 also regulates cell migration and proliferation in other cell types, mainly endothelial cells,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> but also in tumoral cells,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> HEC-1B endometrial cells,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and human spermatozoa.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">GPR18 is especially relevant during the resolution phase of an inflammatory response. During this phase there is a shift from proinflammatory to anti-inflammatory factors, which in turn induces a proresolution phenotype on macrophages characterized by an increased clearance of the harmful agent and dead polymorphonuclear cells (PMNs). Proresolving lipid mediators, such as the GPR18 endogenous ligand RvD2, are the ones coordinating this shift.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The proresolution role of GPR18 has been shown in an <i>E. coli</i>-induced peritonitis animal model, where a single RvD2 treatment induced macrophage efferocytosis, reduced PMN numbers, and lowered counts of <i>E. coli</i> colonies in a GPR18-dependent manner.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The proresolution profile of GPR18 activation has also been reproduced in a periodontitis model where RvD2 reduced inflammation and cell accumulation while upregulating GPR18 expression.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Moreover, GPR18 was shown to be indispensable for the proresolving effects and increased survival under RvD2 treatment in a mouse model of polymicrobial systemic sepsis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In fact, low GPR18 expression levels on PMNs of septic patients have been shown to correlate with increased severity and poorer prognosis, suggesting that GPR18 expression could be considered as a marker for sepsis outcome.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">GPR18 is also involved in resolution of sterile inflammation, such as ischemia/reperfusion (I/R) injury.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> During I/R injury high levels of reactive oxygen species (ROS) and an exacerbated inflammatory response further extend tissue damage. After cerebral I/R injury producing endogenous RvD2 and GPR18 downregulation, exogenous RvD2 reduced proinflammatory cytokines, decreased edema and infarct area size, and recovered GPR18 levels in neurons and endothelial cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The protective effect of RvD2 treatment was also observed in a model of lung I/R injury, where GPR18-WT mice, but not KO mice, showed lower PMN infiltration and protection from organ reflow injury.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The decrease of proinflammatory cytokine levels by RvD2 was also observed in an animal hind limb ischemia model, where RvD2 enhanced endothelial cell migration and increased arteriogenesis. These effects were reversed by the GPR18 antagonist O-1918 described later in the text.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Interestingly, RvD2 was also able to reverse defective reperfusion in obese mice.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Indeed, metabolic disorders such as obesity or type 2 diabetes causes the adipose tissue to release proinflammatory adipocytokines, generating a systemic chronic low-grade inflammation status which in turn becomes a risk factor for cardiovascular diseases, strokes, or cancer.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This chronic inflammation affects hypothalamic neurons that oversee caloric intake which over time become unresponsive to stimulus. Both RvD2 and its precursor docosahexaenoic acid (DHA) reduced hypothalamic proinflammatory cytokines, caloric intake, and glucose tolerance while upregulating GPR18 expression.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Furthermore, abnormal cannabidiol (Abn-CBD), a full agonist at GPR18, reduced oxidative stress, restored NO and adiponectin levels, and upregulated GPR18 in diabetic rats.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These cardioprotective effects were blocked when coadministrating O-1918. Studies on vasoactive effects of GPR18 have been published.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34">(31−34)</a> The GPR18 agonists NAGly and Abn-CBD showed vasodilation effects on murine retinal arterioles,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as well as hypotensive and antioxidant effects in the murine rostral ventrolateral medulla.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The mechanism behind the decrease in blood pressure appeared to involve the eNOS-NO-cGMP pathway,<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> and it was reversed by O-1918.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34">(31−34)</a> In addition, GPR18 activation by NAGly<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> or (−)-Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> has been shown to lower intraocular pressure in male mice during the day, providing a new potential therapeutic target for glaucoma. It is worth mentioning that Δ<sup>9</sup>-THC exhibits this effect through a combined action at CB<sub>1</sub>R and GPR18.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Chronic inflammation may promote tumor initiation and growth, and vice versa the tumor microenvironment promotes further protumorigenic inflammation while becoming resistant to antitumorigenic actions of the immune system.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, the role that GPR18 might play in cancer is yet unclear. Bioinformatic analysis using The Cancer Genome Atlas (TCGA) and/or Gene Expression Omnibus (GEO) public database has recently shown that GPR18 may be a potential protective factor in hepatocellular carcinoma<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and breast cancer.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In contrast, GPR18 was found to be overexpressed in human melanoma metastases and blockade of GPR18 expression with siRNA enhanced apoptosis.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Another relevant role of GPR18 for cancer patients might be in pain reduction. Treatment with RvD2 reduced mechanical allodynia and hyperalgesia in a xenograft mouse model of oral squamous carcinoma while also reducing proinflammatory cytokines and stimulating macrophage efferocytosis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In fact, both of the GPR18 endogenous ligands, NAGly and RvD2, have been shown to decrease inflammatory hyperalgesia, neuropathic pain, and mechanical allodynia.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a></div><div class="NLM_p">Systemic chronic inflammation can also induce pathological changes in the central nervous system that may lead to the development of neurodegenerative diseases. The defensive function of microglia is central to maintain neuroprotection. However, it may exacerbate neuronal damage during neurodegenerative disorders such as Alzheimer’s disease or multiple sclerosis.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> GPR18 is expressed in BV-2 microglial cells, where nanomolar concentrations of NAGly stimulate cell migration, proliferation, morphology, and cytokine production.<a onclick="showRef(event, 'ref14 ref15 ref44'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref44">(14,15,44)</a> NAGly reduced NMDA-induced excitotoxic damage in organotypic hippocampal cultures in a GPR18-dependent manner.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Confirmatory studies are still required to ascertain the potential role of GPR18 on pathologies affecting the central nervous system.</div><div class="NLM_p last">Additional roles have also been ascribed to GPR18. Activation of GPR18 expressed in the midpiece of human spermatozoa by NAGly promoted the acrosome reaction, a pivotal step toward egg cell fertilization.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Moreover, GPR18 was also found on human endometrial cell cultures, where activation by both NAGly and Δ<sup>9</sup>-THC induced endometrial cell migration,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> a key hallmark in endometriosis.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Molecules Targeting GPR18</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Endogenous Ligands</h3><div class="NLM_p">NAGly is an endogenous signaling lipid with a wide variety of biological activity; however, until recently, GPR18’s mechanism of signaling was poorly understood. By measurement of intracellular Ca<sup>2+</sup> mobilization of a library of 198 lipid compounds using GPR18-expressing L929 cells, NAGly was identified as the first endogenous GPR18 agonist.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> NAGly also induces an increase in intracellular Ca<sup>2+</sup> concentration in GPR18-expressing HEK293 cells<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and a decrease in the accumulation of cAMP in GPR18-CHO cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The fact that these properties are abolished by pretreatment with PTX<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and that NAGly does not have an effect on β-arrestin recruitment<a onclick="showRef(event, 'ref3 ref47'); return false;" href="javascript:void(0);" class="ref ref3 ref47">(3,47)</a> supports the hypothesis that NAGly is a biased-Gα<sub>i/o</sub> coupled GPR18 ligand that signals via G-protein only. NAGly induces another downstream effector of Gα<sub>i/o</sub> coupled receptor, P44/42 MAPK.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> NAGly also mediates microglia migration through a PTX-sensitive pathway in different cell types.<a onclick="showRef(event, 'ref4 ref7 ref14'); return false;" href="javascript:void(0);" class="ref ref4 ref7 ref14">(4,7,14)</a> However, unexpected negative outcomes were obtained for NAGly in SCG neurons, suggesting that NAGly could not activate GPR18 signaling via canonical pathways.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Since activation of G<sub>αi</sub> coupled GPCRs is generally associated with a decrease in calcium current via N-channel modulation, yet an increase in calcium current following exposure to NAGly and AbnCBD was observed, these investigators reported that these ligands did not activate GPR18.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In contrast, Console-Bram et al.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> examined the properties of GPR18 in HEK293 cells that are known to be devoid of N-type voltage gated calcium channels<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and ryanodine receptors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Consequently, any change in calcium mobilization would be a consequence of GPR18 activation, not channel activity. Their findings demonstrated that GPR18 is activated by NAGly resulting in increased calcium mobilization. Finlay et al.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> reported that GPR18 was unresponsive to NAGly in several different cell types (with heterologous and endogenous GPR18 expression); however calcium mobilization was not assessed in any of the lines. Thus, functional discrepancies between readouts indicate the complex pharmacology of GPR18 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). It is interesting to highlight that NAGly has recently been proposed as an endogenous GPR55 modulator.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> GPCR-independent modulation of ion channels and transporters has also been demonstrated by Bondarenko and colleagues.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity at GPR18 of Lipid-like, Natural, or Synthetic Compounds in Reported Pharmacological Assays<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0009.gif" alt="" id="gr100" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">ne: no effect.</p></div></div><div></div></div><div class="NLM_p"><i>N</i>-Arachidonoyl-<span class="smallcaps smallerCapital">l</span>-serine (ARA-S; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), an endocannabinoid-like lipid initially isolated from bovine brain and characterized by very weak activity at CBRs, TRPV-1, and agonism at GPR55,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> was considered the first selective endogenous ligand of GPR18.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Activation of this receptor by ARA-S results in phosphorylation of p44/42MAPK and protein kinase B/Akt in human umbilical vein endothelial cells.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> However, it has also been reported that ARA-S inhibits NAGly-induced directed migration of HEK293-GPR18 cells with the same potency as the putative GPR18 antagonist O-1918.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Inhibition of MAPK activity induced by different GPR18 agonists supports ARA-S as an antagonist.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">As aforementioned, the lipid RvD2 has been proposed as an endogenous ligand of GPR18 based on enhancement of phosphorylation of CREB, ERK1/2, and STAT3 by RvD2 in WT but not in DRV2/GPR18-KO macrophages.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> RvD2 also enhances cAMP levels by a DRV2/GPR18-dependent mechanism.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Despite evidence for RvD2 to bind recombinant-GPR18 using a radiolabeled-RvD binding assay,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> RvD2 as a GPR18 ligand has not been deeply explored probably in part due to stability issues.</div><div class="NLM_p last">Considering GPR55 and GPR18 promiscuity, in general terms, it is worthy to note here that the GPR55 endogenous ligand LPI does not significantly recruit β-arrestin at GPR18.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> To the best of our knowledge, LPI GPR18 activity through other signaling pathways has not been yet reported.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cannabinoid-Related GPR18 Ligands</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Endocannabinoid-Related GPR18 Ligands</h4><div class="NLM_p last">Investigations have raised the prospect that AEA (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) biological activities are in part via non-CB<sub>1</sub>R and non-CB<sub>2</sub>R mechanisms, among them GPR18.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Metabolic studies support evidence that AEA metabolizes into NAGly; thus non-CBR effects of AEA could be due to the action of NAGly at GPR18.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> So far, signaling of AEA and other endocannabinoids at GPR18 has been poorly studied. The agonist profile of AEA and 2-AG (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has been proposed on the basis of their capacity to elicit microglial migration albeit with less potency than NAGly.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> AEA and its synthetic analogs arachidonylcyclopropylamide (ACPA; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and R1-methanandamide (R1-methAEA; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) induce P44/42 MAPK phosphorylation,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> but AEA did not have any significant effect on β-arrestin recruitment, suggesting possible signaling bias at GPR18.<a onclick="showRef(event, 'ref3 ref47'); return false;" href="javascript:void(0);" class="ref ref3 ref47">(3,47)</a></div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Phytocannabinoid-Related GPR18 Ligands</h4><div class="NLM_p">Cannabinoids Δ<sup>9</sup>-THC, Abn-CBD, and CBD (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) have been assessed for biological activity at GPR18 as outlined in this review. However, their signaling at GPR18 has been poorly characterized pharmacologically. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, evidence supports Δ<sup>9</sup>-THC as agonist with significant potency in Ca<sup>2+</sup> mobilization,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> β-arrestin recruitment,<a onclick="showRef(event, 'ref3 ref58'); return false;" href="javascript:void(0);" class="ref ref3 ref58">(3,58)</a> and P44/42 MAPK<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and ERK1/2<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> phosphorylation assays. CBD displays low efficacy as an agonist in β-arrestin recruitment,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> whereas it efficiently antagonizes the effects of NAGly and Δ<sup>9</sup>-THC on microglia migration and morphology and cytokine signaling plasticity in BV-2 microglia.<a onclick="showRef(event, 'ref4 ref14 ref44'); return false;" href="javascript:void(0);" class="ref ref4 ref14 ref44">(4,14,44)</a> This agonist/antagonist functionality difference has been suggested to depend on receptor expression-levels.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The regioisomer of CBD, Abn-CBD, played a major role in the discovery of GPR18 that was first called Abn-CBD sensitive endothelial receptor.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Abn-CBD is described as full agonist at GPR18 in several pharmacological assays.<a onclick="showRef(event, 'ref3 ref4 ref14'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref14">(3,4,14)</a> A negative β-arrestin recruitment outcome<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> could suggest a possible G-protein biased-agonism.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of cannabinoid-related compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">O-1602 and O-1918 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) are two synthetic analogs of CBD and Abn-CBD, respectively. Lacking activity at CB<sub>1</sub>R and CB<sub>2</sub>R, both are used as pharmacological tools for GPR55 and GPR18 activity.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> There is evidence that O-1602 has significant agonist effects at GPR18.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> O-1602 induces receptor trafficking through GPR18 by stimulating Ca<sup>2+</sup> influx and by inducing MAPK (p44/42;<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> ERK1/2<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>) phosphorylation, both in HEK293 cells (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Bias functionality has been suggested due to its inability to recruit β-arrestin in a CHO-K1 GPR18 cell line.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Interestingly, O-1602 drives cellular migration in BV-2 microglia with the same potency as NAGly.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The Abn-CBD analog O-1918 has been used in different biological assays as a GPR18 antagonist, as previously commented in the biological relevance of GPR18 section. It has also been shown to attenuate NAGly-, Abn-CBD-, and O-1602-induced migration in BV-2 or HEK293-GPR18 cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, O-1918 showed similar agonist properties to O-1602 in ERK1/2 phosphorylation and Ca<sup>2+</sup> assays with a lack of activity in β-arrestin recruitment assays.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Activity differences between assays highlight the need of further characterize the pharmacology of this putative antagonist <i>in vitro</i> and <i>in vivo</i>. GPR18 knockdown assays may clarify the functionality of this antagonist.</div><div class="NLM_p">Amauromine (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) has a natural origin but does not come from <i>Cannabis sativa</i>. This alkaloid extracted from the marine sponge-derived fungus <i>Auxarthron reticulatum</i> is known for its vasodilating and antibiotic properties. Recently, it has been described as a potent GPR18 antagonist and CB<sub>1</sub>R antagonist without effect on GPR55.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> 27-<i>O</i>-Methylasporyzin C, another natural product, is the first reported selective GPR18 ligand of fungal origin that significantly inhibits LPI-mediated β-arrestin recruitment.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of the natural products amauromine and 27-<i>O</i>-methylasporyzin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Synthetic Cannabinoid-Related GPR18 Ligands</h4><div class="NLM_p">Despite being a large family of structurally diverse compounds capable of exerting a broad range of pharmacologic effects, only standard synthetic cannabinoids have been tested and reported as GPR18 ligands. In β-arrestin recruitment assays, CP 55,940 and SR141716 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) showed the same weak antagonistic properties at GPR18, while they differed in their cannabinoid and GPR55 activity (CP 55,940, CB<sub>1</sub>R/CB<sub>2</sub>R agonist and GPR55 antagonist; SR141716, CB<sub>1</sub>R antagonist and GPR55 agonist).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> WIN55212-2, CP55,940, SR144528, SR141716, JWH-133, and JWH-015 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) have no effect on MAPK phosphorylation assays performed in HEK293 cells overexpressing GPR18, whereas AM251 is able to antagonize NAGly and Δ<sup>9</sup>-THC.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Efforts have been devoted to the pharmacology of endogenous compounds and structurally related cannabinoids that raise issues in terms of selectivity vs GPR55, CB<sub>1</sub>R, and CB<sub>2</sub>R. The Venn diagram shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> illustrates the selectivity profile among cannabinoid related GPCRs of compounds tested at GPR18. <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> summarizes reported functionality of these compounds at GPR18.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Venn diagram classification of compounds tested at GPR18 regarding their activity at the related GPCRs CB<sub>1</sub>R, CB<sub>2</sub>R, GPR55, and GPR18. Compounds <b>S4</b>, <b>S5</b>, and <b>S9</b> are not included in the diagram since their activity at these other receptors has not been reported yet.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Non-CBR Related GPR18 Compounds</h3><div class="NLM_p">Very few studies focused on the discovery of selective synthetic GPR18 ligands. The only synthetic non-cannabinoid GPR18 ligands reported so far are based on imidazothiazinone and coumarin scaffolds.<a onclick="showRef(event, 'ref56 ref58 ref62'); return false;" href="javascript:void(0);" class="ref ref56 ref58 ref62">(56,58,62)</a> The first coumarins acting on GPR18 were discovered among a series of chromen-4-one-2-carboxylic acids designed as GPR55 ligands.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> By use of β-arrestin recruitment assays on CHO cells stably expressing GPR18, some of these GPR55 ligands antagonized the effects of Δ<sup>9</sup>-THC at GPR18. The most potent compound of this series at GPR18 is PSB-18337 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). This compound exhibits very high potency but low efficacy at GPR55.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Screening a compound library focusing on lipophilic structures, Müller and co-workers<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> identified imidazothiazinone as a GPR18 scaffold using β-arrestin recruitment assays. Further systematic structural modification on this scaffold led to PSB-CB5<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and PSB-CB27<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). PSB-CB5 was identified as the first potent GPR18 antagonist with good selectivity vs related GPCRs (over 36-fold selective vs GPR55 and CB<sub>1</sub>R and 14-fold vs CB<sub>2</sub>R).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Subsequent optimization efforts led these authors to identify PSB-CB27, which displays improved blockade of THC-induced GPR18 activation and increased selectivity.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of selected synthetic GPR18 ligands.<a onclick="showRef(event, 'ref56 ref58 ref62'); return false;" href="javascript:void(0);" class="ref ref56 ref58 ref62">(56,58,62)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Very recently, a series of pyrazolylbenzene-1,3-diols have been disclosed in a patent.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Two regioisomers <b>S4</b> and <b>S5</b> present different pharmacological profiles (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). <b>S5</b> acts as a GPR18 agonist in intracellular Ca<sup>2+</sup> measurements and β-arrestin recruitment assays, whereas <b>S4</b> antagonizes the effect of NAGly in Ca<sup>2+</sup> assays and behaves as an inverse agonist in β-arrestin pathway.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> From this series, <b>S9</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), an inverse agonist at β-arrestin recruitment and partial agonist at Ca<sup>2+</sup> assay, also displays antagonism in TPRV1-expressing cells.</div><div class="NLM_p last">Moreover, a just released article describes the identification of a family of tricyclic xanthines that activate GPR18 in β-arrestin recruitment assays.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> PSB-KD107 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), one of the most potent and efficacious agonists of this series, shows full selectivity vs GPR55, CB<sub>1</sub>R, and CB<sub>2</sub>R.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Structural Highlights from Molecular Modeling</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Even though in the past 5 years the amount of protein structures solved through NMR, crystallographic, and cryo-EM studies has grown exponentially, very little is still known about orphan class A GPCRs. The lack of structural knowledge on GPR18 led us to recently develop a human GPR18 homology model based on the δ opioid receptor (DOR, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N6H">4N6H</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The high resolution crystal of the inactive state DOR was used as a template not only because of its relatively high sequence homology (26%) but also because of its similarities at key structural features including crucial cysteines in the extracellular loop 2 (EC-2 loop) and transmembrane helix 3 (TMH3) C3.25 that form a disulfide bridge, or the conserved proline at position 2.58 (the Ballesteros and Weinstein numbering system<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> has been used throughout this article). GPR18 shares key conserved residues or motifs not only with the DOR but also with GPR55, whereas the CBRs differ from them resulting in significant structural divergences (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> shows the sequence alignment of human GPR18 with the DOR and the cannabinoid related receptors CB<sub>1</sub>R, CB<sub>2</sub>R, and GPR55).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Human sequence alignments of GPR18, DOR, GPR55, CB<sub>1</sub>R, and CB<sub>2</sub>R: (A) transmembrane helix 1 (TMH1), (B) TMH2, (C) TMH3, (D) TMH4, (E) EC2 loop, (F) TMH5, (G) TMH6, and (H) TMH7. Color code: red, prolines; yellow, highly conserved residues across class A GPCRs; magenta, cysteines in an internal disulfide bridge; blue, cysteines in TMH3 to EC2 disulfide bridge; lavender, GW motif.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the sequence similarities, specific residue differences between GPR18 and DOR (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) were identified and studied due to their potential to dictate conformational deviations from the initial template. These include the presence of a proline at position 3.36 in the GPR18 sequence (absent in the DOR) and a significant change in the NPXXY motif in TMH7 (DVILY in GPR18, vs NPXXY in DOR). This motif displays two striking features that characterize GPR18: it lacks the highly conserved proline at 7.50, and it has a D7.49 instead of an N7.49, which may have a significant effect on the sodium binding pocket in GPR18.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> These differences have the ability to impact the overall bundle, and therefore, they were explored using the Conformational Memories program.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a><a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A shows the GPR18 inactive state bundle obtained upon conformational examination and subsequent minimization of the receptor.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. GPR18 inactive state model: (A) lipid view of the bundle; (B) zoomed in view of the toggle switch residues M7.42 and F6.48; (C) zoomed in view of the “ionic lock” formed by R3.50 and S6.33. This figure has been done for this review using our previously reported model.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As widely demonstrated among class A GPCRs, G protein activation is characterized by two main conformational rearrangements: at the “ionic lock” and the toggle switch.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a> The “ionic lock” consists of a strong interaction formed by residues at the intracellular (IC) end of TMH3 and TMH6 (typically a salt bridge between R3.50 and D/E6.30) that hold the receptor in its inactive state. Breakage of this interaction generates an opening that enables Gα coupling. GPR18 lacks a negatively charged residue at the end of TMH6 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>); consequently, this “ionic lock” is formed by a hydrogen bond between S6.33 and R3.50 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). MD simulations with our homology models suggest that GPR18 constitutive activity could be due to the weakness of this “ionic lock”.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div><div class="NLM_p">The so-called toggle switch refers to binding pocket residues that change their conformational state upon receptor activation. Generally, in the inactive state, W6.48 is held in its χ1 = g+ conformation by another binding pocket residue transitioning to χ1 = trans when an agonist binds. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B, F6.48 and M7.42 form the GPR18 toggle switch.</div><div class="NLM_p">Given the therapeutic interest in GPR18, other groups have also recently reported GPR18 homology models.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> Neumann et al.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> averaged the inactive and active template coordinates in their method using Modeller, while Kuder and co-workers<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> discarded the chosen active state template and only included the inactive template. None of these models address activation structural features or the development of active state bundles.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Binding Pocket</h3><div class="NLM_p">GPR18 contains diverse positively charged amino acids that face the binding crevice and could therefore be crucial spots for ligand docking. These residues include arginines R2.60 and R5.42 (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), which could establish strong interactions with orthosteric GPR18 modulators. Phenylalanines at positions 6.55 and 6.51, as well as residues Y2.64 and N5.39, are also accessible for ligand binding and could be crucial interaction sites for specific chemotypes (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Specific residues in the EC-2 loop, including K(161), K(174), or Y(180), can point toward the binding crevice and may also be critical at stabilizing ligands at the GPR18 orthosteric site. Nonetheless, direct site mutagenesis is required to determine the structural relevance of these residues for agonist and antagonist binding.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. GPR18 binding pocket (EC view, loops have been removed for clarity). Potential interacting residues are displayed in green tubes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Reported docking studies with the imidazothiazinone antagonist PSB-CB5 and phytocannabinoid GPR18 agonists CBD and THC suggest similar interacting sites to what we have observed in our model.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70,71)</a> However, discrepancies in binding site interactions have been found between these two reports. While Kuder et al.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> propose that PSB-CB5 directly interacts with arginines R2.60 and R5.42, according to Neumann and co-workers,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> this imidazothiazinone is mainly stabilized by interactions with K(161), Y2.64, and C6.54. Similarly, the first article proposes both arginines as H-bonding residues with the hydroxyl groups of CBD, whereas in the second report proposes THC complexes with GPR18 engaging with R5.42, K(161) and N5.39.</div><div class="NLM_p last">This structural knowledge may help in understanding this orphan GPCR and guide future drug design of compounds with tailored activities at GPR18.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To date, the therapeutic potential of GPR18 has been demonstrated through <i>in vitro</i> and animal model studies. Due to the lack of selective modulators and its challenging biological validation, little research has been translated into humans. So far, the role of GPR18 in human pathophysiology has only been explored from a predictive standpoint, where this GPCR could be used as a biomarker in patients with sepsis,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> several cancer types,<a onclick="showRef(event, 'ref38 ref39 ref72'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref72">(38,39,72)</a> and sarcoidosis.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">Due to its relationship with the ECS, the interest of this target has exponentially increased in the past years. A wide range of cannabinoids have been tested at this receptor, and even though some of them present intriguing functional profiles, their activity at GPR18 has been proved to mediate some of their therapeutic effects. The putative GPR18 endogenous signaling lipids NAGly and RvD2 produce also a wide variety of biological activity whose signaling at GPR18 is still poorly understood.</div><div class="NLM_p">As previously indicated, GPR18 shares sequence commonalities with GPR55 at crucial positions while clearly diverging from the cannabinoid receptors at specific structural features. Similarities between these two ECS-related orphan receptors are also demonstrated by their ability to recognize similar ligands that do not bind at CB<sub>1</sub>R or CB<sub>2</sub>R as illustrated in the Venn diagram (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). However, some endocannabinoids and phytocannabinoids are able to target these four lipidic GPCRs probably due to their hydrophobic nature.</div><div class="NLM_p last">Crystal and cryo-EM structures of CB<sub>1</sub>R<a onclick="showRef(event, 'ref74 ref75 ref76 ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref74 ref75 ref76 ref77 ref78 ref79">(74−79)</a> and CB<sub>2</sub>R<a onclick="showRef(event, 'ref74 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref74 ref80 ref81">(74,80,81)</a> in their active and inactive states have been recently reported shedding light on cannabinoid pharmacology. Nevertheless, as aforementioned, due to their low sequence homology, these structures do not serve as a basis to understand GPR18. In this context, our recently reported GPR18 homology model provides insights into the activation mechanism of this orphan GPCR.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Identification of key binding site residues may guide future design of selective GPR18 compounds to fully unravel this promising GPCR. Selective GPR18 ligands are yet emerging, and their pharmacology at this complex receptor is not still fully unraveled. Due to the intricate signaling responses of GPR18, characterization at different pathways is needed. In fact, identification of potential GPR18 G-protein biased agonists could be useful for the treatment of GPR18-related chronic diseases such as diabetes and autoimmune or neurodegenerative disorders with reduced tolerance as already shown for other GPCRs such as opioids.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00926" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66238" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66238" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia H. Reggio</span> - <span class="hlFld-Affiliation affiliation">Chemistry
and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, North Carolina 27412, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f0809882959797999fb0859e9397de959485"><span class="__cf_email__" data-cfemail="21514953444646484e61544f42460f444554">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary E. Abood</span> - <span class="hlFld-Affiliation affiliation">Center
for Substance Abuse Research, Lewis Katz
School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, Pennsylvania 19140, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1744-2820" title="Orcid link">http://orcid.org/0000-0002-1744-2820</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b6dbd7c4cf98d7d4d9d9d2f6c2d3dbc6dad398d3d2c3"><span class="__cf_email__" data-cfemail="dcb1bdaea5f2bdbeb3b3b89ca8b9b1acb0b9f2b9b8a9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nadine Jagerovic</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, CSIC, Calle Juan de la Cierva, 3, 28006 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2642-6969" title="Orcid link">http://orcid.org/0000-0003-2642-6969</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f111e1b16111a3f160e12511c0c161c511a0c"><span class="__cf_email__" data-cfemail="4f212e2b26212a0f263e22612c3c262c612a3c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paula Morales</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, CSIC, Calle Juan de la Cierva, 3, 28006 Madrid, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6209-8600" title="Orcid link">http://orcid.org/0000-0002-6209-8600</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Lago-Fernandez</span> - <span class="hlFld-Affiliation affiliation">Instituto
de Química Médica, CSIC, Calle Juan de la Cierva, 3, 28006 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dow P. Hurst</span> - <span class="hlFld-Affiliation affiliation">Chemistry
and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, North Carolina 27412, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noori Sotudeh</span> - <span class="hlFld-Affiliation affiliation">Chemistry
and Biochemistry Department, UNC Greensboro, 1400 Spring Garden Street, Greensboro, North Carolina 27412, United States</span>; 
    <span>Present Address:
                        N.S.: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugen Brailoiu</span> - <span class="hlFld-Affiliation affiliation">Center
for Substance Abuse Research, Lewis Katz
School of Medicine at Temple University, 3500 N. Broad Street, Philadelphia, Pennsylvania 19140, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Paula Morales</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1416-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Paula Morales</b> obtained her Ph.D. in Medicinal Chemistry in 2015 from the Autonomous University of Madrid upon completion of her thesis project on the development of novel cannabinoid ligands at the Instituto de Química Médica (IQM-CSIC). After that, she moved to a postdoctoral position on computational chemistry at the University of North Carolina at Greensboro (2016–2018) and then to the protein NMR group at the Instituto de Química Física Rocasolano (2018–2019). She is currently a postdoctoral fellow at IQM-CSIC, and her research interests include the identification of novel molecules targeting orphan receptors involved in the endocannabinoid system.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Ana Lago-Fernandez</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1421-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ana Lago-Fernandez</b> obtained her Bachelor’s degree in Biochemistry and Molecular Biology in 2015 from the University Rovira i Virgili (Spain) and her Master’s degree in Mental Health Research in 2019 from the University of Cádiz (Spain). Her M.A. thesis explored GPCR activity and biased signaling. Currently, she is a first-year Ph.D. student at the Instituto de Química Médica (IQM-CSIC), where she is developing novel ligands for cannabinoid-related receptors through a multidisciplinary approach.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Dow P. Hurst</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1426-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dow P. Hurst</b> is Senior Research Scientist in the research group of Dr. Patricia Reggio at UNC Greensboro. He received his B.S. degree in Chemistry from Kennesaw State University in 1996. He has been part of the Reggio group for 20 years. To date, he has coauthored 45 peer-reviewed papers in top-tier international journals. His first author paper on the lipid pathway for ligand binding in the cannabinoid CB2 receptor (PMID 20220143) identified the TMH6-TMH7 portal for the CB2 endogenous ligand 2-AGenters CB2. This paper was a Faculty of 1000 Medicine Selection and has been highly cited in subsequent X-ray crystal structure papers of lipid type receptors (e.g., S1P1 receptor) in which such lipid portals are clearly visible.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Noori Sotudeh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1431-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Noori Sotudeh</b> obtained his Ph.D. from the University of North Carolina at Greensboro where he focused on the construction and validation of the GPR18 in silico model. He continued modeling GPCRs as a postdoctoral associate in Dr. Auerbach’s lab, University at Buffalo, and succeeded in developing a model for muscarinic receptors and performed simulations against electrophysiology experimental data. Currently, he is working as Research Fellow in Dana Farber Cancer Institute in Boston to help advance understanding of precision cancer medicine, drug resistance, and immunotherapy.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Eugen Brailoiu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1436-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Eugen Brailoiu</b> obtained his MD at the University of Medicine and Pharmacy, Iasi (Romania), in 1990 and subsequently was awarded a faculty position there. In 1998, he did postdoctoral studies at East Tennessee State University (U.S.) and remained there as an Assistant Professor until 2003, when he joined Temple University (U.S.). He is currently an Associate Professor in the Center for Substance Abuse Research. He has made ground-breaking discoveries in cell signaling, by characterizing and identifying new Ca<sup>2+</sup> mobilizing second messengers.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Patricia H. Reggio</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1444-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Patricia H. Reggio</b>, Ph.D., is Marie Foscue Rourk Professor of Chemistry and Biochemistry at the University of North Carolina, Greensboro, NC (2004 to present). Dr. Reggio has focused her entire research career on the cannabinoids and the receptors through which cannabinoids signal. This includes the class A G-protein coupled receptors (GPCRs), the cannabinoid CB1 and CB2 receptors; orphan class A GPCRs, such as GPR18, GPR55, GPR3, GPR6, and GPR12; and the ionotropic cannabinoid receptor, the TRP-V1 channel. Dr. Reggio was the recipient of the 2010 Mechoulam Award from the International Cannabinoid Research Society for outstanding contributions to the cannabinoid field. Her work on the cannabinoids has been funded by the National Institutes of Health for over 30 years.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Mary E. Abood</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1449-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mary E. Abood</b> completed her Ph.D. degree at the University of California, San Francisco (U.S.), in 1986. She did postdoctoral studies at Stanford University (U.S.). In 1990, she joined Virginia Commonwealth University as an Assistant Professor in Pharmacology and Toxicology and was tenured in 1996. In 1999, she joined California Pacific Medical Center Research Institute (U.S.) and continued her research program there until 2008, when she moved to Temple University (U.S.). She is currently a Professor in the Center for Substance Abuse Research and Department of Anatomy and Cell Biology. She has studied cannabinoid receptors and related GPCRs since 1991 and was honored to receive the Mechoulam Award for Outstanding Contributions to Cannabinoid Research by the International Cannabinoid Research Society in 2015.</p></figure></div><div class="bio" rid="ath8"><figure id="ath8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Nadine Jagerovic</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=BIO-d7e1454-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nadine Jagerovic</b> completed her Ph.D. degree at the University of Burgundy (France) in 1990 before carrying out a postdoctoral position at the University of California Davis (U.S.). In 1993, she joined the Medicinal Chemistry Institute (Madrid, Spain), with a Marie Curie Fellowship in the program “Human Capital and Mobility”, where she was later appointed to a permanent position in 1999. Over the past 15 years, her scientific interests are focused on the discovery of modulators of G-protein-coupled receptors related to the endocannabinoid system.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">P.M., A.L.-F., and N.J. are supported by the Ministry of Science, Innovation, and Universities, Spain (MCIU)/FEDER Grant RTI2018-095544-B-I00, and the Spanish National Research Council (CSIC) Grant PIE-201580E033. M.E.A., P.H.R., and N.J. are supported by National Institutes of Health Grant R01 DA0455698-01. P.M. acknowledges the Comunidad de Madrid (CM) program “Atraccion de Talento” Grant 2018-T2/BMD-10819.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Abn-CBD</td><td class="NLM_def"><p class="first last">abnormal cannabidiol</p></td></tr><tr><td class="NLM_term">ACPA</td><td class="NLM_def"><p class="first last">arachidonylcyclopropylamide</p></td></tr><tr><td class="NLM_term">AEA</td><td class="NLM_def"><p class="first last">anandamide</p></td></tr><tr><td class="NLM_term">CBR</td><td class="NLM_def"><p class="first last">cannabinoid receptor</p></td></tr><tr><td class="NLM_term">ARA-S</td><td class="NLM_def"><p class="first last"><i>N</i>-arachidonoyl-<span class="smallcaps smallerCapital">l</span>-serine</p></td></tr><tr><td class="NLM_term">CB1R</td><td class="NLM_def"><p class="first last">CB<sub>1</sub> cannabinoid receptor</p></td></tr><tr><td class="NLM_term">CB2R</td><td class="NLM_def"><p class="first last">CB<sub>2</sub> cannabinoid receptor</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CBD</td><td class="NLM_def"><p class="first last">cannabidiol</p></td></tr><tr><td class="NLM_term">DOR</td><td class="NLM_def"><p class="first last">δ-opioid receptor</p></td></tr><tr><td class="NLM_term">EC-2 loop</td><td class="NLM_def"><p class="first last">extracellular-2 loop</p></td></tr><tr><td class="NLM_term">ECS</td><td class="NLM_def"><p class="first last">endocannabinoid system</p></td></tr><tr><td class="NLM_term"><i>E. coli</i></td><td class="NLM_def"><p class="first last"><i>Escherichia coli</i></p></td></tr><tr><td class="NLM_term">cryo-EM</td><td class="NLM_def"><p class="first last">cryogenic electron microscopy</p></td></tr><tr><td class="NLM_term">ERK1/2</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinases 1 and 2</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">I/R</td><td class="NLM_def"><p class="first last">ischemia/reperfusion</p></td></tr><tr><td class="NLM_term">KO mice</td><td class="NLM_def"><p class="first last">knockout mice</p></td></tr><tr><td class="NLM_term">LPI</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-α-lysophosphatidylinositol</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">NAGly</td><td class="NLM_def"><p class="first last"><i>N</i>-arachidonoylglycine</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">PTX</td><td class="NLM_def"><p class="first last">pertussis toxin:RvD2, resolvin D2</p></td></tr><tr><td class="NLM_term">SCG</td><td class="NLM_def"><p class="first last">superior cervical ganglion</p></td></tr><tr><td class="NLM_term">Δ<sup>9</sup>-THC</td><td class="NLM_def"><p class="first last">(−)-Δ<sup>9</sup>-tetrahydrocannabinol</p></td></tr><tr><td class="NLM_term">TMH</td><td class="NLM_def"><p class="first last">transmembrane helix</p></td></tr><tr><td class="NLM_term">TRPV</td><td class="NLM_def"><p class="first last">transient receptor potential cation channel</p></td></tr><tr><td class="NLM_term">WT mice</td><td class="NLM_def"><p class="first last">wild-type mice</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 82 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gantz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelson, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">Cloning and Chromosomal Localization of a Gene (GPR18) Encoding a Novel Seven Transmembrane Receptor Highly Expressed in Spleen and Testis</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1006/geno.1997.4752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1006%2Fgeno.1997.4752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=9205118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADyaK2sXktFOnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1997&pages=462-466&issue=3&author=I.+Gantzauthor=A.+Muraokaauthor=Y.+K.+Yangauthor=L.+C.+Samuelsonauthor=E.+M.+Zimmermanauthor=H.+Cookauthor=T.+Yamada&title=Cloning+and+Chromosomal+Localization+of+a+Gene+%28GPR18%29+Encoding+a+Novel+Seven+Transmembrane+Receptor+Highly+Expressed+in+Spleen+and+Testis&doi=10.1006%2Fgeno.1997.4752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis</span></div><div class="casAuthors">Gantz, Ira; Muraoka, Akira; Yang, Ying-Kui; Samuelson, Linda C.; Zimmerman, Ellen M.; Cook, Helen; Yamada, Tadataka</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">462-466</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Using the techniques of relaxed stringency polymerase chain reaction and genomic library screening, we have isolated homologous canine and human genes that encode a novel putative seven transmembrane G-protein-linked receptor.  The gene encodes an open reading frame (ORF) of 993 bp.  The sequences of the canine and human ORFs are highly conserved, sharing 89% nucleotide identity and 92% amino acid similarity between the two species.  Northern blot anal. demonstrates that mRNA transcripts of the gene are abundantly expressed in testis and spleen with a lesser degree of expression obsd. in several other tissues assocd. with endocrine and immunol./hematol. function.  The gene, designated GPR18, was localized to human chromosome 13q32 using fluorescence in situ hybridization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrUiWzbYa5XLVg90H21EOLACvtfcHk0lg5M16vDmHsLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFOnu7w%253D&md5=7dfbf29ab1bdd930ab59abe808be9d38</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1997.4752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1997.4752%26sid%3Dliteratum%253Aachs%26aulast%3DGantz%26aufirst%3DI.%26aulast%3DMuraoka%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DY.%2BK.%26aulast%3DSamuelson%26aufirst%3DL.%2BC.%26aulast%3DZimmerman%26aufirst%3DE.%2BM.%26aulast%3DCook%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DCloning%2520and%2520Chromosomal%2520Localization%2520of%2520a%2520Gene%2520%2528GPR18%2529%2520Encoding%2520a%2520Novel%2520Seven%2520Transmembrane%2520Receptor%2520Highly%2520Expressed%2520in%2520Spleen%2520and%2520Testis%26jtitle%3DGenomics%26date%3D1997%26volume%3D42%26issue%3D3%26spage%3D462%26epage%3D466%26doi%3D10.1006%2Fgeno.1997.4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elphick, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. A.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1124%2Fpr.110.003004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=21079038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktler" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=588-631&issue=4&author=R.+G.+Pertweeauthor=A.+C.+Howlettauthor=M.+E.+Aboodauthor=S.+P.+H.+Alexanderauthor=V.+Di+Marzoauthor=M.+R.+Elphickauthor=P.+J.+Greasleyauthor=H.+S.+Hansenauthor=G.+Kunosauthor=K.+Mackieauthor=R.+Mechoulamauthor=R.+A.+Ross&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXIX.+Cannabinoid+Receptors+and+Their+Ligands%3A+Beyond+CB1+and+CB2&doi=10.1124%2Fpr.110.003004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2</span></div><div class="casAuthors">Pertwee, R. G.; Howlett, A. C.; Abood, M. E.; Alexander, S. P. H.; di Marzo, V.; Elphick, M. R.; Greasley, P. J.; Hansen, H. S.; Kunos, G.; Mackie, K.; Mechoulam, R.; Ross, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">588-631</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  There are at least two types of cannabinoid receptors (CB1 and CB2).  Ligands activating these G protein-coupled receptors (GPCRs) include the phytocannabinoid Δ9-tetrahydrocannabinol, numerous synthetic compds., and endogenous compds. known as endocannabinoids.  Cannabinoid receptor antagonists have also been developed.  Some of these ligands activate or block one type of cannabinoid receptor more potently than the other type.  This review summarizes current data indicating the extent to which cannabinoid receptor ligands undergo orthosteric or allosteric interactions with non-CB1, non-CB2 established GPCRs, deorphanized receptors such as GPR55, ligand-gated ion channels, transient receptor potential (TRP) channels, and other ion channels or peroxisome proliferator-activated nuclear receptors.  From these data, it is clear that some ligands that interact similarly with CB1 and/or CB2 receptors are likely to display significantly different pharmacol. profiles.  The review also lists some criteria that any novel "CB3" cannabinoid receptor or channel should fulfil and concludes that these criteria are not currently met by any non-CB1, non-CB2 pharmacol. receptor or channel.  However, it does identify certain pharmacol. targets that should be investigated further as potential CB3 receptors or channels.  These include TRP vanilloid 1, which possibly functions as an ionotropic cannabinoid receptor under physiol. and/or pathol. conditions, and some deorphanized GPCRs.  Also discussed are (1) the ability of CB1 receptors to form heteromeric complexes with certain other GPCRs, (2) phylogenetic relationships that exist between CB1/CB2 receptors and other GPCRs, (3) evidence for the existence of several as-yet-uncharacterized non-CB1, non-CB2 cannabinoid receptors; and (4) current cannabinoid receptor nomenclature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEKWR8v5x6rVg90H21EOLACvtfcHk0lg5M16vDmHsLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktler&md5=d0d2bf8e13bcf82ab67b34a61a82668e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003004%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DHowlett%26aufirst%3DA.%2BC.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DAlexander%26aufirst%3DS.%2BP.%2BH.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DElphick%26aufirst%3DM.%2BR.%26aulast%3DGreasley%26aufirst%3DP.%2BJ.%26aulast%3DHansen%26aufirst%3DH.%2BS.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXIX.%2520Cannabinoid%2520Receptors%2520and%2520Their%2520Ligands%253A%2520Beyond%2520CB1%2520and%2520CB2%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26issue%3D4%26spage%3D588%26epage%3D631%26doi%3D10.1124%2Fpr.110.003004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Console-Bram, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brailoiu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brailoiu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span> <span> </span><span class="NLM_article-title">Activation of GPR18 by Cannabinoid Compounds: A Tale of Biased Agonism</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3908</span>– <span class="NLM_lpage">3917</span>, <span class="refDoi"> DOI: 10.1111/bph.12746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fbph.12746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24762058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1WmsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3908-3917&issue=16&author=L.+Console-Bramauthor=E.+Brailoiuauthor=G.+C.+Brailoiuauthor=H.+Sharirauthor=M.+E.+Abood&title=Activation+of+GPR18+by+Cannabinoid+Compounds%3A+A+Tale+of+Biased+Agonism&doi=10.1111%2Fbph.12746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of GPR18 by cannabinoid compounds: a tale of biased agonism</span></div><div class="casAuthors">Console-Bram, Linda; Brailoiu, Eugen; Brailoiu, Gabriela Cristina; Sharir, Haleli; Abood, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3908-3917</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : GPR18 is a candidate cannabinoid receptor, but its classification as such is controversial.  The rationale of the study presented herein was to consider the effects of N-arachidonoyl glycine (NAGly) and cannabinoids via differential G-protein coupled pathways, in addn. to β-arrestin signalling.  Cellular localization of GPR18 receptors was also examd.  Exptl. Approach : Calcium mobilization and ERK1/2 phosphorylation were quantified in a cell line stably expressing GPR18 (HEK293/GPR18 cells).  In addn., using the DiscoveRx PathHunter CHO-K1 GPR18 β-arrestin cell line, recruitment of β-arrestin was quantified.  Key Results : Concn.-dependent increases in intracellular calcium and ERK1/2 phosphorylation were obsd. in the presence of NAGly, abnormal cannabidiol (AbnCBD), O-1602, O-1918 and Δ9-tetrahydrocannabinol (Δ9-THC) in HEK293/GPR18 cells.  The initial rise in intracellular calcium in the presence of NAGly, O1918 and THC was blocked by either Gαq or Gαi/o inhibition.  The ERK1/2 phosphorylation was inhibited by Pertussis toxin and N-arachidonoyl-L-serine (NARAS).  Recruitment of β-arrestin in the PathHunter CHO-K1 GPR18 cell line revealed a differential pattern of GPR18 activation; of all the ligands tested, only Δ9-THC produced a concn.-dependent response.  The localization of GPR18 receptors within the HEK293/GPR18 cells is both intracellular, and on the plasma membrane.  Conclusions and Implications : These findings suggest that GPR18 activation involves several signal transduction pathways indicative of biased agonism, thereby providing a plausible explanation for the apparent discrepancies in GPR18 activation found in the literature.  Addnl., the results presented herein provide further evidence for GPR18 as a candidate cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEqZFY8uPyNLVg90H21EOLACvtfcHk0lgEGq29l_6usg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1WmsrjN&md5=4685930ff193dd4c44fea180be190dcb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12746%26sid%3Dliteratum%253Aachs%26aulast%3DConsole-Bram%26aufirst%3DL.%26aulast%3DBrailoiu%26aufirst%3DE.%26aulast%3DBrailoiu%26aufirst%3DG.%2BC.%26aulast%3DSharir%26aufirst%3DH.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DActivation%2520of%2520GPR18%2520by%2520Cannabinoid%2520Compounds%253A%2520A%2520Tale%2520of%2520Biased%2520Agonism%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D16%26spage%3D3908%26epage%3D3917%26doi%3D10.1111%2Fbph.12746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">Δ9-Tetrahydrocannabinol and N-Arachidonyl Glycine Are Full Agonists at GPR18 Receptors and Induce Migration in Human Endometrial HEC-1B Cells</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2414</span>– <span class="NLM_lpage">2424</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01497.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1476-5381.2011.01497.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=21595653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVajsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=2414-2424&issue=8&author=D.+McHughauthor=J.+Pageauthor=E.+Dunnauthor=H.+B.+Bradshaw&title=%CE%949-Tetrahydrocannabinol+and+N-Arachidonyl+Glycine+Are+Full+Agonists+at+GPR18+Receptors+and+Induce+Migration+in+Human+Endometrial+HEC-1B+Cells&doi=10.1111%2Fj.1476-5381.2011.01497.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Δ9-tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells</span></div><div class="casAuthors">McHugh, Douglas; Page, Jeremy; Dunn, Emily; Bradshaw, Heather B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2414-2424</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Endometriosis is a disorder in which the endometrium forms growths outside the uterus and is assocd. with chronic pain.  Recent evidence suggests that endometrial motility plays a role in the etiol. of endometriosis.  The endocannabinoid system regulates cellular migration.  Given the growing involvement of the endocannabinoids in reprodn., we investigated the role of the endocannabinoid system in migration of endometrial cells.  Exptl. Approach: Migration of the human endometrial HEC-1B cells was assayed.  Std. PCR techniques were used to det. the presence of the GPCR, GPR18, in HEC-1B cells, and p44/42 MAPK was assayed in stably transfected HEK293-GPR18 cells to det. receptor specificity for known cannabinoid agonists and antagonists.  N-arachidonoyl ethanolamine (AEA) metab. was measured, using HPLC/MS/MS for lipid anal.  Key Results: AEA, Δ9-tetrahydrocannabinol (Δ9-THC) and N-arachidonoyl glycine (NAGly) induce migration of HEC-1B cells through cannabinoid CB1 receptor-independent mechanisms.  MAPK activation in HEK293-GPR18 cells revealed novel pharmacol. for known CB1 and CB2 receptor ligands at GPR18 receptors, including Δ9-THC, which activates MAPK at nanomolar concns., whereas WIN 55212-2, CP55940, JWH-133 and JWH-015, and arachidonyl-1-hydroxy-2-propylamide (R1-methanandamide) had no effect.  Moreover, HEC-1B migration and MAPK activation by NAGly and Δ9-THC were antagonized by Pertussis toxin, AM251 and cannabidiol.  Conclusions and Implications: An understanding of the function and regulation of GPR18 and its mol. interactions with endogenous ligands, and how phytocannabinoids play a role with GPR18 signalling is vital if we are to comprehensively assess the function of the cannabinoid signalling system in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKp4A_A8HgGbVg90H21EOLACvtfcHk0lgEGq29l_6usg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVajsL0%253D&md5=fbef8e8cf1ba07b9f359a1b21dea725e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01497.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01497.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3D%25CE%25949-Tetrahydrocannabinol%2520and%2520N-Arachidonyl%2520Glycine%2520Are%2520Full%2520Agonists%2520at%2520GPR18%2520Receptors%2520and%2520Induce%2520Migration%2520in%2520Human%2520Endometrial%2520HEC-1B%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26issue%3D8%26spage%3D2414%26epage%3D2424%26doi%3D10.1111%2Fj.1476-5381.2011.01497.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassilatis, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranchalis, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortrud, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaitanaris, G. A.</span></span> <span> </span><span class="NLM_article-title">The G Protein-Coupled Receptor Repertoires of Human and Mouse</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4903</span>– <span class="NLM_lpage">4908</span>, <span class="refDoi"> DOI: 10.1073/pnas.0230374100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1073%2Fpnas.0230374100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=12679517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt12nt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4903-4908&issue=8&author=D.+K.+Vassilatisauthor=J.+G.+Hohmannauthor=H.+Zengauthor=F.+Liauthor=J.+E.+Ranchalisauthor=M.+T.+Mortrudauthor=A.+Brownauthor=S.+S.+Rodriguezauthor=J.+R.+Wellerauthor=A.+C.+Wrightauthor=J.+E.+Bergmannauthor=G.+A.+Gaitanaris&title=The+G+Protein-Coupled+Receptor+Repertoires+of+Human+and+Mouse&doi=10.1073%2Fpnas.0230374100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-coupled receptor repertoires of human and mouse</span></div><div class="casAuthors">Vassilatis, Demetrios K.; Hohmann, John G.; Zeng, Hongkui; Li, Fusheng; Ranchalis, Jane E.; Mortrud, Marty T.; Brown, Analisa; Rodriguez, Stephanie S.; Weller, John R.; Wright, Abbie C.; Bergmann, John E.; Gaitanaris, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4903-4908</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Diverse members of the G protein-coupled receptor (GPCR) super-family participate in a variety of physiol. functions and are major targets of pharmaceutical drugs.  Here we report that the repertoire of GPCRs for endogenous ligands consists of 367 receptors in humans and 392 in mice.  Included here are 26 human and 83 mouse GPCRs not previously identified.  A direct comparison of GPCRs in the two species reveals an unexpected level of orthol.  The evolutionary preservation of these mols. argues against functional redundancy among highly related receptors.  Phylogenetic analyses cluster 60% of GPCRs according to ligand preference, allowing prediction of ligand types for dozens of orphan receptors.  Expression profiling of 100 GPCRs demonstrates that most are expressed in multiple tissues and that individual tissues express multiple GPCRs.  Over 90% of GPCRs are expressed in the brain.  Strikingly, however, the profiles of most GPCRs are unique, yielding thousands of tissue- and cell-specific receptor combinations for the modulation of physiol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnKe3CCaGZ6LVg90H21EOLACvtfcHk0lhWwJ28jUnOhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt12nt70%253D&md5=d164253c5320b591469b509b91323ff4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0230374100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0230374100%26sid%3Dliteratum%253Aachs%26aulast%3DVassilatis%26aufirst%3DD.%2BK.%26aulast%3DHohmann%26aufirst%3DJ.%2BG.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DRanchalis%26aufirst%3DJ.%2BE.%26aulast%3DMortrud%26aufirst%3DM.%2BT.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DS.%2BS.%26aulast%3DWeller%26aufirst%3DJ.%2BR.%26aulast%3DWright%26aufirst%3DA.%2BC.%26aulast%3DBergmann%26aufirst%3DJ.%2BE.%26aulast%3DGaitanaris%26aufirst%3DG.%2BA.%26atitle%3DThe%2520G%2520Protein-Coupled%2520Receptor%2520Repertoires%2520of%2520Human%2520and%2520Mouse%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D8%26spage%3D4903%26epage%3D4908%26doi%3D10.1073%2Fpnas.0230374100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasukawa, M.</span></span> <span> </span><span class="NLM_article-title">Identification of N-Arachidonylglycine as the Endogenous Ligand for Orphan G-Protein-Coupled Receptor GPR18</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>347</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.06.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bbrc.2006.06.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=16844083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD28Xntl2jurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2006&pages=827-832&issue=3&author=M.+Kohnoauthor=H.+Hasegawaauthor=A.+Inoueauthor=M.+Muraokaauthor=T.+Miyazakiauthor=K.+Okaauthor=M.+Yasukawa&title=Identification+of+N-Arachidonylglycine+as+the+Endogenous+Ligand+for+Orphan+G-Protein-Coupled+Receptor+GPR18&doi=10.1016%2Fj.bbrc.2006.06.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18</span></div><div class="casAuthors">Kohno, Masashi; Hasegawa, Hitoshi; Inoue, Atsushi; Muraoka, Masatake; Miyazaki, Tatsuhiko; Oka, Keizo; Yasukawa, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">827-832</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">An orphan G-protein-coupled receptor, GPR18, was cloned on the basis of degenerate-oligonucleotide PCR anal. of HUT 102 cells using primers designed from the conservative regions of the human chemokine receptor.  GPR18 was expressed significantly in lymphoid cell lines, but not in non-lymphoid hematopoietic cell lines.  Moreover, the expression of the GPR18 gene was higher in peripheral lymphocyte subsets (CD4+, CD4+CD45RA+, CD4+CD45RO+, CD8+, and CD19+) than in monocytes and lymphoid cell lines, and was increased after stimulation with phytohemagglutinin.  By screening using a lipid library, N-arachidonylglycine (NAGly) induced an increase in intracellular Ca2+ concn. in GPR18-transfected cells, which was significantly greater than that in mock-transfected cells.  NAGly also inhibited forskolin-induced cAMP prodn. in a pertussis toxin-sensitive manner in the GPR18-transfected CHO cells.  This is the first study to demonstrate that NAGly is a natural ligand for GPR18.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVsg34QDIs7Vg90H21EOLACvtfcHk0lh6g5JOjupy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xntl2jurw%253D&md5=2065a390b3130d768257defcc0384dd8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.06.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.06.175%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DMuraoka%26aufirst%3DM.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DK.%26aulast%3DYasukawa%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520N-Arachidonylglycine%2520as%2520the%2520Endogenous%2520Ligand%2520for%2520Orphan%2520G-Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D347%26issue%3D3%26spage%3D827%26epage%3D832%26doi%3D10.1016%2Fj.bbrc.2006.06.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takenouchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, A.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine Induces Macrophage Apoptosis via GPR18</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>418</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2012.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bbrc.2012.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=22266325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Crt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2012&pages=366-371&issue=2&author=R.+Takenouchiauthor=K.+Inoueauthor=Y.+Kambeauthor=A.+Miyata&title=N-Arachidonoyl+Glycine+Induces+Macrophage+Apoptosis+via+GPR18&doi=10.1016%2Fj.bbrc.2012.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine induces macrophage apoptosis via GPR18</span></div><div class="casAuthors">Takenouchi, Rina; Inoue, Kazuhiko; Kambe, Yuki; Miyata, Atsuro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-371</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-arachidonoyl glycine (NAGly), a member of lipoamino acids, was reported to exhibit anti-inflammatory effects in exptl. ear edema or peritonitis.  However the underlying mechanisms have not been clarified so far.  In this study, we attempt to investigate the effects of NAGly on macrophages, including the relevant signaling pathways.  NAGly potently induced apoptosis in mouse macrophage-derived cell line, RAW264.7.  Pretreatment with inhibitors for MEK and p38 MAPK prevented the apoptosis induced by NAGly, although NAGly activated ERK1/2, p38 MAPK and JNK.  Further, we focused on implication of GPR18, one of the orphan G protein-coupled receptors, because NAGly has been reported as a candidate ligand for GPR18.  Pretreatment with pertussis toxin or siRNA to knock down the expression of GPR18 significantly attenuated the apoptosis induced by NAGly.  In mouse peritoneal macrophages, the expression of GPR18 mRNA was elevated in proinflammatory stimulated macrophages but not in anti-inflammatory stimulated macrophages; consistently, NAGly remarkably reduced cell viability of the former, as compared to the latter.  These results suggest that NAGly might be involved in function of macrophages through GPR18.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvH3m2AZNCZ7Vg90H21EOLACvtfcHk0lh6g5JOjupy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Crt7o%253D&md5=b3d71262301889d560d9ba9b044707ac</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DTakenouchi%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKambe%26aufirst%3DY.%26aulast%3DMiyata%26aufirst%3DA.%26atitle%3DN-Arachidonoyl%2520Glycine%2520Induces%2520Macrophage%2520Apoptosis%2520via%2520GPR18%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D418%26issue%3D2%26spage%3D366%26epage%3D371%26doi%3D10.1016%2Fj.bbrc.2012.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puhl, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S. R.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonyl Glycine Does Not Activate G Protein-Coupled Receptor 18 Signaling via Canonical Pathways</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1124/mol.112.081182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1124%2Fmol.112.081182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23104136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=267-282&issue=1&author=V.+B.+Luauthor=H.+L.+Puhlauthor=S.+R.+Ikeda&title=N-Arachidonyl+Glycine+Does+Not+Activate+G+Protein-Coupled+Receptor+18+Signaling+via+Canonical+Pathways&doi=10.1124%2Fmol.112.081182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways</span></div><div class="casAuthors">Lu, Van B.; Puhl, Henry L., III; Ikeda, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">267-282</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent studies propose that N-arachidonoyl glycine (NAGly), a carboxylic analog of anandamide, is an endogenous ligand of the Gαi/o protein-coupled receptor 18 (GPR18).  However, a high-throughput β-arrestin-based screen failed to detect activation of GPR18 by NAGly.  To address this inconsistency, this study investigated GPR18 coupling in a native neuronal system with endogenous signaling pathways and effectors.  GPR18 was heterologously expressed in rat sympathetic neurons, and the modulation of N-type (Cav2.2) calcium channels was examd.  Proper expression and trafficking of receptor were confirmed by the "rim-like" fluorescence of fluorescently tagged receptor and the pos. staining of external hemagglutinin-tagged GPR18-expressing cells.  Application of NAGly on GPR18-expressing neurons did not inhibit calcium currents but instead potentiated currents in a voltage-dependent manner, similar to what has previously been reported.  Other proposed agonists of GPR18, including anandamide and abnormal cannabidiol, also failed to induce inhibition of calcium currents.  Mutants of GPR18, designed to constitutively activate receptors, did not tonically inhibit calcium currents, indicating a lack of GPR18 activation or coupling to endogenous G proteins.  Other downstream effectors of Gαi/o-coupled receptors, G protein-coupled inwardly rectifying potassium channels and adenylate cyclase, were not modulated by GPR18 signaling.  Furthermore, GPR18 did not couple to other G proteins tested: Gαs, Gαz, and Gα15.  These results suggest NAGly is not an agonist for GPR18 or that GPR18 signaling involves noncanonical pathways not examd. in these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPdZlYf2-4pbVg90H21EOLACvtfcHk0ljgNvW7llaMPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLY%253D&md5=3d977146c3f795562944ec03e504f59b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.081182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.081182%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DV.%2BB.%26aulast%3DPuhl%26aufirst%3DH.%2BL.%26aulast%3DIkeda%26aufirst%3DS.%2BR.%26atitle%3DN-Arachidonyl%2520Glycine%2520Does%2520Not%2520Activate%2520G%2520Protein-Coupled%2520Receptor%252018%2520Signaling%2520via%2520Canonical%2520Pathways%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26issue%3D1%26spage%3D267%26epage%3D282%26doi%3D10.1124%2Fmol.112.081182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colas, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Identification of Resolvin D2 Receptor Mediating Resolution of Infections and Organ Protection</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1084/jem.20150225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1084%2Fjem.20150225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=26195725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=1203-1217&issue=8&author=N.+Chiangauthor=J.+Dalliauthor=R.+A.+Colasauthor=C.+N.+Serhan&title=Identification+of+Resolvin+D2+Receptor+Mediating+Resolution+of+Infections+and+Organ+Protection&doi=10.1084%2Fjem.20150225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of resolvin D2 receptor mediating resolution of infections and organ protection</span></div><div class="casAuthors">Chiang, Nan; Dalli, Jesmond; Colas, Romain A.; Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1203-1217</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Endogenous mechanisms that orchestrate resoln. of acute inflammation are essential in host defense and the return to homeostasis.  Resolvin (Rv)D2 is a potent immunoresolvent biosynthesized during active resoln. that stereoselectively stimulates resoln. of acute inflammation.  Here, using an unbiased G protein-coupled receptor-β-arrestin-based screening and functional sensing systems, we identified a receptor for RvD2, namely GPR18, that is expressed on human leukocytes, including polymorphonuclear neutrophils (PMN), monocytes, and macrophages (MΦ).  In human MΦ, RvD2-stimulated intracellular cAMP was dependent on GPR18.  RvD2-stimulated phagocytosis of Escherichia coli and apoptotic PMN (efferocytosis) were enhanced with GPR18 overexpression and significantly reduced by shRNA knockdown.  Specific binding of RvD2 to recombinant GPR18 was confirmed using a synthetic 3H-labeled-RvD2.  Scatchard anal. gave a Kd of ∼10 nM consistent with RvD2 bioactive concn. range.  In both E. coli and Staphylococcus aureus infections, RvD2 limited PMN infiltration, enhanced phagocyte clearance of bacteria, and accelerated resoln.  These actions were lost in GPR18-deficient mice.  During PMN-mediated second organ injury, RvD2's protective actions were also significantly diminished in GPR18-deficient mice.  Together, these results provide evidence for a novel RvD2-GPR18 resoln. axis that stimulates human and mouse phagocyte functions to control bacterial infections and promote organ protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhwWqS1_Wl-bVg90H21EOLACvtfcHk0ljgNvW7llaMPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqurrO&md5=f53d3570d565367a5064bb3c173c0216</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150225%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DDalli%26aufirst%3DJ.%26aulast%3DColas%26aufirst%3DR.%2BA.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DIdentification%2520of%2520Resolvin%2520D2%2520Receptor%2520Mediating%2520Resolution%2520of%2520Infections%2520and%2520Organ%2520Protection%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26issue%3D8%26spage%3D1203%26epage%3D1217%26doi%3D10.1084%2Fjem.20150225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimsey, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, M.</span></span> <span> </span><span class="NLM_article-title">GPR18 Undergoes a High Degree of Constitutive Trafficking but Is Unresponsive to N-Arachidonoyl Glycine</span>. <i>PeerJ</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e1835</span> <span class="refDoi"> DOI: 10.7717/peerj.1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.7717%2Fpeerj.1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27018161" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=D.+B.+Finlayauthor=W.+R.+Josephauthor=N.+L.+Grimseyauthor=M.+Glass&title=GPR18+Undergoes+a+High+Degree+of+Constitutive+Trafficking+but+Is+Unresponsive+to+N-Arachidonoyl+Glycine&doi=10.7717%2Fpeerj.1835"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7717%2Fpeerj.1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7717%252Fpeerj.1835%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DD.%2BB.%26aulast%3DJoseph%26aufirst%3DW.%2BR.%26aulast%3DGrimsey%26aufirst%3DN.%2BL.%26aulast%3DGlass%26aufirst%3DM.%26atitle%3DGPR18%2520Undergoes%2520a%2520High%2520Degree%2520of%2520Constitutive%2520Trafficking%2520but%2520Is%2520Unresponsive%2520to%2520N-Arachidonoyl%2520Glycine%26jtitle%3DPeerJ%26date%3D2016%26volume%3D4%26doi%3D10.7717%2Fpeerj.1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdegaal, E. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siderius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebelman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tensen, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osanto, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative Expression Profiling of G-Protein-Coupled Receptors (GPCRs) in Metastatic Melanoma: The Constitutively Active Orphan GPCR GPR18 as Novel Drug Target</span>. <i>Pigm. Cell Melanoma Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1111/j.1755-148X.2010.00781.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1755-148X.2010.00781.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=20880198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVCmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=207-218&issue=1&author=Y.+Qinauthor=E.+M.+E.+Verdegaalauthor=M.+Sideriusauthor=J.+P.+Bebelmanauthor=M.+J.+Smitauthor=R.+Leursauthor=R.+Willemzeauthor=C.+P.+Tensenauthor=S.+Osanto&title=Quantitative+Expression+Profiling+of+G-Protein-Coupled+Receptors+%28GPCRs%29+in+Metastatic+Melanoma%3A+The+Constitutively+Active+Orphan+GPCR+GPR18+as+Novel+Drug+Target&doi=10.1111%2Fj.1755-148X.2010.00781.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target</span></div><div class="casAuthors">Qin, Y.; Verdegaal, E. M. E.; Siderius, M.; Bebelman, J. P.; Smit, M. J.; Leurs, R.; Willemze, R.; Tensen, C. P.; Osanto, S.</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-218</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">G-protein-coupled receptors (GPCRs) have been implicated in the tumorigenesis and metastasis of human cancers and are considered amongst the most desirable targets for drug development.  Utilizing a robust quant. PCR array, we quantified expression of 94 human GPCRs, including 75 orphan GPCRs and 19 chemokine receptors, and 36 chemokine ligands, in 40 melanoma metastases from different individuals and benign nevi.  Inter-metastatic site comparison revealed that orphan GPR174 and CCL28 are statistically significantly overexpressed in s.c. metastases, while P2RY5 is overexpressed in brain metastases.  Comparison between metastases (all three metastatic sites) and benign nevi revealed that 16 genes, including six orphan receptors (GPR18, GPR34, GPR119, GPR160, GPR183 and P2RY10) and chemokine receptors CCR5, CXCR4, and CXCR6, were statistically significantly differentially expressed.  Subsequent functional expts. in yeast and melanoma cells indicate that GPR18, the most abundantly overexpressed orphan GPCR in all melanoma metastases, is constitutively active and inhibits apoptosis, indicating an important role for GPR18 in tumor cell survival.  GPR18 and five other orphan GPCRs with yet unknown biol. function may be considered potential novel anticancer targets in metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCIRsrII70KbVg90H21EOLACvtfcHk0lixeBUn-8uoJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVCmuro%253D&md5=81c2064cbd01e0a8bddc46a5c38900f1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-148X.2010.00781.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-148X.2010.00781.x%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DY.%26aulast%3DVerdegaal%26aufirst%3DE.%2BM.%2BE.%26aulast%3DSiderius%26aufirst%3DM.%26aulast%3DBebelman%26aufirst%3DJ.%2BP.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DWillemze%26aufirst%3DR.%26aulast%3DTensen%26aufirst%3DC.%2BP.%26aulast%3DOsanto%26aufirst%3DS.%26atitle%3DQuantitative%2520Expression%2520Profiling%2520of%2520G-Protein-Coupled%2520Receptors%2520%2528GPCRs%2529%2520in%2520Metastatic%2520Melanoma%253A%2520The%2520Constitutively%2520Active%2520Orphan%2520GPCR%2520GPR18%2520as%2520Novel%2520Drug%2520Target%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2011%26volume%3D24%26issue%3D1%26spage%3D207%26epage%3D218%26doi%3D10.1111%2Fj.1755-148X.2010.00781.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramírez-Orozco, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Ruiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalón, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafán-Bernal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marichal-Cancino, B. A.</span></span> <span> </span><span class="NLM_article-title">Potential Metabolic and Behavioural Roles of the Putative Endocannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">June</span>),  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.2174/1570159X17666190118143014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.2174%2F1570159X17666190118143014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31146657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2is7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=947-960&issue=June&author=R.+E.+Ram%C3%ADrez-Orozcoauthor=R.+Garc%C3%ADa-Ruizauthor=P.+Moralesauthor=C.+M.+Villal%C3%B3nauthor=J.+R.+Villaf%C3%A1n-Bernalauthor=B.+A.+Marichal-Cancino&title=Potential+Metabolic+and+Behavioural+Roles+of+the+Putative+Endocannabinoid+Receptors+GPR18%2C+GPR55+and+GPR119+in+Feeding&doi=10.2174%2F1570159X17666190118143014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding</span></div><div class="casAuthors">Ramirez-Orozco, Ricardo E.; Garcia-Ruiz, Ricardo; Morales, Paula; Villalon, Carlos M.; Villafan-Bernal, J. Rafael; Marichal-Cancino, Bruno A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">947-960</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Endocannabinoids are ancient biomols. involved in several cellular (e.g., metab.) and physiol. (e.g., eating behavior) functions.  Indeed, eating behavior alterations in marijuana users have led to investigate the orexigenic/anorexigenic effects of cannabinoids in animal/ human models.  This increasing body of research suggests that the endocannabinoid system plays an important role in feeding control.  Accordingly, within the endocannabinoid system, cannabinoid receptors, enzymes and genes represent potential therapeutic targets for dealing with multiple metabolic and behavioral dysfunctions (e.g., obesity, anorexia, etc.).  Paradoxically, our understanding on the endocannabinoid system as a cellular mediator is yet limited.  For example: (i) only two cannabinoid receptors have been classified, but they are not enough to explain the pharmacol. profile of several exptl. effects induced by cannabinoids; and (ii) several orphan G protein-coupled receptors (GPCRs) interact with cannabinoids and we do not know how to classify them (e.g., GPR18, GPR55 and GPR119; amongst others).  On this basis, the present review attempts to summarize the lines of evidence supporting the potential role of GPR18, GPR55 and GPR119 in metab. and feeding control that may explain some of the divergent effects and puzzling data related to cannabinoid research.  Moreover, their therapeutic potential in feeding behavior alterations will be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ6OHxyfcxg7Vg90H21EOLACvtfcHk0lixeBUn-8uoJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2is7nM&md5=f5ce06b7c28da740fafe4436bce8aedf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1570159X17666190118143014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X17666190118143014%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez-Orozco%26aufirst%3DR.%2BE.%26aulast%3DGarc%25C3%25ADa-Ruiz%26aufirst%3DR.%26aulast%3DMorales%26aufirst%3DP.%26aulast%3DVillal%25C3%25B3n%26aufirst%3DC.%2BM.%26aulast%3DVillaf%25C3%25A1n-Bernal%26aufirst%3DJ.%2BR.%26aulast%3DMarichal-Cancino%26aufirst%3DB.%2BA.%26atitle%3DPotential%2520Metabolic%2520and%2520Behavioural%2520Roles%2520of%2520the%2520Putative%2520Endocannabinoid%2520Receptors%2520GPR18%252C%2520GPR55%2520and%2520GPR119%2520in%2520Feeding%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2019%26volume%3D17%26issue%3DJune%26spage%3D947%26epage%3D960%26doi%3D10.2174%2F1570159X17666190118143014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flegel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofreuter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojcik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockmeyer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmüller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gisselmann, G.</span></span> <span> </span><span class="NLM_article-title">Characterization of Non-Olfactory GPCRs in Human Sperm with a Focus on GPR18</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32255</span>, <span class="refDoi"> DOI: 10.1038/srep32255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fsrep32255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27572937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=32255&author=C.+Flegelauthor=F.+Vogelauthor=A.+Hofreuterauthor=S.+Wojcikauthor=C.+Schoederauthor=K.+Kie%C4%87-Kononowiczauthor=N.+H.+Brockmeyerauthor=C.+E.+M%C3%BCllerauthor=C.+Beckerauthor=J.+Altm%C3%BCllerauthor=H.+Hattauthor=G.+Gisselmann&title=Characterization+of+Non-Olfactory+GPCRs+in+Human+Sperm+with+a+Focus+on+GPR18&doi=10.1038%2Fsrep32255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18</span></div><div class="casAuthors">Flegel, Caroline; Vogel, Felix; Hofreuter, Adrian; Wojcik, Sebastian; Schoeder, Clara; Kiec-Kononowicz, Katarzyna; Brockmeyer, Norbert H.; Mueller, Christa E.; Becker, Christian; Altmueller, Janine; Hatt, Hanns; Gisselmann, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32255</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) transduce external chem. cues into intracellular signals and are involved in a plethora of physiol. processes, but knowledge regarding the function of these receptors in spermatozoa is limited.  In the present study, we performed RNA-Seq and analyzed the expression of the all GPCRs except olfactory receptors in human spermatozoa.  We revealed the expression of up to 223 different GPCR transcripts in human spermatozoa (FPKM > 0.1) and identified GPR18, a newly described cannabinoid receptor, together with GPR137 and GPR135, as one of the three most highly expressed GPCRs.  To date, the expression of GPR18 was completely unknown in human spermatozoa.  We confirmed GPR18 expression using RT-PCR and immuncytochem. expts. and localized the GPR18 protein in the midpiece of human spermatozoa.  Stimulation of human spermatozoa with the GPR18 ligand N-arachidonoylglycine induced the phosphorylation of 12 protein kinases, some of them are for example known to be involved in the acrosome reaction.  In line with this, N-arachidonoylglycine affected the cytoskeleton by changing levels of F-actin and inducing the acrosome reaction in human spermatozoa in a concn.-dependent manner.  Our results indicate that GPR18 might be involved in physiol. processes of human spermatozoa, suggesting GPR18 to be a potential player in sperm physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvAFasp877UbVg90H21EOLACvtfcHk0ljOi1w4SnZXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjt7zE&md5=b387d47d690afc94eab3fed637591013</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsrep32255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32255%26sid%3Dliteratum%253Aachs%26aulast%3DFlegel%26aufirst%3DC.%26aulast%3DVogel%26aufirst%3DF.%26aulast%3DHofreuter%26aufirst%3DA.%26aulast%3DWojcik%26aufirst%3DS.%26aulast%3DSchoeder%26aufirst%3DC.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DBrockmeyer%26aufirst%3DN.%2BH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DAltm%25C3%25BCller%26aufirst%3DJ.%26aulast%3DHatt%26aufirst%3DH.%26aulast%3DGisselmann%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520Non-Olfactory%2520GPCRs%2520in%2520Human%2520Sperm%2520with%2520a%2520Focus%2520on%2520GPR18%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D32255%26doi%3D10.1038%2Fsrep32255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmerman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juknat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine, an Abundant Endogenous Lipid, Potently Drives Directed Cellular Migration through GPR18, the Putative Abnormal Cannabidiol Receptor</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">44</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-11-44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2F1471-2202-11-44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=20346144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BC3czhtlSntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=44&author=D.+McHughauthor=S.+S.+J.+Huauthor=N.+Rimmermanauthor=A.+Juknatauthor=Z.+Vogelauthor=J.+M.+Walkerauthor=H.+B.+Bradshaw&title=N-Arachidonoyl+Glycine%2C+an+Abundant+Endogenous+Lipid%2C+Potently+Drives+Directed+Cellular+Migration+through+GPR18%2C+the+Putative+Abnormal+Cannabidiol+Receptor&doi=10.1186%2F1471-2202-11-44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor</span></div><div class="casAuthors">McHugh Douglas; Hu Sherry S J; Rimmerman Neta; Juknat Ana; Vogel Zvi; Walker J Michael; Bradshaw Heather B</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Microglia provide continuous immune surveillance of the CNS and upon activation rapidly change phenotype to express receptors that respond to chemoattractants during CNS damage or infection.  These activated microglia undergo directed migration towards affected tissue.  Importantly, the molecular species of chemoattractant encountered determines if microglia respond with pro- or anti-inflammatory behaviour, yet the signaling molecules that trigger migration remain poorly understood.  The endogenous cannabinoid system regulates microglial migration via CB2 receptors and an as yet unidentified GPCR termed the 'abnormal cannabidiol' (Abn-CBD) receptor.  Abn-CBD is a synthetic isomer of the phytocannabinoid cannabidiol (CBD) and is inactive at CB1 or CB2 receptors, but functions as a selective agonist at this Gi/o-coupled GPCR.  N-arachidonoyl glycine (NAGly) is an endogenous metabolite of the endocannabinoid anandamide and acts as an efficacious agonist at GPR18.  Here, we investigate the relationship between NAGly, Abn-CBD, the unidentified 'Abn-CBD' receptor, GPR18, and BV-2 microglial migration.  RESULTS:  Using Boyden chamber migration experiments, yellow tetrazolium (MTT) conversion, In-cell Western, qPCR and immunocytochemistry we show that NAGly, at sub-nanomolar concentrations, and Abn-CBD potently drive cellular migration in both BV-2 microglia and HEK293-GPR18 transfected cells, but neither induce migration in HEK-GPR55 or non-transfected HEK293 wildtype cells.  Migration effects are blocked or attenuated in both systems by the 'Abn-CBD' receptor antagonist O-1918, and low efficacy agonists N-arachidonoyl-serine and cannabidiol.  NAGly promotes proliferation and activation of MAP kinases in BV-2 microglia and HEK293-GPR18 cells at low nanomolar concentrations - cellular responses correlated with microglial migration.  Additionally, BV-2 cells show GPR18 immunocytochemical staining and abundant GPR18 mRNA. qPCR demonstrates that primary microglia, likewise, express abundant amounts of GPR18 mRNA.  CONCLUSIONS:  NAGly is the most effective lipid recruiter of BV-2 microglia currently reported and its effects mimic those of Abn-CBD.  The data generated from this study supports the hypothesis that GPR18 is the previously unidentified 'Abn-CBD' receptor.  The marked potency of NAGly acting on GPR18 to elicit directed migration, proliferation and perhaps other MAPK-dependent phenomena advances our understanding of the lipid-based signaling mechanisms employed by the CNS to actively recruit microglia to sites of interest.  It offers a novel research avenue for developing therapeutics to elicit a self-renewing population of neuroregenerative microglia, or alternatively, to prevent the accumulation of misdirected, pro-inflammatory microglia which contribute to and exacerbate neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtR9ShKLQLpjQLBVDQn4bCfW6udTcc2eaK01jBOskxgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czhtlSntg%253D%253D&md5=151782cc176d13a91ac6ad36f545e54c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-11-44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-11-44%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DS.%2BS.%2BJ.%26aulast%3DRimmerman%26aufirst%3DN.%26aulast%3DJuknat%26aufirst%3DA.%26aulast%3DVogel%26aufirst%3DZ.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3DN-Arachidonoyl%2520Glycine%252C%2520an%2520Abundant%2520Endogenous%2520Lipid%252C%2520Potently%2520Drives%2520Directed%2520Cellular%2520Migration%2520through%2520GPR18%252C%2520the%2520Putative%2520Abnormal%2520Cannabidiol%2520Receptor%26jtitle%3DBMC%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D44%26doi%3D10.1186%2F1471-2202-11-44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager-Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">SiRNA Knockdown of GPR18 Receptors in BV-2 Microglia Attenuates N-Arachidonoyl Glycine-Induced Cell Migration</span>. <i>J. Mol. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">0</span>),  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/1750-2187-7-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2F1750-2187-7-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=10&issue=0&author=D.+McHughauthor=J.+Wager-Millerauthor=J.+Pageauthor=H.+B.+Bradshaw&title=SiRNA+Knockdown+of+GPR18+Receptors+in+BV-2+Microglia+Attenuates+N-Arachidonoyl+Glycine-Induced+Cell+Migration&doi=10.1186%2F1750-2187-7-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2F1750-2187-7-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-2187-7-10%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DWager-Miller%26aufirst%3DJ.%26aulast%3DPage%26aufirst%3DJ.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3DSiRNA%2520Knockdown%2520of%2520GPR18%2520Receptors%2520in%2520BV-2%2520Microglia%2520Attenuates%2520N-Arachidonoyl%2520Glycine-Induced%2520Cell%2520Migration%26jtitle%3DJ.%2520Mol.%2520Signaling%26date%3D2014%26volume%3D7%26issue%3D0%26spage%3D10%26doi%3D10.1186%2F1750-2187-7-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span> <span> </span><span class="NLM_article-title">Orphan Endogenous Lipids and Orphan GPCRs: A Good Match</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2009.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.prostaglandins.2009.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=131-134&issue=3%E2%80%934&author=H.+B.+Bradshawauthor=S.+H.+Leeauthor=D.+McHugh&title=Orphan+Endogenous+Lipids+and+Orphan+GPCRs%3A+A+Good+Match&doi=10.1016%2Fj.prostaglandins.2009.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Orphan endogenous lipids and orphan GPCRs: A good match</span></div><div class="casAuthors">Bradshaw, Heather B.; Lee, Sung Ha; McHugh, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">131-134</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A large and growing family of over 70 endogenous lipids of the basic structure N-acyl amide has been identified during the last 10 years.  Only a few of these lipids have been characterized for biol. activity, however, those that have shown a wide-range of activity may act at G-protein coupled receptors (GPCRs).  Like orphan GPCRs that are identified as being in the genome and expressed in tissue, the majority of these endogenous lipids many produced throughout the body, some predominately in nervous tissue, remain orphaned.  Here, we give a brief history of these orphan lipids and highlight the activity of N-arachidonoyl glycine, and farnesyl pyrophosphate at the orphan receptors GPR18 and GPR92, resp., as well as summarizing the biol. and pharmacol. data for the recently identified N-palmitoyl glycine that suggests activity at a novel GPCR.  Working to deorphanize both lipids and GPCRs together provides a unique opportunity for a greater understanding of cellular signaling and a challenge to find them all a home.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpuA1O-mjZ7Vg90H21EOLACvtfcHk0lhqjiHOQnabag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7jF&md5=8113a4c4fc02ed06d29af0a79b7ba687</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DMcHugh%26aufirst%3DD.%26atitle%3DOrphan%2520Endogenous%2520Lipids%2520and%2520Orphan%2520GPCRs%253A%2520A%2520Good%2520Match%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2009%26volume%3D89%26issue%3D3%25E2%2580%25934%26spage%3D131%26epage%3D134%26doi%3D10.1016%2Fj.prostaglandins.2009.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P. H.</span>; <span class="NLM_string-name">Battey, J.</span>; <span class="NLM_string-name">Benson, H. E.</span>; <span class="NLM_string-name">Benya, R. V.</span>; <span class="NLM_string-name">Bonner, T. I.</span>; <span class="NLM_string-name">Anthony, P.</span>; <span class="NLM_string-name">Eguchi, S.</span>; <span class="NLM_string-name">Harmar, A.</span>; <span class="NLM_string-name">Holliday, N.</span>; <span class="NLM_string-name">Jensen, R. T.</span>; <span class="NLM_string-name">Karnik, S.</span>; <span class="NLM_string-name">Kostenis, E.</span>; <span class="NLM_string-name">Liew, W. C.</span>; <span class="NLM_string-name">Monaghan, A. E.</span>; <span class="NLM_string-name">Mpamhanga, C.</span>; <span class="NLM_string-name">Neubig, C.</span>; <span class="NLM_string-name">Pawson, A. J.</span>; <span class="NLM_string-name">Pin, J.</span>; <span class="NLM_string-name">Sharman, J. L.</span>; <span class="NLM_string-name">Spedding, M.</span>; <span class="NLM_string-name">Spindel, E.</span>; <span class="NLM_string-name">Stoddart, L.</span>; <span class="NLM_string-name">Storjohann, L.</span>; <span class="NLM_string-name">Thomas, W. G.</span>; <span class="NLM_string-name">Tirupula, K.</span>; <span class="NLM_string-name">Vanderheyden, P.</span></span> <span> </span><span class="NLM_article-title">Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database</span>.  <i>GtoPdb CITE</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume">2019</span>, <span class="refDoi"> DOI: 10.2218/gtopdb/F16/2019.5</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.2218%2Fgtopdb%2FF16%2F2019.5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&author=S.+P.+H.+Alexander&author=J.+Battey&author=H.+E.+Benson&author=R.+V.+Benya&author=T.+I.+Bonner&author=P.+Anthony&author=S.+Eguchi&author=A.+Harmar&author=N.+Holliday&author=R.+T.+Jensen&author=S.+Karnik&author=E.+Kostenis&author=W.+C.+Liew&author=A.+E.+Monaghan&author=C.+Mpamhanga&author=C.+Neubig&author=A.+J.+Pawson&author=J.+Pin&author=J.+L.+Sharman&author=M.+Spedding&author=E.+Spindel&author=L.+Stoddart&author=L.+Storjohann&author=W.+G.+Thomas&author=K.+Tirupula&author=P.+Vanderheyden&title=Class+A+Orphans+%28version+2019.5%29+in+the+IUPHAR%2FBPS+Guide+to+Pharmacology+Database&doi=10.2218%2Fgtopdb%2FF16%2F2019.5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2218%2Fgtopdb%2FF16%2F2019.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2218%252Fgtopdb%252FF16%252F2019.5%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DS.%2BP.%2BH.%26atitle%3DClass%2520A%2520Orphans%2520%2528version%25202019.5%2529%2520in%2520the%2520IUPHAR%252FBPS%2520Guide%2520to%2520Pharmacology%2520Database%26jtitle%3DGtoPdb%2520CITE%26date%3D2019%26volume%3D2019%26doi%3D10.2218%2Fgtopdb%2FF16%2F2019.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reyes-Resina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguinaga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canela, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaluski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saura, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Molecular and Functional Interaction between GPR18 and Cannabinoid CB2 G-Protein-Coupled Receptors. Relevance in Neurodegenerative Diseases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bcp.2018.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29870711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOitr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=169-179&author=I.+Reyes-Resinaauthor=G.+Navarroauthor=D.+Aguinagaauthor=E.+I.+Canelaauthor=C.+T.+Schoederauthor=M.+Zaluskiauthor=K.+Kiec-Kononowiczauthor=C.+A.+Sauraauthor=C.+E.+M%C3%BCllerauthor=R.+Franco&title=Molecular+and+Functional+Interaction+between+GPR18+and+Cannabinoid+CB2+G-Protein-Coupled+Receptors.+Relevance+in+Neurodegenerative+Diseases&doi=10.1016%2Fj.bcp.2018.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases</span></div><div class="casAuthors">Reyes-Resina, Irene; Navarro, Gemma; Aguinaga, David; Canela, Enric I.; Schoeder, Clara T.; Zaluski, Michal; Kiec-Kononowicz, Katarzyna; Saura, Carlos A.; Muller, Christa E.; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-179</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR18, still considered an orphan receptor, may respond to endocannabinoids, whose canonical receptors are CB1 and CB2.  GPR18 and CB2 receptors share a role in peripheral immune response regulation and are co-expressed in microglia, which are immunocompetent cells in the central nervous system (CNS).  We aimed at identifying heteroreceptor complexes formed by GPR18 and CB1R or CB2R in resting and activated microglia.  Receptor-receptor interaction was assessed using energy-transfer approaches, and receptor function by detg. cAMP levels and ERK1/2 phosphorylation in heterologous cells and primary cultures of microglia.  Heteroreceptor identification in primary cultures of microglia was achieved by in situ proximity ligation assays.  Energy transfer results showed interaction of GPR18 with CB2R but not with CB1R.  CB2-GPR18 heteroreceptor complexes displayed particular functional properties (heteromer prints) often consisting of neg. cross-talk (activation of one receptor reduces signaling arising from the partner receptor) and cross-antagonism (the response of one of the receptors is blocked by a selective antagonist of the partner receptor).  Activated microglia showed the heteromer print (neg. cross-talk and bidirectional cross-antagonism) and increased expression of CB2R and GPR18.  Due to the important role of CB2R in neuroprotection, we further investigated heteroreceptor occurrence in primary cultures of microglia from transgenic mice overexpressing human APPSw,Ind, an Alzheimer's disease model.  Microglial cells from transgenic mice showed the heteromer print and functional interactions that were similar to those found in cells from wild-type animals that were activated by treatment with lipopolysaccharide and interferon-γ.  Our results suggest that GPR18 and its heteromers may play important roles in neurodegenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX37_OQFD4jLVg90H21EOLACvtfcHk0lg0nrSAK5FABQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOitr%252FO&md5=502d1c37132dfadcb20a50c20e4dc4ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DReyes-Resina%26aufirst%3DI.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DAguinaga%26aufirst%3DD.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DZaluski%26aufirst%3DM.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DSaura%26aufirst%3DC.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DMolecular%2520and%2520Functional%2520Interaction%2520between%2520GPR18%2520and%2520Cannabinoid%2520CB2%2520G-Protein-Coupled%2520Receptors.%2520Relevance%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D157%26spage%3D169%26epage%3D179%26doi%3D10.1016%2Fj.bcp.2018.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheff, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernabé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeramachaneni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viet, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viet, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. L.</span></span> <span> </span><span class="NLM_article-title">Anti-Cancer and Analgesic Effects of Resolvin D2 in Oral Squamous Cell Carcinoma</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.neuropharm.2018.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30009833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlentLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2018&pages=182-193&author=Y.+Yeauthor=N.+N.+Scheffauthor=D.+Bernab%C3%A9author=E.+Salvoauthor=K.+Onoauthor=C.+Liuauthor=R.+Veeramachaneniauthor=C.+T.+Vietauthor=D.+T.+Vietauthor=J.+C.+Dolanauthor=B.+L.+Schmidt&title=Anti-Cancer+and+Analgesic+Effects+of+Resolvin+D2+in+Oral+Squamous+Cell+Carcinoma&doi=10.1016%2Fj.neuropharm.2018.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma</span></div><div class="casAuthors">Ye, Yi; Scheff, Nicole N.; Bernabe, Daniel; Salvo, Elizabeth; Ono, Kentaro; Liu, Cheng; Veeramachaneni, Ratna; Viet, Chi T.; Viet, Dan T.; Dolan, John C.; Schmidt, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">182-193</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study investigated the potential of RvDs (RvD1 and RvD2) to treat oral cancer and alleviate oral cancer pain.  We found down-regulated mRNA levels of GPR18 and GPR32 (which code for receptors RvD1 and RvD2) in oral cancer cells.  Both RvD1 and RvD2 inhibited oral cancer proliferation in vitro.  Using two validated mouse oral squamous cell carcinoma xenograft models, we found that RvD2, the more potent anti-inflammatory lipid mediator, significantly reduced tumor size.  The mechanism of this action might involve suppression of IL-6, C-X-C motif chemokine 10 (CXCL10), and redn. of tumor necrosis.  RvD2 generated short-lasting analgesia in xenograft cancer models, which coincided with decreased neutrophil infiltration and myeloperoxidase activity.  Using a cancer supernatant model, we demonstrated that RvD2 reduced cancer-derived cytokines/chemokines (TNF-a, IL-6, CXCL10, and MCP-1), cancer mediator-induced CD11b+Ly6G- myeloid cells, and nociception.  We infer from our results that manipulation of the endogenous pro-resoln. pathway might provide a novel approach to improve oral cancer and cancer pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrolc9_AoK6xbVg90H21EOLACvtfcHk0lg0nrSAK5FABQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlentLzF&md5=c81c49f345077fbfd7b77a432c425891</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DScheff%26aufirst%3DN.%2BN.%26aulast%3DBernab%25C3%25A9%26aufirst%3DD.%26aulast%3DSalvo%26aufirst%3DE.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DVeeramachaneni%26aufirst%3DR.%26aulast%3DViet%26aufirst%3DC.%2BT.%26aulast%3DViet%26aufirst%3DD.%2BT.%26aulast%3DDolan%26aufirst%3DJ.%2BC.%26aulast%3DSchmidt%26aufirst%3DB.%2BL.%26atitle%3DAnti-Cancer%2520and%2520Analgesic%2520Effects%2520of%2520Resolvin%2520D2%2520in%2520Oral%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DNeuropharmacology%26date%3D2018%26volume%3D139%26spage%3D182%26epage%3D193%26doi%3D10.1016%2Fj.neuropharm.2018.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dyke, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashiba, S.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">307</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2019.00307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3389%2Ffimmu.2019.00307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30863409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVKmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=307&author=Y.+D.+Siddiquiauthor=K.+Omoriauthor=T.+Itoauthor=K.+Yamashiroauthor=S.+Nakamuraauthor=K.+Okamotoauthor=M.+Onoauthor=T.+Yamamotoauthor=T.+E.+Van+Dykeauthor=S.+Takashiba&title=Resolvin+D2+Induces+Resolution+of+Periapical+Inflammation+and+Promotes+Healing+of+Periapical+Lesions+in+Rat+Periapical+Periodontitis&doi=10.3389%2Ffimmu.2019.00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 induces resolution of periapical inflammation and promotes healing of periapical lesions in rat periapical periodontitis</span></div><div class="casAuthors">Siddiqui, Yasir Dilshad; Omori, Kazuhiro; Ito, Takashi; Yamashiro, Keisuke; Nakamura, Shin; Okamoto, Kentaro; Ono, Mitsuaki; Yamamoto, Tadashi; Van Dyke, Thomas E.; Takashiba, Shogo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">307</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Periapical periodontitis results from pulpal infection leading to pulpal necrosis and resorption of periapical bone.  The current treatment is root canal therapy, which attempts to eliminate infection and necrotic tissue.  But, in some cases periapical inflammation doesn't resolve even after treatment.  Resolvins belongs to a large family of specialized pro-resolving lipid mediators that actively resolves inflammation signaling via specific receptors.  Resolvin D2 (RvD2), a metabolite of docosahexaenoic acid (DHA), was tested as an intracanal medicament in rats in vivo.  Mechanism was evaluated in rat primary dental pulp cells (DPCs) in vitro.  The results demonstrate that RvD2 reduces inflammatory cell infiltrate, periapical lesion size, and fosters pulp like tissue regeneration and healing of periapical lesion.  RvD2 enhanced expression of its receptor, GPR18, dentin matrix acidic phosphoprotein 1 (DMP1) and mineralization in vivo and in vitro.  Moreover, RvD2 induces phosphorylation of Stat3 transcription factor in dental pulp cells.  We conclude that intracanal treatment with RvD2 resolves inflammation and promoting calcification around root apex and healing of periapical bone lesions.  The data suggest that RvD2 induces active resoln. of inflammation with pulp-like tissue regeneration after root canal infection and thus maybe suitable for treating periapical lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH8-Sb44G7tLVg90H21EOLACvtfcHk0lgXpXbeSKFaiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVKmtL3I&md5=2f92001c6a00ed35f713b211ec2d91c3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2019.00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2019.00307%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DY.%2BD.%26aulast%3DOmori%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DYamashiro%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DVan%2BDyke%26aufirst%3DT.%2BE.%26aulast%3DTakashiba%26aufirst%3DS.%26atitle%3DResolvin%2520D2%2520Induces%2520Resolution%2520of%2520Periapical%2520Inflammation%2520and%2520Promotes%2520Healing%2520of%2520Periapical%2520Lesions%2520in%2520Rat%2520Periapical%2520Periodontitis%26jtitle%3DFront.%2520Immunol.%26date%3D2019%26volume%3D10%26spage%3D307%26doi%3D10.3389%2Ffimmu.2019.00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyster, J. G.</span></span> <span> </span><span class="NLM_article-title">GPR18 Is Required for a Normal CD8αα Intestinal Intraepithelial Lymphocyte Compartment</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2359</span>, <span class="refDoi"> DOI: 10.1084/jem.20140646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1084%2Fjem.20140646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=25348153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGntLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=2351-2359&issue=12&author=X.+Wangauthor=H.+Sumidaauthor=J.+G.+Cyster&title=GPR18+Is+Required+for+a+Normal+CD8%CE%B1%CE%B1+Intestinal+Intraepithelial+Lymphocyte+Compartment&doi=10.1084%2Fjem.20140646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment</span></div><div class="casAuthors">Wang, Xiaoming; Sumida, Hayakazu; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2351-2359</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Intraepithelial lymphocytes (IELs) play an important role in maintaining the physiol. of the small intestine.  The majority of mouse IELs express CD8αα and are either γδ or αβ T cells.  Although the development and homing of CD8αα IELs have been studied in some detail, the factors controlling their homeostasis and positioning are incompletely understood.  Here we demonstrate that G protein-coupled receptor 18 (GPR18) is abundantly expressed in CD8αα IELs and that mice lacking this orphan receptor have reduced nos. of γδT IELs.  Mixed bone marrow chimera expts. reveal a markedly reduced contribution of GPR18-deficient cells to the CD8αα IEL compartment and a redn. in the CD8αβ T cell subset.  These defects could be rescued by transduction with a GPR18-expressing retrovirus.  The GPR18-deficient γδT IELs that remained in mixed chimeras had elevated Thy1, and there were less granzyme B+ and Vγ7+ cells, indicating a greater redn. in effector-type cells.  Flow cytometric anal. indicated GPR18 deficiency more strongly affected the CD8αα cells in the intraepithelial compared with the adjacent lamina propria compartment.  These findings establish a requirement for GPR18 in CD8αα and CD8αβ IELs, and we suggest the receptor has a role in augmenting the accumulation of CD8 T cells in the intraepithelial vs. lamina propria compartment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXe-lIMofBbVg90H21EOLACvtfcHk0lgXpXbeSKFaiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGntLnK&md5=38654ca2bf2353935d3f7f4de6d19e84</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1084%2Fjem.20140646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20140646%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSumida%26aufirst%3DH.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DGPR18%2520Is%2520Required%2520for%2520a%2520Normal%2520CD8%25CE%25B1%25CE%25B1%2520Intestinal%2520Intraepithelial%2520Lymphocyte%2520Compartment%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26issue%3D12%26spage%3D2351%26epage%3D2359%26doi%3D10.1084%2Fjem.20140646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Rosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libreros, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Novel Resolvin D2 Receptor Axis in Infectious Inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1601650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.4049%2Fjimmunol.1601650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27994074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFWrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=842-851&issue=2&author=N.+Chiangauthor=X.+de+la+Rosaauthor=S.+Librerosauthor=C.+N.+Serhan&title=Novel+Resolvin+D2+Receptor+Axis+in+Infectious+Inflammation&doi=10.4049%2Fjimmunol.1601650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Resolvin D2 Receptor Axis in Infectious Inflammation</span></div><div class="casAuthors">Chiang, Nan; de la Rosa, Xavier; Libreros, Stephania; Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">842-851</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Resoln. of acute inflammation is an active process governed by specialized proresolving mediators, including resolvin (Rv)D2, that activates a cell surface G protein-coupled receptor, GPR18/DRV2.  In this study, we investigated RvD2-DRV2-dependent resoln. mechanisms using DRV2-deficient mice (DRV2-knockout [KO]).  In polymicrobial sepsis initiated by cecal ligation and puncture, RvD2 (∼2.7 nmol/mouse) significantly increased survival (>50%) of wild-type mice and reduced hypothermia and bacterial titers compared with vehicle-treated cecal ligation and puncture mice that succumbed at 48 h.  Protection by RvD2 was abolished in DRV2-KO mice.  Mass spectrometry-based lipid mediator metabololipidomics demonstrated that DRV2-KO infectious exudates gave higher proinflammatory leukotriene B4 and procoagulating thromboxane B2, as well as lower specialized proresolving mediators, including RvD1 and RvD3, compared with wild-type.  RvD2-DRV2-initiated intracellular signals were investigated using mass cytometry (cytometry by time-of-flight), which demonstrated that RvD2 enhanced phosphorylation of CREB, ERK1/2, and STAT3 in WT but not DRV2-KO macrophages.  Monitored by real-time imaging, RvD2-DRV2 interaction significantly enhanced phagocytosis of live Escherichia coli, an action dependent on protein kinase A and STAT3 in macrophages.  Taken together, we identified an RvD2/DRV2 axis that activates intracellular signaling pathways that increase phagocytosis-mediated bacterial clearance, survival, and organ protection.  Moreover, these results provide evidence for RvD2-DRV2 and their downstream pathways in pathophysiol. of infectious inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpD7zV2j0hbVg90H21EOLACvtfcHk0lhDBZ-6BxeAeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFWrtrw%253D&md5=bb8036c37cd2bb59a3c8a38c6c5e65ff</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1601650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1601650%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DN.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DX.%26aulast%3DLibreros%26aufirst%3DS.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DNovel%2520Resolvin%2520D2%2520Receptor%2520Axis%2520in%2520Infectious%2520Inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26issue%3D2%26spage%3D842%26epage%3D851%26doi%3D10.4049%2Fjimmunol.1601650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murataeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhopeshwarkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonanno, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea</span>. <i>Cornea</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1097/ICO.0000000000001934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1097%2FICO.0000000000001934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30969262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FjvVyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=905-913&issue=7&author=N.+Murataevaauthor=L.+Dailyauthor=X.+Taylorauthor=A.+Dhopeshwarkarauthor=S.+S.+J.+Huauthor=S.+Millerauthor=D.+McHughauthor=O.+Oehlerauthor=S.+Liauthor=J.+A.+Bonannoauthor=K.+Mackieauthor=A.+Straiker&title=Evidence+for+a+GPR18+Role+in+Chemotaxis%2C+Proliferation%2C+and+the+Course+of+Wound+Closure+in+the+Cornea&doi=10.1097%2FICO.0000000000001934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea</span></div><div class="casAuthors">Murataeva Natalia; Daily Laura; Taylor Xavier; Dhopeshwarkar Amey; Miller Sally; Oehler Olivia; Mackie Ken; Straiker Alex; Hu Sherry Shu-Jung; McHugh Douglas; Li Shimin; Bonanno Joseph A</div><div class="citationInfo"><span class="NLM_cas:title">Cornea</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">905-913</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We previously showed that cannabinoid-related GPR18 receptors are present in the murine corneal epithelium, but their function remains unknown.  The related CB1 receptors regulate corneal healing, possibly via chemotaxis.  We therefore examined a potential role for GPR18 in corneal epithelial chemotaxis and wound healing.  METHODS:  We examined GPR18 messenger RNA (mRNA) and protein expression in the cornea.  We additionally examined GPR18 action in cultured bovine corneal epithelial cells (bCECs) using Boyden and tracking assays, as well as proliferation and signaling.  Finally, we examined wound closure in murine corneal explants.  RESULTS:  GPR18 mRNA was upregulated with injury in the mouse cornea.  GPR18 protein was present in basal epithelial cells of the mouse and cow and redistributed to the wound site upon injury.  GPR18 ligand N-arachidonoylglycine induced bCEC chemotaxis.  The endocannabinoid arachidonoylethanolamine also induced chemotaxis via fatty acid amide hydrolase-mediated metabolism to N-arachidonoylglycine.  GPR18 receptor activation additionally induced bCEC proliferation.  In an explant model, the GPR18 antagonist O-1918 slowed corneal epithelial cell migration and the rate of corneal wound closure.  CONCLUSIONS:  Corneal GPR18 activation induced both chemotaxis and proliferation in corneal epithelial cells in vitro and impacted wound healing.  GPR18 may contribute to the maintenance of corneal integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLYJ8o9kd5ca__Jf7-eMvJfW6udTcc2ebum66kn0C9f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FjvVyqug%253D%253D&md5=ff28c96f32b3c4a6ef996c95267f6b45</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2FICO.0000000000001934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FICO.0000000000001934%26sid%3Dliteratum%253Aachs%26aulast%3DMurataeva%26aufirst%3DN.%26aulast%3DDaily%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DX.%26aulast%3DDhopeshwarkar%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DS.%2BS.%2BJ.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DOehler%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBonanno%26aufirst%3DJ.%2BA.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DStraiker%26aufirst%3DA.%26atitle%3DEvidence%2520for%2520a%2520GPR18%2520Role%2520in%2520Chemotaxis%252C%2520Proliferation%252C%2520and%2520the%2520Course%2520of%2520Wound%2520Closure%2520in%2520the%2520Cornea%26jtitle%3DCornea%26date%3D2019%26volume%3D38%26issue%3D7%26spage%3D905%26epage%3D913%26doi%3D10.1097%2FICO.0000000000001934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansbury, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conklin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatnagar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creager, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spite, M.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">666</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.116.021894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1161%2FCIRCULATIONAHA.116.021894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27507404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2016&pages=666-680&issue=9&author=M.+J.+Zhangauthor=B.+E.+Sansburyauthor=J.+Hellmannauthor=J.+F.+Bakerauthor=L.+Guoauthor=C.+M.+Parmerauthor=J.+C.+Prennerauthor=D.+J.+Conklinauthor=A.+Bhatnagarauthor=M.+A.+Creagerauthor=M.+Spite&title=Resolvin+D2+Enhances+Postischemic+Revascularization+While+Resolving+Inflammation&doi=10.1161%2FCIRCULATIONAHA.116.021894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation</span></div><div class="casAuthors">Zhang, Michael J.; Sansbury, Brian E.; Hellmann, Jason; Baker, James F.; Guo, Luping; Parmer, Caitlin M.; Prenner, Joshua C.; Conklin, Daniel J.; Bhatnagar, Aruni; Creager, Mark A.; Spite, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">666-680</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Resolvins are lipid mediators generated by leukocytes during the resoln. phase of inflammation.  They have been shown to regulate the transition from inflammation to tissue repair; however, it is unknown whether resolvins play a role in tissue revascularization following ischemia.  Methods: We used a murine model of hind limb ischemia (HLI), coupled with laser Doppler perfusion imaging, microcomputed tomog., and targeted mass spectrometry, to assess the role of resolvins in revascularization and inflammation resoln.  Results: In mice undergoing HLI, we identified resolvin D2 (RvD2) in bone marrow and skeletal muscle by mass spectrometry (n=4-7 per group).  We also identified RvD2 in skeletal muscle biopsies from humans with peripheral artery disease.  Monocytes were recruited to skeletal muscle during HLI and isolated monocytes produced RvD2 in a lipoxygenase-dependent manner.  Exogenous RvD2 enhanced perfusion recovery in HLI and microcomputed tomog. of limb vasculature revealed greater vol., with evidence of tortuous arterioles indicative of arteriogenesis (n=6-8 per group).  Unlike other treatment strategies for therapeutic revascularization that exacerbate inflammation, RvD2 did not increase vascular permeability, but reduced neutrophil accumulation and the plasma levels of tumor necrosis factor-α and granulocyte macrophage colony-stimulating factor.  In mice treated with RvD2, histopathol. anal. of skeletal muscle of ischemic limbs showed more regenerating myocytes with centrally located nuclei.  RvD2 enhanced endothelial cell migration in a Rac-dependent manner, via its receptor, GPR18, and Gpr18-deficient mice had an endogenous defect in perfusion recovery following HLI.  Importantly, RvD2 rescued defective revascularization in diabetic mice.  Conclusions: RvD2 stimulates arteriogenic revascularization during HLI, suggesting that resolvins may be a novel class of mediators that both resolve inflammation and promote arteriogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUwu_dNEWKZ7Vg90H21EOLACvtfcHk0liF_U5Nb5FAzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCns7fN&md5=2edf6653421d2f8c08f58d0ccc38dd34</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.116.021894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.116.021894%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BJ.%26aulast%3DSansbury%26aufirst%3DB.%2BE.%26aulast%3DHellmann%26aufirst%3DJ.%26aulast%3DBaker%26aufirst%3DJ.%2BF.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DParmer%26aufirst%3DC.%2BM.%26aulast%3DPrenner%26aufirst%3DJ.%2BC.%26aulast%3DConklin%26aufirst%3DD.%2BJ.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DCreager%26aufirst%3DM.%2BA.%26aulast%3DSpite%26aufirst%3DM.%26atitle%3DResolvin%2520D2%2520Enhances%2520Postischemic%2520Revascularization%2520While%2520Resolving%2520Inflammation%26jtitle%3DCirculation%26date%3D2016%26volume%3D134%26issue%3D9%26spage%3D666%26epage%3D680%26doi%3D10.1161%2FCIRCULATIONAHA.116.021894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddy, D. M.</span></span> <span> </span><span class="NLM_article-title">New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery</span>. <i>ACS Pharmacol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.9b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.9b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Cqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=88-106&issue=1&author=J.+Parkauthor=C.+J.+Langmeadauthor=D.+M.+Riddy&title=New+Advances+in+Targeting+the+Resolution+of+Inflammation%3A+Implications+for+Specialized+Pro-Resolving+Mediator+GPCR+Drug+Discovery&doi=10.1021%2Facsptsci.9b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery</span></div><div class="casAuthors">Park, Julia; Langmead, Christopher J.; Riddy, Darren M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Pharmacology & Translational Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-106</span>CODEN:
                <span class="NLM_cas:coden">APTSFN</span>;
        ISSN:<span class="NLM_cas:issn">2575-9108</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation is a component of numerous diseases including autoimmune, metabolic, neurodegenerative, and cancer.  The discovery and characterization of specialized pro-resolving mediators (SPMs) crit. to the resoln. of inflammation, and their cognate G protein-coupled receptors (GPCRs) has led to a significant increase in the understanding of this physiol. process.  Approx. 20 ligands, including lipoxins, resolvins, maresins, and protectins, and 6 receptors (FPR2/ALX, GPR32, GPR18, chemerin1, BLT1, and GPR37) have been identified highlighting the complex and multilayered nature of resoln.  Therapeutic efforts in targeting these receptors have proved challenging, with very few ligands apparently progressing through to preclin. or clin. development.  To date, some knowledge gaps remain in the understanding of how the activation of these receptors, and their downstream signaling, results in efficient resoln. via apoptosis, phagocytosis, and efferocytosis of polymorphonuclear leukocytes (mainly neutrophils) and macrophages.  SPMs bind and activate multiple receptors (ligand poly-pharmacol.), while most receptors are activated by multiple ligands (receptor pleiotropy).  In addn., allosteric binding sites have been identified s.ignifying the capacity of more than one ligand to bind simultaneously.  These fundamental characteristics of SPM receptors enable alternative targeting strategies to be considered, including biased signaling and allosteric modulation.  This review describes those ligands and receptors involved in the resoln. of inflammation, and highlights the most recent clin. trial results.  Furthermore, we describe alternative mechanisms by which these SPM receptors could be targeted, paving the way for the identification of new therapeutics, perhaps with greater efficacy and fidelity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohpzw25BnY-LVg90H21EOLACvtfcHk0liF_U5Nb5FAzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Cqtb0%253D&md5=9d3bc680260a3f593b2b16bf37488724</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.9b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.9b00075%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DRiddy%26aufirst%3DD.%2BM.%26atitle%3DNew%2520Advances%2520in%2520Targeting%2520the%2520Resolution%2520of%2520Inflammation%253A%2520Implications%2520for%2520Specialized%2520Pro-Resolving%2520Mediator%2520GPCR%2520Drug%2520Discovery%26jtitle%3DACS%2520Pharmacol.%2520Transl.%2520Sci.%26date%3D2020%26volume%3D3%26issue%3D1%26spage%3D88%26epage%3D106%26doi%3D10.1021%2Facsptsci.9b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">GPR18 Expression on PMNs as Biomarker for Outcome in Patient with Sepsis</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2018.11.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.lfs.2018.11.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30503722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCiur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2019&pages=49-56&author=L.+Zhangauthor=C.+Qiuauthor=L.+Yangauthor=Z.+Zhangauthor=Q.+Zhangauthor=B.+Wangauthor=X.+Wang&title=GPR18+Expression+on+PMNs+as+Biomarker+for+Outcome+in+Patient+with+Sepsis&doi=10.1016%2Fj.lfs.2018.11.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">GPR18 expression on PMNs as biomarker for outcome in patient with sepsis</span></div><div class="casAuthors">Zhang, Lanqiu; Qiu, Chongyang; Yang, Lei; Zhang, Zhen; Zhang, Qi; Wang, Botao; Wang, Ximo</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR18, a G protein-coupled receptor (GPCR), is involved in bacterial clearance and survival in microbial sepsis.  In this study, we examine GPR18 expression on polymorphonuclear neutrophils (PMNs) of patients with sepsis and to det. the potential assocn. with disease severity and outcomes.  We enrolled 81 patients admitted at the intensive care unit (ICU) with the diagnosis of sepsis.  PMNs GPR18 expression was measured by flow cytometry at admission.  Sequential Organ Failure Assessment (SOFA) and Acute Physiol. and Chronic Health Evaluation (APACHEII) as well as other biomarker were measured at admission.  Cox regression anal. was used to det. the influence of PMNs GPR18 expression on 28-day mortality.  Patients with sepsis had a decreased percentage of PMNs bearing GPR18 in comparison with healthy subjects (P < 0.001).  Compared with survivors, non-survivors had lower percentage of GPR18-pos. PMNs, but higher SOFA, APACHEIIscores, and WBC count.  There were inverse correlations between the percentage of GPR18-pos. PMNs and APACHEII, SOFA score and C-recreative protein (CRP).  Using Kaplan-Meier anal., high percentage of PMNs expressing GPR18 (≥43.7%) was assocd. with a preferable 28-day survival (P = 0.004).  High percentage of PMNs expressing GPR18 (≥43.7%) was significantly and independently assocd. with 28-day mortality, with a hazard ratio of 0.36 (P = 0.37).  Moreover, LPS-Toll-like receptor (TLR)4 signaling mediated the GPR18 expression on PMNs.  These results indicate that decreased percentage GPR18-pos. PMNs is assocd. with increased severity and poorer outcome of sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprAonXHCQnr7Vg90H21EOLACvtfcHk0lhYtRezkCfN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCiur7J&md5=f831af203d6f2c4b003ad32cf9014c22</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2018.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2018.11.061%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DGPR18%2520Expression%2520on%2520PMNs%2520as%2520Biomarker%2520for%2520Outcome%2520in%2520Patient%2520with%2520Sepsis%26jtitle%3DLife%2520Sci.%26date%3D2019%26volume%3D217%26spage%3D49%26epage%3D56%26doi%3D10.1016%2Fj.lfs.2018.11.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Protects against Cerebral Ischemia/Reperfusion Injury in Rats</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi"> DOI: 10.1186/s13041-018-0351-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2Fs13041-018-0351-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29439730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyjsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=9&author=G.+Zuoauthor=D.+Zhangauthor=R.+Muauthor=H.+Shenauthor=X.+Liauthor=Z.+Wangauthor=H.+Liauthor=G.+Chen&title=Resolvin+D2+Protects+against+Cerebral+Ischemia%2FReperfusion+Injury+in+Rats&doi=10.1186%2Fs13041-018-0351-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats</span></div><div class="casAuthors">Zuo, Gang; Zhang, Dongping; Mu, Rutao; Shen, Haitao; Li, Xiang; Wang, Zhong; Li, Haiying; Chen, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9/1-9/13</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Cerebral ischemia/reperfusion (I/R) injury is a crit. factor leading to a poor prognosis for ischemic stroke patients. ω-3 fatty acid supplements taken as part of a daily diet have been shown to improve the prognosis of patients with ischemic stroke.  In this study, we aimed to investigate the potential effects of resolvin D2 (RvD2), a deriv. of ω-3 fatty acids, and its possible advantage on cerebral I/R injury in rats.  Cerebral I/R caused by middle cerebral artery occlusion and reperfusion (MCAO/R) was established in Sprague-Dawley rats.  First, in rats fed a regular diet, the MCAO/R stimulus led to a significant decrease in endogenous prodn. of RvD2.  Exogenous supply of RvD2 via i.p. injection reversed MCAO/R-induced brain injury, including infarction, inflammatory response, brain edema, and neurol. dysfunction.  Meanwhile, RvD2 reversed the MCAO/R-induced decrease in the protein level of GPR18, which has been identified as a receptor for RvD2, esp. in neurons and brain microvascular endothelial cells (BMVECs).  Furthermore, RvD2 exerted rescue effects on MCAO/R-induced neuron and BMVEC death.  Moreover, GPR18 antagonist O-1918 could block the rescue effects of RvD2, possibly at least partially though the GPR18-ERK1/2- NOS signaling pathway.  Finally, compared with ω-3 fatty acid supplements, RvD2 treatment had a better rescue effect on cerebral infarction, which may be due to the MCAO/R-induced decrease in 5-lipoxygense phosphorylation and subsequent RvD2 generation.  In conclusion, compared with ω-3 fatty acids, RvD2 may be an optimal alternative and complementary treatment for ischemic stroke patients with recanalization treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmVzM7cyIOrVg90H21EOLACvtfcHk0lhYtRezkCfN5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyjsLzJ&md5=4d2ae56d03dc07202bb9b26a63888f5d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs13041-018-0351-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-018-0351-1%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMu%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DResolvin%2520D2%2520Protects%2520against%2520Cerebral%2520Ischemia%252FReperfusion%2520Injury%2520in%2520Rats%26jtitle%3DMol.%2520Brain%26date%3D2018%26volume%3D11%26spage%3D9%26doi%3D10.1186%2Fs13041-018-0351-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo-De la Concha, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantoja-Meléndez, C. A.</span></span> <span> </span><span class="NLM_article-title">Low-Grade Inflammation and Its Relation to Obesity and Chronic Degenerative Diseases</span>. <i>Rev. Médica del Hosp. Gen. México</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1016/j.hgmx.2016.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.hgmx.2016.06.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=101-105&issue=2&author=A.+M.+Castroauthor=L.+E.+Macedo-De+la+Conchaauthor=C.+A.+Pantoja-Mel%C3%A9ndez&title=Low-Grade+Inflammation+and+Its+Relation+to+Obesity+and+Chronic+Degenerative+Diseases&doi=10.1016%2Fj.hgmx.2016.06.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.hgmx.2016.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hgmx.2016.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%2BM.%26aulast%3DMacedo-De%2Bla%2BConcha%26aufirst%3DL.%2BE.%26aulast%3DPantoja-Mel%25C3%25A9ndez%26aufirst%3DC.%2BA.%26atitle%3DLow-Grade%2520Inflammation%2520and%2520Its%2520Relation%2520to%2520Obesity%2520and%2520Chronic%2520Degenerative%2520Diseases%26jtitle%3DRev.%2520M%25C3%25A9dica%2520del%2520Hosp.%2520Gen.%2520M%25C3%25A9xico%26date%3D2017%26volume%3D80%26issue%3D2%26spage%3D101%26epage%3D105%26doi%3D10.1016%2Fj.hgmx.2016.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pascoal, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bombassaro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalho, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coope, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correa-Da-Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignacio-Souza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razolli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catharino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velloso, L. A.</span></span> <span> </span><span class="NLM_article-title">Resolvin RvD2 Reduces Hypothalamic Inflammation and Rescues Mice from Diet-Induced Obesity</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s12974-016-0777-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2Fs12974-016-0777-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=28086928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=5&author=L.+B.+Pascoalauthor=B.+Bombassaroauthor=A.+F.+Ramalhoauthor=A.+Coopeauthor=R.+F.+Mouraauthor=F.+Correa-Da-Silvaauthor=L.+Ignacio-Souzaauthor=D.+Razolliauthor=D.+de+Oliveiraauthor=R.+Catharinoauthor=L.+A.+Velloso&title=Resolvin+RvD2+Reduces+Hypothalamic+Inflammation+and+Rescues+Mice+from+Diet-Induced+Obesity&doi=10.1186%2Fs12974-016-0777-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity</span></div><div class="casAuthors">Pascoal, Livia B.; Bombassaro, Bruna; Ramalho, Albina F.; Coope, Andressa; Moura, Rodrigo F.; Correa-da-Silva, Felipe; Ignacio-Souza, Leticia; Razolli, Daniela; de Oliveira, Diogo; Catharino, Rodrigo; Velloso, Licio A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5/1-5/12</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Diet-induced hypothalamic inflammation is an important mechanism leading to dysfunction of neurons involved in controlling body mass.  Studies have shown that polyunsatd. fats can reduce hypothalamic inflammation.  Here, we evaluated the presence and function of RvD2, a resolvin produced from docosahexaenoic acid, in the hypothalamus of mice.  Methods: Male Swiss mice were fed either chow or a high-fat diet.  RvD2 receptor and synthetic enzymes were evaluated by real-time PCR and immunofluorescence.  RvD2 was detd. by mass spectrometry.  Dietary and pharmacol. approaches were used to modulate the RvD2 system in the hypothalamus, and metabolic phenotype consequences were detd.  Results: All enzymes involved in the synthesis of RvD2 were detected in the hypothalamus and were modulated in response to the consumption of dietary satd. fats, leading to a redn. of hypothalamic RvD2.  GPR18, the receptor for RvD2, which was detected in POMC and NPY neurons, was also modulated by dietary fats.  The substitution of satd. by polyunsatd. fats in the diet resulted in increased hypothalamic RvD2, which was accompanied by reduced body mass and improved glucose tolerance.  The intracerebroventricular treatment with docosahexaenoic acid resulted in increased expression of the RvD2 synthetic enzymes, increased expression of anti-inflammatory cytokines and improved metabolic phenotype.  Finally, intracerebroventricular treatment with RvD2 resulted in reduced adiposity, improved glucose tolerance and increased hypothalamic expression of anti-inflammatory cytokines.  Conclusions: Thus, RvD2 is produced in the hypothalamus, and its receptor and synthetic enzymes are modulated by dietary fats.  The improved metabolic outcomes of RvD2 make this substance an attractive approach to treat obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2hr-c2S8EDLVg90H21EOLACvtfcHk0limOlGIZ0qlQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqt74%253D&md5=829de17df4e133456329bc78c35acf6b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12974-016-0777-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-016-0777-2%26sid%3Dliteratum%253Aachs%26aulast%3DPascoal%26aufirst%3DL.%2BB.%26aulast%3DBombassaro%26aufirst%3DB.%26aulast%3DRamalho%26aufirst%3DA.%2BF.%26aulast%3DCoope%26aufirst%3DA.%26aulast%3DMoura%26aufirst%3DR.%2BF.%26aulast%3DCorrea-Da-Silva%26aufirst%3DF.%26aulast%3DIgnacio-Souza%26aufirst%3DL.%26aulast%3DRazolli%26aufirst%3DD.%26aulast%3Dde%2BOliveira%26aufirst%3DD.%26aulast%3DCatharino%26aufirst%3DR.%26aulast%3DVelloso%26aufirst%3DL.%2BA.%26atitle%3DResolvin%2520RvD2%2520Reduces%2520Hypothalamic%2520Inflammation%2520and%2520Rescues%2520Mice%2520from%2520Diet-Induced%2520Obesity%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2017%26volume%3D14%26spage%3D5%26doi%3D10.1186%2Fs12974-016-0777-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matouk, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Moselhy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeba, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. A.</span></span> <span> </span><span class="NLM_article-title">Abnormal Cannabidiol Confers Cardioprotection in Diabetic Rats Independent of Glycemic Control</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>820</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2017.12.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejphar.2017.12.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29274332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=820&publication_year=2018&pages=256-264&author=A.+I.+Matoukauthor=A.+Tayeauthor=M.+A.+El-Moselhyauthor=G.+H.+Heebaauthor=A.+A.+Abdel-Rahman&title=Abnormal+Cannabidiol+Confers+Cardioprotection+in+Diabetic+Rats+Independent+of+Glycemic+Control&doi=10.1016%2Fj.ejphar.2017.12.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control</span></div><div class="casAuthors">Matouk, Asmaa I.; Taye, Ashraf; El-Moselhy, Mohamed A.; Heeba, Gehan H.; Abdel-Rahman, Abdel A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">820</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">256-264</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic GPR18 activation by its agonist abnormal cannabidiol (trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; abn-cbd) improves myocardial redox status and function in healthy rats.  Here, we investigated the ability of abn-cbd to alleviate diabetes-evoked cardiovascular pathol. and the contribution of GPR18 to this effect.  Four weeks after diabetes induction by streptozotocin (STZ, 55 mg/kg; i.p), male Wistar rats received abn-cbd, the GPR18 antagonist (1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-,cyclohexen-1-yl]benzene;O-1918), their combination (100μg/kg/day, i.p, each) or their vehicle for 2 wk.  Abn-cbd had no effect on diabetes-evoked cardiac hypertrophy or impaired glycemic control (hyperglycemia and hypoinsulinemia), but alleviated the assocd. redns. in left ventricular (LV) contractility (dP/dtmax) and relaxation (dP/dtmin) indexes, and the increases in LV end diastolic pressure (LVEDP) and cardiac vagal dominance.  Abn-cbd also reversed myocardial oxidative stress by restoring circulating and cardiac nitric oxide (NO) and adiponectin (ADN) levels and enhancing GPR18 expression and phosphorylation of Akt, ERK1/2 and eNOS in diabetic rats' hearts.  Concurrent GPR18 blockade (O-1918) abrogated all favorable effects of abn-cbd in diabetic rats.  Collectively, the current findings present evidence for abn-cbd alleviation of diabetes-evoked cardiovascular anomalies likely via GPR18 dependent restoration of cardiac adiponectin-Akt-eNOS signaling and the diminution of myocardial oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyVjdb6KSAPLVg90H21EOLACvtfcHk0lgQUaIzoFSZ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yksA%253D%253D&md5=96ecf995a5cb551f6ca28313e5d5a226</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.12.039%26sid%3Dliteratum%253Aachs%26aulast%3DMatouk%26aufirst%3DA.%2BI.%26aulast%3DTaye%26aufirst%3DA.%26aulast%3DEl-Moselhy%26aufirst%3DM.%2BA.%26aulast%3DHeeba%26aufirst%3DG.%2BH.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BA.%26atitle%3DAbnormal%2520Cannabidiol%2520Confers%2520Cardioprotection%2520in%2520Diabetic%2520Rats%2520Independent%2520of%2520Glycemic%2520Control%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D820%26spage%3D256%26epage%3D264%26doi%3D10.1016%2Fj.ejphar.2017.12.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denovan-Wright, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. E. M.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid and Lipid-Mediated Vasorelaxation in Retinal Microvasculature</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>735</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejphar.2014.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24751709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFSrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=735&publication_year=2014&pages=105-114&issue=1&author=J.+Macintyreauthor=A.+Dongauthor=A.+Straikerauthor=J.+Zhuauthor=S.+E.+Howlettauthor=A.+Bagherauthor=E.+Denovan-Wrightauthor=D.+Y.+Yuauthor=M.+E.+M.+Kelly&title=Cannabinoid+and+Lipid-Mediated+Vasorelaxation+in+Retinal+Microvasculature&doi=10.1016%2Fj.ejphar.2014.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature</span></div><div class="casAuthors">MacIntyre, Jessica; Dong, Alex; Straiker, Alex; Zhu, Jiequan; Howlett, Susan E.; Bagher, Amina; Denovan-Wright, Eileen; Yu, Dao-Yi; Kelly, Melanie E. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">735</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-114</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endocannabinoid system plays a role in regulation of vasoactivity in the peripheral vasculature; however, little is known about its role in regulation of the CNS microvasculature.  This study investigated the pharmacol. of cannabinoids and cannabimimetic lipids in the retinal microvasculature, a CNS vascular bed that is autoregulated.  Vessel diam. (edge detector) and calcium transients (fura-2) were recorded from segments of retinal microvasculature isolated from adult, male Fischer 344 rats.  Results showed that abnormal cannabidiol (Abn-CBD), an agonist at the putative endothelial cannabinoid receptor, CBe, inhibited endothelin 1 (ET-1) induced vasoconstriction in retinal arterioles.  These actions of Abn-CBD were independent of CB1/CB2 receptors and were not mediated by agonists for GPR55 or affected by nitric oxide synthase (NOS) inhibition.  However, the vasorelaxant effects of Abn-CBD were abolished when the endothelium was removed and were inhibited by the small Ca2+-sensitive K channel (SKCa) blocker, apamin.  The effects of the endogenous endocannabinoid metabolite, N-arachidonoyl glycine (NAGly), a putative agonist for GPR18, were virtually identical to those of Abn-CBD.  GPR18 mRNA and protein were present in the retina, and immunohistochem. demonstrated that GPR18 was localized to the endothelium of retinal vessels.  These findings demonstrate that Abn-CBD and NAGly inhibit ET-1 induced vasoconstriction in retinal arterioles by an endothelium-dependent signaling mechanism that involves SKCa channels.  The endothelial localization of GPR18 suggests that GPR18 could contribute to cannabinoid and lipid-mediated retinal vasoactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp66MSsoYTxLbVg90H21EOLACvtfcHk0lgQUaIzoFSZ_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFSrt7w%253D&md5=e32c54d01a9aa7bd745bc3869b6cbace</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DMacintyre%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DStraiker%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHowlett%26aufirst%3DS.%2BE.%26aulast%3DBagher%26aufirst%3DA.%26aulast%3DDenovan-Wright%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DD.%2BY.%26aulast%3DKelly%26aufirst%3DM.%2BE.%2BM.%26atitle%3DCannabinoid%2520and%2520Lipid-Mediated%2520Vasorelaxation%2520in%2520Retinal%2520Microvasculature%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D735%26issue%3D1%26spage%3D105%26epage%3D114%26doi%3D10.1016%2Fj.ejphar.2014.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penumarti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. A.</span></span> <span> </span><span class="NLM_article-title">The Novel Endocannabinoid Receptor GPR18 Is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.209213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1124%2Fjpet.113.209213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24431468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=29-38&issue=4&author=A.+Penumartiauthor=A.+A.+Abdel-Rahman&title=The+Novel+Endocannabinoid+Receptor+GPR18+Is+Expressed+in+the+Rostral+Ventrolateral+Medulla+and+Exerts+Tonic+Restraining+Influence+on+Blood+Pressure&doi=10.1124%2Fjpet.113.209213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure</span></div><div class="casAuthors">Penumarti, Anusha; Abdel-Rahman, Abdel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Systemic administration of the G-protein-coupled receptor 18 (GPR18) agonist abnormal cannabidiol (Abn CBD) lowers blood pressure (BP).  Whether GPR18 is expressed in the central nervous system (CNS) and plays a role in BP control is not known despite the abundance of the GPR18 ligand N-arachidonoyl glycine (NAGly) in the CNS.  Therefore, we first detd. whether GPR18 is expressed in the presympathetic tyrosine hydroxylase (TH) immunoreactive (ir) neurons of the brainstem cardiovascular regulatory nuclei.  Second, we investigated the impact of GPR18 activation and blockade on BP and heart rate (HR) and neurochem. modulators of sympathetic activity and BP.  Immunofluorescence findings revealed GPR18 expression in TH-ir neurons in the rostral ventrolateral medulla (RVLM).  Intra-RVLM GPR18 activation (Abn CBD) and blockade (O-1918, 1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-,cyclohexen-1-yl]benzene) elicited dose-dependent redns. and elevations in BP, resp., along with resp. increases and decreases in HR in conscious male Sprague-Dawley rats.  RVLM GPR18 activation increased neuronal adiponectin (ADN) and NO and reduced reactive oxygen species (ROS) levels, and GPR18 blockade reduced neuronal ADN and increased oxidative stress (i.e., ROS) in the RVLM.  Finally, we hypothesized that the negligible hypotensive effect caused by the endogenous GPR18 ligand NAGly could be due to concurrent activation of CB1R in the RVLM.  Our findings support this hypothesis because NAGly-evoked hypotension was doubled after RVLM CB1R blockade (SR 141716, rimonabant).  These findings are the first to demonstrate GPR18 expression in the RVLM and to suggest a sympathoinhibitory role for this receptor.  The findings yield new insight into the role of a novel cannabinoid receptor (GPR18) in central BP control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh8-1H3Unzl7Vg90H21EOLACvtfcHk0lh7jPT_C6meVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFGmtbs%253D&md5=a488b1086ec613d4552a113f2f4132d6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.209213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.209213%26sid%3Dliteratum%253Aachs%26aulast%3DPenumarti%26aufirst%3DA.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BA.%26atitle%3DThe%2520Novel%2520Endocannabinoid%2520Receptor%2520GPR18%2520Is%2520Expressed%2520in%2520the%2520Rostral%2520Ventrolateral%2520Medulla%2520and%2520Exerts%2520Tonic%2520Restraining%2520Influence%2520on%2520Blood%2520Pressure%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26issue%3D4%26spage%3D29%26epage%3D38%26doi%3D10.1124%2Fjpet.113.209213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al
Suleimani, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mahruqi, A. S.</span></span> <span> </span><span class="NLM_article-title">The Endogenous Lipid N-Arachidonoyl Glycine Is Hypotensive and Nitric Oxide-CGMP-Dependent Vasorelaxant</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>794</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejphar.2016.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27890711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2gt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=794&publication_year=2017&pages=209-215&author=Y.+M.+Al%0ASuleimaniauthor=A.+S.+Al+Mahruqi&title=The+Endogenous+Lipid+N-Arachidonoyl+Glycine+Is+Hypotensive+and+Nitric+Oxide-CGMP-Dependent+Vasorelaxant&doi=10.1016%2Fj.ejphar.2016.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant</span></div><div class="casAuthors">Al Suleimani, Yousuf M.; Al Mahruqi, Ahmed S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">794</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-215</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-arachidonoyl glycine (NAGLY), is the endogenous lipid that activates the G protein-couple receptor 18 (GPR18) with vasodilatory activity in resistance arteries.  This study investigates its hemodynamic effects and mechanisms of vasorelaxation.  Hemodynamic effects of NAGLY in rats were assessed using a Biopac system and its vascular responses were assessed using a wire myograph.  NAGLY (1 mg/kg) decreased blood pressure by 69.4±5.5% and reduced renal blood flow by 88±12% and the effects were not sensitive to inhibition by O-1918 (3 mg/kg).  In resistant vessels, NAGLY (1-30 μM) induced concn.- and endothelium-dependent vasorelaxation and the effect was inhibited by the nitric oxide synthase inhibitor, L-NAME (300 μM), a cGMP synthase inhibitor, ODQ (10 μM), the antagonists of "endothelial anandamide" receptor, rimonabant (3 μM) and O-1918 (10 μM) and the inhibitor of Na+/Ca2+ exchanger (NCX), KB-R7943 (10 μM).  On the other hand, NAGLY-induced vasorelaxation was not affected by CID 16020046 (GPR55 antagonist), AM 251 (cannabinoid CB1 receptor antagonist), AM 630 (cannabinoid CB2 receptor antagonist), capsazepine (TRPV1 antagonist), indomethacin (cyclooxygenase inhibitor), TRAM34 (IKCa channel blocker), iberiotoxin (BKCa channel blocker) and GW9662 (PPARγ antagonist).  At low concns. of carbachol, NAGLY potentiated carbachol-induced vasorelaxation.  NAGLY is an endothelium-dependent vasodilator and hypotensive lipid.  The vasorelaxation is predominantly via activation of nitric oxide-cGMP pathway and NCX and probably mediated by the "endothelial anandamide" receptor, while the hypotensive effect of NAGLY appears not to involve the anandamide receptor.  NAGLY also potentiates carbachol-induced vasorelaxation, the mechanism of which might involve stimulation of NO release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUHSpSD0qiWLVg90H21EOLACvtfcHk0lh7jPT_C6meVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2gt73J&md5=d27f191d65e5b22533724331f0e1807e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BSuleimani%26aufirst%3DY.%2BM.%26aulast%3DAl%2BMahruqi%26aufirst%3DA.%2BS.%26atitle%3DThe%2520Endogenous%2520Lipid%2520N-Arachidonoyl%2520Glycine%2520Is%2520Hypotensive%2520and%2520Nitric%2520Oxide-CGMP-Dependent%2520Vasorelaxant%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D794%26spage%3D209%26epage%3D215%26doi%3D10.1016%2Fj.ejphar.2016.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matouk, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Moselhy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeba, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. A.</span></span> <span> </span><span class="NLM_article-title">The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats</span>. <i>J. Cardiovasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1097/FJC.0000000000000438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1097%2FFJC.0000000000000438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27676325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps12i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2017&pages=23-33&issue=1&author=A.+I.+Matoukauthor=A.+Tayeauthor=M.+A.+El-Moselhyauthor=G.+H.+Heebaauthor=A.+A.+Abdel-Rahman&title=The+Effect+of+Chronic+Activation+of+the+Novel+Endocannabinoid+Receptor+GPR18+on+Myocardial+Function+and+Blood+Pressure+in+Conscious+Rats&doi=10.1097%2FFJC.0000000000000438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats</span></div><div class="casAuthors">Matouk, Asmaa I.; Taye, Ashraf; El-Moselhy, Mohamed A.; Heeba, Gehan H.; Abdel-Rahman, Abdel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">JCPCDT</span>;
        ISSN:<span class="NLM_cas:issn">0160-2446</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Although acute activation of the novel endocannabinoid receptor GPR18 causes hypotension, there are no reports on GPR18 expression in the heart or its chronic modulation of cardiovascular function.  In this study, after demonstrating GPR18 expression in the heart, we show that chronic (2 wk) GPR18 activation with its agonist abnormal cannabidiol (abn-cbd; 100 μg·kg·d; i.p) produced hypotension, suppressed the cardiac sympathetic dominance, and improved left ventricular (LV) function (increased the contractility index dp/dtmax and reduced LV end-diastolic pressure, LVEDP) in conscious rats.  Ex vivo studies revealed increased: (1) cardiac and plasma adiponectin (ADN) levels; (2) vascular (aortic) endothelial nitric oxide synthase (eNOS) expression, (3) vascular and serum nitric oxide (NO) levels; (4) myocardial and plasma cyclic guanosine monophosphate (cGMP) levels; (5) phosphorylation of myocardial protein kinase B (Akt) and extracellular signal regulated kinase 1/2 (ERK1/2) along with reduced myocardial reactive oxygen species (ROS) in abn-cbd treated rats.  These biochem. responses contributed to the hemodynamic responses and were GPR18-mediated because concurrent treatment with the competitive GPR18 antagonist (O-1918) abrogated the abn-cbd-evoked hemodynamic and biochem. responses.  The current findings present new evidence for a salutary cardiovascular role for GPR18, mediated, at least partly, via elevation in the levels of adiponectin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRWCRTzCTBMLVg90H21EOLACvtfcHk0lhhI7rnihIXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps12i&md5=85b4c421f70654ad6eb9f5d2fddf4feb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000438%26sid%3Dliteratum%253Aachs%26aulast%3DMatouk%26aufirst%3DA.%2BI.%26aulast%3DTaye%26aufirst%3DA.%26aulast%3DEl-Moselhy%26aufirst%3DM.%2BA.%26aulast%3DHeeba%26aufirst%3DG.%2BH.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BA.%26atitle%3DThe%2520Effect%2520of%2520Chronic%2520Activation%2520of%2520the%2520Novel%2520Endocannabinoid%2520Receptor%2520GPR18%2520on%2520Myocardial%2520Function%2520and%2520Blood%2520Pressure%2520in%2520Conscious%2520Rats%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2017%26volume%3D69%26issue%3D1%26spage%3D23%26epage%3D33%26doi%3D10.1097%2FFJC.0000000000000438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leishman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murataeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager-Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6419</span>– <span class="NLM_lpage">6426</span>, <span class="refDoi"> DOI: 10.1167/iovs.16-19437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1167%2Fiovs.16-19437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27893106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=6419-6426&issue=14&author=S.+Millerauthor=E.+Leishmanauthor=O.+Oehlerauthor=L.+Dailyauthor=N.+Murataevaauthor=J.+Wager-Millerauthor=H.+Bradshawauthor=A.+Straiker&title=Evidence+for+a+GPR18+Role+in+Diurnal+Regulation+of+Intraocular+Pressure&doi=10.1167%2Fiovs.16-19437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a GPR18 role in diurnal regulation of intraocular pressure</span></div><div class="casAuthors">Miller, Sally; Leishman, Emma; Oehler, Olivia; Daily, Laura; Murataeva, Natalia; Wager-Miller, Jim; Bradshaw, Heather; Straiker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6419-6425</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">PURPOSE.  The diurnal cycling of intraocular pressure (IOP) was first described in humans more than a century ago.  This cycling is preserved in other species.  The physiol. underpinning of this diurnal variation in IOP remains a mystery, even though elevated pressure is indicated in most forms of glaucoma, a common cause of blindness.  Once identified, the system that underlies diurnal variation would represent a natural target for therapeutic intervention.  METHODS.  Using normotensive mice, we measured the regulation of ocular lipid species by the enzymes fatty acid amide hydrolase (FAAH) and N-arachidonoyl phosphatidylethanolamine phospholipase (NAPE-PLD), mRNA expression of these enzymes, and their functional role in diurnal regulation of IOP.  RESULTS.  We now report that NAPE-PLD and FAAH mice do not exhibit a diurnal cycling of IOP.  These enzymes produce and break down acylethanolamines, including the endogenous cannabinoid anandamide.  The diurnal lipid profile in mice shows that levels of most N-acyl ethanolamines and, intriguingly, N-arachidonoyl glycine (NAGly), decline at night: NAGly is a metabolite of arachidonoyl ethanolamine and a potent agonist at GPR18 that lowers intraocular pressure.  The GPR18 blocker O1918 raises IOP during the day when pressure is low, but not at night.  Quant. PCR anal. shows that FAAH mRNA levels rise with pressure, suggesting that FAAH mediates the changes in pressure.  CONCLUSIONS.  Our results support FAAH-dependent NAGly action at GPR18 as the physiol. basis of the diurnal variation of intraocular pressure in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr8-FhpMpQrbVg90H21EOLACvtfcHk0lhhI7rnihIXJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKrs7w%253D&md5=0171f0ae960f2796b190ceced467b043</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1167%2Fiovs.16-19437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.16-19437%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DLeishman%26aufirst%3DE.%26aulast%3DOehler%26aufirst%3DO.%26aulast%3DDaily%26aufirst%3DL.%26aulast%3DMurataeva%26aufirst%3DN.%26aulast%3DWager-Miller%26aufirst%3DJ.%26aulast%3DBradshaw%26aufirst%3DH.%26aulast%3DStraiker%26aufirst%3DA.%26atitle%3DEvidence%2520for%2520a%2520GPR18%2520Role%2520in%2520Diurnal%2520Regulation%2520of%2520Intraocular%2520Pressure%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2016%26volume%3D57%26issue%3D14%26spage%3D6419%26epage%3D6426%26doi%3D10.1167%2Fiovs.16-19437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leishman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span> <span> </span><span class="NLM_article-title">Δ 9 -Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5904</span>– <span class="NLM_lpage">5911</span>, <span class="refDoi"> DOI: 10.1167/iovs.18-24838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1167%2Fiovs.18-24838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30550613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWiur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=5904-5911&issue=15&author=S.+Millerauthor=L.+Dailyauthor=E.+Leishmanauthor=H.+Bradshawauthor=A.+Straiker&title=%CE%94+9+-Tetrahydrocannabinol+and+Cannabidiol+Differentially+Regulate+Intraocular+Pressure&doi=10.1167%2Fiovs.18-24838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">D9-tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure</span></div><div class="casAuthors">Miller, Sally; Daily, Laura; Leishman, Emma; Bradshaw, Heather; Straiker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5904-5911</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">Purpose: It has been known for nearly 50 years that cannabis and the psychoactive constituent D9-tetrahydrocannabinol (THC) reduce intraocular pressure (IOP).  Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a major cause of blindness.  THC likely acts via one of the known cannabinoid-related receptors (CB1, CB2, GPR18, GPR119, GPR55) but this has never been detd. explicitly.  Cannabidiol (CBD) is a second major constituent of cannabis that has been found to be without effect on IOP in most studies.  Methods: Effects of topically applied THC and CBD were tested in living mice by using tonometry and measurements of mRNA levels.  In addn. the lipidomic consequences of CBD treatment were tested by using lipid anal.  Results: We now report that a single topical application of THC lowered IOP substantially (∼28%) for 8 h in male mice.  This effect is due to combined activation of CB1 and GPR18 receptors each of which has been shown to lower ocular pressure when activated.  We also found that the effect was sex-dependent, being stronger in male mice, and that mRNA levels of CB1 and GPR18 were higher in males.  Far from inactive, CBD was found to have two opposing effects on ocular pressure, one of which involved antagonism of tonic signaling.  CBD prevents THC from lowering ocular pressure.  Conclusions: We conclude that THC lowers IOP by activating two receptors-CB1 and GPR18-but in a sex-dependent manner.  CBD, contrary to expectation, has two opposing effects on IOP and can interfere with the effects of THC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFU0ff5TSO4bVg90H21EOLACvtfcHk0ljBmOw-TsH5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWiur7O&md5=7c7bc1116a1e9686d450cf8cf3c1f775</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1167%2Fiovs.18-24838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.18-24838%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DDaily%26aufirst%3DL.%26aulast%3DLeishman%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DH.%26aulast%3DStraiker%26aufirst%3DA.%26atitle%3D%25CE%2594%25209%2520-Tetrahydrocannabinol%2520and%2520Cannabidiol%2520Differentially%2520Regulate%2520Intraocular%2520Pressure%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2018%26volume%3D59%26issue%3D15%26spage%3D5904%26epage%3D5911%26doi%3D10.1167%2Fiovs.18-24838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grivennikov, S. I.</span></span> <span> </span><span class="NLM_article-title">Inflammation and Cancer: Triggers, Mechanisms, and Consequences</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2019.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.immuni.2019.06.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31315034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlyls7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2019&pages=27-41&issue=1&author=F.+R.+Gretenauthor=S.+I.+Grivennikov&title=Inflammation+and+Cancer%3A+Triggers%2C+Mechanisms%2C+and+Consequences&doi=10.1016%2Fj.immuni.2019.06.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and Cancer: Triggers, Mechanisms, and Consequences</span></div><div class="casAuthors">Greten, Florian R.; Grivennikov, Sergei I.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-41</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis.  Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME).  Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics.  Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis.  We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations.  Defining the cornerstone rules of engagement governing mol. and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-8xulWOP50bVg90H21EOLACvtfcHk0ljBmOw-TsH5pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlyls7jP&md5=0d39409f4a26c18100163b7b49367d46</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2019.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2019.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DGrivennikov%26aufirst%3DS.%2BI.%26atitle%3DInflammation%2520and%2520Cancer%253A%2520Triggers%252C%2520Mechanisms%252C%2520and%2520Consequences%26jtitle%3DImmunity%26date%3D2019%26volume%3D51%26issue%3D1%26spage%3D27%26epage%3D41%26doi%3D10.1016%2Fj.immuni.2019.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.-R.</span></span> <span> </span><span class="NLM_article-title">Identification of an Eight-Gene Signature for Survival Prediction for Patients with Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis</span>. <i>PeerJ</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e6548</span> <span class="refDoi"> DOI: 10.7717/peerj.6548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.7717%2Fpeerj.6548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30918751" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&author=G.-J.+Qiaoauthor=L.+Chenauthor=J.-C.+Wuauthor=Z.-R.+Li&title=Identification+of+an+Eight-Gene+Signature+for+Survival+Prediction+for+Patients+with+Hepatocellular+Carcinoma+Based+on+Integrated+Bioinformatics+Analysis&doi=10.7717%2Fpeerj.6548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.7717%2Fpeerj.6548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7717%252Fpeerj.6548%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DG.-J.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.-C.%26aulast%3DLi%26aufirst%3DZ.-R.%26atitle%3DIdentification%2520of%2520an%2520Eight-Gene%2520Signature%2520for%2520Survival%2520Prediction%2520for%2520Patients%2520with%2520Hepatocellular%2520Carcinoma%2520Based%2520on%2520Integrated%2520Bioinformatics%2520Analysis%26jtitle%3DPeerJ%26date%3D2019%26volume%3D7%26doi%3D10.7717%2Fpeerj.6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span> <span> </span><span class="NLM_article-title">Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">e920212</span> <span class="refDoi"> DOI: 10.12659/MSM.920212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.12659%2FMSM.920212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32251269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1Kls7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&author=H.+Renauthor=D.+Huauthor=Y.+Maoauthor=X.+Su&title=Identification+of+Genes+with+Prognostic+Value+in+the+Breast+Cancer+Microenvironment+Using+Bioinformatics+Analysis&doi=10.12659%2FMSM.920212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of genes with prognostic value in the breast cancer microenvironment using bioinformatics analysis</span></div><div class="casAuthors">Ren, Haoyu; Hu, Daixing; Mao, Yu; Su, Xinliang</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e920212</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1643-3750</span>.
    
            (<span class="NLM_cas:orgname">International Scientific Information, Inc.</span>)
        </div><div class="casAbstract">Background: Stromal and immune cells play essential roles in the development of breast cancer (BC).  This study was conducted to identify prognosis-related genes from the tumor microenvironment.  Material/Methods: The gene expression profiles of 622 BC samples were downloaded from TCGA (The Cancer Genome Atlas) database.  Stromal and immune scores were calcd. by using the Est. (Estn. of STromal and Immune cells in MAlignant Tumors using Expression data) algorithm.  Then, differentially expressed genes (DEGs) between the high score group and the low score group were screened.  The intersecting DEGs were selected through Venn diagrams, and survival anal. was conducted.  Functional and pathway enrichment analyses were performed using the DAVID (Database for Annotation, Visualization and Integrated Discovery), and a protein-protein interaction (PPI) network was constructed with the STRING database and Cytoscape.  These genes were validated for prognostic value by use of the KM (Kaplan-Meier) plotter tool.  Results: The low immune score group was assocd. with a poor prognosis.  However, there was no difference in the prognosis between the high and low stromal score groups.  A total of 248 intersecting DEGs were found in BC, and 61 genes were significantly assocd. with the prognosis of BC patients in the TCGA database.  These genes were enriched in the immune response, components of the plasma membrane, and receptor activity.  Furthermore, in the validation group, 31 of 61 genes were significantly assocd. with prognosis.  Conclusions: Our bioinformatics anal. identified 31 tumor microenvironment-related genes as potential prognostic predictors for breast cancer patients.  Some of these genes that have not been widely investigated previously, such as CXCL9, GPR18, S1PR4, SASH3, and PYH1N1, might be addnl. predictive factors for BC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAQAkEbi1KuLVg90H21EOLACvtfcHk0lgnMuzUz9dhxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1Kls7jK&md5=47bf4866b81236136cbbd2062a0841f8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.12659%2FMSM.920212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.920212%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DX.%26atitle%3DIdentification%2520of%2520Genes%2520with%2520Prognostic%2520Value%2520in%2520the%2520Breast%2520Cancer%2520Microenvironment%2520Using%2520Bioinformatics%2520Analysis%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2020%26volume%3D26%26doi%3D10.12659%2FMSM.920212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atabaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roohbakhsh, A.</span></span> <span> </span><span class="NLM_article-title">The Role of Orphan G Protein-Coupled Receptors in the Modulation of Pain: A Review</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">April</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2018.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.lfs.2018.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30236869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVejsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2018&pages=59-69&issue=April&author=F.+Nourbakhshauthor=R.+Atabakiauthor=A.+Roohbakhsh&title=The+Role+of+Orphan+G+Protein-Coupled+Receptors+in+the+Modulation+of+Pain%3A+A+Review&doi=10.1016%2Fj.lfs.2018.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of orphan G protein-coupled receptors in the modulation of pain: A review</span></div><div class="casAuthors">Nourbakhsh, Fahimeh; Atabaki, Rabi; Roohbakhsh, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) comprise a large no. of receptors.  Orphan GPCRs are divided into six families.  These groups contain orphan receptors for which the endogenous ligands are unclear.  They have various physiol. effects in the body and have the potential to be used in the treatment of different diseases.  Considering their important role in the central and peripheral nervous system, their role in the treatment of pain has been the subject of some recent studies.  At present, there are effective therapeutics for the treatment of pain including opioid medications and non-steroidal anti-inflammatory drugs.  However, the side effects of these drugs and the risks of tolerance and dependence remain a major problem.  In addn., neuropathic pain is a condition that does not respond to currently available analgesic medications well.  In the present review article, we aimed to review the most recent findings regarding the role of orphan GPCRs in the treatment of pain.  Accordingly, based on the preclin. findings, the role of GPR3, GPR7, GPR8, GPR18, GPR30, GPR35, GPR40, GPR55, GPR74, and GPR147 in the treatment of pain was discussed.  The present study highlights the role of orphan GPCRs in the modulation of pain and implies that these receptors are potential new targets for finding better and more efficient therapeutics for the management of pain particularly neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeLh8oJ6vxmbVg90H21EOLACvtfcHk0lgnMuzUz9dhxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVejsb7M&md5=dece17ced834a6217fbb2f446400eb82</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2018.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2018.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DNourbakhsh%26aufirst%3DF.%26aulast%3DAtabaki%26aufirst%3DR.%26aulast%3DRoohbakhsh%26aufirst%3DA.%26atitle%3DThe%2520Role%2520of%2520Orphan%2520G%2520Protein-Coupled%2520Receptors%2520in%2520the%2520Modulation%2520of%2520Pain%253A%2520A%2520Review%26jtitle%3DLife%2520Sci.%26date%3D2018%26volume%3D212%26issue%3DApril%26spage%3D59%26epage%3D69%26doi%3D10.1016%2Fj.lfs.2018.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Relieving Radicular Pain Is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2384</span>– <span class="NLM_lpage">2392</span>, <span class="refDoi"> DOI: 10.1007/s11064-018-2666-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1007%2Fs11064-018-2666-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30443715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1eisbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=2384-2392&issue=12&author=L.-y.+Zhangauthor=Z.-h.+Liuauthor=Q.+Zhuauthor=S.+Wenauthor=C.-x.+Yangauthor=Z.-j.+Fuauthor=T.+Sun&title=Resolvin+D2+Relieving+Radicular+Pain+Is+Associated+with+Regulation+of+Inflammatory+Mediators%2C+Akt%2FGSK-3%CE%B2+Signal+Pathway+and+GPR18&doi=10.1007%2Fs11064-018-2666-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18</span></div><div class="casAuthors">Zhang, Lan-yu; Liu, Zhi-hua; Zhu, Qing; Wen, Shuang; Yang, Cong-xian; Fu, Zhi-jian; Sun, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2384-2392</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuroinflammation induced by protruded nucleus pulposus (NP) has been shown to play a significant role in facilitation of radicular pain.  Resolvin D2 (RvD2), a novel member of resolvin family, exhibits potent anti-inflammatory, pro-resolving and antinociceptive effects.  But the effect of RvD2 in radicular pain remains unknown.  The radicular pain rat models were induced by application of NP to L5 dorsal root ganglion.  Each animal received intrathecal injections of vehicle or RvD2 (10 ng μl-1 or 100 ng μl-1).  Mech. thresholds were detd. by measuring the paw withdrawal threshold for 7 days.  The expressions of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and transforming growth factor-β1 (TGF-β1) in ipsilateral lumbar segment of rat spinal dorsal horns were measured by using ELISA and real time-PCR.  Western blot was used to measure the expressions of phosphorylated Akt (p-Akt) and phosphorylated glycogen synthase kinase 3 beta (p-GSK-3β).  The expressions and distributions of RvD2 receptor, G-protein-coupled receptor 18 (GPR18), were also explored in the spinal cord of rats by using double-label immunofluorescence.  RvD2 treatment caused significant redns. in the intensity of mech. hypersensitivity and spinal expressions of TNF-α and IL-6.  Meanwhile, RvD2 increased the expressions of TGF-β1 and regulated Akt/GSK-3β signaling.  Furthermore, immunofluorescence showed that GPR18 colocalized with neurons and astrocytes in spinal cord.  The results suggested that RvD2 might attenuate mech. allodynia via regulating the expressions of inflammatory mediators and activation of Akt/GSK-3β signal pathway.  RvD2 might offer a hopeful method for radicular pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk2iA5SsdarLVg90H21EOLACvtfcHk0lh2MEa4T2vMaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1eisbzN&md5=5ce4fc174906734b09220a8655a2b5ac</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs11064-018-2666-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-018-2666-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-y.%26aulast%3DLiu%26aufirst%3DZ.-h.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-x.%26aulast%3DFu%26aufirst%3DZ.-j.%26aulast%3DSun%26aufirst%3DT.%26atitle%3DResolvin%2520D2%2520Relieving%2520Radicular%2520Pain%2520Is%2520Associated%2520with%2520Regulation%2520of%2520Inflammatory%2520Mediators%252C%2520Akt%252FGSK-3%25CE%25B2%2520Signal%2520Pathway%2520and%2520GPR18%26jtitle%3DNeurochem.%2520Res.%26date%3D2018%26volume%3D43%26issue%3D12%26spage%3D2384%26epage%3D2392%26doi%3D10.1007%2Fs11064-018-2666-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero-Alba, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barragán-Iglesias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Hernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez-Moráles, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granados-Soto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condés-Lara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marichal-Cancino, B. A.</span></span> <span> </span><span class="NLM_article-title">Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1496</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3389%2Ffphar.2018.01496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30670965" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1496&author=R.+Guerrero-Albaauthor=P.+Barrag%C3%A1n-Iglesiasauthor=A.+Gonz%C3%A1lez-Hern%C3%A1ndezauthor=E.+E.+Valdez-Mor%C3%A1lesauthor=V.+Granados-Sotoauthor=M.+Cond%C3%A9s-Laraauthor=M.+G.+Rodr%C3%ADguezauthor=B.+A.+Marichal-Cancino&title=Some+Prospective+Alternatives+for+Treating+Pain%3A+The+Endocannabinoid+System+and+Its+Putative+Receptors+GPR18+and+GPR55&doi=10.3389%2Ffphar.2018.01496"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01496%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrero-Alba%26aufirst%3DR.%26aulast%3DBarrag%25C3%25A1n-Iglesias%26aufirst%3DP.%26aulast%3DGonz%25C3%25A1lez-Hern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DValdez-Mor%25C3%25A1les%26aufirst%3DE.%2BE.%26aulast%3DGranados-Soto%26aufirst%3DV.%26aulast%3DCond%25C3%25A9s-Lara%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DM.%2BG.%26aulast%3DMarichal-Cancino%26aufirst%3DB.%2BA.%26atitle%3DSome%2520Prospective%2520Alternatives%2520for%2520Treating%2520Pain%253A%2520The%2520Endocannabinoid%2520System%2520and%2520Its%2520Putative%2520Receptors%2520GPR18%2520and%2520GPR55%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D9%26spage%3D1496%26doi%3D10.3389%2Ffphar.2018.01496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Khoury, J.</span></span> <span> </span><span class="NLM_article-title">Microglia in Neurodegeneration</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1359</span>– <span class="NLM_lpage">1369</span>, <span class="refDoi"> DOI: 10.1038/s41593-018-0242-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fs41593-018-0242-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30258234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSmsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2018&pages=1359-1369&issue=10&author=S.+Hickmanauthor=S.+Izzyauthor=P.+Senauthor=L.+Morsettauthor=J.+El+Khoury&title=Microglia+in+Neurodegeneration&doi=10.1038%2Fs41593-018-0242-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia in neurodegeneration</span></div><div class="casAuthors">Hickman, Suzanne; Izzy, Saef; Sen, Pritha; Morsett, Liza; El Khoury, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1359-1369</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The neuroimmune system is involved in development, normal functioning, aging, and injury of the central nervous system.  Microglia, first described a century ago, are the main neuroimmune cells and have three essential functions: a sentinel function involved in const. sensing of changes in their environment, a housekeeping function that promotes neuronal well-being and normal operation, and a defense function necessary for responding to such changes and providing neuroprotection.  Microglia use a defined armamentarium of genes to perform these tasks.  In response to specific stimuli, or with neuroinflammation, microglia also have the capacity to damage and kill neurons.  Injury to neurons in Alzheimer's, Parkinson's, Huntington's, and prion diseases, as well as in amyotrophic lateral sclerosis, frontotemporal dementia, and chronic traumatic encephalopathy, results from disruption of the sentinel or housekeeping functions and dysregulation of the defense function and neuroinflammation.  Pathways assocd. with such injury include several sensing and housekeeping pathways, such as the Trem2, Cx3cr1 and progranulin pathways, which act as immune checkpoints to keep the microglial inflammatory response under control, and the scavenger receptor pathways, which promote clearance of injurious stimuli.  Peripheral interference from systemic inflammation or the gut microbiome can also alter progression of such injury.  Initiation or exacerbation of neurodegeneration results from an imbalance between these microglial functions; correcting such imbalance may be a potential mode for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot-4F88NHuQbVg90H21EOLACvtfcHk0lgsoR3i06INRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSmsbrI&md5=2a00c64af74e7e3229e1edab9963ae7d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fs41593-018-0242-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41593-018-0242-x%26sid%3Dliteratum%253Aachs%26aulast%3DHickman%26aufirst%3DS.%26aulast%3DIzzy%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DP.%26aulast%3DMorsett%26aufirst%3DL.%26aulast%3DEl%2BKhoury%26aufirst%3DJ.%26atitle%3DMicroglia%2520in%2520Neurodegeneration%26jtitle%3DNat.%2520Neurosci.%26date%3D2018%26volume%3D21%26issue%3D10%26spage%3D1359%26epage%3D1369%26doi%3D10.1038%2Fs41593-018-0242-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roskowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">Δ9-THC and N-Arachidonoyl Glycine Regulate BV-2 Microglial Morphology and Cytokine Release Plasticity: Implications for Signaling at GPR18</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">162</span>, <span class="refDoi"> DOI: 10.3389/fphar.2013.00162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3389%2Ffphar.2013.00162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24427137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BC2czls1SjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=162&author=D.+McHughauthor=D.+Roskowskiauthor=S.+Xieauthor=H.+B.+Bradshaw&title=%CE%949-THC+and+N-Arachidonoyl+Glycine+Regulate+BV-2+Microglial+Morphology+and+Cytokine+Release+Plasticity%3A+Implications+for+Signaling+at+GPR18&doi=10.3389%2Ffphar.2013.00162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18</span></div><div class="casAuthors">McHugh Douglas; Roskowski Daniel; Xie Sisi; Bradshaw Heather B</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">162</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Microglial cells are extremely plastic and undergo a variety of CNS-prompted shape changes relative to their location and current role.  Signaling molecules from neurons also regulate microglial cytokine production.  Neurons are known to employ the endogenous cannabinoid system to communicate with other cells of the CNS.  N-arachidonoyl glycine (NAGly) and Δ(9)-tetrahydrocannabinol (Δ(9)-THC) signaling via GPR18 has been introduced as an important new target in microglial-neuronal communication.  Our hypothesis is that endogenous NAGly-GPR18 signaling regulates phenotypic shape and cytokine production in microglia, and is mimicked by Δ(9)-THC in the BV-2 microglia model system.  BV-2 microglia were exposed to NAGly and Δ(9)-THC or Vh for 12 h, which resulted in significant differences in the cell morphologies expressed.  Cannabidiol (CBD) was effective at antagonizing the effects of both NAGly and Δ(9)-THC.  Using ELISA-based microarrays, BV-2 microglia were exposed to NAGly and Δ(9)-THC or Vh for 3 h and the presence of 40 cytokines in the culture media quantified.  Production of Axl, CD40, IGF-I, OPN, and Pro-MMP-9 were significantly altered by NAGly and Δ(9)-THC, and antagonized by CBD.  These data add to an emerging profile that emphasizes NAGly as a component of an endogenous system present in the CNS that tightly integrates microglial proliferation, recruitment, and adhesion with neuron-glia interactivity and tissue remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9ZHjvbyki-EwlCcfExbvbfW6udTcc2ebCGC9cNdv7-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czls1SjtA%253D%253D&md5=932bc29aa961119c6670e9300a57bd61</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00162%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DRoskowski%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3D%25CE%25949-THC%2520and%2520N-Arachidonoyl%2520Glycine%2520Regulate%2520BV-2%2520Microglial%2520Morphology%2520and%2520Cytokine%2520Release%2520Plasticity%253A%2520Implications%2520for%2520Signaling%2520at%2520GPR18%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D4%26spage%3D162%26doi%3D10.3389%2Ffphar.2013.00162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabiec, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothgänger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehghani, F.</span></span> <span> </span><span class="NLM_article-title">Protective Effect of N-Arachidonoyl Glycine-GPR18 Signaling after Excitotoxical Lesion in Murine Organotypic Hippocampal Slice Cultures</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1266</span>, <span class="refDoi"> DOI: 10.3390/ijms20061266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3390%2Fijms20061266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFWntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=1266&issue=6&author=U.+Grabiecauthor=T.+Hohmannauthor=C.+Ghadbanauthor=C.+Rothg%C3%A4ngerauthor=D.+Wongauthor=A.+Antoniettiauthor=T.+Grothauthor=K.+Mackieauthor=F.+Dehghani&title=Protective+Effect+of+N-Arachidonoyl+Glycine-GPR18+Signaling+after+Excitotoxical+Lesion+in+Murine+Organotypic+Hippocampal+Slice+Cultures&doi=10.3390%2Fijms20061266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of N-arachidonoyl glycine-GPR18 signaling after excitotoxical lesion in murine organotypic hippocampal slice cultures</span></div><div class="casAuthors">Grabiec, Urszula; Hohmann, Tim; Ghadban, Chal; Rothgaenger, Candy; Wong, Daniel; Antonietti, Alexandra; Groth, Thomas; Mackie, Ken; Dehghani, Faramarz</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1266</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">N-arachidonoyl glycine (NAGly) is an endocannabinoid involved in the regulation of different immune cells.  It was shown to activate the GPR18 receptor, which was postulated to switch macrophages from cytotoxic to reparative.  To study GPR18 expression and neuroprotection after NAGly treatment we used excitotoxically lesioned organotypic hippocampal slice cultures (OHSC).  The effect of NAGly was also tested in isolated microglia and astrocytes as these cells play a crucial role during neuronal injury.  In the present study, the GPR18 receptor was found in OHSC at mRNA level and was downregulated after N-Methyl-D-aspartate (NMDA) treatment at a single time point.  Furthermore, treatment with NAGly reduced neuronal damage and this effect was abolished by GPR18 and cannabinoid receptor (CB)2 receptor antagonists.  The activation but not motility of primary microglia and astrocytes was influenced when incubated with NAGly.  However, NAGly alone reduced the phosphorylation of Akt but no changes in activation of the p44/42 and p38 MAPK and CREB pathways in BV2 cells could be obsd.  Given NAGly mediated actions we speculate that GPR18 and its ligand NAGly are modulators of glial and neuronal cells during neuronal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJHLl12_4CLVg90H21EOLACvtfcHk0lgsoR3i06INRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFWntb0%253D&md5=e45cac1dafd085b272e69d577df5ab8c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fijms20061266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20061266%26sid%3Dliteratum%253Aachs%26aulast%3DGrabiec%26aufirst%3DU.%26aulast%3DHohmann%26aufirst%3DT.%26aulast%3DGhadban%26aufirst%3DC.%26aulast%3DRothg%25C3%25A4nger%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DAntonietti%26aufirst%3DA.%26aulast%3DGroth%26aufirst%3DT.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DDehghani%26aufirst%3DF.%26atitle%3DProtective%2520Effect%2520of%2520N-Arachidonoyl%2520Glycine-GPR18%2520Signaling%2520after%2520Excitotoxical%2520Lesion%2520in%2520Murine%2520Organotypic%2520Hippocampal%2520Slice%2520Cultures%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D1266%26doi%3D10.3390%2Fijms20061266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weimar, C. H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macklon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post
Uiterweer, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosens, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellersen, B.</span></span> <span> </span><span class="NLM_article-title">The Motile and Invasive Capacity of Human Endometrial Stromal Cells: Implications for Normal and Impaired Reproductive Function</span>. <i>Hum. Reprod. Update</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1093/humupd/dmt025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1093%2Fhumupd%2Fdmt025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23827985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=542-557&issue=5&author=C.+H.+E.+Weimarauthor=N.+S.+Macklonauthor=E.+D.+Post%0AUiterweerauthor=J.+J.+Brosensauthor=B.+Gellersen&title=The+Motile+and+Invasive+Capacity+of+Human+Endometrial+Stromal+Cells%3A+Implications+for+Normal+and+Impaired+Reproductive+Function&doi=10.1093%2Fhumupd%2Fdmt025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function</span></div><div class="casAuthors">Weimar, Charlotte H. E.; Macklon, Nick S.; Post Uiterweer, Emiel D.; Brosens, Jan J.; Gellersen, Birgit</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction Update</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-557</span>CODEN:
                <span class="NLM_cas:coden">HRUPF8</span>;
        ISSN:<span class="NLM_cas:issn">1355-4786</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  BACKGROUND Mechanisms underlying early reproductive loss in the human are beginning to be elucidated.  The migratory and invasive capacity of human endometrial stromal cells (ESCs) is increasingly recognized to contribute to the intense tissue remodelling assocd. with embryo implantation, trophoblast invasion and endometrial regeneration.  In this review, we examine the signals and mechanisms that control ESC migration and invasion and assess how deregulation of these cell functions contributes to common reproductive disorders.  METHODS The PubMed database was searched for publications on motility and invasiveness of human ESCs in normal endometrial function and in reproductive disorders including implantation failure, recurrent pregnancy loss (RPL), endometriosis and adenomyosis, covering the period 2000-2012.  RESULTS Increasing evidence suggests that implantation failure and RPL involve abnormal migratory responses of decidualizing ESCs to embryo and trophoblast signals.  Numerous reports indicate that endometriosis, as well as adenomyosis, is assocd. with increased basal and stimulated invasiveness of ESCs and their progenitor cells, suggesting a link between a heightened menstrual repair response and the formation of ectopic implants.  Migration and invasiveness of ESCs are controlled by a complex array of hormones, growth factors, chemokines and inflammatory mediators, and involve signalling through Rho GTPases, phosphatidylinositol-3-kinase and mitogen-activated protein kinase pathways.  CONCLUSIONS Novel concepts are extending our understanding of the key functions of ESCs in effecting tissue repair imposed by cyclic menstruation and parturition.  Migration of decidualizing ESCs also serves to support blastocyst implantation and embryo selection through discriminate motile responses directed by embryo quality.  Targeting regulatory mols. holds promise for developing new strategies for the treatment of reproductive disorders such as endometriosis and recurrent miscarriage; and harnessing the migratory capacity of progenitor mesenchymal stem cells in the endometrium may offer new opportunities in regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolsTOGNu9eAbVg90H21EOLACvtfcHk0lhXdPJnFoXPvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7nJ&md5=ed835adc1b943b4b7c362dc85a8286c9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fhumupd%2Fdmt025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumupd%252Fdmt025%26sid%3Dliteratum%253Aachs%26aulast%3DWeimar%26aufirst%3DC.%2BH.%2BE.%26aulast%3DMacklon%26aufirst%3DN.%2BS.%26aulast%3DPost%2BUiterweer%26aufirst%3DE.%2BD.%26aulast%3DBrosens%26aufirst%3DJ.%2BJ.%26aulast%3DGellersen%26aufirst%3DB.%26atitle%3DThe%2520Motile%2520and%2520Invasive%2520Capacity%2520of%2520Human%2520Endometrial%2520Stromal%2520Cells%253A%2520Implications%2520for%2520Normal%2520and%2520Impaired%2520Reproductive%2520Function%26jtitle%3DHum.%2520Reprod.%2520Update%26date%3D2013%26volume%3D19%26issue%3D5%26spage%3D542%26epage%3D557%26doi%3D10.1093%2Fhumupd%2Fdmt025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. A.</span></span> <span> </span><span class="NLM_article-title">Lipid G Protein-Coupled Receptor Ligand Identification Using Beta-Arrestin Path Hunter Assay</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">12328</span>– <span class="NLM_lpage">12338</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806516200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1074%2Fjbc.M806516200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=19286662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=12328-12338&issue=18&author=H.+Yinauthor=A.+Chuauthor=W.+Liauthor=B.+Wangauthor=F.+Sheltonauthor=F.+Oteroauthor=D.+G.+Nguyenauthor=J.+S.+Caldwellauthor=Y.+A.+Chen&title=Lipid+G+Protein-Coupled+Receptor+Ligand+Identification+Using+Beta-Arrestin+Path+Hunter+Assay&doi=10.1074%2Fjbc.M806516200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter Assay</span></div><div class="casAuthors">Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12328-12338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A growing no. of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors.  These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports.  We used the β-arrestin PathHunter assay system, a newly developed, generic GPCR assay format that measures β-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing.  This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation.  We screened a large no. of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of ∼400 lipid mols. to try to identify the receptor ligand in an unbiased fashion.  GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate.  The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids.  G2A receptor was confirmed to be an oxidized free fatty acid receptor.  In addn., we discovered that 3,3'-diindolylmethane, a dietary mol. from cruciferous vegetables, which has known anti-cancer properties, to be a CB2 receptor partial agonist, with binding affinity around 1 μM.  The anti-inflammatory effect of 3,3'-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQnRS1OGXeVrVg90H21EOLACvtfcHk0lhXdPJnFoXPvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D&md5=beb6f1fe11d9dab29329d2a2a85ab051</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806516200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806516200%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DShelton%26aufirst%3DF.%26aulast%3DOtero%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DD.%2BG.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DY.%2BA.%26atitle%3DLipid%2520G%2520Protein-Coupled%2520Receptor%2520Ligand%2520Identification%2520Using%2520Beta-Arrestin%2520Path%2520Hunter%2520Assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D18%26spage%3D12328%26epage%3D12338%26doi%3D10.1074%2Fjbc.M806516200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berjukow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döring, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froschmayr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, S.</span></span> <span> </span><span class="NLM_article-title">Endogenous Calcium Channels in Human Embryonic Kidney (HEK293) Cells</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1996.tb15463.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1476-5381.1996.tb15463.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=8762103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Git7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=748-754&issue=3&author=S.+Berjukowauthor=F.+D%C3%B6ringauthor=M.+Froschmayrauthor=M.+Grabnerauthor=H.+Glossmannauthor=S.+Hering&title=Endogenous+Calcium+Channels+in+Human+Embryonic+Kidney+%28HEK293%29+Cells&doi=10.1111%2Fj.1476-5381.1996.tb15463.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous calcium channels in human embryonic kidney (HEK293) cells</span></div><div class="casAuthors">Berjukow, Stanislav; Doering, Frank; Froschmayr, Monika; Grabner, Manfred; Glossmann, Hartmut; Hering, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">748-754</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">We have identified endogenous calcium channel currents in HEK293 cells.  Whole cell endogenous current (ISr -HEK) were studied in single HEK293 cells with 10 mM strontium as the charge carrier by the patch clamp technique.  The kinetic properties and pharmacol. features of ISr-HEK were characterized and compared with the properties of a heterologously expressed chimeric L-type calcium channel construct.  ISr-HEK activated on depolarization to voltage pos. of -40 mV.  It had transient current kinetics with a time to peak of 16 ± 1.4 ms (n = 7) and an activation times const. of 52 ± 5 ms (n = 7) at a test potential of 0 mV.  The voltage for half maximal activation was -19.0 U 1.5 mV (n = 7) and the voltage for half maximal steady-state inactivation was -39.7 ± 2.3 mV (n = 7).  Block of Isr-HEK by the dihydropyridine isradipine was not selective: 1 μM (+) and (-)- isradipine inhibited the current by 30 ± 4% (n = 3) and 29 ± 2% (n = 4) resp.  (+)-Isradipine and (=)-isradipine (10 μM) inhibited ISr-HEK by 89-4% (n = 5) and 88 ± 8% (n = 3) resp.  The 7-bromo substituted (±)-isradipine (VO2605, 10 μM) which is almost inactive on L-type calcium channels also inhibited ISr-HEK (83 ± 9%, n = 3) as was obsd. for 10 μM (-)-nimodipine (78 ± 6%, n =).  Interestingly, 10 μM (±)-Bay K 8644 (n = 5) had no effect on the current.  ISr-HEK was only slightly inhibited by the cone snail toxins ω-CTx GVIA (1 μM, inhibition by 17 ± 3%, n = 4) and ω-CTx MVIIC (1 μM, inhibition by 20 ± 3%, n = 4).  The funnel web spider toxin ω-Aga IVA (200 nM) inhibited ISr-HEK by 19 ± 2%, (n = 4).  In cells expressing ISr-HEK, max. inward current densities of 0.24 ± 0.03 pA/pF and 0.39 ± 0.7 pA/pF (at a test potential of -10 mV) were estd. in two different batches of HEK293 cells.  The c.d. increased to 0.88 ± 0.18 pA/pF or 1.11 ± 0.2 pA/pF resp., if the cells were cultured for 4 days in serum-free medium.  Co-expression of a chimeric L-type calcium channel construct revealed that ISr-HEK and L-type calcium channel currents could be distinguished by their different voltage-dependencies and current kinetics.  The c.d. after heterologous expression of the L-type α1 subunit chimera was estd. to be about ten times higher in serum contg. medium (2.14 ± 0.45 pA/pF) than that of ISr-HEK under the same conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGvxkIfqTGM7Vg90H21EOLACvtfcHk0lisQV2M2dc-3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Git7g%253D&md5=1e619ff0d1cc315b804b7b6645786da7</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15463.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15463.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerjukow%26aufirst%3DS.%26aulast%3DD%25C3%25B6ring%26aufirst%3DF.%26aulast%3DFroschmayr%26aufirst%3DM.%26aulast%3DGrabner%26aufirst%3DM.%26aulast%3DGlossmann%26aufirst%3DH.%26aulast%3DHering%26aufirst%3DS.%26atitle%3DEndogenous%2520Calcium%2520Channels%2520in%2520Human%2520Embryonic%2520Kidney%2520%2528HEK293%2529%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D118%26issue%3D3%26spage%3D748%26epage%3D754%26doi%3D10.1111%2Fj.1476-5381.1996.tb15463.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuzono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaizumi, Y.</span></span> <span> </span><span class="NLM_article-title">Requirement of Ryanodine Receptors for Pacemaker Ca2+ Activity in ICC and HEK293 Cells</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2813</span>– <span class="NLM_lpage">2825</span>, <span class="refDoi"> DOI: 10.1242/jcs.01136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1242%2Fjcs.01136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=15169838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFehtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=2813-2825&issue=13&author=M.+Aoyamaauthor=A.+Yamadaauthor=J.+Wangauthor=S.+Ohyaauthor=S.+Furuzonoauthor=T.+Gotoauthor=S.+Hottaauthor=Y.+Itoauthor=T.+Matsubaraauthor=K.+Shimokataauthor=W.+Chenauthor=Y.+Imaizumi&title=Requirement+of+Ryanodine+Receptors+for+Pacemaker+Ca2%2B+Activity+in+ICC+and+HEK293+Cells&doi=10.1242%2Fjcs.01136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of ryanodine receptors for pacemaker Ca2+ activity in ICC and HEK293 cells</span></div><div class="casAuthors">Aoyama, Masahiro; Yamada, Aki; Wang, Jing; Ohya, Susumu; Furuzono, Shinji; Goto, Takayo; Hotta, Shingo; Ito, Yasushi; Matsubara, Tatsuaki; Shimokata, Kaoru; Chen, S. R. Wayne; Imaizumi, Yuji; Nakayama, Shinsuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2813-2825</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Intracellular Ca2+ ([Ca2+]i) oscillations seen in interstitial cells of Cajal (ICCs) are considered to be the primary pacemaker activity in the gut.  Here, we show evidence that periodic Ca2+ release from intracellular Ca2+ stores produces [Ca2+]i oscillations in ICCs, using cell cluster prepns. isolated from mouse ileum.  The pacemaker [Ca2+]i oscillations in ICCs are preserved in the presence of dihydropyridine Ca2+ antagonists, which suppress Ca2+ activity in smooth muscle cells.  However, applications of drugs affecting either ryanodine receptors or inositol 1,4,5-trisphosphate receptors terminated [Ca2+]i oscillations at relatively low concns.  RT-PCR analyses revealed a predominant expression of type 3 RyR (RyR3) in isolated c-Kit-immunopos. cells (ICCs).  Furthermore, we demonstrate that pacemaker-like global [Ca2+]i oscillation activity is endowed by introducing RyR3 into HEK293 cells, which originally express only IP3Rs.  The reconstituted [Ca2+]i oscillations in HEK293 cells possess essentially the same pharmacol. characteristics as seen in ICCs.  The results support the functional role of RyR3 in ICCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUVQVYlZx47Vg90H21EOLACvtfcHk0lisQV2M2dc-3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFehtL8%253D&md5=4605d072330942aec0f97fa009c87287</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1242%2Fjcs.01136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.01136%26sid%3Dliteratum%253Aachs%26aulast%3DAoyama%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DOhya%26aufirst%3DS.%26aulast%3DFuruzono%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DMatsubara%26aufirst%3DT.%26aulast%3DShimokata%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DImaizumi%26aufirst%3DY.%26atitle%3DRequirement%2520of%2520Ryanodine%2520Receptors%2520for%2520Pacemaker%2520Ca2%252B%2520Activity%2520in%2520ICC%2520and%2520HEK293%2520Cells%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2004%26volume%3D117%26issue%3D13%26spage%3D2813%26epage%3D2825%26doi%3D10.1242%2Fjcs.01136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Console-Bram, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuciu, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipkin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brailoiu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine, Another Endogenous Agonist of GPR55</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>490</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1389</span>– <span class="NLM_lpage">1393</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2017.07.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bbrc.2017.07.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=28698140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2017&pages=1389-1393&issue=4&author=L.+Console-Bramauthor=S.+M.+Ciuciuauthor=P.+Zhaoauthor=R.+E.+Zipkinauthor=E.+Brailoiuauthor=M.+E.+Abood&title=N-Arachidonoyl+Glycine%2C+Another+Endogenous+Agonist+of+GPR55&doi=10.1016%2Fj.bbrc.2017.07.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine, another endogenous agonist of GPR55</span></div><div class="casAuthors">Console-Bram, Linda; Ciuciu, Sandra M.; Zhao, Pingwei; Zipkin, Robert E.; Brailoiu, Eugen; Abood, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1389-1393</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Interest in lipoamino acids as endogenous modulators of G-protein coupled receptors has escalated due to their involvement in a variety of physiol. processes.  In particular, a role for these amino acid conjugates has emerged in the endocannabinoid system.  The study presented herein investigated the effects of N-arachidonoyl glycine (NAGly) on a candidate endocannabinoid receptor, GPR55.  Our novel findings reveal that NAGly induces concn. dependent increases in calcium mobilization and mitogen-activated protein kinase activities in HAGPR55/CHO cells.  These increases were attenuated by the selective GPR55 antagonist ML193 (N-[4-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide), supporting receptor mediated signaling.  To our knowledge this is the first report identifying GPR55 as a target of the endogenous lipoamino acid, NAGly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx8GQEqbQziLVg90H21EOLACvtfcHk0liqPB-0SSXLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKht7zL&md5=4590520db0b526edae7ee95c52651315</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DConsole-Bram%26aufirst%3DL.%26aulast%3DCiuciu%26aufirst%3DS.%2BM.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DZipkin%26aufirst%3DR.%2BE.%26aulast%3DBrailoiu%26aufirst%3DE.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DN-Arachidonoyl%2520Glycine%252C%2520Another%2520Endogenous%2520Agonist%2520of%2520GPR55%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D490%26issue%3D4%26spage%3D1389%26epage%3D1393%26doi%3D10.1016%2Fj.bbrc.2017.07.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deak, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groschner, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seles, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondarenko, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graier, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malli, R.</span></span> <span> </span><span class="NLM_article-title">The Endocannabinoid N-Arachidonoyl Glycine (NAGly) Inhibits Store-Operated Ca2+ Entry by Preventing STIM1-Orai1 Interaction</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1242/jcs.118075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1242%2Fjcs.118075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23239024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFaitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=879-888&issue=4&author=A.+T.+Deakauthor=L.+N.+Groschnerauthor=M.+R.+Alamauthor=E.+Selesauthor=A.+I.+Bondarenkoauthor=W.+F.+Graierauthor=R.+Malli&title=The+Endocannabinoid+N-Arachidonoyl+Glycine+%28NAGly%29+Inhibits+Store-Operated+Ca2%2B+Entry+by+Preventing+STIM1-Orai1+Interaction&doi=10.1242%2Fjcs.118075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interaction</span></div><div class="casAuthors">Deak, Andras T.; Groschner, Lukas N.; Alam, Muhammad Rizwan; Seles, Elisabeth; Bondarenko, Alexander I.; Graier, Wolfgang F.; Malli, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoid anandamide (AEA) and its derivate N-arachidonoyl glycine (NAGly) have a broad spectrum of physiol. effects, which are induced by both binding to receptors and receptor-independent modulations of ion channels and transporters.  The impact of AEA and NAGly on store-operated Ca2+ entry (SOCE), a ubiquitous Ca2+ entry pathway regulating many cellular functions, is unknown.  Here we show that NAGly, but not AEA reversibly hinders SOCE in a time- and concn.-dependent manner.  The inhibitory effect of NAGly on SOCE was found in the human endothelial cell line EA.hy926, the rat pancreatic β-cell line INS-1 832/13, and the rat basophilic leukemia cell line RBL-2H3.  NAGly diminished SOCE independently from the mode of Ca2+ depletion of the endoplasmic reticulum, whereas it had no effect on Ca2+ entry through L-type voltage-gated Ca2+ channels.  Enhanced Ca2+ entry was effectively hampered by NAGly in cells overexpressing the key mol. constituents of SOCE, stromal interacting mol. 1 (STIM1) and the pore-forming subunit of SOCE channels, Orai1.  Fluorescence microscopy revealed that NAGly did not affect STIM1 oligomerization, STIM1 clustering, or the colocalization of STIM1 with Orai1, which were induced by Ca2+ depletion of the endoplasmic reticulum.  In contrast, independently from its slow depolarizing effect on mitochondria, NAGly instantly and strongly diminished the interaction of STIM1 with Orai1, indicating that NAGly inhibits SOCE primarily by uncoupling STIM1 from Orai1.  In summary, our findings revealed the STIM1-Orai1-mediated SOCE machinery as a mol. target of NAGly, which might have many implications in cell physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptf1swH4VvWbVg90H21EOLACvtfcHk0liqPB-0SSXLCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFaitb8%253D&md5=744da2d1fe0bc08d7231f77c993b661b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1242%2Fjcs.118075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.118075%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DA.%2BT.%26aulast%3DGroschner%26aufirst%3DL.%2BN.%26aulast%3DAlam%26aufirst%3DM.%2BR.%26aulast%3DSeles%26aufirst%3DE.%26aulast%3DBondarenko%26aufirst%3DA.%2BI.%26aulast%3DGraier%26aufirst%3DW.%2BF.%26aulast%3DMalli%26aufirst%3DR.%26atitle%3DThe%2520Endocannabinoid%2520N-Arachidonoyl%2520Glycine%2520%2528NAGly%2529%2520Inhibits%2520Store-Operated%2520Ca2%252B%2520Entry%2520by%2520Preventing%2520STIM1-Orai1%2520Interaction%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2013%26volume%3D126%26issue%3D4%26spage%3D879%26epage%3D888%26doi%3D10.1242%2Fjcs.118075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondarenko, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panasiuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drachuk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montecucco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, F.</span></span> <span> </span><span class="NLM_article-title">The Quest for Endothelial Atypical Cannabinoid Receptor: BKCa Channels Act as Cellular Sensors for Cannabinoids in in Vitro and in Situ Endothelial Cells</span>. <i>Vasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.vph.2018.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.vph.2018.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29355732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2qtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2018&pages=44-55&author=A.+I.+Bondarenkoauthor=O.+Panasiukauthor=K.+Drachukauthor=F.+Montecuccoauthor=K.+J.+Brandtauthor=F.+Mach&title=The+Quest+for+Endothelial+Atypical+Cannabinoid+Receptor%3A+BKCa+Channels+Act+as+Cellular+Sensors+for+Cannabinoids+in+in+Vitro+and+in+Situ+Endothelial+Cells&doi=10.1016%2Fj.vph.2018.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells</span></div><div class="casAuthors">Bondarenko, Alexander I.; Panasiuk, Olga; Drachuk, Konstantin; Montecucco, Fabrizio; Brandt, Karim J.; Mach, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-55</span>CODEN:
                <span class="NLM_cas:coden">VPAHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1537-1891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endothelium-dependent component of cannabinoid-induced vasodilation has been postulated to require G-protein-coupled non-CB1/CB2 endothelial cannabinoid (eCB) receptor.  GPR18 was proposed as a candidate for eCBR.  To address the hypothesis that the effects attributed to eCBR are mediated by G-protein-coupled receptor (GPCR)-independent targets, we studied the elec. responses in endothelial cells, focusing on BKCa channels.  In patches excised from endothelial-derived EA.hy926 cells, N-arachidonoyl glycine (NAGly) and abnormal cannabidiol (abn-cbd), prototypical agonists for eCB receptor, stimulate single BKCa activity in a concn.- and Ca2+-dependent manner.  The postulated eCB receptor inhibitors rimonabant and AM251 were found to inhibit basal and stimulated by NAGly- and abn-cbd BKCa activity in cell-free patches.  In isolated mice aortas, abn-cbd and NAGly produced endothelial cell hyperpolarization that was sensitive to paxilline, a selective BKCa inhibitor, but not to GPR18 antibody, and mimicked by NS1619, a direct BKCa opener.  In excised patches from mice aortic endothelium, single channel activity with characteristics similar to BKCa was established by the addn. of abn-cbd and NAGly.  In this paper conclude that the two cannabinoids abn-cbd and NAGly initiate a GPR18-independent activation of BKCa channels in mice aortic endothelial cells that might contribute to vasodilation to cannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQFA0rT5e9ErVg90H21EOLACvtfcHk0liHSDd1tNZq6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2qtrY%253D&md5=0433bec6bf4dc31832d14641f07bf4da</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2018.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2018.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DBondarenko%26aufirst%3DA.%2BI.%26aulast%3DPanasiuk%26aufirst%3DO.%26aulast%3DDrachuk%26aufirst%3DK.%26aulast%3DMontecucco%26aufirst%3DF.%26aulast%3DBrandt%26aufirst%3DK.%2BJ.%26aulast%3DMach%26aufirst%3DF.%26atitle%3DThe%2520Quest%2520for%2520Endothelial%2520Atypical%2520Cannabinoid%2520Receptor%253A%2520BKCa%2520Channels%2520Act%2520as%2520Cellular%2520Sensors%2520for%2520Cannabinoids%2520in%2520in%2520Vitro%2520and%2520in%2520Situ%2520Endothelial%2520Cells%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2018%26volume%3D102%26spage%3D44%26epage%3D55%26doi%3D10.1016%2Fj.vph.2018.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondarenko, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drachuk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panasiuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagach, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graier, W. F.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine Suppresses Na+/Ca2+ Exchanger-Mediated Ca2+ Entry into Endothelial Cells and Activates BKCa Channels Independently of GPCRs</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>169</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1111/bph.12180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fbph.12180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23517055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=933-948&issue=4&author=A.+I.+Bondarenkoauthor=K.+Drachukauthor=O.+Panasiukauthor=V.+Sagachauthor=A.+T.+Deakauthor=R.+Malliauthor=W.+F.+Graier&title=N-Arachidonoyl+Glycine+Suppresses+Na%2B%2FCa2%2B+Exchanger-Mediated+Ca2%2B+Entry+into+Endothelial+Cells+and+Activates+BKCa+Channels+Independently+of+GPCRs&doi=10.1111%2Fbph.12180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine suppresses Na+/Ca2+ exchanger-mediated Ca2+ entry into endothelial cells and activates BKCa channels independently of GPCRs</span></div><div class="casAuthors">Bondarenko, Alexander I.; Drachuk, Konstantin; Panasiuk, Olga; Sagach, Vadim; Deak, Andras T.; Malli, Roland; Graier, Wolfgang F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">933-948</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: N-arachidonoyl glycine (NAGly) is a lipoamino acid with vasorelaxant properties.  We aimed to explore the mechanisms of NAGly's action on unstimulated and agonist-stimulated endothelial cells.  Exptl. Approach: The effects of NAGly on endothelial elec. signaling were studied in combination with vascular reactivity.  Key Results: In EA.hy926 cells, the sustained hyperpolarization to histamine was inhibited by the non-selective Na+/Ca2+ exchanger (NCX) inhibitor bepridil and by an inhibitor of reversed mode NCX, KB-R 7943.  In cells dialyzed with Cs+-based Na+-contg. soln., the outwardly rectifying current with typical characteristics of NCX was augmented following histamine exposure, further increased upon external Na+ withdrawal and inhibited by bepridil.  NAGly (0.3-30 μM) suppressed NCX currents in a URB 597- and guanosine 5'-O-(2-thiodiphosphate) (GDPβS)-insensitive manner, [Ca2+]i elevation evoked by Na+ removal and the hyperpolarization to histamine.  In rat aorta, NAGly opposed the endothelial hyperpolarization and relaxation response to ACh.  In unstimulated EA.hy926 cells, NAGly potentiated the whole-cell current attributable to large-conductance Ca2+-activated K+ (BKCa) channels in a GDPβS-insensitive, paxilline-sensitive manner and produced a sustained hyperpolarization.  In cell-free inside-out patches, NAGly stimulated single BKCa channel activity.  Conclusion and Implications: Our data showed that NCX is a Ca2+ entry pathway in endothelial cells and that NAGly is a potent G-protein-independent modulator of endothelial elec. signaling and has a dual effect on endothelial elec. responses.  In agonist pre-stimulated cells, NAGly opposes hyperpolarization and relaxation via inhibition of NCX-mediated Ca2+ entry, while in unstimulated cells, it promotes hyperpolarization via receptor-independent activation of BKCa channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOyiZb5Eb6KbVg90H21EOLACvtfcHk0liHSDd1tNZq6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOhsrc%253D&md5=f48651d9a5d66a6bc84f741f4d6fd663</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fbph.12180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12180%26sid%3Dliteratum%253Aachs%26aulast%3DBondarenko%26aufirst%3DA.%2BI.%26aulast%3DDrachuk%26aufirst%3DK.%26aulast%3DPanasiuk%26aufirst%3DO.%26aulast%3DSagach%26aufirst%3DV.%26aulast%3DDeak%26aufirst%3DA.%2BT.%26aulast%3DMalli%26aufirst%3DR.%26aulast%3DGraier%26aufirst%3DW.%2BF.%26atitle%3DN-Arachidonoyl%2520Glycine%2520Suppresses%2520Na%252B%252FCa2%252B%2520Exchanger-Mediated%2520Ca2%252B%2520Entry%2520into%2520Endothelial%2520Cells%2520and%2520Activates%2520BKCa%2520Channels%2520Independently%2520of%2520GPCRs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26issue%3D4%26spage%3D933%26epage%3D948%26doi%3D10.1111%2Fbph.12180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maor, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groopman, J. E.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid-like N-Arachidonoyl Serine Is a Novel pro-Angiogenic Mediator</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1583</span>– <span class="NLM_lpage">1594</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00841.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1476-5381.2010.00841.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=20649563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1583-1594&issue=7&author=X.+Zhangauthor=Y.+Maorauthor=J.+F.+Wangauthor=G.+Kunosauthor=J.+E.+Groopman&title=Endocannabinoid-like+N-Arachidonoyl+Serine+Is+a+Novel+pro-Angiogenic+Mediator&doi=10.1111%2Fj.1476-5381.2010.00841.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator</span></div><div class="casAuthors">Zhang, X.; Maor, Y.; Wang, J. F.; Kunos, G.; Groopman, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1583-1594</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">N-arachidonoyl serine (ARA-S) is a recently identified endocannabinoid-like lipid with weak affinity for the fully characterized cannabinoid receptors (CB1 and CB2) and the transient receptor potential vanilloid receptor 1 (TRPV-1).  ARA-S induces vasodilatation and shows vasoprotective potential via activation of key signaling pathways in endothelial cells.  Based on these findings, the effect of ARA-S on endothelial functions was further studied.  Primary human dermal microvascular endothelial cells (HMVEC) were used to investigate effects of ARA-S (0-10 mM) on certain endothelial functions, using cell proliferation, migration and wound repair models in vitro, and angiogenesis assays in vitro and ex vivo.  Selective CB receptor antagonists and specific siRNAs were deployed to block individual CB receptors.  Results showed that ARA-S stimulated angiogenesis and endothelial wound healing through induction of vascular endothelial growth factor C and its cognate receptor expression in primary HMVEC.  Moreover, knock-down of G protein-coupled receptor 55 (GPR55) partly inhibited ARA-S-induced signal transduction and endothelial functions.  Thus, our results indicate that ARA-S is a pro-angiogenic factor in addn. to a vessel dilator.  The GPR55 receptor may serve as one target of ARA-S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfC28ICw33KLVg90H21EOLACvtfcHk0liNVp42CBoK2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgurzN&md5=9019355944c5dc68c7945ee6dfb649c2</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00841.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00841.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMaor%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%2BF.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DGroopman%26aufirst%3DJ.%2BE.%26atitle%3DEndocannabinoid-like%2520N-Arachidonoyl%2520Serine%2520Is%2520a%2520Novel%2520pro-Angiogenic%2520Mediator%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26issue%3D7%26spage%3D1583%26epage%3D1594%26doi%3D10.1111%2Fj.1476-5381.2010.00841.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maor, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Lafi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallily, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batkai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offertaler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span> <span> </span><span class="NLM_article-title">Brain Constituent with Vasodilatory Properties</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2428</span>– <span class="NLM_lpage">2433</span>, <span class="refDoi"> DOI: 10.1073/pnas.0510676103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1073%2Fpnas.0510676103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=16467152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2428-2433&issue=7&author=G.+Milmanauthor=Y.+Maorauthor=S.+Abu-Lafiauthor=M.+Horowitzauthor=R.+Gallilyauthor=S.+Batkaiauthor=F.+Moauthor=L.+Offertalerauthor=P.+Pacherauthor=G.+Kunosauthor=R.+Mechoulam&title=Brain+Constituent+with+Vasodilatory+Properties&doi=10.1073%2Fpnas.0510676103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties</span></div><div class="casAuthors">Milman, Garry; Maor, Yehoshua; Abu-Lafi, Saleh; Horowitz, Michal; Gallily, Ruth; Batkai, Sandor; Mo, Fong-Ming; Offertaler, Laszlo; Pacher, Pal; Kunos, George; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2428-2433</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The endocannabinoid N-arachidonoyl ethanolamine (anandamide), found both in the CNS and in the periphery, plays a role in numerous physiol. systems.  One might expect that the chem. related N-arachidonoyl-L-serine (ARA-S) could also be formed alongside anandamide.  We have now isolated ARA-S from bovine brain and elucidated its structure by comparison with synthetic ARA-S.  Contrary to anandamide, ARA-S binds very weakly to cannabinoid CB1 and CB2 or vanilloid TRPV1 (transient receptor potential vanilloid 1) receptors.  However, it produces endothelium-dependent vasodilation of rat isolated mesenteric arteries and abdominal aorta and stimulates phosphorylation of p44/42 mitogen-activated protein (MAP) kinase and protein kinase B/Akt in cultured endothelial cells.  ARA-S also suppresses LPS-induced formation of TNF-α in a murine macrophage cell line and in wild-type mice, as well as in mice deficient in CB1 or CB2 receptors.  Many of these effects parallel those reported for abnormal cannabidiol (Abn-CBD), a synthetic agonist of a putative novel cannabinoid-type receptor.  Hence, ARA-S may represent an endogenous agonist for this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKfjaFnck3_LVg90H21EOLACvtfcHk0liNVp42CBoK2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslGjtLs%253D&md5=3742d1ab2d54bd4cdcac0ee8cb3035f6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0510676103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0510676103%26sid%3Dliteratum%253Aachs%26aulast%3DMilman%26aufirst%3DG.%26aulast%3DMaor%26aufirst%3DY.%26aulast%3DAbu-Lafi%26aufirst%3DS.%26aulast%3DHorowitz%26aufirst%3DM.%26aulast%3DGallily%26aufirst%3DR.%26aulast%3DBatkai%26aufirst%3DS.%26aulast%3DMo%26aufirst%3DF.%26aulast%3DOffertaler%26aufirst%3DL.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DBrain%2520Constituent%2520with%2520Vasodilatory%2520Properties%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D7%26spage%3D2428%26epage%3D2433%26doi%3D10.1073%2Fpnas.0510676103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrenswerth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaleta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Imidazole-4-One Derivatives: A New Class of Antagonists for the Orphan G Protein-Coupled Receptors GPR18 and GPR55</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">632</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1039/C3MD00394A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1039%2FC3MD00394A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXms1Wqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=632-649&issue=5&author=V.+Rempelauthor=K.+Atzlerauthor=A.+Behrenswerthauthor=T.+Karczauthor=C.+Schoederauthor=S.+Hinzauthor=M.+Kaletaauthor=D.+Thimmauthor=K.+Kiec-Kononowiczauthor=C.+E.+M%C3%BCller&title=Bicyclic+Imidazole-4-One+Derivatives%3A+A+New+Class+of+Antagonists+for+the+Orphan+G+Protein-Coupled+Receptors+GPR18+and+GPR55&doi=10.1039%2FC3MD00394A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic imidazole-4-one derivatives: a new class of antagonists for the orphan G protein-coupled receptors GPR18 and GPR55</span></div><div class="casAuthors">Rempel, V.; Atzler, K.; Behrenswerth, A.; Karcz, T.; Schoeder, C.; Hinz, S.; Kaleta, M.; Thimm, D.; Kiec-Kononowicz, K.; Mueller, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">632-649</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">GPR18 and GPR55 are orphan G protein-coupled receptors (GPCRs) that interact with certain cannabinoid (CB) receptor ligands.  In the present study bicyclic imidazole-4-one derivs. were discovered as new scaffolds for the development of antagonists for GPR18 and GPR55.  Interaction with CB1 and CB2 receptors was also studied to assess selectivity.  The presented extensive structure-activity relationship study of 49 derivs. investigated at all four GPCRs revealed structural requirements for the development of potent and selective GPR18 and GPR55 antagonists. (Z)-(2,3-Difluorobenzylidene)-6,7-dihydro-2H-imidazo[2,1b][1,3]thiazin-3(5H)-one (18) was identified as a selective GPR55 antagonist (IC50 3.15 μM).  The most potent GPR18 antagonist was (Z)-2-(3-(4-chlorobenzyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1b][1,3]-thiazin-3(5H)-one (32, IC50 0.279 μM, >36-fold selective vs. CB1 and GPR55, 14-fold selective vs. CB2) representing the first selective GPR18 antagonist.  The new compds. may serve as lead structures and as tools to explore the (patho-)physiol. roles of these orphan GPCRs and their potential as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7qHijbZ4H97Vg90H21EOLACvtfcHk0li1hGMxFr3cWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXms1Wqs7g%253D&md5=6cd5f3bd0f5915369dfb7885bff24728</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC3MD00394A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MD00394A%26sid%3Dliteratum%253Aachs%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DAtzler%26aufirst%3DK.%26aulast%3DBehrenswerth%26aufirst%3DA.%26aulast%3DKarcz%26aufirst%3DT.%26aulast%3DSchoeder%26aufirst%3DC.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DKaleta%26aufirst%3DM.%26aulast%3DThimm%26aufirst%3DD.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DBicyclic%2520Imidazole-4-One%2520Derivatives%253A%2520A%2520New%2520Class%2520of%2520Antagonists%2520for%2520the%2520Orphan%2520G%2520Protein-Coupled%2520Receptors%2520GPR18%2520and%2520GPR55%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D632%26epage%3D649%26doi%3D10.1039%2FC3MD00394A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmerman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dell, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span> <span> </span><span class="NLM_article-title">The Endocannabinoid Anandamide Is a Precursor for the Signaling Lipid N-Arachidonoyl Glycine by Two Distinct Pathways</span>. <i>BMC Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1186/1471-2091-10-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2F1471-2091-10-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=19460156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BD1MzotFKquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=14&author=H.+B.+Bradshawauthor=N.+Rimmermanauthor=S.+J.+Huauthor=V.+M.+Bentonauthor=J.+M.+Stuartauthor=K.+Masudaauthor=B.+F.+Cravattauthor=D.+K.+O%E2%80%99Dellauthor=J.+M.+Walker&title=The+Endocannabinoid+Anandamide+Is+a+Precursor+for+the+Signaling+Lipid+N-Arachidonoyl+Glycine+by+Two+Distinct+Pathways&doi=10.1186%2F1471-2091-10-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways</span></div><div class="casAuthors">Bradshaw Heather B; Rimmerman Neta; Hu Sherry Shu-Jung; Benton Valery M; Stuart Jordyn M; Masuda Kim; Cravatt Benjamin F; O'Dell David K; Walker J Michael</div><div class="citationInfo"><span class="NLM_cas:title">BMC biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  N-arachidonoyl glycine (NAGly) is an endogenous signaling lipid with a wide variety of biological activity whose biosynthesis is poorly understood.  Two primary biosynthetic pathways have been proposed.  One suggests that NAGly is formed via an enzymatically regulated conjugation of arachidonic acid (AA) and glycine.  The other suggests that NAGly is an oxidative metabolite of the endogenous cannabinoid, anandamide (AEA), through an alcohol dehydrogenase.  Here using both in vitro and in vivo assays measuring metabolites with LC/MS/MS we test the hypothesis that both pathways are present in mammalian cells.  RESULTS:  The metabolic products of deuterium-labeled AEA, D4AEA (deuterium on ethanolamine), indicated that NAGly is formed by the oxidation of the ethanolamine creating a D2NAGly product in both RAW 264.7 and C6 glioma cells.  Significantly, D4AEA produced a D0NAGly product only in C6 glioma cells suggesting that the hydrolysis of AEA yielded AA that was used preferentially in a conjugation reaction.  Addition of the fatty acid amide (FAAH) inhibitor URB 597 blocked the production of D0NAGly in these cells.  Incubation with D8AA in C6 glioma cells likewise produced D8NAGly; however, with significantly less efficacy leading to the hypothesis that FAAH-initiated AEA-released AA conjugation with glycine predominates in these cells.  Furthermore, the levels of AEA in the brain were significantly increased, whereas those of NAGly were significantly decreased after systemic injection of URB 597 in rats and in FAAH KO mice further supporting a role for FAAH in endogenous NAGly biosynthesis.  Incubations of NAGly and recombinant FAAH demonstrated that NAGly is a significantly less efficacious substrate for FAAH with only ~50% hydrolysis at 30 minutes compared to 100% hydrolysis of AEA.  Co-incubations of AEA and glycine with recombinant FAAH did not, however, produce NAGly.  CONCLUSION:  These data support the hypothesis that the signaling lipid NAGly is a metabolic product of AEA by both oxidative metabolism of the AEA ethanolamine moiety and through the conjugation of glycine to AA that is released during AEA hydrolysis by FAAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbc0zcJk3XZ6e0F5ixvZgXfW6udTcc2eZa2bIeeApZX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzotFKquw%253D%253D&md5=d3df8125eb32445776bc0f74502fb1a9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1186%2F1471-2091-10-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2091-10-14%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26aulast%3DRimmerman%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DS.%2BJ.%26aulast%3DBenton%26aufirst%3DV.%2BM.%26aulast%3DStuart%26aufirst%3DJ.%2BM.%26aulast%3DMasuda%26aufirst%3DK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DD.%2BK.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Endocannabinoid%2520Anandamide%2520Is%2520a%2520Precursor%2520for%2520the%2520Signaling%2520Lipid%2520N-Arachidonoyl%2520Glycine%2520by%2520Two%2520Distinct%2520Pathways%26jtitle%3DBMC%2520Biochem.%26date%3D2009%26volume%3D10%26spage%3D14%26doi%3D10.1186%2F1471-2091-10-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gläser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bräse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4798</span>– <span class="NLM_lpage">4810</span>, <span class="refDoi"> DOI: 10.1021/jm4005175</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005175" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVCrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4798-4810&issue=11&author=V.+Rempelauthor=N.+Volzauthor=F.+Gl%C3%A4serauthor=M.+Niegerauthor=S.+Br%C3%A4seauthor=C.+E.+M%C3%BCller&title=Antagonists+for+the+Orphan+G-Protein-Coupled+Receptor+GPR55+Based+on+a+Coumarin+Scaffold&doi=10.1021%2Fjm4005175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold</span></div><div class="casAuthors">Rempel, Viktor; Volz, Nicole; Glaeser, Franziska; Nieger, Martin; Brase, Stefan; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4798-4810</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The orphan G-protein-coupled receptor GPR55, which is activated by 1-lysophosphatidylinositol and interacts with cannabinoid (CB) receptor ligands, has been proposed as a new potential drug target for the treatment of diabetes, Parkinson's disease, neuropathic pain, and cancer.  The authors applied β-arrestin assays to identify 3-substituted coumarins as a novel class of antagonists and performed an extensive structure-activity relationship study for GPR55.  Selectivity vs. the related receptors CB1, CB2, and GPR18 was assessed.  Among the 7-unsubstituted coumarins selective, competitive GPR55 antagonists were identified, such as 3-(2-hydroxybenzyl)-5-isopropyl-8-methyl-2H-chromen-2-one (12, PSB-SB-489, IC50 = 1.77 μM, pA2 = 0.547 μM).  Derivs. with long alkyl chains in position 7 were potent, possibly allosteric GPR55 antagonists which showed ancillary CB receptor affinity. 7-(1,1-Dimethyloctyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one (69, PSB-SB-487, IC50 = 0.113 μM, KB = 0.561 μM) and 7-(1,1-dimethylheptyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one (67, PSB-SB-1203, IC50 = 0.261 μM) were the most potent GPR55 antagonists of the present series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1c2tlkbeBlLVg90H21EOLACvtfcHk0lhkpJ_l24NEfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVCrt7k%253D&md5=399b24223430db4307a74604ef37ca2d</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm4005175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005175%26sid%3Dliteratum%253Aachs%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DVolz%26aufirst%3DN.%26aulast%3DGl%25C3%25A4ser%26aufirst%3DF.%26aulast%3DNieger%26aufirst%3DM.%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DAntagonists%2520for%2520the%2520Orphan%2520G-Protein-Coupled%2520Receptor%2520GPR55%2520Based%2520on%2520a%2520Coumarin%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D11%26spage%3D4798%26epage%3D4810%26doi%3D10.1021%2Fjm4005175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, N.</span></span> <span> </span><span class="NLM_article-title">Arachidonylcyclopropylamide Increases Microglial Cell Migration through Cannabinoid CB2 and Abnormal-Cannabidiol-Sensitive Receptors</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>474</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(03)02074-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2FS0014-2999%2803%2902074-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=12921861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Kjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2003&pages=195-198&issue=2%E2%80%933&author=A.+Franklinauthor=N.+Stella&title=Arachidonylcyclopropylamide+Increases+Microglial+Cell+Migration+through+Cannabinoid+CB2+and+Abnormal-Cannabidiol-Sensitive+Receptors&doi=10.1016%2FS0014-2999%2803%2902074-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors</span></div><div class="casAuthors">Franklin, Allyn; Stella, Nephi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">195-198</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Microglial cells, the macrophages of the brain, express low, yet detectable levels of cannabinoid CB1 receptors, which are known to modulate cell migration.  To det. if cannabinoid CB1 receptors expressed by microglial cells modulate their migration, we assessed whether arachidonylcyclopropylamide (ACPA, an agonist shown to selectively activate CB1 receptors) affects the migration of BV-2 cells, a mouse microglial cell line.  We found that ACPA induced a dose-dependent increase in BV-2 cell migration (EC50=2.2 nM).  This ACPA response was blocked by pertussis toxin pretreatment, suggesting the involvement of Gi/o protein-coupled receptors.  However, the cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride (SR141716A) did not prevent ACPA-induced BV-2 cell migration.  Two antagonists of cannabinoid CB2 receptors N-(1,S)-endo-1,3,3-trimethyl bicyclo(2,2,1)heptan-2-yl-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528) and cannabinol, as well as two antagonists of the newly identified "abnormal-cannabidiol-sensitive" (abn-CBD) receptors (O-1918 and cannabidiol) prevented this response.  Our results suggest that cannabinoid CB2 receptors and abn-CBD receptors, rather than cannabinoid CB1 receptors, regulate microglial cell migration, and that ACPA is a broad cannabinoid receptor agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zHj8AYgkq7Vg90H21EOLACvtfcHk0liQsMtpNrMQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Kjurc%253D&md5=17d2d107eacd2eb588d33b1e9fcc9d56</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2902074-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252902074-0%26sid%3Dliteratum%253Aachs%26aulast%3DFranklin%26aufirst%3DA.%26aulast%3DStella%26aufirst%3DN.%26atitle%3DArachidonylcyclopropylamide%2520Increases%2520Microglial%2520Cell%2520Migration%2520through%2520Cannabinoid%2520CB2%2520and%2520Abnormal-Cannabidiol-Sensitive%2520Receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D474%26issue%3D2%25E2%2580%25933%26spage%3D195%26epage%3D198%26doi%3D10.1016%2FS0014-2999%2803%2902074-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nazir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loef, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehraus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maddah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, G. M.</span></span> <span> </span><span class="NLM_article-title">GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron Reticulatum</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">12–13</span>),  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1145</span>, <span class="refDoi"> DOI: 10.1055/s-0035-1545979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1055%2Fs-0035-1545979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=26287693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKksLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2015&pages=1141-1145&issue=12%E2%80%9313&author=M.+Nazirauthor=H.+Harmsauthor=I.+Loefauthor=S.+Kehrausauthor=F.+El+Maddahauthor=I.+Arslanauthor=V.+Rempelauthor=C.+E.+M%C3%BCllerauthor=G.+M.+K%C3%B6nig&title=GPR18+Inhibiting+Amauromine+and+the+Novel+Triterpene+Glycoside+Auxarthonoside+from+the+Sponge-Derived+Fungus+Auxarthron+Reticulatum&doi=10.1055%2Fs-0035-1545979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum *</span></div><div class="casAuthors">Nazir, Mamona; Harms, Henrik; Loef, Irene; Kehraus, Stefan; El Maddah, Fayrouz; Arslan, Idris; Rempel, Viktor; Mueller, Christa E.; Koenig, Gabriele M.</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">12/13</span>),
    <span class="NLM_cas:pages">1141-1145</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The marine sponge-derived fungus Auxarthron reticulatum produces the cannabinoid receptor antagonist amauromine (1).  Recultivation of the fungus to obtain further amts. for more detailed pharmacol. evaluation of 1 addnl. yielded the novel triterpene glycoside auxarthonoside (2), bearing, in nature, a rather rare sugar moiety, i.e., N-acetyl-6-methoxy-glucosamine.  Amauromine (1), which inhibited cannabinoid CB1 receptors (Ki 0.178 μM) also showed antagonistic activity at the cannabinoid-like orphan receptor GPR18 (IC50 3.74 μM).  The diketopiperazine 1 may thus serve as a lead structure for the development of more potent and selective GPR18 antagonists, which are required to study the orphan receptor's potential as a new drug target.  Despite the execution of many biol. assays, to date, no bioactivity could be found for auxarthonoside (2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj0Qyf9MIt9LVg90H21EOLACvtfcHk0liQsMtpNrMQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKksLnK&md5=7c69eac23721159e0576a71218c1ac91</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1545979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1545979%26sid%3Dliteratum%253Aachs%26aulast%3DNazir%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DH.%26aulast%3DLoef%26aufirst%3DI.%26aulast%3DKehraus%26aufirst%3DS.%26aulast%3DEl%2BMaddah%26aufirst%3DF.%26aulast%3DArslan%26aufirst%3DI.%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DK%25C3%25B6nig%26aufirst%3DG.%2BM.%26atitle%3DGPR18%2520Inhibiting%2520Amauromine%2520and%2520the%2520Novel%2520Triterpene%2520Glycoside%2520Auxarthonoside%2520from%2520the%2520Sponge-Derived%2520Fungus%2520Auxarthron%2520Reticulatum%26jtitle%3DPlanta%2520Med.%26date%3D2015%26volume%3D81%26issue%3D12%25E2%2580%259313%26spage%3D1141%26epage%3D1145%26doi%3D10.1055%2Fs-0035-1545979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harms, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehraus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufendiek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, G. M.</span></span> <span> </span><span class="NLM_article-title">Indoloditerpenes from a Marine-Derived Fungal Strain of Dichotomomyces Cejpii with Antagonistic Activity at GPR18 and Cannabinoid Receptors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1021/np400850g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400850g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=673-677&issue=3&author=H.+Harmsauthor=V.+Rempelauthor=S.+Kehrausauthor=M.+Kaiserauthor=P.+Hufendiekauthor=C.+E.+M%C3%BCllerauthor=G.+M.+K%C3%B6nig&title=Indoloditerpenes+from+a+Marine-Derived+Fungal+Strain+of+Dichotomomyces+Cejpii+with+Antagonistic+Activity+at+GPR18+and+Cannabinoid+Receptors&doi=10.1021%2Fnp400850g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors</span></div><div class="casAuthors">Harms, Henrik; Rempel, Viktor; Kehraus, Stefan; Kaiser, Marcel; Hufendiek, Peter; Mueller, Christa E.; Koenig, Gabriele M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-677</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A marine-derived strain of Dichotomomyces cejpii produces the new compds. emindole SB beta-mannoside (1) and 27-O-methylasporyzin C (2), as well as the known indoloditerpenes JBIR-03 (3) and emindole SB (4).  Indole deriv. 1 was found to be a CB2 antagonist, while 2 was identified as the first selective GPR18 antagonist with an indole structure.  Compd. 4 was found to be a nonselective CB1/CB2 antagonist.  The new natural indole derivs. may serve as lead structures for the development of GPR18- and CB receptor-blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJWAD4tAxharVg90H21EOLACvtfcHk0liQsMtpNrMQNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCntbo%253D&md5=bbbab2b5b0843b41d02b896e3a02b56a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fnp400850g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400850g%26sid%3Dliteratum%253Aachs%26aulast%3DHarms%26aufirst%3DH.%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DKehraus%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DHufendiek%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DK%25C3%25B6nig%26aufirst%3DG.%2BM.%26atitle%3DIndoloditerpenes%2520from%2520a%2520Marine-Derived%2520Fungal%2520Strain%2520of%2520Dichotomomyces%2520Cejpii%2520with%2520Antagonistic%2520Activity%2520at%2520GPR18%2520and%2520Cannabinoid%2520Receptors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26issue%3D3%26spage%3D673%26epage%3D677%26doi%3D10.1021%2Fnp400850g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaleta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz-Maciej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łażewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of Imidazothiazinones and Analogs as Antagonists of the Cannabinoid-Activated Orphan G Protein-Coupled Receptor GPR18</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejmech.2018.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29902723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFemsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2018&pages=381-397&author=C.+T.+Schoederauthor=M.+Kaletaauthor=A.+B.+Mahardhikaauthor=A.+Olejarz-Maciejauthor=D.+%C5%81a%C5%BCewskaauthor=K.+Kie%C4%87-Kononowiczauthor=C.+E.+M%C3%BCller&title=Structure-Activity+Relationships+of+Imidazothiazinones+and+Analogs+as+Antagonists+of+the+Cannabinoid-Activated+Orphan+G+Protein-Coupled+Receptor+GPR18&doi=10.1016%2Fj.ejmech.2018.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18</span></div><div class="casAuthors">Schoeder, Clara T.; Kaleta, Maria; Mahardhika, Andhika B.; Olejarz-Maciej, Agnieszka; Lazewska, Dorota; Kiec-Kononowicz, Katarzyna; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">381-397</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">GPR18 is a cannabinoid-activated orphan G protein-coupled receptor (GPCR) that is selectively expressed on immune cells.  Despite its significant potential as a drug target for inflammatory diseases and cancer immunotherapy, only very few GPR18 ligands have been described to date.  In the present study we investigated the structure-activity relationships (SARs) of (Z)-2-(3-(4-chlorobenzyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1-b][1,3]thiazin-3(5H)-one (PSB-CB5, 5), the most potent GPR18 antagonist described to date.  Analogs were synthesized that exhibit broad modifications of the heterocyclic core and/or variation of substituents at the benzylidene moiety.  The compds. were investigated in β-arrestin recruitment assays as inhibitors of human GPR18 activation by tetrahydrocannabinol (THC).  Selectivity was assessed vs. the cannabinoid receptors (CB1 and CB2) and vs. GPR55, another orphan GPCR that interacts with cannabinoids.  Phenyloxyalkyloxy-substituted benzylidenethiazinones with long alkyl chains (optimal length: hexamethylene) efficiently blocked GPR18 with similarly high potency as lead structure 5.  (Z)-2-(3-(6-(4-Chlorophenoxy)hexyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1-b][1,3]thiazin-3(5H)-one (PSB-CB-27, 23) exhibited the best profile: it displayed an IC50 value of 650 nM at GPR18 and showed improved selectivity vs. CB receptors as compared to lead structure 5.  Importantly, in contrast to 5, which showed only partial inhibition (60%), 23 led to a complete blockade of THC-induced GPR18 activation and is thus a superior tool for target validation.  In addn., several compds. were identified as dual GPR18/GPR55 antagonists with similar potency at both targets, and selectivity vs. CB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqW1W8TE9bQLVg90H21EOLACvtfcHk0lgHYL7NtliFig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFemsbzJ&md5=f972f1e05e4080dd6165899d6d1acbaf</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DKaleta%26aufirst%3DM.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DOlejarz-Maciej%26aufirst%3DA.%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DD.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DStructure-Activity%2520Relationships%2520of%2520Imidazothiazinones%2520and%2520Analogs%2520as%2520Antagonists%2520of%2520the%2520Cannabinoid-Activated%2520Orphan%2520G%2520Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D155%26spage%3D381%26epage%3D397%26doi%3D10.1016%2Fj.ejmech.2018.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaschke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Development of Chromen-4-One Derivatives as (Ant)Agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">4276</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1021/acsomega.8b03695</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b03695" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1KmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=4276-4295&issue=2&author=C.+T.+Schoederauthor=A.+Meyerauthor=A.+B.+Mahardhikaauthor=D.+Thimmauthor=T.+Blaschkeauthor=M.+Funkeauthor=C.+E.+M%C3%BCller&title=Development+of+Chromen-4-One+Derivatives+as+%28Ant%29Agonists+for+the+Lipid-Activated+G+Protein-Coupled+Receptor+GPR55+with+Tunable+Efficacy&doi=10.1021%2Facsomega.8b03695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy</span></div><div class="casAuthors">Schoeder, Clara T.; Meyer, Anne; Mahardhika, Andhika B.; Thimm, Dominik; Blaschke, Thomas; Funke, Mario; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">4276-4295</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lipid-activated G protein-coupled receptor (GPCR) GPR55 has been proposed as a drug target for the treatment of chronic diseases including inflammation, neurodegeneration, neuropathic pain, metabolic diseases, and cancer.  A series of chromen-4-one-2-carboxylic derivs. was synthesized with the aim to obtain potent and selective ligands for GPR55 by (i) attachment of a variety of substituted 8-benzamido residues, (ii) substitution in position 6 by halogen atoms, and (iii) thioation of the 4-oxo function.  The compds. were investigated in β-arrestin recruitment assays using enzyme complementation.  Depending on the substitution pattern, a spectrum of efficacies was obtained ranging from (partial) agonists to antagonists.  6-Chloro-8-(3-((5-cyclohexylpentyl)oxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (PSB-18251) displayed the highest efficacy of the series combined with high potency (EC50 0.196 μM).  6-Chloro-8-(3-(heptyloxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (PSB-18337) exhibited higher affinity (EC50 0.0400 μM) but lower efficacy (39%).  Several GPR55 antagonists were discovered including 8-(3-(cyclohexylmethoxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (PSB-18263) (IC50 8.23 μM) and 4-oxo-8-(3-phenethoxybenzamido)-4H-chromene-2-carboxylic acid (PSB-18270) (IC50 3.96 μM).  These potent GPR55 agonists and antagonists showed high selectivity vs. the related GPCRs GPR18 and GPR35 tested in the same assay system, while 8-(4-(4-cyclohexylbutoxy)benzamido)-6-fluoro-4-oxo-4H-chromene-2-carboxylic acid (PSB-18177) represents a dual GPR35/GPR55 antagonist (IC50 GPR55: 3.26 μM, GPR35: 2.57 μM).  Binding studies of selected compds. at CB1 and CB2 receptors indicated GPR55 selectivity also vs. CB receptors.  The newly developed GPR55 (partial) agonists and antagonists will be useful tools for evaluating the suitability of GPR55 as a drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoukMaZwtl17Vg90H21EOLACvtfcHk0lhEDsi1fYo0FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1KmtLs%253D&md5=b4e6f5152c174e175fb8d578fd2c300f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b03695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b03695%26sid%3Dliteratum%253Aachs%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DThimm%26aufirst%3DD.%26aulast%3DBlaschke%26aufirst%3DT.%26aulast%3DFunke%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDevelopment%2520of%2520Chromen-4-One%2520Derivatives%2520as%2520%2528Ant%2529Agonists%2520for%2520the%2520Lipid-Activated%2520G%2520Protein-Coupled%2520Receptor%2520GPR55%2520with%2520Tunable%2520Efficacy%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26issue%3D2%26spage%3D4276%26epage%3D4295%26doi%3D10.1021%2Facsomega.8b03695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagerovic, N.</span>; <span class="NLM_string-name">Lago-Fernandez, A.</span>; <span class="NLM_string-name">Morales, P.</span>; <span class="NLM_string-name">Abood, M. E.</span>; <span class="NLM_string-name">Brailoiu, E.</span>; <span class="NLM_string-name">Leo, L. M.</span>; <span class="NLM_string-name">Zhao, P.</span>; <span class="NLM_string-name">Reggio, P. H.</span>; <span class="NLM_string-name">Hurst, D. P.</span>; <span class="NLM_string-name">Chafi, N.</span></span> <span> </span><span class="NLM_article-title">Pyrazolylbenzene-1,3-Diols for Diseases Associated with G Protein-Coupled Receptor 18 and in Combination with Transient Receptor Potential Vanilloid 1</span>. European Patent <span class="NLM_patent">EP 20382324</span>, Apr 22, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=N.+Jagerovic&author=A.+Lago-Fernandez&author=P.+Morales&author=M.+E.+Abood&author=E.+Brailoiu&author=L.+M.+Leo&author=P.+Zhao&author=P.+H.+Reggio&author=D.+P.+Hurst&author=N.+Chafi&title=Pyrazolylbenzene-1%2C3-Diols+for+Diseases+Associated+with+G+Protein-Coupled+Receptor+18+and+in+Combination+with+Transient+Receptor+Potential+Vanilloid+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJagerovic%26aufirst%3DN.%26atitle%3DPyrazolylbenzene-1%252C3-Diols%2520for%2520Diseases%2520Associated%2520with%2520G%2520Protein-Coupled%2520Receptor%252018%2520and%2520in%2520Combination%2520with%2520Transient%2520Receptor%2520Potential%2520Vanilloid%25201%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drabczyńska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+T.+Schoederauthor=A.+B.+Mahardhikaauthor=A.+Drabczy%C5%84skaauthor=K.+Kie%C4%87-Kononowiczauthor=C.+E.+M%C3%BCller&title=Discovery+of+Tricyclic+Xanthines+as+Agonists+of+the+Cannabinoid-Activated+Orphan+G-Protein-Coupled+Receptor+GPR18&doi=10.1021%2Facsmedchemlett.0c00208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00208%26sid%3Dliteratum%253Aachs%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DDrabczy%25C5%2584ska%26aufirst%3DA.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520of%2520Tricyclic%2520Xanthines%2520as%2520Agonists%2520of%2520the%2520Cannabinoid-Activated%2520Orphan%2520G-Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26doi%3D10.1021%2Facsmedchemlett.0c00208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sotudeh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P. H.</span></span> <span> </span><span class="NLM_article-title">Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2300</span>, <span class="refDoi"> DOI: 10.3390/ijms20092300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3390%2Fijms20092300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=2300&author=N.+Sotudehauthor=P.+Moralesauthor=D.+P.+Hurstauthor=D.+L.+Lynchauthor=P.+H.+Reggio&title=Towards+A+Molecular+Understanding+of+The+Cannabinoid+Related+Orphan+Receptor+GPR18%3A+A+Focus+on+Its+Constitutive+Activity&doi=10.3390%2Fijms20092300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a molecular understanding of the cannabinoid related orphan receptor GPR18: a focus on its constitutive activity</span></div><div class="casAuthors">Sotudeh, Noori; Morales, Paula; Hurst, Dow P.; Lynch, Diane L.; Reggio, Patricia H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2300</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The orphan G-protein coupled receptor (GPCR), GPR18, has been recently proposed as a potential member of the cannabinoid family as it recognizes several endogenous, phytogenic, and synthetic cannabinoids.  Potential therapeutic applications for GPR18 include intraocular pressure, metabolic disorders, and cancer.  GPR18 has been reported to have high constitutive activity, i.e., activation/signaling occurs in the absence of an agonist.  This activity can be reduced significantly by the A3.39N mutation.  At the intracellular (IC) ends of (transmembrane helixes) TMH3 and TMH6 in GPCRs, typically, a pair of oppositely charged amino acids form a salt bridge called the "ionic lock".  Breaking of this salt bridge creates an IC opening for coupling with G protein.  The GPR18 "ionic lock" residues (R3.50/S6.33) can form only a hydrogen bond.  In this paper, we test the hypothesis that the high constitutive activity of GPR18 is due to the weakness of its "ionic lock" and that the A3.39N mutation strengthens this lock.  To this end, we report mol. dynamics simulations of wild-type (WT) GPR18 and the A3.39N mutant in fully hydrated (POPC) phophatidylcholine lipid bilayers.  Results suggest that in the A3.39N mutant, TMH6 rotates and brings R3.50 and S6.33 closer together, thus strengthening the GPR18 "ionic lock".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9HRytw-tD8LVg90H21EOLACvtfcHk0lhEDsi1fYo0FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWlsLo%253D&md5=bb957e136dc3e939906b478102dbfe9b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3390%2Fijms20092300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20092300%26sid%3Dliteratum%253Aachs%26aulast%3DSotudeh%26aufirst%3DN.%26aulast%3DMorales%26aufirst%3DP.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DLynch%26aufirst%3DD.%2BL.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26atitle%3DTowards%2520A%2520Molecular%2520Understanding%2520of%2520The%2520Cannabinoid%2520Related%2520Orphan%2520Receptor%2520GPR18%253A%2520A%2520Focus%2520on%2520Its%2520Constitutive%2520Activity%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D2300%26doi%3D10.3390%2Fijms20092300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, J.</span>; <span class="NLM_string-name">Weinstein, H.</span></span> <span> </span><span class="NLM_article-title">Integrated Methods for the Construction of Three-Dimensional Models and Computational Probing of Structure-Function Relations in G Protein-Coupled Receptors</span>. In  <i>Methods in Neurosciences</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, C. S.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">San Diego, CA</span>, <span class="NLM_year">1995</span>; Vol.  <span class="NLM_volume">25</span>, pp  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">428</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=366-428&author=J.+Ballesteros&author=H.+Weinsteinauthor=C.+S.+Stuart&title=Methods+in+Neurosciences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%26atitle%3DIntegrated%2520Methods%2520for%2520the%2520Construction%2520of%2520Three-Dimensional%2520Models%2520and%2520Computational%2520Probing%2520of%2520Structure-Function%2520Relations%2520in%2520G%2520Protein-Coupled%2520Receptors%26btitle%3DMethods%2520in%2520Neurosciences%26aulast%3DStuart%26aufirst%3DC.%2BS.%26pub%3DElsevier%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhnovich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span> <span> </span><span class="NLM_article-title">Common Activation Mechanism of Class a GPCRs</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e50279</span> <span class="refDoi"> DOI: 10.7554/eLife.50279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.7554%2FeLife.50279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31855179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlertLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=Q.+Zhouauthor=D.+Yangauthor=M.+Wuauthor=Y.+Guoauthor=W.+Guoauthor=L.+Zhongauthor=X.+Caiauthor=A.+Daiauthor=W.+Jangauthor=E.+Shakhnovichauthor=Z.+Liuauthor=R.+Stevensauthor=N.+A.+Lambertauthor=M.+M.+Babuauthor=M.+Wangauthor=S.+Zhao&title=Common+Activation+Mechanism+of+Class+a+GPCRs&doi=10.7554%2FeLife.50279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Common activation mechanism of class A GPCRs</span></div><div class="casAuthors">Zhou, Qingtong; Yang, Dehua; Wu, Meng; Guo, Yu; Guo, Wanjing; Zhong, Li; Cai, Xiaoqing; Dai, Antao; Jang, Wonjo; Shakhnovich, Eugene I.; Liu, Zhi-Jie; Stevens, Raymond C.; Lambert, Nevin A.; Madan Babu, M.; Wang, Ming-Wei; Zhao, Suwen</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e50279/1-e50279/31</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Class A G-protein-coupled receptors (GPCRs) influence virtually every aspect of human physiol.  Understanding receptor activation mechanism is crit. for discovering novel therapeutics since about one-third of all marketed drugs target members of this family.  GPCR activation is an allosteric process that couples agonist binding to G-protein recruitment, with the hallmark outward movement of transmembrane helix 6 (TM6).  However, what leads to TM6 movement and the key residue level changes of this movement remain less well understood.  Here, we report a framework to quantify conformational changes.  By analyzing the conformational changes in 234 structures from 45 class A GPCRs, we discovered a common GPCR activation pathway comprising of 34 residue pairs and 35 residues.  The pathway unifies previous findings into a common activation mechanism and strings together the scattered key motifs such as CWxP, DRY, Na+ pocket, NPxxY and PIF, thereby directly linking the bottom of ligand-binding pocket with G-protein coupling region.  Site-directed mutagenesis expts. support this proposition and reveal that rational mutations of residues in this pathway can be used to obtain receptors that are constitutively active or inactive.  The common activation pathway provides the mechanistic interpretation of constitutively activating, inactivating and disease mutations.  As a module responsible for activation, the common pathway allows for decoupling of the evolution of the ligand binding site and G-protein-binding region.  Such an architecture might have facilitated GPCRs to emerge as a highly successful family of proteins for signal transduction in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGqDzu0ZVRbVg90H21EOLACvtfcHk0li-DULXinXHAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlertLfI&md5=1bc80278e242ff048b07492ea1f10ff9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.7554%2FeLife.50279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.50279%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DA.%26aulast%3DJang%26aufirst%3DW.%26aulast%3DShakhnovich%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DN.%2BA.%26aulast%3DBabu%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26atitle%3DCommon%2520Activation%2520Mechanism%2520of%2520Class%2520a%2520GPCRs%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.50279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">The Molecular Basis of G Protein–Coupled Receptor Activation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-060614-033910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1146%2Fannurev-biochem-060614-033910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29925258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=897-919&issue=1&author=W.+I.+Weisauthor=B.+K.+Kobilka&title=The+Molecular+Basis+of+G+Protein%E2%80%93Coupled+Receptor+Activation&doi=10.1146%2Fannurev-biochem-060614-033910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Basis of G Protein-Coupled Receptor Activation</span></div><div class="casAuthors">Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">897-919</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) mediate the majority of cellular responses to external stimuli.  Upon activation by a ligand, the receptor binds to a partner heterotrimeric G protein and promotes exchange of GTP for GDP, leading to dissocn. of the G protein into α and βγ subunits that mediate downstream signals.  GPCRs can also activate distinct signaling pathways through arrestins.  Active states of GPCRs form by small rearrangements of the ligand-binding, or orthosteric, site that are amplified into larger conformational changes.  Mol. understanding of the allosteric coupling between ligand binding and G protein or arrestin interaction is emerging from structures of several GPCRs crystd. in inactive and active states, spectroscopic data, and computer simulations.  The coupling is loose, rather than concerted, and agonist binding does not fully stabilize the receptor in an active conformation.  Distinct intermediates whose populations are shifted by ligands of different efficacies underlie the complex pharmacol. of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfSIylPxq7yLVg90H21EOLACvtfcHk0li-DULXinXHAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM&md5=71f1f2d3c1d9be27da70dd472d7d44f2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-060614-033910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-060614-033910%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Molecular%2520Basis%2520of%2520G%2520Protein%25E2%2580%2593Coupled%2520Receptor%2520Activation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26issue%3D1%26spage%3D897%26epage%3D919%26doi%3D10.1146%2Fannurev-biochem-060614-033910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">686</span>, <span class="refDoi"> DOI: 10.3390/biom10050686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3390%2Fbiom10050686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvVOltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=686&issue=5&author=A.+Neumannauthor=V.+Engelauthor=A.+B.+Mahardhikaauthor=C.+T.+Schoederauthor=V.+Namasivayamauthor=K.+Kie%C4%87-Kononowiczauthor=C.+E.+M%C3%BCller&title=Computational+Investigations+on+the+Binding+Mode+of+Ligands+for+the+Cannabinoid-Activated+G+Protein-Coupled+Receptor+GPR18&doi=10.3390%2Fbiom10050686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Computational investigations on the binding mode of ligands for the cannabinoid-activated G protein-coupled receptor GPR18</span></div><div class="casAuthors">Neumann, Alexander; Engel, Viktor; Mahardhika, Andhika B.; Schoeder, Clara T.; Namasivayam, Vigneshwaran; Kiec-Kononowicz, Katarzyna; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">GPR18 is an orphan G protein-coupled receptor (GPCR) expressed in cells of the immune system.  It is activated by the cannabinoid receptor (CB) agonist Δ9-tetrahydrocannabinol (THC).  Several further lipids have been proposed to act as GPR18 agonists, but these results still require unambiguous confirmation.  In the present study, we constructed a homol. model of the human GPR18 based on an ensemble of three GPCR crystal structures to investigate the binding modes of the agonist THC and the recently reported antagonists which feature an imidazothiazinone core to which a (substituted) Ph ring is connected via a lipophilic linker.  Docking and mol. dynamics simulation studies were performed.  As a result, a hydrophobic binding pocket is predicted to accommodate the imidazothiazinone core, while the terminal Ph ring projects towards an arom. pocket.  Hydrophobic interaction of Cys251 with substituents on the Ph ring could explain the high potency of the most potent derivs.  Mol. dynamics simulation studies suggest that the binding of imidazothiazinone antagonists stabilizes transmembrane regions TM1, TM6 and TM7 of the receptor through a salt bridge between Asp118 and Lys133.  The agonist THC is presumed to bind differently to GPR18 than to the distantly related CB receptors.  This study provides insights into the binding mode of GPR18 agonists and antagonists which will facilitate future drug design for this promising potential drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ZcOlmh2vZLVg90H21EOLACvtfcHk0lhsNCOOvDHbSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvVOltb0%253D&md5=c5eab5ec9c4d3b73cf56ddd12dbe91f1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.3390%2Fbiom10050686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom10050686%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DV.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DComputational%2520Investigations%2520on%2520the%2520Binding%2520Mode%2520of%2520Ligands%2520for%2520the%2520Cannabinoid-Activated%2520G%2520Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DBiomolecules%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D686%26doi%3D10.3390%2Fbiom10050686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaleta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Molecular Modeling of an Orphan GPR18 Receptor</span>. <i>Lett. Drug Des. Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.2174/1570180815666180810114847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.2174%2F1570180815666180810114847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2isb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=1167-1174&issue=10&author=K.+J.+Kuderauthor=T.+Karczauthor=M.+Kaletaauthor=K.+Kiec-Kononowicz&title=Molecular+Modeling+of+an+Orphan+GPR18+Receptor&doi=10.2174%2F1570180815666180810114847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Modeling of an Orphan GPR18 Receptor</span></div><div class="casAuthors">Kuder, Kamil J.; Karcz, Tadeusz; Kaleta, Maria; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Drug Design & Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1167-1174</span>CODEN:
                <span class="NLM_cas:coden">LDDDAW</span>;
        ISSN:<span class="NLM_cas:issn">1875-628X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: One of the best known to date GPCR class A (Rhodopsin) includes more than 100 orphan receptors for which the endogenous ligand is not known or is unclear.  One of them is N-arachidonyl glycine receptor, named GPR18, a receptor that has been reported to be activated by Δ9-THC, endogenous cannabinoid receptors agonist anandamide and other cannabinoid receptor ligands suggesting it could be considered as third cannabinoid receptor.  GPR18 activity, as well as its distribution might suggest usage of GPR18 ligands in treatment of endometriosis, cancer, and neurodegenerative disorders.  Yet, so far only few GPR18 antagonists have been described, thus only ligand-based design approaches appear to be most useful to identify new ligands for this orphan receptor.  Methods: Main goal of this study, GPR18 inactive form homol. model was built on the basis of the evolutionary closest homologous template: Human P2Y1 Receptor crystal structure.  Results: Obtained model was further evaluated and showed active/nonactive ligands differentiating properties with acceptable confidence.  Moreover, it allowed for preliminary assessment of proteinligand interactions for a set of previously described ligands.  Conclusion: Thus collected data might serve as a starting point for a discovery of novel, active GPR18 blocking ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFm5NNB5gparVg90H21EOLACvtfcHk0lhsNCOOvDHbSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2isb3F&md5=a1de6bdec48204b89a0b0c06768d5cb4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F1570180815666180810114847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180815666180810114847%26sid%3Dliteratum%253Aachs%26aulast%3DKuder%26aufirst%3DK.%2BJ.%26aulast%3DKarcz%26aufirst%3DT.%26aulast%3DKaleta%26aufirst%3DM.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26atitle%3DMolecular%2520Modeling%2520of%2520an%2520Orphan%2520GPR18%2520Receptor%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2019%26volume%3D16%26issue%3D10%26spage%3D1167%26epage%3D1174%26doi%3D10.2174%2F1570180815666180810114847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, V. W. Y.</span></span> <span> </span><span class="NLM_article-title">Omics-Wide Quantitative B-Cell Infiltration Analyses Identify GPR18 for Human Cancer Prognosis with Superiority over CD20</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">234</span>, <span class="refDoi"> DOI: 10.1038/s42003-020-0964-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fs42003-020-0964-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32398659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BB38vmtVSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=234&author=Y.+Liuauthor=L.+Wangauthor=K.-W.+Loauthor=V.+W.+Y.+Lui&title=Omics-Wide+Quantitative+B-Cell+Infiltration+Analyses+Identify+GPR18+for+Human+Cancer+Prognosis+with+Superiority+over+CD20&doi=10.1038%2Fs42003-020-0964-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Omics-wide quantitative B-cell infiltration analyses identify GPR18 for human cancer prognosis with superiority over CD20</span></div><div class="casAuthors">Liu Yuchen; Wang Li; Lui Vivian Wai Yan; Lo Kwok-Wai</div><div class="citationInfo"><span class="NLM_cas:title">Communications biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">234</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor-infiltrating B lymphocyte (TIL-B), and TIL-B-related biomarkers have clinical prognostic values for human cancers.  CD20 (encoded by MS4A1) is a widely used TIL-B biomarker.  Using TCGA-quantitative multiomics datasets, we first cross-compare prognostic powers of intratumoral CD20 protein, mRNA and TIL-B levels in pan-cancers.  Here, we show that MS4A1 and TIL-B are consistently prognostic in 5 cancers (head and neck, lung, cervical, kidney and low-grade glioma), while unexpectedly, CD20 protein levels lack quantitative correlations with MS4A1/TIL-B levels and demonstrate limited prognosticity.  Subsequent bioinformatics discovery for TIL-B prognostic gene identifies a single gene, GPR18 with stand-alone prognosticity across 9 cancers (superior over CD20), with further validations in multiple non-TCGA cohorts.  GPR18's immune signature denotes major B-cell-T-cell interactions, with its intratumoral expression strongly tied to a "T-cell active", likely cytolytic, status across human cancers, suggesting its functional link to cytolytic T-cell activity in cancer.  GPR18 merits biological and clinical utility assessments over CD20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRekrVMksnQDkodMGTatQ7LfW6udTcc2ebZocbF7-ewX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38vmtVSitA%253D%253D&md5=029349acbf5e22193d0d37ca198b6ac7</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fs42003-020-0964-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-020-0964-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLo%26aufirst%3DK.-W.%26aulast%3DLui%26aufirst%3DV.%2BW.%2BY.%26atitle%3DOmics-Wide%2520Quantitative%2520B-Cell%2520Infiltration%2520Analyses%2520Identify%2520GPR18%2520for%2520Human%2520Cancer%2520Prognosis%2520with%2520Superiority%2520over%2520CD20%26jtitle%3DCommun.%2520Biol.%26date%3D2020%26volume%3D3%26spage%3D234%26doi%3D10.1038%2Fs42003-020-0964-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span> <span> </span><span class="NLM_article-title">Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">e925438</span> <span class="refDoi"> DOI: 10.12659/MSM.925438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.12659%2FMSM.925438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32701935" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&author=M.+Zhaoauthor=X.+Diauthor=X.+Jinauthor=C.+Tianauthor=S.+Congauthor=J.+Liuauthor=K.+Wang&title=Identification+of+Biomarkers+for+Sarcoidosis+and+Tuberculosis+of+the+Lung+Using+Systematic+and+Integrated+Analysis&doi=10.12659%2FMSM.925438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.12659%2FMSM.925438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.925438%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DDi%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DC.%26aulast%3DCong%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Biomarkers%2520for%2520Sarcoidosis%2520and%2520Tuberculosis%2520of%2520the%2520Lung%2520Using%2520Systematic%2520and%2520Integrated%2520Analysis%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2020%26volume%3D26%26doi%3D10.12659%2FMSM.925438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iliopoulos-Tsoutsouvas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchama, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>180</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2020.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32004463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFeqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2020&pages=655-665&issue=4&author=T.+Huaauthor=X.+Liauthor=L.+Wuauthor=C.+Iliopoulos-Tsoutsouvasauthor=Y.+Wangauthor=M.+Wuauthor=L.+Shenauthor=C.+A.+Johnstonauthor=S.+P.+Nikasauthor=F.+Songauthor=X.+Songauthor=S.+Yuanauthor=Q.+Sunauthor=Y.+Wuauthor=S.+Jiangauthor=T.+Grimauthor=O.+Benchamaauthor=E.+L.+Stahlauthor=N.+Zvonokauthor=S.+Zhaoauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=Z.+Liu&title=Activation+and+Signaling+Mechanism+Revealed+by+Cannabinoid+Receptor-Gi+Complex+Structures&doi=10.1016%2Fj.cell.2020.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures</span></div><div class="casAuthors">Hua, Tian; Li, Xiaoting; Wu, Lijie; Iliopoulos-Tsoutsouvas, Christos; Wang, Yuxia; Wu, Meng; Shen, Ling; Johnston, Christina A.; Nikas, Spyros P.; Song, Feng; Song, Xiyong; Yuan, Shuguang; Sun, Qianqian; Wu, Yiran; Jiang, Shan; Grim, Travis W.; Benchama, Othman; Stahl, Edward L.; Zvonok, Nikolai; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-665.e18</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human endocannabinoid systems modulate multiple physiol. processes mainly through the activation of cannabinoid receptors CB1 and CB2.  Their high sequence similarity, low agonist selectivity, and lack of activation and G protein-coupling knowledge have hindered the development of therapeutic applications.  Importantly, missing structural information has significantly held back the development of promising CB2-selective agonist drugs for treating inflammatory and neuropathic pain without the psychoactivity of CB1.  Here, we report the cryoelectron microscopy structures of synthetic cannabinoid-bound CB2 and CB1 in complex with Gi, as well as agonist-bound CB2 crystal structure.  Of important scientific and therapeutic benefit, our results reveal a diverse activation and signaling mechanism, the structural basis of CB2-selective agonists design, and the unexpected interaction of cholesterol with CB1, suggestive of its endogenous allosteric modulating role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgy9tDrt9HArVg90H21EOLACvtfcHk0liJTVedYsDO6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFeqtbc%253D&md5=b9d4dd05094f3bae76b315a41a11c21b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DIliopoulos-Tsoutsouvas%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DC.%2BA.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DSong%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DGrim%26aufirst%3DT.%26aulast%3DBenchama%26aufirst%3DO.%26aulast%3DStahl%26aufirst%3DE.%2BL.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DActivation%2520and%2520Signaling%2520Mechanism%2520Revealed%2520by%2520Cannabinoid%2520Receptor-Gi%2520Complex%2520Structures%26jtitle%3DCell%26date%3D2020%26volume%3D180%26issue%3D4%26spage%3D655%26epage%3D665%26doi%3D10.1016%2Fj.cell.2020.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span> <span> </span><span class="NLM_article-title">Structure of an Allosteric Modulator Bound to the CB1 Cannabinoid Receptor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1038/s41589-019-0387-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fs41589-019-0387-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31659318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVCksLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1199-1205&issue=12&author=Z.+Shaoauthor=W.+Yanauthor=K.+Chapmanauthor=K.+Rameshauthor=A.+J.+Ferrellauthor=J.+Yinauthor=X.+Wangauthor=Q.+Xuauthor=D.+M.+Rosenbaum&title=Structure+of+an+Allosteric+Modulator+Bound+to+the+CB1+Cannabinoid+Receptor&doi=10.1038%2Fs41589-019-0387-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an allosteric modulator bound to the CB1 cannabinoid receptor</span></div><div class="casAuthors">Shao, Zhenhua; Yan, Wei; Chapman, Karen; Ramesh, Karthik; Ferrell, Aaron J.; Yin, Jie; Wang, Xuehui; Xu, Qingping; Rosenbaum, Daniel M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1199-1205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The CB1 receptor mediates the central nervous system response to cannabinoids, and is a drug target for pain, anxiety and seizures.  CB1 also responds to allosteric modulators, which influence cannabinoid binding and efficacy.  To understand the mechanism of these compds., we solved the crystal structure of CB1 with the neg. allosteric modulator (NAM) ORG27569 and the agonist CP55940.  The structure reveals that the NAM binds to an extrahelical site within the inner leaflet of the membrane, which overlaps with a conserved site of cholesterol interaction in many G protein-coupled receptors (GPCRs).  The ternary structure with ORG27569 and CP55940 captures an intermediate state of the receptor, in which arom. residues at the base of the agonist-binding pocket adopt an inactive conformation despite the large contraction of the orthosteric pocket.  The structure illustrates a potential strategy for drug modulation of CB1 and other class A GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz52KMEDfkTbVg90H21EOLACvtfcHk0lipNKxQFgwDCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVCksLnM&md5=58150bc1805c874c5dce7ed13fcf7c68</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0387-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0387-2%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DRamesh%26aufirst%3DK.%26aulast%3DFerrell%26aufirst%3DA.%2BJ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26atitle%3DStructure%2520of%2520an%2520Allosteric%2520Modulator%2520Bound%2520to%2520the%2520CB1%2520Cannabinoid%2520Receptor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26issue%3D12%26spage%3D1199%26epage%3D1205%26doi%3D10.1038%2Fs41589-019-0387-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishna
Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalev-Benami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banister, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrens, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span> <span> </span><span class="NLM_article-title">Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2018.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30639101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=448-458&issue=3&author=K.+Krishna%0AKumarauthor=M.+Shalev-Benamiauthor=M.+J.+Robertsonauthor=H.+Huauthor=S.+D.+Banisterauthor=S.+A.+Hollingsworthauthor=N.+R.+Latorracaauthor=H.+E.+Katoauthor=D.+Hilgerauthor=S.+Maedaauthor=W.+I.+Weisauthor=D.+L.+Farrensauthor=R.+Drorauthor=S.+V.+Malhotraauthor=B.+Kobilkaauthor=G.+Skiniotis&title=Structure+of+a+Signaling+Cannabinoid+Receptor+1-G+Protein+Complex&doi=10.1016%2Fj.cell.2018.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex</span></div><div class="casAuthors">Krishna Kumar, Kaavya; Shalev-Benami, Moran; Robertson, Michael J.; Hu, Hongli; Banister, Samuel D.; Hollingsworth, Scott A.; Latorraca, Naomi R.; Kato, Hideaki E.; Hilger, Daniel; Maeda, Shoji; Weis, William I.; Farrens, David L.; Dror, Ron O.; Malhotra, Sanjay V.; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">448-458.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cannabis elicits its mood-enhancing and analgesic effects through the cannabinoid receptor 1 (CB1), a G protein-coupled receptor (GPCR) that signals primarily through the adenylyl cyclase-inhibiting heterotrimeric G protein Gi.  Activation of CB1-Gi signaling pathways holds potential for treating a no. of neurol. disorders and is thus crucial to understand the mechanism of Gi activation by CB1.  Here, we present the structure of the CB1-Gi signaling complex bound to the highly potent agonist MDMB-Fubinaca (FUB), a recently emerged illicit synthetic cannabinoid infused in street drugs that have been assocd. with numerous overdoses and fatalities.  The structure illustrates how FUB stabilizes the receptor in an active state to facilitate nucleotide exchange in Gi.  The results compose the structural framework to explain CB1 activation by different classes of ligands and provide insights into the G protein coupling and selectivity mechanisms adopted by the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovBXFMO5ZXtrVg90H21EOLACvtfcHk0lipNKxQFgwDCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFKkuw%253D%253D&md5=de5d2da4a5fd3b4a1c8f7e9b2ac08f6f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DKrishna%2BKumar%26aufirst%3DK.%26aulast%3DShalev-Benami%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DM.%2BJ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DHollingsworth%26aufirst%3DS.%2BA.%26aulast%3DLatorraca%26aufirst%3DN.%2BR.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DHilger%26aufirst%3DD.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DFarrens%26aufirst%3DD.%2BL.%26aulast%3DDror%26aufirst%3DR.%26aulast%3DMalhotra%26aufirst%3DS.%2BV.%26aulast%3DKobilka%26aufirst%3DB.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DStructure%2520of%2520a%2520Signaling%2520Cannabinoid%2520Receptor%25201-G%2520Protein%2520Complex%26jtitle%3DCell%26date%3D2019%26volume%3D176%26issue%3D3%26spage%3D448%26epage%3D458%26doi%3D10.1016%2Fj.cell.2018.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzemska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span> <span> </span><span class="NLM_article-title">High-Resolution Crystal Structure of the Human CB1 Cannabinoid Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>540</i></span> (<span class="NLM_issue">7634</span>),  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/nature20613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fnature20613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27851727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=540&publication_year=2016&pages=602-606&issue=7634&author=Z.+Shaoauthor=J.+Yinauthor=K.+Chapmanauthor=M.+Grzemskaauthor=L.+Clarkauthor=J.+Wangauthor=D.+M.+Rosenbaum&title=High-Resolution+Crystal+Structure+of+the+Human+CB1+Cannabinoid+Receptor&doi=10.1038%2Fnature20613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution crystal structure of the human CB1 cannabinoid receptor</span></div><div class="casAuthors">Shao, Zhenhua; Yin, Jie; Chapman, Karen; Grzemska, Magdalena; Clark, Lindsay; Wang, Junmei; Rosenbaum, Daniel M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">540</span>
        (<span class="NLM_cas:issue">7634</span>),
    <span class="NLM_cas:pages">602-606</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human cannabinoid G-protein-coupled receptors (GPCRs) CB1 and CB2 mediate the functional responses to the endocannabinoids anandamide and 2-arachidonyl glycerol (2-AG) and to the widely consumed plant phytocannabinoid Δ9-tetrahydrocannabinol (THC).  The cannabinoid receptors have been the targets of intensive drug discovery efforts, because modulation of these receptors has therapeutic potential to control pain, epilepsy, obesity, and other disorders.  Although much progress in understanding the biophys. properties of GPCRs has recently been made, investigations of the mol. mechanisms of the cannabinoids and their receptors have lacked high-resoln. structural data.  Here we report the use of GPCR engineering and lipidic cubic phase crystn. to det. the structure of the human CB1 receptor bound to the inhibitor taranabant at 2.6-Å resoln.  We found that the extracellular surface of CB1, including the highly conserved membrane-proximal N-terminal region, is distinct from those of other lipid-activated GPCRs, forming a crit. part of the ligand-binding pocket.  Docking studies further demonstrate how this same pocket may accommodate the cannabinoid agonist THC.  Our CB1 structure provides an at. framework for studying cannabinoid receptor function and will aid the design and optimization of therapeutic modulators of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrry3sr0ztbEbVg90H21EOLACvtfcHk0lgrrUpeYEhF2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgtL3L&md5=cccd3a0e0d0ccf9795777e4b9e722102</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fnature20613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature20613%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DGrzemska%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26atitle%3DHigh-Resolution%2520Crystal%2520Structure%2520of%2520the%2520Human%2520CB1%2520Cannabinoid%2520Receptor%26jtitle%3DNature%26date%3D2016%26volume%3D540%26issue%3D7634%26spage%3D602%26epage%3D606%26doi%3D10.1038%2Fnature20613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprairie, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Agonist-Bound Human Cannabinoid Receptor CB1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>547</i></span> (<span class="NLM_issue">7664</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1038/nature23272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fnature23272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=28678776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2017&pages=468-471&issue=7664&author=T.+Huaauthor=K.+Vemuriauthor=S.+P.+Nikasauthor=R.+B.+Laprairieauthor=Y.+Wuauthor=L.+Quauthor=M.+Puauthor=A.+Kordeauthor=S.+Jiangauthor=J.-H.+Hoauthor=G.+W.+Hanauthor=K.+Dingauthor=X.+Liauthor=H.+Liuauthor=M.+H.+Hansonauthor=S.+Zhaoauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+Stevensauthor=Z.-J.+Liu&title=Crystal+Structures+of+Agonist-Bound+Human+Cannabinoid+Receptor+CB1&doi=10.1038%2Fnature23272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of agonist-bound human cannabinoid receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Nikas, Spyros P.; Laprairie, Robert B.; Wu, Yiran; Qu, Lu; Pu, Mengchen; Korde, Anisha; Jiang, Shan; Ho, Jo-Hao; Han, Gye Won; Ding, Kang; Li, Xuanxuan; Liu, Haiguang; Hanson, Michael A.; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">7664</span>),
    <span class="NLM_cas:pages">468-471</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).  Here the authors report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resoln., resp.  The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% redn. in the vol. of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region.  In addn., a 'twin toggle switch' of Phe 2003.36 and Trp 3566.48 (superscripts denote Ballesteros-Weinstein numbering) is exptl. obsd. and appears to be essential for receptor activation.  The structures reveal important insights into the activation mechanism of CB1 and provide a mol. basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids.  The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors.  These findings should inspire the design of chem. diverse ligands with distinct pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6XE4Hx5gDrVg90H21EOLACvtfcHk0ljkrZh5j0vi1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E&md5=f77fcc823e5856ece0bb5730ac00ea07</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnature23272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23272%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DJ.-H.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHanson%26aufirst%3DM.%2BH.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520Structures%2520of%2520Agonist-Bound%2520Human%2520Cannabinoid%2520Receptor%2520CB1%26jtitle%3DNature%26date%3D2017%26volume%3D547%26issue%3D7664%26spage%3D468%26epage%3D471%26doi%3D10.1038%2Fnature23272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Cannabinoid CB 1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2016.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27768894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=750-762&author=T.+Huaauthor=K.+Vemuriauthor=M.+Puauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.+Liu&title=Crystal+Structure+of+the+Human+Cannabinoid+CB+1&doi=10.1016%2Fj.cell.2016.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Pu, Mengchen; Qu, Lu; Han, Gye Won; Wu, Yiran; Zhao, Suwen; Shui, Wenqing; Li, Shanshan; Korde, Anisha; Laprairie, Robert B.; Stahl, Edward L.; Ho, Jo-Hao; Zvonok, Nikolai; Zhou, Han; Kufareva, Irina; Wu, Beili; Zhao, Qiang; Hanson, Michael A.; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">750-762.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chem. from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use.  CB1 is activated by endocannabinoids and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.  Here, the authors present the 2.8 Å crystal structure of human CB1 in complex with AM6538, a stabilizing antagonist, synthesized and characterized for this structural study.  The structure of the CB1-AM6538 complex reveals key features of the receptor and crit. interactions for antagonist binding.  In combination with functional studies and mol. modeling, the structure provides insight into the binding mode of naturally occurring CB1 ligands, such as THC, and synthetic cannabinoids.  This enhances the understanding of the mol. basis for the physiol. functions of CB1 and provides new opportunities for the design of next-generation CB1-targeting pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuMgAfmO22bVg90H21EOLACvtfcHk0lje-Aqo-vbD6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI&md5=f4862c31391550ee2b83ef198c9c7b17</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Cannabinoid%2520CB%25201%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D750%26epage%3D762%26doi%3D10.1016%2Fj.cell.2016.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchama, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Cannabinoid Receptor CB2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2018.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30639103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=459-467&issue=3&author=X.+Liauthor=T.+Huaauthor=K.+Vemuriauthor=J.+H.+Hoauthor=Y.+Wuauthor=L.+Wuauthor=P.+Popovauthor=O.+Benchamaauthor=N.+Zvonokauthor=K.+Lockeauthor=L.+Quauthor=G.+W.+Hanauthor=M.+R.+Iyerauthor=R.+Cinarauthor=N.+J.+Coffeyauthor=J.+Wangauthor=M.+Wuauthor=V.+Katritchauthor=S.+Zhaoauthor=G.+Kunosauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+Stevensauthor=Z.-J.+Liu&title=Crystal+Structure+of+the+Human+Cannabinoid+Receptor+CB2&doi=10.1016%2Fj.cell.2018.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB2</span></div><div class="casAuthors">Li, Xiaoting; Hua, Tian; Vemuri, Kiran; Ho, Jo-Hao; Wu, Yiran; Wu, Lijie; Popov, Petr; Benchama, Othman; Zvonok, Nikolai; Locke, K'ara; Qu, Lu; Han, Gye Won; Iyer, Malliga R.; Cinar, Resat; Coffey, Nathan J.; Wang, Jingjing; Wu, Meng; Katritch, Vsevolod; Zhao, Suwen; Kunos, George; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-467.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cannabinoid receptor CB2 is predominately expressed in the immune system, and selective modulation of CB2 without the psychoactivity of CB1 has therapeutic potential in inflammatory, fibrotic, and neurodegenerative diseases.  Here, we report the crystal structure of human CB2 in complex with a rationally designed antagonist, AM10257, at 2.8 Å resoln.  The CB2-AM10257 structure reveals a distinctly different binding pose compared with CB1.  However, the extracellular portion of the antagonist-bound CB2 shares a high degree of conformational similarity with the agonist-bound CB1, which led to the discovery of AM10257's unexpected opposing functional profile of CB2 antagonism vs. CB1 agonism.  Further structural anal. using mutagenesis studies and mol. docking revealed the mol. basis of their function and selectivity for CB2 and CB1.  Addnl. analyses of our designed antagonist and agonist pairs provide important insight into the activation mechanism of CB2.  The present findings should facilitate rational drug design toward precise modulation of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFwNUEO0q03LVg90H21EOLACvtfcHk0lje-Aqo-vbD6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D&md5=90ee72a6dc13b74b84fb6799c3aa0471</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DPopov%26aufirst%3DP.%26aulast%3DBenchama%26aufirst%3DO.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLocke%26aufirst%3DK.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DIyer%26aufirst%3DM.%2BR.%26aulast%3DCinar%26aufirst%3DR.%26aulast%3DCoffey%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Cannabinoid%2520Receptor%2520CB2%26jtitle%3DCell%26date%3D2019%26volume%3D176%26issue%3D3%26spage%3D459%26epage%3D467%26doi%3D10.1016%2Fj.cell.2018.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.-Q.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM Structure of the Human Cannabinoid Receptor CB2-G i Signaling Complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2020.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32004460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2020&pages=645-654&author=C.+Xingauthor=Y.+Zhuangauthor=T.-H.+Xuauthor=Z.+Fengauthor=X.+E.+Zhouauthor=M.+Chenauthor=L.+Wangauthor=X.+Mengauthor=Y.+Xueauthor=J.+Wangauthor=H.+Liuauthor=T.+F.+McGuireauthor=G.+Zhaoauthor=K.+Melcherauthor=C.+Zhangauthor=H.+E.+Xuauthor=X.-Q.+Xie&title=Cryo-EM+Structure+of+the+Human+Cannabinoid+Receptor+CB2-G+i+Signaling+Complex&doi=10.1016%2Fj.cell.2020.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex</span></div><div class="casAuthors">Xing, Changrui; Zhuang, Youwen; Xu, Ting-Hai; Feng, Zhiwei; Zhou, X. Edward; Chen, Maozi; Wang, Lei; Meng, Xing; Xue, Ying; Wang, Junmei; Liu, Heng; McGuire, Terence Francis; Zhao, Gongpu; Melcher, Karsten; Zhang, Cheng; Xu, H. Eric; Xie, Xiang-Qun</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">645-654.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Drugs selectively targeting CB2 hold promise for treating neurodegenerative disorders, inflammation, and pain while avoiding psychotropic side effects mediated by CB1.  The mechanisms underlying CB2 activation and signaling are poorly understood but crit. for drug design.  Here we report the cryo-EM structure of the human CB2-Gi signaling complex bound to the agonist WIN 55,212-2.  The 3D structure reveals the binding mode of WIN 55,212-2 and structural determinants for distinguishing CB2 agonists from antagonists, which are supported by a pair of rationally designed agonist and antagonist.  Further structural analyses with computational docking results uncover the differences between CB2 and CB1 in receptor activation, ligand recognition, and Gi coupling.  These findings are expected to facilitate rational structure-based discovery of drugs targeting the cannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxe6yMtfE8RbVg90H21EOLACvtfcHk0lhE-GL0pNk7kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFequr8%253D&md5=2c54b7bd90e2f9b33b141adb36e57688</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DT.-H.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%2BE.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMcGuire%26aufirst%3DT.%2BF.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMelcher%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DXie%26aufirst%3DX.-Q.%26atitle%3DCryo-EM%2520Structure%2520of%2520the%2520Human%2520Cannabinoid%2520Receptor%2520CB2-G%2520i%2520Signaling%2520Complex%26jtitle%3DCell%26date%3D2020%26volume%3D180%26spage%3D645%26epage%3D654%26doi%3D10.1016%2Fj.cell.2020.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobingier, B. T.</span></span> <span> </span><span class="NLM_article-title">A Cellular Perspective of Bias at G Protein-Coupled Receptors</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1354</span>, <span class="refDoi"> DOI: 10.1002/pro.3872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1002%2Fpro.3872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32297394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVOqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2020&pages=1345-1354&author=T.+J.+Fernandezauthor=M.+De+Mariaauthor=B.+T.+Lobingier&title=A+Cellular+Perspective+of+Bias+at+G+Protein-Coupled+Receptors&doi=10.1002%2Fpro.3872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">A cellular perspective of bias at G protein-coupled receptors</span></div><div class="casAuthors">Fernandez, Thomas J.; De Maria, Monica; Lobingier, Braden T.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1345-1354</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) modulate cell function over short- and long-term timescales.  GPCR signaling depends on biochem. parameters that define the what, when, and where of receptor function: what proteins mediate and regulate receptor signaling, where within the cell these interactions occur, and how long these interactions persist.  These parameters can vary significantly depending on the activating ligand.  Collectivity, differential agonist activity at a GPCR is called bias or functional selectivity.  Here we review agonist bias at GPCRs with a focus on ligands that show dramatically different cellular responses from their unbiased counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXtcFevqvi2bVg90H21EOLACvtfcHk0lhE-GL0pNk7kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVOqs74%253D&md5=9ef6e3cebf44a073d7cd156f9b1b65d4</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fpro.3872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3872%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DT.%2BJ.%26aulast%3DDe%2BMaria%26aufirst%3DM.%26aulast%3DLobingier%26aufirst%3DB.%2BT.%26atitle%3DA%2520Cellular%2520Perspective%2520of%2520Bias%2520at%2520G%2520Protein-Coupled%2520Receptors%26jtitle%3DProtein%2520Sci.%26date%3D2020%26volume%3D29%26spage%3D1345%26epage%3D1354%26doi%3D10.1002%2Fpro.3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samuel Obeng, Takato Hiranita, Francisco León, Lance R. McMahon, <span class="NLM_string-name hlFld-ContribAuthor">Christopher R. McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6523-6548. <a href="https://doi.org/10.1021/acs.jmedchem.1c00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BApproaches%25252C%252BDrug%252BCandidates%25252C%252Band%252BTargets%252Bin%252BPain%252BDrug%252BDiscovery%26aulast%3DObeng%26aufirst%3DSamuel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6523%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felipe  Patricio</span>, <span class="hlFld-ContribAuthor ">Alan Axel  Morales-Andrade</span>, <span class="hlFld-ContribAuthor ">Aleidy  Patricio-Martínez</span>, <span class="hlFld-ContribAuthor ">Ilhuicamina Daniel  Limón</span>. </span><span class="cited-content_cbyCitation_article-title">Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.595635" title="DOI URL">https://doi.org/10.3389/fphar.2020.595635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.595635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.595635%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DCannabidiol%252Bas%252Ba%252BTherapeutic%252BTarget%25253A%252BEvidence%252Bof%252Bits%252BNeuroprotective%252Band%252BNeuromodulatory%252BFunction%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DPatricio%26aufirst%3DFelipe%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of lipid-like compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of cannabinoid-related compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of the natural products amauromine and 27-<i>O</i>-methylasporyzin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Venn diagram classification of compounds tested at GPR18 regarding their activity at the related GPCRs CB<sub>1</sub>R, CB<sub>2</sub>R, GPR55, and GPR18. Compounds <b>S4</b>, <b>S5</b>, and <b>S9</b> are not included in the diagram since their activity at these other receptors has not been reported yet.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structures of selected synthetic GPR18 ligands.<a onclick="showRef(event, 'ref56 ref58 ref62'); return false;" href="javascript:void(0);" class="ref ref56 ref58 ref62">(56,58,62)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Human sequence alignments of GPR18, DOR, GPR55, CB<sub>1</sub>R, and CB<sub>2</sub>R: (A) transmembrane helix 1 (TMH1), (B) TMH2, (C) TMH3, (D) TMH4, (E) EC2 loop, (F) TMH5, (G) TMH6, and (H) TMH7. Color code: red, prolines; yellow, highly conserved residues across class A GPCRs; magenta, cysteines in an internal disulfide bridge; blue, cysteines in TMH3 to EC2 disulfide bridge; lavender, GW motif.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. GPR18 inactive state model: (A) lipid view of the bundle; (B) zoomed in view of the toggle switch residues M7.42 and F6.48; (C) zoomed in view of the “ionic lock” formed by R3.50 and S6.33. This figure has been done for this review using our previously reported model.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/medium/jm0c00926_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. GPR18 binding pocket (EC view, loops have been removed for clarity). Potential interacting residues are displayed in green tubes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c00926/20201203/images/large/jm0c00926_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00926&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 82 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gantz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelson, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, T.</span></span> <span> </span><span class="NLM_article-title">Cloning and Chromosomal Localization of a Gene (GPR18) Encoding a Novel Seven Transmembrane Receptor Highly Expressed in Spleen and Testis</span>. <i>Genomics</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">466</span>, <span class="refDoi"> DOI: 10.1006/geno.1997.4752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1006%2Fgeno.1997.4752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=9205118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADyaK2sXktFOnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1997&pages=462-466&issue=3&author=I.+Gantzauthor=A.+Muraokaauthor=Y.+K.+Yangauthor=L.+C.+Samuelsonauthor=E.+M.+Zimmermanauthor=H.+Cookauthor=T.+Yamada&title=Cloning+and+Chromosomal+Localization+of+a+Gene+%28GPR18%29+Encoding+a+Novel+Seven+Transmembrane+Receptor+Highly+Expressed+in+Spleen+and+Testis&doi=10.1006%2Fgeno.1997.4752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis</span></div><div class="casAuthors">Gantz, Ira; Muraoka, Akira; Yang, Ying-Kui; Samuelson, Linda C.; Zimmerman, Ellen M.; Cook, Helen; Yamada, Tadataka</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">462-466</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Using the techniques of relaxed stringency polymerase chain reaction and genomic library screening, we have isolated homologous canine and human genes that encode a novel putative seven transmembrane G-protein-linked receptor.  The gene encodes an open reading frame (ORF) of 993 bp.  The sequences of the canine and human ORFs are highly conserved, sharing 89% nucleotide identity and 92% amino acid similarity between the two species.  Northern blot anal. demonstrates that mRNA transcripts of the gene are abundantly expressed in testis and spleen with a lesser degree of expression obsd. in several other tissues assocd. with endocrine and immunol./hematol. function.  The gene, designated GPR18, was localized to human chromosome 13q32 using fluorescence in situ hybridization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrUiWzbYa5XLVg90H21EOLACvtfcHk0lhFLokMxljUBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktFOnu7w%253D&md5=7dfbf29ab1bdd930ab59abe808be9d38</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1006%2Fgeno.1997.4752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgeno.1997.4752%26sid%3Dliteratum%253Aachs%26aulast%3DGantz%26aufirst%3DI.%26aulast%3DMuraoka%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DY.%2BK.%26aulast%3DSamuelson%26aufirst%3DL.%2BC.%26aulast%3DZimmerman%26aufirst%3DE.%2BM.%26aulast%3DCook%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DT.%26atitle%3DCloning%2520and%2520Chromosomal%2520Localization%2520of%2520a%2520Gene%2520%2528GPR18%2529%2520Encoding%2520a%2520Novel%2520Seven%2520Transmembrane%2520Receptor%2520Highly%2520Expressed%2520in%2520Spleen%2520and%2520Testis%26jtitle%3DGenomics%26date%3D1997%26volume%3D42%26issue%3D3%26spage%3D462%26epage%3D466%26doi%3D10.1006%2Fgeno.1997.4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pertwee, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Marzo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elphick, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R. A.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">588</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1124%2Fpr.110.003004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=21079038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktler" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=588-631&issue=4&author=R.+G.+Pertweeauthor=A.+C.+Howlettauthor=M.+E.+Aboodauthor=S.+P.+H.+Alexanderauthor=V.+Di+Marzoauthor=M.+R.+Elphickauthor=P.+J.+Greasleyauthor=H.+S.+Hansenauthor=G.+Kunosauthor=K.+Mackieauthor=R.+Mechoulamauthor=R.+A.+Ross&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXIX.+Cannabinoid+Receptors+and+Their+Ligands%3A+Beyond+CB1+and+CB2&doi=10.1124%2Fpr.110.003004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2</span></div><div class="casAuthors">Pertwee, R. G.; Howlett, A. C.; Abood, M. E.; Alexander, S. P. H.; di Marzo, V.; Elphick, M. R.; Greasley, P. J.; Hansen, H. S.; Kunos, G.; Mackie, K.; Mechoulam, R.; Ross, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">588-631</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  There are at least two types of cannabinoid receptors (CB1 and CB2).  Ligands activating these G protein-coupled receptors (GPCRs) include the phytocannabinoid Δ9-tetrahydrocannabinol, numerous synthetic compds., and endogenous compds. known as endocannabinoids.  Cannabinoid receptor antagonists have also been developed.  Some of these ligands activate or block one type of cannabinoid receptor more potently than the other type.  This review summarizes current data indicating the extent to which cannabinoid receptor ligands undergo orthosteric or allosteric interactions with non-CB1, non-CB2 established GPCRs, deorphanized receptors such as GPR55, ligand-gated ion channels, transient receptor potential (TRP) channels, and other ion channels or peroxisome proliferator-activated nuclear receptors.  From these data, it is clear that some ligands that interact similarly with CB1 and/or CB2 receptors are likely to display significantly different pharmacol. profiles.  The review also lists some criteria that any novel "CB3" cannabinoid receptor or channel should fulfil and concludes that these criteria are not currently met by any non-CB1, non-CB2 pharmacol. receptor or channel.  However, it does identify certain pharmacol. targets that should be investigated further as potential CB3 receptors or channels.  These include TRP vanilloid 1, which possibly functions as an ionotropic cannabinoid receptor under physiol. and/or pathol. conditions, and some deorphanized GPCRs.  Also discussed are (1) the ability of CB1 receptors to form heteromeric complexes with certain other GPCRs, (2) phylogenetic relationships that exist between CB1/CB2 receptors and other GPCRs, (3) evidence for the existence of several as-yet-uncharacterized non-CB1, non-CB2 cannabinoid receptors; and (4) current cannabinoid receptor nomenclature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBEKWR8v5x6rVg90H21EOLACvtfcHk0liEVfKh65v8Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktler&md5=d0d2bf8e13bcf82ab67b34a61a82668e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003004%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DHowlett%26aufirst%3DA.%2BC.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DAlexander%26aufirst%3DS.%2BP.%2BH.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DElphick%26aufirst%3DM.%2BR.%26aulast%3DGreasley%26aufirst%3DP.%2BJ.%26aulast%3DHansen%26aufirst%3DH.%2BS.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXIX.%2520Cannabinoid%2520Receptors%2520and%2520Their%2520Ligands%253A%2520Beyond%2520CB1%2520and%2520CB2%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26issue%3D4%26spage%3D588%26epage%3D631%26doi%3D10.1124%2Fpr.110.003004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Console-Bram, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brailoiu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brailoiu, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span> <span> </span><span class="NLM_article-title">Activation of GPR18 by Cannabinoid Compounds: A Tale of Biased Agonism</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>171</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3908</span>– <span class="NLM_lpage">3917</span>, <span class="refDoi"> DOI: 10.1111/bph.12746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fbph.12746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24762058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1WmsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=3908-3917&issue=16&author=L.+Console-Bramauthor=E.+Brailoiuauthor=G.+C.+Brailoiuauthor=H.+Sharirauthor=M.+E.+Abood&title=Activation+of+GPR18+by+Cannabinoid+Compounds%3A+A+Tale+of+Biased+Agonism&doi=10.1111%2Fbph.12746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of GPR18 by cannabinoid compounds: a tale of biased agonism</span></div><div class="casAuthors">Console-Bram, Linda; Brailoiu, Eugen; Brailoiu, Gabriela Cristina; Sharir, Haleli; Abood, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3908-3917</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : GPR18 is a candidate cannabinoid receptor, but its classification as such is controversial.  The rationale of the study presented herein was to consider the effects of N-arachidonoyl glycine (NAGly) and cannabinoids via differential G-protein coupled pathways, in addn. to β-arrestin signalling.  Cellular localization of GPR18 receptors was also examd.  Exptl. Approach : Calcium mobilization and ERK1/2 phosphorylation were quantified in a cell line stably expressing GPR18 (HEK293/GPR18 cells).  In addn., using the DiscoveRx PathHunter CHO-K1 GPR18 β-arrestin cell line, recruitment of β-arrestin was quantified.  Key Results : Concn.-dependent increases in intracellular calcium and ERK1/2 phosphorylation were obsd. in the presence of NAGly, abnormal cannabidiol (AbnCBD), O-1602, O-1918 and Δ9-tetrahydrocannabinol (Δ9-THC) in HEK293/GPR18 cells.  The initial rise in intracellular calcium in the presence of NAGly, O1918 and THC was blocked by either Gαq or Gαi/o inhibition.  The ERK1/2 phosphorylation was inhibited by Pertussis toxin and N-arachidonoyl-L-serine (NARAS).  Recruitment of β-arrestin in the PathHunter CHO-K1 GPR18 cell line revealed a differential pattern of GPR18 activation; of all the ligands tested, only Δ9-THC produced a concn.-dependent response.  The localization of GPR18 receptors within the HEK293/GPR18 cells is both intracellular, and on the plasma membrane.  Conclusions and Implications : These findings suggest that GPR18 activation involves several signal transduction pathways indicative of biased agonism, thereby providing a plausible explanation for the apparent discrepancies in GPR18 activation found in the literature.  Addnl., the results presented herein provide further evidence for GPR18 as a candidate cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEqZFY8uPyNLVg90H21EOLACvtfcHk0liEVfKh65v8Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1WmsrjN&md5=4685930ff193dd4c44fea180be190dcb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fbph.12746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12746%26sid%3Dliteratum%253Aachs%26aulast%3DConsole-Bram%26aufirst%3DL.%26aulast%3DBrailoiu%26aufirst%3DE.%26aulast%3DBrailoiu%26aufirst%3DG.%2BC.%26aulast%3DSharir%26aufirst%3DH.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DActivation%2520of%2520GPR18%2520by%2520Cannabinoid%2520Compounds%253A%2520A%2520Tale%2520of%2520Biased%2520Agonism%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26issue%3D16%26spage%3D3908%26epage%3D3917%26doi%3D10.1111%2Fbph.12746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">Δ9-Tetrahydrocannabinol and N-Arachidonyl Glycine Are Full Agonists at GPR18 Receptors and Induce Migration in Human Endometrial HEC-1B Cells</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2414</span>– <span class="NLM_lpage">2424</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01497.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1476-5381.2011.01497.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=21595653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVajsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=2414-2424&issue=8&author=D.+McHughauthor=J.+Pageauthor=E.+Dunnauthor=H.+B.+Bradshaw&title=%CE%949-Tetrahydrocannabinol+and+N-Arachidonyl+Glycine+Are+Full+Agonists+at+GPR18+Receptors+and+Induce+Migration+in+Human+Endometrial+HEC-1B+Cells&doi=10.1111%2Fj.1476-5381.2011.01497.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Δ9-tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells</span></div><div class="casAuthors">McHugh, Douglas; Page, Jeremy; Dunn, Emily; Bradshaw, Heather B.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2414-2424</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: Endometriosis is a disorder in which the endometrium forms growths outside the uterus and is assocd. with chronic pain.  Recent evidence suggests that endometrial motility plays a role in the etiol. of endometriosis.  The endocannabinoid system regulates cellular migration.  Given the growing involvement of the endocannabinoids in reprodn., we investigated the role of the endocannabinoid system in migration of endometrial cells.  Exptl. Approach: Migration of the human endometrial HEC-1B cells was assayed.  Std. PCR techniques were used to det. the presence of the GPCR, GPR18, in HEC-1B cells, and p44/42 MAPK was assayed in stably transfected HEK293-GPR18 cells to det. receptor specificity for known cannabinoid agonists and antagonists.  N-arachidonoyl ethanolamine (AEA) metab. was measured, using HPLC/MS/MS for lipid anal.  Key Results: AEA, Δ9-tetrahydrocannabinol (Δ9-THC) and N-arachidonoyl glycine (NAGly) induce migration of HEC-1B cells through cannabinoid CB1 receptor-independent mechanisms.  MAPK activation in HEK293-GPR18 cells revealed novel pharmacol. for known CB1 and CB2 receptor ligands at GPR18 receptors, including Δ9-THC, which activates MAPK at nanomolar concns., whereas WIN 55212-2, CP55940, JWH-133 and JWH-015, and arachidonyl-1-hydroxy-2-propylamide (R1-methanandamide) had no effect.  Moreover, HEC-1B migration and MAPK activation by NAGly and Δ9-THC were antagonized by Pertussis toxin, AM251 and cannabidiol.  Conclusions and Implications: An understanding of the function and regulation of GPR18 and its mol. interactions with endogenous ligands, and how phytocannabinoids play a role with GPR18 signalling is vital if we are to comprehensively assess the function of the cannabinoid signalling system in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKp4A_A8HgGbVg90H21EOLACvtfcHk0ljjfti86Sx_4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVajsL0%253D&md5=fbef8e8cf1ba07b9f359a1b21dea725e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01497.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01497.x%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DPage%26aufirst%3DJ.%26aulast%3DDunn%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3D%25CE%25949-Tetrahydrocannabinol%2520and%2520N-Arachidonyl%2520Glycine%2520Are%2520Full%2520Agonists%2520at%2520GPR18%2520Receptors%2520and%2520Induce%2520Migration%2520in%2520Human%2520Endometrial%2520HEC-1B%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26issue%3D8%26spage%3D2414%26epage%3D2424%26doi%3D10.1111%2Fj.1476-5381.2011.01497.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassilatis, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranchalis, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortrud, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaitanaris, G. A.</span></span> <span> </span><span class="NLM_article-title">The G Protein-Coupled Receptor Repertoires of Human and Mouse</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4903</span>– <span class="NLM_lpage">4908</span>, <span class="refDoi"> DOI: 10.1073/pnas.0230374100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1073%2Fpnas.0230374100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=12679517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt12nt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4903-4908&issue=8&author=D.+K.+Vassilatisauthor=J.+G.+Hohmannauthor=H.+Zengauthor=F.+Liauthor=J.+E.+Ranchalisauthor=M.+T.+Mortrudauthor=A.+Brownauthor=S.+S.+Rodriguezauthor=J.+R.+Wellerauthor=A.+C.+Wrightauthor=J.+E.+Bergmannauthor=G.+A.+Gaitanaris&title=The+G+Protein-Coupled+Receptor+Repertoires+of+Human+and+Mouse&doi=10.1073%2Fpnas.0230374100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-coupled receptor repertoires of human and mouse</span></div><div class="casAuthors">Vassilatis, Demetrios K.; Hohmann, John G.; Zeng, Hongkui; Li, Fusheng; Ranchalis, Jane E.; Mortrud, Marty T.; Brown, Analisa; Rodriguez, Stephanie S.; Weller, John R.; Wright, Abbie C.; Bergmann, John E.; Gaitanaris, George A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4903-4908</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Diverse members of the G protein-coupled receptor (GPCR) super-family participate in a variety of physiol. functions and are major targets of pharmaceutical drugs.  Here we report that the repertoire of GPCRs for endogenous ligands consists of 367 receptors in humans and 392 in mice.  Included here are 26 human and 83 mouse GPCRs not previously identified.  A direct comparison of GPCRs in the two species reveals an unexpected level of orthol.  The evolutionary preservation of these mols. argues against functional redundancy among highly related receptors.  Phylogenetic analyses cluster 60% of GPCRs according to ligand preference, allowing prediction of ligand types for dozens of orphan receptors.  Expression profiling of 100 GPCRs demonstrates that most are expressed in multiple tissues and that individual tissues express multiple GPCRs.  Over 90% of GPCRs are expressed in the brain.  Strikingly, however, the profiles of most GPCRs are unique, yielding thousands of tissue- and cell-specific receptor combinations for the modulation of physiol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnKe3CCaGZ6LVg90H21EOLACvtfcHk0ljjfti86Sx_4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt12nt70%253D&md5=d164253c5320b591469b509b91323ff4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0230374100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0230374100%26sid%3Dliteratum%253Aachs%26aulast%3DVassilatis%26aufirst%3DD.%2BK.%26aulast%3DHohmann%26aufirst%3DJ.%2BG.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DRanchalis%26aufirst%3DJ.%2BE.%26aulast%3DMortrud%26aufirst%3DM.%2BT.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DS.%2BS.%26aulast%3DWeller%26aufirst%3DJ.%2BR.%26aulast%3DWright%26aufirst%3DA.%2BC.%26aulast%3DBergmann%26aufirst%3DJ.%2BE.%26aulast%3DGaitanaris%26aufirst%3DG.%2BA.%26atitle%3DThe%2520G%2520Protein-Coupled%2520Receptor%2520Repertoires%2520of%2520Human%2520and%2520Mouse%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D8%26spage%3D4903%26epage%3D4908%26doi%3D10.1073%2Fpnas.0230374100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasukawa, M.</span></span> <span> </span><span class="NLM_article-title">Identification of N-Arachidonylglycine as the Endogenous Ligand for Orphan G-Protein-Coupled Receptor GPR18</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>347</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">832</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.06.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bbrc.2006.06.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=16844083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD28Xntl2jurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2006&pages=827-832&issue=3&author=M.+Kohnoauthor=H.+Hasegawaauthor=A.+Inoueauthor=M.+Muraokaauthor=T.+Miyazakiauthor=K.+Okaauthor=M.+Yasukawa&title=Identification+of+N-Arachidonylglycine+as+the+Endogenous+Ligand+for+Orphan+G-Protein-Coupled+Receptor+GPR18&doi=10.1016%2Fj.bbrc.2006.06.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18</span></div><div class="casAuthors">Kohno, Masashi; Hasegawa, Hitoshi; Inoue, Atsushi; Muraoka, Masatake; Miyazaki, Tatsuhiko; Oka, Keizo; Yasukawa, Masaki</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">827-832</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">An orphan G-protein-coupled receptor, GPR18, was cloned on the basis of degenerate-oligonucleotide PCR anal. of HUT 102 cells using primers designed from the conservative regions of the human chemokine receptor.  GPR18 was expressed significantly in lymphoid cell lines, but not in non-lymphoid hematopoietic cell lines.  Moreover, the expression of the GPR18 gene was higher in peripheral lymphocyte subsets (CD4+, CD4+CD45RA+, CD4+CD45RO+, CD8+, and CD19+) than in monocytes and lymphoid cell lines, and was increased after stimulation with phytohemagglutinin.  By screening using a lipid library, N-arachidonylglycine (NAGly) induced an increase in intracellular Ca2+ concn. in GPR18-transfected cells, which was significantly greater than that in mock-transfected cells.  NAGly also inhibited forskolin-induced cAMP prodn. in a pertussis toxin-sensitive manner in the GPR18-transfected CHO cells.  This is the first study to demonstrate that NAGly is a natural ligand for GPR18.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeVsg34QDIs7Vg90H21EOLACvtfcHk0lg4FBr0BE8qIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xntl2jurw%253D&md5=2065a390b3130d768257defcc0384dd8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.06.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.06.175%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DM.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DA.%26aulast%3DMuraoka%26aufirst%3DM.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DK.%26aulast%3DYasukawa%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520N-Arachidonylglycine%2520as%2520the%2520Endogenous%2520Ligand%2520for%2520Orphan%2520G-Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D347%26issue%3D3%26spage%3D827%26epage%3D832%26doi%3D10.1016%2Fj.bbrc.2006.06.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takenouchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, A.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine Induces Macrophage Apoptosis via GPR18</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>418</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2012.01.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bbrc.2012.01.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=22266325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Crt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2012&pages=366-371&issue=2&author=R.+Takenouchiauthor=K.+Inoueauthor=Y.+Kambeauthor=A.+Miyata&title=N-Arachidonoyl+Glycine+Induces+Macrophage+Apoptosis+via+GPR18&doi=10.1016%2Fj.bbrc.2012.01.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine induces macrophage apoptosis via GPR18</span></div><div class="casAuthors">Takenouchi, Rina; Inoue, Kazuhiko; Kambe, Yuki; Miyata, Atsuro</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-371</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-arachidonoyl glycine (NAGly), a member of lipoamino acids, was reported to exhibit anti-inflammatory effects in exptl. ear edema or peritonitis.  However the underlying mechanisms have not been clarified so far.  In this study, we attempt to investigate the effects of NAGly on macrophages, including the relevant signaling pathways.  NAGly potently induced apoptosis in mouse macrophage-derived cell line, RAW264.7.  Pretreatment with inhibitors for MEK and p38 MAPK prevented the apoptosis induced by NAGly, although NAGly activated ERK1/2, p38 MAPK and JNK.  Further, we focused on implication of GPR18, one of the orphan G protein-coupled receptors, because NAGly has been reported as a candidate ligand for GPR18.  Pretreatment with pertussis toxin or siRNA to knock down the expression of GPR18 significantly attenuated the apoptosis induced by NAGly.  In mouse peritoneal macrophages, the expression of GPR18 mRNA was elevated in proinflammatory stimulated macrophages but not in anti-inflammatory stimulated macrophages; consistently, NAGly remarkably reduced cell viability of the former, as compared to the latter.  These results suggest that NAGly might be involved in function of macrophages through GPR18.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvH3m2AZNCZ7Vg90H21EOLACvtfcHk0lg4FBr0BE8qIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Crt7o%253D&md5=b3d71262301889d560d9ba9b044707ac</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2012.01.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2012.01.027%26sid%3Dliteratum%253Aachs%26aulast%3DTakenouchi%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKambe%26aufirst%3DY.%26aulast%3DMiyata%26aufirst%3DA.%26atitle%3DN-Arachidonoyl%2520Glycine%2520Induces%2520Macrophage%2520Apoptosis%2520via%2520GPR18%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2012%26volume%3D418%26issue%3D2%26spage%3D366%26epage%3D371%26doi%3D10.1016%2Fj.bbrc.2012.01.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puhl, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S. R.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonyl Glycine Does Not Activate G Protein-Coupled Receptor 18 Signaling via Canonical Pathways</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>83</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1124/mol.112.081182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1124%2Fmol.112.081182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23104136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=267-282&issue=1&author=V.+B.+Luauthor=H.+L.+Puhlauthor=S.+R.+Ikeda&title=N-Arachidonyl+Glycine+Does+Not+Activate+G+Protein-Coupled+Receptor+18+Signaling+via+Canonical+Pathways&doi=10.1124%2Fmol.112.081182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways</span></div><div class="casAuthors">Lu, Van B.; Puhl, Henry L., III; Ikeda, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">267-282</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent studies propose that N-arachidonoyl glycine (NAGly), a carboxylic analog of anandamide, is an endogenous ligand of the Gαi/o protein-coupled receptor 18 (GPR18).  However, a high-throughput β-arrestin-based screen failed to detect activation of GPR18 by NAGly.  To address this inconsistency, this study investigated GPR18 coupling in a native neuronal system with endogenous signaling pathways and effectors.  GPR18 was heterologously expressed in rat sympathetic neurons, and the modulation of N-type (Cav2.2) calcium channels was examd.  Proper expression and trafficking of receptor were confirmed by the "rim-like" fluorescence of fluorescently tagged receptor and the pos. staining of external hemagglutinin-tagged GPR18-expressing cells.  Application of NAGly on GPR18-expressing neurons did not inhibit calcium currents but instead potentiated currents in a voltage-dependent manner, similar to what has previously been reported.  Other proposed agonists of GPR18, including anandamide and abnormal cannabidiol, also failed to induce inhibition of calcium currents.  Mutants of GPR18, designed to constitutively activate receptors, did not tonically inhibit calcium currents, indicating a lack of GPR18 activation or coupling to endogenous G proteins.  Other downstream effectors of Gαi/o-coupled receptors, G protein-coupled inwardly rectifying potassium channels and adenylate cyclase, were not modulated by GPR18 signaling.  Furthermore, GPR18 did not couple to other G proteins tested: Gαs, Gαz, and Gα15.  These results suggest NAGly is not an agonist for GPR18 or that GPR18 signaling involves noncanonical pathways not examd. in these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPdZlYf2-4pbVg90H21EOLACvtfcHk0lg4FBr0BE8qIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKitLY%253D&md5=3d977146c3f795562944ec03e504f59b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.081182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.081182%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DV.%2BB.%26aulast%3DPuhl%26aufirst%3DH.%2BL.%26aulast%3DIkeda%26aufirst%3DS.%2BR.%26atitle%3DN-Arachidonyl%2520Glycine%2520Does%2520Not%2520Activate%2520G%2520Protein-Coupled%2520Receptor%252018%2520Signaling%2520via%2520Canonical%2520Pathways%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26issue%3D1%26spage%3D267%26epage%3D282%26doi%3D10.1124%2Fmol.112.081182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colas, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Identification of Resolvin D2 Receptor Mediating Resolution of Infections and Organ Protection</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1084/jem.20150225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1084%2Fjem.20150225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=26195725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2015&pages=1203-1217&issue=8&author=N.+Chiangauthor=J.+Dalliauthor=R.+A.+Colasauthor=C.+N.+Serhan&title=Identification+of+Resolvin+D2+Receptor+Mediating+Resolution+of+Infections+and+Organ+Protection&doi=10.1084%2Fjem.20150225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of resolvin D2 receptor mediating resolution of infections and organ protection</span></div><div class="casAuthors">Chiang, Nan; Dalli, Jesmond; Colas, Romain A.; Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1203-1217</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Endogenous mechanisms that orchestrate resoln. of acute inflammation are essential in host defense and the return to homeostasis.  Resolvin (Rv)D2 is a potent immunoresolvent biosynthesized during active resoln. that stereoselectively stimulates resoln. of acute inflammation.  Here, using an unbiased G protein-coupled receptor-β-arrestin-based screening and functional sensing systems, we identified a receptor for RvD2, namely GPR18, that is expressed on human leukocytes, including polymorphonuclear neutrophils (PMN), monocytes, and macrophages (MΦ).  In human MΦ, RvD2-stimulated intracellular cAMP was dependent on GPR18.  RvD2-stimulated phagocytosis of Escherichia coli and apoptotic PMN (efferocytosis) were enhanced with GPR18 overexpression and significantly reduced by shRNA knockdown.  Specific binding of RvD2 to recombinant GPR18 was confirmed using a synthetic 3H-labeled-RvD2.  Scatchard anal. gave a Kd of ∼10 nM consistent with RvD2 bioactive concn. range.  In both E. coli and Staphylococcus aureus infections, RvD2 limited PMN infiltration, enhanced phagocyte clearance of bacteria, and accelerated resoln.  These actions were lost in GPR18-deficient mice.  During PMN-mediated second organ injury, RvD2's protective actions were also significantly diminished in GPR18-deficient mice.  Together, these results provide evidence for a novel RvD2-GPR18 resoln. axis that stimulates human and mouse phagocyte functions to control bacterial infections and promote organ protection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhwWqS1_Wl-bVg90H21EOLACvtfcHk0lialmYvFtqXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqurrO&md5=f53d3570d565367a5064bb3c173c0216</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1084%2Fjem.20150225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20150225%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DN.%26aulast%3DDalli%26aufirst%3DJ.%26aulast%3DColas%26aufirst%3DR.%2BA.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DIdentification%2520of%2520Resolvin%2520D2%2520Receptor%2520Mediating%2520Resolution%2520of%2520Infections%2520and%2520Organ%2520Protection%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2015%26volume%3D212%26issue%3D8%26spage%3D1203%26epage%3D1217%26doi%3D10.1084%2Fjem.20150225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimsey, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, M.</span></span> <span> </span><span class="NLM_article-title">GPR18 Undergoes a High Degree of Constitutive Trafficking but Is Unresponsive to N-Arachidonoyl Glycine</span>. <i>PeerJ</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e1835</span> <span class="refDoi"> DOI: 10.7717/peerj.1835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.7717%2Fpeerj.1835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27018161" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&author=D.+B.+Finlayauthor=W.+R.+Josephauthor=N.+L.+Grimseyauthor=M.+Glass&title=GPR18+Undergoes+a+High+Degree+of+Constitutive+Trafficking+but+Is+Unresponsive+to+N-Arachidonoyl+Glycine&doi=10.7717%2Fpeerj.1835"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7717%2Fpeerj.1835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7717%252Fpeerj.1835%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DD.%2BB.%26aulast%3DJoseph%26aufirst%3DW.%2BR.%26aulast%3DGrimsey%26aufirst%3DN.%2BL.%26aulast%3DGlass%26aufirst%3DM.%26atitle%3DGPR18%2520Undergoes%2520a%2520High%2520Degree%2520of%2520Constitutive%2520Trafficking%2520but%2520Is%2520Unresponsive%2520to%2520N-Arachidonoyl%2520Glycine%26jtitle%3DPeerJ%26date%3D2016%26volume%3D4%26doi%3D10.7717%2Fpeerj.1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verdegaal, E. M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siderius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bebelman, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leurs, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemze, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tensen, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osanto, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative Expression Profiling of G-Protein-Coupled Receptors (GPCRs) in Metastatic Melanoma: The Constitutively Active Orphan GPCR GPR18 as Novel Drug Target</span>. <i>Pigm. Cell Melanoma Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1111/j.1755-148X.2010.00781.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1755-148X.2010.00781.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=20880198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVCmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=207-218&issue=1&author=Y.+Qinauthor=E.+M.+E.+Verdegaalauthor=M.+Sideriusauthor=J.+P.+Bebelmanauthor=M.+J.+Smitauthor=R.+Leursauthor=R.+Willemzeauthor=C.+P.+Tensenauthor=S.+Osanto&title=Quantitative+Expression+Profiling+of+G-Protein-Coupled+Receptors+%28GPCRs%29+in+Metastatic+Melanoma%3A+The+Constitutively+Active+Orphan+GPCR+GPR18+as+Novel+Drug+Target&doi=10.1111%2Fj.1755-148X.2010.00781.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target</span></div><div class="casAuthors">Qin, Y.; Verdegaal, E. M. E.; Siderius, M.; Bebelman, J. P.; Smit, M. J.; Leurs, R.; Willemze, R.; Tensen, C. P.; Osanto, S.</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-218</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">G-protein-coupled receptors (GPCRs) have been implicated in the tumorigenesis and metastasis of human cancers and are considered amongst the most desirable targets for drug development.  Utilizing a robust quant. PCR array, we quantified expression of 94 human GPCRs, including 75 orphan GPCRs and 19 chemokine receptors, and 36 chemokine ligands, in 40 melanoma metastases from different individuals and benign nevi.  Inter-metastatic site comparison revealed that orphan GPR174 and CCL28 are statistically significantly overexpressed in s.c. metastases, while P2RY5 is overexpressed in brain metastases.  Comparison between metastases (all three metastatic sites) and benign nevi revealed that 16 genes, including six orphan receptors (GPR18, GPR34, GPR119, GPR160, GPR183 and P2RY10) and chemokine receptors CCR5, CXCR4, and CXCR6, were statistically significantly differentially expressed.  Subsequent functional expts. in yeast and melanoma cells indicate that GPR18, the most abundantly overexpressed orphan GPCR in all melanoma metastases, is constitutively active and inhibits apoptosis, indicating an important role for GPR18 in tumor cell survival.  GPR18 and five other orphan GPCRs with yet unknown biol. function may be considered potential novel anticancer targets in metastatic melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCIRsrII70KbVg90H21EOLACvtfcHk0lialmYvFtqXlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVCmuro%253D&md5=81c2064cbd01e0a8bddc46a5c38900f1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-148X.2010.00781.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-148X.2010.00781.x%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DY.%26aulast%3DVerdegaal%26aufirst%3DE.%2BM.%2BE.%26aulast%3DSiderius%26aufirst%3DM.%26aulast%3DBebelman%26aufirst%3DJ.%2BP.%26aulast%3DSmit%26aufirst%3DM.%2BJ.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3DWillemze%26aufirst%3DR.%26aulast%3DTensen%26aufirst%3DC.%2BP.%26aulast%3DOsanto%26aufirst%3DS.%26atitle%3DQuantitative%2520Expression%2520Profiling%2520of%2520G-Protein-Coupled%2520Receptors%2520%2528GPCRs%2529%2520in%2520Metastatic%2520Melanoma%253A%2520The%2520Constitutively%2520Active%2520Orphan%2520GPCR%2520GPR18%2520as%2520Novel%2520Drug%2520Target%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2011%26volume%3D24%26issue%3D1%26spage%3D207%26epage%3D218%26doi%3D10.1111%2Fj.1755-148X.2010.00781.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramírez-Orozco, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Ruiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalón, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villafán-Bernal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marichal-Cancino, B. A.</span></span> <span> </span><span class="NLM_article-title">Potential Metabolic and Behavioural Roles of the Putative Endocannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">June</span>),  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.2174/1570159X17666190118143014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.2174%2F1570159X17666190118143014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31146657" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2is7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=947-960&issue=June&author=R.+E.+Ram%C3%ADrez-Orozcoauthor=R.+Garc%C3%ADa-Ruizauthor=P.+Moralesauthor=C.+M.+Villal%C3%B3nauthor=J.+R.+Villaf%C3%A1n-Bernalauthor=B.+A.+Marichal-Cancino&title=Potential+Metabolic+and+Behavioural+Roles+of+the+Putative+Endocannabinoid+Receptors+GPR18%2C+GPR55+and+GPR119+in+Feeding&doi=10.2174%2F1570159X17666190118143014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding</span></div><div class="casAuthors">Ramirez-Orozco, Ricardo E.; Garcia-Ruiz, Ricardo; Morales, Paula; Villalon, Carlos M.; Villafan-Bernal, J. Rafael; Marichal-Cancino, Bruno A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">947-960</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Endocannabinoids are ancient biomols. involved in several cellular (e.g., metab.) and physiol. (e.g., eating behavior) functions.  Indeed, eating behavior alterations in marijuana users have led to investigate the orexigenic/anorexigenic effects of cannabinoids in animal/ human models.  This increasing body of research suggests that the endocannabinoid system plays an important role in feeding control.  Accordingly, within the endocannabinoid system, cannabinoid receptors, enzymes and genes represent potential therapeutic targets for dealing with multiple metabolic and behavioral dysfunctions (e.g., obesity, anorexia, etc.).  Paradoxically, our understanding on the endocannabinoid system as a cellular mediator is yet limited.  For example: (i) only two cannabinoid receptors have been classified, but they are not enough to explain the pharmacol. profile of several exptl. effects induced by cannabinoids; and (ii) several orphan G protein-coupled receptors (GPCRs) interact with cannabinoids and we do not know how to classify them (e.g., GPR18, GPR55 and GPR119; amongst others).  On this basis, the present review attempts to summarize the lines of evidence supporting the potential role of GPR18, GPR55 and GPR119 in metab. and feeding control that may explain some of the divergent effects and puzzling data related to cannabinoid research.  Moreover, their therapeutic potential in feeding behavior alterations will be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ6OHxyfcxg7Vg90H21EOLACvtfcHk0lh7LVpR5Gincw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2is7nM&md5=f5ce06b7c28da740fafe4436bce8aedf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F1570159X17666190118143014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570159X17666190118143014%26sid%3Dliteratum%253Aachs%26aulast%3DRam%25C3%25ADrez-Orozco%26aufirst%3DR.%2BE.%26aulast%3DGarc%25C3%25ADa-Ruiz%26aufirst%3DR.%26aulast%3DMorales%26aufirst%3DP.%26aulast%3DVillal%25C3%25B3n%26aufirst%3DC.%2BM.%26aulast%3DVillaf%25C3%25A1n-Bernal%26aufirst%3DJ.%2BR.%26aulast%3DMarichal-Cancino%26aufirst%3DB.%2BA.%26atitle%3DPotential%2520Metabolic%2520and%2520Behavioural%2520Roles%2520of%2520the%2520Putative%2520Endocannabinoid%2520Receptors%2520GPR18%252C%2520GPR55%2520and%2520GPR119%2520in%2520Feeding%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2019%26volume%3D17%26issue%3DJune%26spage%3D947%26epage%3D960%26doi%3D10.2174%2F1570159X17666190118143014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flegel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofreuter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojcik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brockmeyer, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmüller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gisselmann, G.</span></span> <span> </span><span class="NLM_article-title">Characterization of Non-Olfactory GPCRs in Human Sperm with a Focus on GPR18</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">32255</span>, <span class="refDoi"> DOI: 10.1038/srep32255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fsrep32255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27572937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=32255&author=C.+Flegelauthor=F.+Vogelauthor=A.+Hofreuterauthor=S.+Wojcikauthor=C.+Schoederauthor=K.+Kie%C4%87-Kononowiczauthor=N.+H.+Brockmeyerauthor=C.+E.+M%C3%BCllerauthor=C.+Beckerauthor=J.+Altm%C3%BCllerauthor=H.+Hattauthor=G.+Gisselmann&title=Characterization+of+Non-Olfactory+GPCRs+in+Human+Sperm+with+a+Focus+on+GPR18&doi=10.1038%2Fsrep32255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18</span></div><div class="casAuthors">Flegel, Caroline; Vogel, Felix; Hofreuter, Adrian; Wojcik, Sebastian; Schoeder, Clara; Kiec-Kononowicz, Katarzyna; Brockmeyer, Norbert H.; Mueller, Christa E.; Becker, Christian; Altmueller, Janine; Hatt, Hanns; Gisselmann, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32255</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) transduce external chem. cues into intracellular signals and are involved in a plethora of physiol. processes, but knowledge regarding the function of these receptors in spermatozoa is limited.  In the present study, we performed RNA-Seq and analyzed the expression of the all GPCRs except olfactory receptors in human spermatozoa.  We revealed the expression of up to 223 different GPCR transcripts in human spermatozoa (FPKM > 0.1) and identified GPR18, a newly described cannabinoid receptor, together with GPR137 and GPR135, as one of the three most highly expressed GPCRs.  To date, the expression of GPR18 was completely unknown in human spermatozoa.  We confirmed GPR18 expression using RT-PCR and immuncytochem. expts. and localized the GPR18 protein in the midpiece of human spermatozoa.  Stimulation of human spermatozoa with the GPR18 ligand N-arachidonoylglycine induced the phosphorylation of 12 protein kinases, some of them are for example known to be involved in the acrosome reaction.  In line with this, N-arachidonoylglycine affected the cytoskeleton by changing levels of F-actin and inducing the acrosome reaction in human spermatozoa in a concn.-dependent manner.  Our results indicate that GPR18 might be involved in physiol. processes of human spermatozoa, suggesting GPR18 to be a potential player in sperm physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvAFasp877UbVg90H21EOLACvtfcHk0lh8j7Mw07UN-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjt7zE&md5=b387d47d690afc94eab3fed637591013</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsrep32255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32255%26sid%3Dliteratum%253Aachs%26aulast%3DFlegel%26aufirst%3DC.%26aulast%3DVogel%26aufirst%3DF.%26aulast%3DHofreuter%26aufirst%3DA.%26aulast%3DWojcik%26aufirst%3DS.%26aulast%3DSchoeder%26aufirst%3DC.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DBrockmeyer%26aufirst%3DN.%2BH.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DAltm%25C3%25BCller%26aufirst%3DJ.%26aulast%3DHatt%26aufirst%3DH.%26aulast%3DGisselmann%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520Non-Olfactory%2520GPCRs%2520in%2520Human%2520Sperm%2520with%2520a%2520Focus%2520on%2520GPR18%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D32255%26doi%3D10.1038%2Fsrep32255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmerman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juknat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine, an Abundant Endogenous Lipid, Potently Drives Directed Cellular Migration through GPR18, the Putative Abnormal Cannabidiol Receptor</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">44</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-11-44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2F1471-2202-11-44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=20346144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BC3czhtlSntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=44&author=D.+McHughauthor=S.+S.+J.+Huauthor=N.+Rimmermanauthor=A.+Juknatauthor=Z.+Vogelauthor=J.+M.+Walkerauthor=H.+B.+Bradshaw&title=N-Arachidonoyl+Glycine%2C+an+Abundant+Endogenous+Lipid%2C+Potently+Drives+Directed+Cellular+Migration+through+GPR18%2C+the+Putative+Abnormal+Cannabidiol+Receptor&doi=10.1186%2F1471-2202-11-44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor</span></div><div class="casAuthors">McHugh Douglas; Hu Sherry S J; Rimmerman Neta; Juknat Ana; Vogel Zvi; Walker J Michael; Bradshaw Heather B</div><div class="citationInfo"><span class="NLM_cas:title">BMC neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Microglia provide continuous immune surveillance of the CNS and upon activation rapidly change phenotype to express receptors that respond to chemoattractants during CNS damage or infection.  These activated microglia undergo directed migration towards affected tissue.  Importantly, the molecular species of chemoattractant encountered determines if microglia respond with pro- or anti-inflammatory behaviour, yet the signaling molecules that trigger migration remain poorly understood.  The endogenous cannabinoid system regulates microglial migration via CB2 receptors and an as yet unidentified GPCR termed the 'abnormal cannabidiol' (Abn-CBD) receptor.  Abn-CBD is a synthetic isomer of the phytocannabinoid cannabidiol (CBD) and is inactive at CB1 or CB2 receptors, but functions as a selective agonist at this Gi/o-coupled GPCR.  N-arachidonoyl glycine (NAGly) is an endogenous metabolite of the endocannabinoid anandamide and acts as an efficacious agonist at GPR18.  Here, we investigate the relationship between NAGly, Abn-CBD, the unidentified 'Abn-CBD' receptor, GPR18, and BV-2 microglial migration.  RESULTS:  Using Boyden chamber migration experiments, yellow tetrazolium (MTT) conversion, In-cell Western, qPCR and immunocytochemistry we show that NAGly, at sub-nanomolar concentrations, and Abn-CBD potently drive cellular migration in both BV-2 microglia and HEK293-GPR18 transfected cells, but neither induce migration in HEK-GPR55 or non-transfected HEK293 wildtype cells.  Migration effects are blocked or attenuated in both systems by the 'Abn-CBD' receptor antagonist O-1918, and low efficacy agonists N-arachidonoyl-serine and cannabidiol.  NAGly promotes proliferation and activation of MAP kinases in BV-2 microglia and HEK293-GPR18 cells at low nanomolar concentrations - cellular responses correlated with microglial migration.  Additionally, BV-2 cells show GPR18 immunocytochemical staining and abundant GPR18 mRNA. qPCR demonstrates that primary microglia, likewise, express abundant amounts of GPR18 mRNA.  CONCLUSIONS:  NAGly is the most effective lipid recruiter of BV-2 microglia currently reported and its effects mimic those of Abn-CBD.  The data generated from this study supports the hypothesis that GPR18 is the previously unidentified 'Abn-CBD' receptor.  The marked potency of NAGly acting on GPR18 to elicit directed migration, proliferation and perhaps other MAPK-dependent phenomena advances our understanding of the lipid-based signaling mechanisms employed by the CNS to actively recruit microglia to sites of interest.  It offers a novel research avenue for developing therapeutics to elicit a self-renewing population of neuroregenerative microglia, or alternatively, to prevent the accumulation of misdirected, pro-inflammatory microglia which contribute to and exacerbate neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtR9ShKLQLpjQLBVDQn4bCfW6udTcc2eZgkYqR8TnFJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czhtlSntg%253D%253D&md5=151782cc176d13a91ac6ad36f545e54c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-11-44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-11-44%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DS.%2BS.%2BJ.%26aulast%3DRimmerman%26aufirst%3DN.%26aulast%3DJuknat%26aufirst%3DA.%26aulast%3DVogel%26aufirst%3DZ.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3DN-Arachidonoyl%2520Glycine%252C%2520an%2520Abundant%2520Endogenous%2520Lipid%252C%2520Potently%2520Drives%2520Directed%2520Cellular%2520Migration%2520through%2520GPR18%252C%2520the%2520Putative%2520Abnormal%2520Cannabidiol%2520Receptor%26jtitle%3DBMC%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D44%26doi%3D10.1186%2F1471-2202-11-44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager-Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">SiRNA Knockdown of GPR18 Receptors in BV-2 Microglia Attenuates N-Arachidonoyl Glycine-Induced Cell Migration</span>. <i>J. Mol. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">0</span>),  <span class="NLM_fpage">10</span>, <span class="refDoi"> DOI: 10.1186/1750-2187-7-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2F1750-2187-7-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=10&issue=0&author=D.+McHughauthor=J.+Wager-Millerauthor=J.+Pageauthor=H.+B.+Bradshaw&title=SiRNA+Knockdown+of+GPR18+Receptors+in+BV-2+Microglia+Attenuates+N-Arachidonoyl+Glycine-Induced+Cell+Migration&doi=10.1186%2F1750-2187-7-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2F1750-2187-7-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1750-2187-7-10%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DWager-Miller%26aufirst%3DJ.%26aulast%3DPage%26aufirst%3DJ.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3DSiRNA%2520Knockdown%2520of%2520GPR18%2520Receptors%2520in%2520BV-2%2520Microglia%2520Attenuates%2520N-Arachidonoyl%2520Glycine-Induced%2520Cell%2520Migration%26jtitle%3DJ.%2520Mol.%2520Signaling%26date%3D2014%26volume%3D7%26issue%3D0%26spage%3D10%26doi%3D10.1186%2F1750-2187-7-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span> <span> </span><span class="NLM_article-title">Orphan Endogenous Lipids and Orphan GPCRs: A Good Match</span>. <i>Prostaglandins Other Lipid Mediators</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>89</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1016/j.prostaglandins.2009.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.prostaglandins.2009.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2009&pages=131-134&issue=3%E2%80%934&author=H.+B.+Bradshawauthor=S.+H.+Leeauthor=D.+McHugh&title=Orphan+Endogenous+Lipids+and+Orphan+GPCRs%3A+A+Good+Match&doi=10.1016%2Fj.prostaglandins.2009.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Orphan endogenous lipids and orphan GPCRs: A good match</span></div><div class="casAuthors">Bradshaw, Heather B.; Lee, Sung Ha; McHugh, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">131-134</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A large and growing family of over 70 endogenous lipids of the basic structure N-acyl amide has been identified during the last 10 years.  Only a few of these lipids have been characterized for biol. activity, however, those that have shown a wide-range of activity may act at G-protein coupled receptors (GPCRs).  Like orphan GPCRs that are identified as being in the genome and expressed in tissue, the majority of these endogenous lipids many produced throughout the body, some predominately in nervous tissue, remain orphaned.  Here, we give a brief history of these orphan lipids and highlight the activity of N-arachidonoyl glycine, and farnesyl pyrophosphate at the orphan receptors GPR18 and GPR92, resp., as well as summarizing the biol. and pharmacol. data for the recently identified N-palmitoyl glycine that suggests activity at a novel GPCR.  Working to deorphanize both lipids and GPCRs together provides a unique opportunity for a greater understanding of cellular signaling and a challenge to find them all a home.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCpuA1O-mjZ7Vg90H21EOLACvtfcHk0lgVXvxrnhFkzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2lu7jF&md5=8113a4c4fc02ed06d29af0a79b7ba687</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DMcHugh%26aufirst%3DD.%26atitle%3DOrphan%2520Endogenous%2520Lipids%2520and%2520Orphan%2520GPCRs%253A%2520A%2520Good%2520Match%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2009%26volume%3D89%26issue%3D3%25E2%2580%25934%26spage%3D131%26epage%3D134%26doi%3D10.1016%2Fj.prostaglandins.2009.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P. H.</span>; <span class="NLM_string-name">Battey, J.</span>; <span class="NLM_string-name">Benson, H. E.</span>; <span class="NLM_string-name">Benya, R. V.</span>; <span class="NLM_string-name">Bonner, T. I.</span>; <span class="NLM_string-name">Anthony, P.</span>; <span class="NLM_string-name">Eguchi, S.</span>; <span class="NLM_string-name">Harmar, A.</span>; <span class="NLM_string-name">Holliday, N.</span>; <span class="NLM_string-name">Jensen, R. T.</span>; <span class="NLM_string-name">Karnik, S.</span>; <span class="NLM_string-name">Kostenis, E.</span>; <span class="NLM_string-name">Liew, W. C.</span>; <span class="NLM_string-name">Monaghan, A. E.</span>; <span class="NLM_string-name">Mpamhanga, C.</span>; <span class="NLM_string-name">Neubig, C.</span>; <span class="NLM_string-name">Pawson, A. J.</span>; <span class="NLM_string-name">Pin, J.</span>; <span class="NLM_string-name">Sharman, J. L.</span>; <span class="NLM_string-name">Spedding, M.</span>; <span class="NLM_string-name">Spindel, E.</span>; <span class="NLM_string-name">Stoddart, L.</span>; <span class="NLM_string-name">Storjohann, L.</span>; <span class="NLM_string-name">Thomas, W. G.</span>; <span class="NLM_string-name">Tirupula, K.</span>; <span class="NLM_string-name">Vanderheyden, P.</span></span> <span> </span><span class="NLM_article-title">Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database</span>.  <i>GtoPdb CITE</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume">2019</span>, <span class="refDoi"> DOI: 10.2218/gtopdb/F16/2019.5</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.2218%2Fgtopdb%2FF16%2F2019.5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2019&publication_year=2019&author=S.+P.+H.+Alexander&author=J.+Battey&author=H.+E.+Benson&author=R.+V.+Benya&author=T.+I.+Bonner&author=P.+Anthony&author=S.+Eguchi&author=A.+Harmar&author=N.+Holliday&author=R.+T.+Jensen&author=S.+Karnik&author=E.+Kostenis&author=W.+C.+Liew&author=A.+E.+Monaghan&author=C.+Mpamhanga&author=C.+Neubig&author=A.+J.+Pawson&author=J.+Pin&author=J.+L.+Sharman&author=M.+Spedding&author=E.+Spindel&author=L.+Stoddart&author=L.+Storjohann&author=W.+G.+Thomas&author=K.+Tirupula&author=P.+Vanderheyden&title=Class+A+Orphans+%28version+2019.5%29+in+the+IUPHAR%2FBPS+Guide+to+Pharmacology+Database&doi=10.2218%2Fgtopdb%2FF16%2F2019.5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2218%2Fgtopdb%2FF16%2F2019.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2218%252Fgtopdb%252FF16%252F2019.5%26sid%3Dliteratum%253Aachs%26aulast%3DAlexander%26aufirst%3DS.%2BP.%2BH.%26atitle%3DClass%2520A%2520Orphans%2520%2528version%25202019.5%2529%2520in%2520the%2520IUPHAR%252FBPS%2520Guide%2520to%2520Pharmacology%2520Database%26jtitle%3DGtoPdb%2520CITE%26date%3D2019%26volume%3D2019%26doi%3D10.2218%2Fgtopdb%2FF16%2F2019.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reyes-Resina, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguinaga, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canela, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaluski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saura, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Molecular and Functional Interaction between GPR18 and Cannabinoid CB2 G-Protein-Coupled Receptors. Relevance in Neurodegenerative Diseases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bcp.2018.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29870711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOitr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=169-179&author=I.+Reyes-Resinaauthor=G.+Navarroauthor=D.+Aguinagaauthor=E.+I.+Canelaauthor=C.+T.+Schoederauthor=M.+Zaluskiauthor=K.+Kiec-Kononowiczauthor=C.+A.+Sauraauthor=C.+E.+M%C3%BCllerauthor=R.+Franco&title=Molecular+and+Functional+Interaction+between+GPR18+and+Cannabinoid+CB2+G-Protein-Coupled+Receptors.+Relevance+in+Neurodegenerative+Diseases&doi=10.1016%2Fj.bcp.2018.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases</span></div><div class="casAuthors">Reyes-Resina, Irene; Navarro, Gemma; Aguinaga, David; Canela, Enric I.; Schoeder, Clara T.; Zaluski, Michal; Kiec-Kononowicz, Katarzyna; Saura, Carlos A.; Muller, Christa E.; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-179</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR18, still considered an orphan receptor, may respond to endocannabinoids, whose canonical receptors are CB1 and CB2.  GPR18 and CB2 receptors share a role in peripheral immune response regulation and are co-expressed in microglia, which are immunocompetent cells in the central nervous system (CNS).  We aimed at identifying heteroreceptor complexes formed by GPR18 and CB1R or CB2R in resting and activated microglia.  Receptor-receptor interaction was assessed using energy-transfer approaches, and receptor function by detg. cAMP levels and ERK1/2 phosphorylation in heterologous cells and primary cultures of microglia.  Heteroreceptor identification in primary cultures of microglia was achieved by in situ proximity ligation assays.  Energy transfer results showed interaction of GPR18 with CB2R but not with CB1R.  CB2-GPR18 heteroreceptor complexes displayed particular functional properties (heteromer prints) often consisting of neg. cross-talk (activation of one receptor reduces signaling arising from the partner receptor) and cross-antagonism (the response of one of the receptors is blocked by a selective antagonist of the partner receptor).  Activated microglia showed the heteromer print (neg. cross-talk and bidirectional cross-antagonism) and increased expression of CB2R and GPR18.  Due to the important role of CB2R in neuroprotection, we further investigated heteroreceptor occurrence in primary cultures of microglia from transgenic mice overexpressing human APPSw,Ind, an Alzheimer's disease model.  Microglial cells from transgenic mice showed the heteromer print and functional interactions that were similar to those found in cells from wild-type animals that were activated by treatment with lipopolysaccharide and interferon-γ.  Our results suggest that GPR18 and its heteromers may play important roles in neurodegenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX37_OQFD4jLVg90H21EOLACvtfcHk0liwMzgC84l74A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOitr%252FO&md5=502d1c37132dfadcb20a50c20e4dc4ad</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DReyes-Resina%26aufirst%3DI.%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DAguinaga%26aufirst%3DD.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DZaluski%26aufirst%3DM.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DSaura%26aufirst%3DC.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DMolecular%2520and%2520Functional%2520Interaction%2520between%2520GPR18%2520and%2520Cannabinoid%2520CB2%2520G-Protein-Coupled%2520Receptors.%2520Relevance%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D157%26spage%3D169%26epage%3D179%26doi%3D10.1016%2Fj.bcp.2018.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheff, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernabé, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeramachaneni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viet, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viet, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B. L.</span></span> <span> </span><span class="NLM_article-title">Anti-Cancer and Analgesic Effects of Resolvin D2 in Oral Squamous Cell Carcinoma</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">193</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2018.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.neuropharm.2018.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30009833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlentLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2018&pages=182-193&author=Y.+Yeauthor=N.+N.+Scheffauthor=D.+Bernab%C3%A9author=E.+Salvoauthor=K.+Onoauthor=C.+Liuauthor=R.+Veeramachaneniauthor=C.+T.+Vietauthor=D.+T.+Vietauthor=J.+C.+Dolanauthor=B.+L.+Schmidt&title=Anti-Cancer+and+Analgesic+Effects+of+Resolvin+D2+in+Oral+Squamous+Cell+Carcinoma&doi=10.1016%2Fj.neuropharm.2018.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma</span></div><div class="casAuthors">Ye, Yi; Scheff, Nicole N.; Bernabe, Daniel; Salvo, Elizabeth; Ono, Kentaro; Liu, Cheng; Veeramachaneni, Ratna; Viet, Chi T.; Viet, Dan T.; Dolan, John C.; Schmidt, Brian L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">182-193</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study investigated the potential of RvDs (RvD1 and RvD2) to treat oral cancer and alleviate oral cancer pain.  We found down-regulated mRNA levels of GPR18 and GPR32 (which code for receptors RvD1 and RvD2) in oral cancer cells.  Both RvD1 and RvD2 inhibited oral cancer proliferation in vitro.  Using two validated mouse oral squamous cell carcinoma xenograft models, we found that RvD2, the more potent anti-inflammatory lipid mediator, significantly reduced tumor size.  The mechanism of this action might involve suppression of IL-6, C-X-C motif chemokine 10 (CXCL10), and redn. of tumor necrosis.  RvD2 generated short-lasting analgesia in xenograft cancer models, which coincided with decreased neutrophil infiltration and myeloperoxidase activity.  Using a cancer supernatant model, we demonstrated that RvD2 reduced cancer-derived cytokines/chemokines (TNF-a, IL-6, CXCL10, and MCP-1), cancer mediator-induced CD11b+Ly6G- myeloid cells, and nociception.  We infer from our results that manipulation of the endogenous pro-resoln. pathway might provide a novel approach to improve oral cancer and cancer pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrolc9_AoK6xbVg90H21EOLACvtfcHk0lh0KzCjv39N-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlentLzF&md5=c81c49f345077fbfd7b77a432c425891</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2018.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2018.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DScheff%26aufirst%3DN.%2BN.%26aulast%3DBernab%25C3%25A9%26aufirst%3DD.%26aulast%3DSalvo%26aufirst%3DE.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DVeeramachaneni%26aufirst%3DR.%26aulast%3DViet%26aufirst%3DC.%2BT.%26aulast%3DViet%26aufirst%3DD.%2BT.%26aulast%3DDolan%26aufirst%3DJ.%2BC.%26aulast%3DSchmidt%26aufirst%3DB.%2BL.%26atitle%3DAnti-Cancer%2520and%2520Analgesic%2520Effects%2520of%2520Resolvin%2520D2%2520in%2520Oral%2520Squamous%2520Cell%2520Carcinoma%26jtitle%3DNeuropharmacology%26date%3D2018%26volume%3D139%26spage%3D182%26epage%3D193%26doi%3D10.1016%2Fj.neuropharm.2018.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Dyke, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashiba, S.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">307</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2019.00307</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3389%2Ffimmu.2019.00307" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30863409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVKmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=307&author=Y.+D.+Siddiquiauthor=K.+Omoriauthor=T.+Itoauthor=K.+Yamashiroauthor=S.+Nakamuraauthor=K.+Okamotoauthor=M.+Onoauthor=T.+Yamamotoauthor=T.+E.+Van+Dykeauthor=S.+Takashiba&title=Resolvin+D2+Induces+Resolution+of+Periapical+Inflammation+and+Promotes+Healing+of+Periapical+Lesions+in+Rat+Periapical+Periodontitis&doi=10.3389%2Ffimmu.2019.00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 induces resolution of periapical inflammation and promotes healing of periapical lesions in rat periapical periodontitis</span></div><div class="casAuthors">Siddiqui, Yasir Dilshad; Omori, Kazuhiro; Ito, Takashi; Yamashiro, Keisuke; Nakamura, Shin; Okamoto, Kentaro; Ono, Mitsuaki; Yamamoto, Tadashi; Van Dyke, Thomas E.; Takashiba, Shogo</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">307</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Periapical periodontitis results from pulpal infection leading to pulpal necrosis and resorption of periapical bone.  The current treatment is root canal therapy, which attempts to eliminate infection and necrotic tissue.  But, in some cases periapical inflammation doesn't resolve even after treatment.  Resolvins belongs to a large family of specialized pro-resolving lipid mediators that actively resolves inflammation signaling via specific receptors.  Resolvin D2 (RvD2), a metabolite of docosahexaenoic acid (DHA), was tested as an intracanal medicament in rats in vivo.  Mechanism was evaluated in rat primary dental pulp cells (DPCs) in vitro.  The results demonstrate that RvD2 reduces inflammatory cell infiltrate, periapical lesion size, and fosters pulp like tissue regeneration and healing of periapical lesion.  RvD2 enhanced expression of its receptor, GPR18, dentin matrix acidic phosphoprotein 1 (DMP1) and mineralization in vivo and in vitro.  Moreover, RvD2 induces phosphorylation of Stat3 transcription factor in dental pulp cells.  We conclude that intracanal treatment with RvD2 resolves inflammation and promoting calcification around root apex and healing of periapical bone lesions.  The data suggest that RvD2 induces active resoln. of inflammation with pulp-like tissue regeneration after root canal infection and thus maybe suitable for treating periapical lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH8-Sb44G7tLVg90H21EOLACvtfcHk0lh0KzCjv39N-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVKmtL3I&md5=2f92001c6a00ed35f713b211ec2d91c3</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2019.00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2019.00307%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DY.%2BD.%26aulast%3DOmori%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DYamashiro%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DVan%2BDyke%26aufirst%3DT.%2BE.%26aulast%3DTakashiba%26aufirst%3DS.%26atitle%3DResolvin%2520D2%2520Induces%2520Resolution%2520of%2520Periapical%2520Inflammation%2520and%2520Promotes%2520Healing%2520of%2520Periapical%2520Lesions%2520in%2520Rat%2520Periapical%2520Periodontitis%26jtitle%3DFront.%2520Immunol.%26date%3D2019%26volume%3D10%26spage%3D307%26doi%3D10.3389%2Ffimmu.2019.00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyster, J. G.</span></span> <span> </span><span class="NLM_article-title">GPR18 Is Required for a Normal CD8αα Intestinal Intraepithelial Lymphocyte Compartment</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>211</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2351</span>– <span class="NLM_lpage">2359</span>, <span class="refDoi"> DOI: 10.1084/jem.20140646</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1084%2Fjem.20140646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=25348153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGntLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2014&pages=2351-2359&issue=12&author=X.+Wangauthor=H.+Sumidaauthor=J.+G.+Cyster&title=GPR18+Is+Required+for+a+Normal+CD8%CE%B1%CE%B1+Intestinal+Intraepithelial+Lymphocyte+Compartment&doi=10.1084%2Fjem.20140646"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment</span></div><div class="casAuthors">Wang, Xiaoming; Sumida, Hayakazu; Cyster, Jason G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2351-2359</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Intraepithelial lymphocytes (IELs) play an important role in maintaining the physiol. of the small intestine.  The majority of mouse IELs express CD8αα and are either γδ or αβ T cells.  Although the development and homing of CD8αα IELs have been studied in some detail, the factors controlling their homeostasis and positioning are incompletely understood.  Here we demonstrate that G protein-coupled receptor 18 (GPR18) is abundantly expressed in CD8αα IELs and that mice lacking this orphan receptor have reduced nos. of γδT IELs.  Mixed bone marrow chimera expts. reveal a markedly reduced contribution of GPR18-deficient cells to the CD8αα IEL compartment and a redn. in the CD8αβ T cell subset.  These defects could be rescued by transduction with a GPR18-expressing retrovirus.  The GPR18-deficient γδT IELs that remained in mixed chimeras had elevated Thy1, and there were less granzyme B+ and Vγ7+ cells, indicating a greater redn. in effector-type cells.  Flow cytometric anal. indicated GPR18 deficiency more strongly affected the CD8αα cells in the intraepithelial compared with the adjacent lamina propria compartment.  These findings establish a requirement for GPR18 in CD8αα and CD8αβ IELs, and we suggest the receptor has a role in augmenting the accumulation of CD8 T cells in the intraepithelial vs. lamina propria compartment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodXe-lIMofBbVg90H21EOLACvtfcHk0lhyPq9E_GRo8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGntLnK&md5=38654ca2bf2353935d3f7f4de6d19e84</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1084%2Fjem.20140646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20140646%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSumida%26aufirst%3DH.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DGPR18%2520Is%2520Required%2520for%2520a%2520Normal%2520CD8%25CE%25B1%25CE%25B1%2520Intestinal%2520Intraepithelial%2520Lymphocyte%2520Compartment%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2014%26volume%3D211%26issue%3D12%26spage%3D2351%26epage%3D2359%26doi%3D10.1084%2Fjem.20140646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Rosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libreros, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serhan, C. N.</span></span> <span> </span><span class="NLM_article-title">Novel Resolvin D2 Receptor Axis in Infectious Inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>198</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1601650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.4049%2Fjimmunol.1601650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27994074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFWrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=198&publication_year=2017&pages=842-851&issue=2&author=N.+Chiangauthor=X.+de+la+Rosaauthor=S.+Librerosauthor=C.+N.+Serhan&title=Novel+Resolvin+D2+Receptor+Axis+in+Infectious+Inflammation&doi=10.4049%2Fjimmunol.1601650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Resolvin D2 Receptor Axis in Infectious Inflammation</span></div><div class="casAuthors">Chiang, Nan; de la Rosa, Xavier; Libreros, Stephania; Serhan, Charles N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">198</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">842-851</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Resoln. of acute inflammation is an active process governed by specialized proresolving mediators, including resolvin (Rv)D2, that activates a cell surface G protein-coupled receptor, GPR18/DRV2.  In this study, we investigated RvD2-DRV2-dependent resoln. mechanisms using DRV2-deficient mice (DRV2-knockout [KO]).  In polymicrobial sepsis initiated by cecal ligation and puncture, RvD2 (∼2.7 nmol/mouse) significantly increased survival (>50%) of wild-type mice and reduced hypothermia and bacterial titers compared with vehicle-treated cecal ligation and puncture mice that succumbed at 48 h.  Protection by RvD2 was abolished in DRV2-KO mice.  Mass spectrometry-based lipid mediator metabololipidomics demonstrated that DRV2-KO infectious exudates gave higher proinflammatory leukotriene B4 and procoagulating thromboxane B2, as well as lower specialized proresolving mediators, including RvD1 and RvD3, compared with wild-type.  RvD2-DRV2-initiated intracellular signals were investigated using mass cytometry (cytometry by time-of-flight), which demonstrated that RvD2 enhanced phosphorylation of CREB, ERK1/2, and STAT3 in WT but not DRV2-KO macrophages.  Monitored by real-time imaging, RvD2-DRV2 interaction significantly enhanced phagocytosis of live Escherichia coli, an action dependent on protein kinase A and STAT3 in macrophages.  Taken together, we identified an RvD2/DRV2 axis that activates intracellular signaling pathways that increase phagocytosis-mediated bacterial clearance, survival, and organ protection.  Moreover, these results provide evidence for RvD2-DRV2 and their downstream pathways in pathophysiol. of infectious inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpD7zV2j0hbVg90H21EOLACvtfcHk0lhyPq9E_GRo8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFWrtrw%253D&md5=bb8036c37cd2bb59a3c8a38c6c5e65ff</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1601650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1601650%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DN.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DX.%26aulast%3DLibreros%26aufirst%3DS.%26aulast%3DSerhan%26aufirst%3DC.%2BN.%26atitle%3DNovel%2520Resolvin%2520D2%2520Receptor%2520Axis%2520in%2520Infectious%2520Inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2017%26volume%3D198%26issue%3D2%26spage%3D842%26epage%3D851%26doi%3D10.4049%2Fjimmunol.1601650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murataeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhopeshwarkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonanno, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea</span>. <i>Cornea</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">905</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1097/ICO.0000000000001934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1097%2FICO.0000000000001934" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30969262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BB3M%252FjvVyqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=905-913&issue=7&author=N.+Murataevaauthor=L.+Dailyauthor=X.+Taylorauthor=A.+Dhopeshwarkarauthor=S.+S.+J.+Huauthor=S.+Millerauthor=D.+McHughauthor=O.+Oehlerauthor=S.+Liauthor=J.+A.+Bonannoauthor=K.+Mackieauthor=A.+Straiker&title=Evidence+for+a+GPR18+Role+in+Chemotaxis%2C+Proliferation%2C+and+the+Course+of+Wound+Closure+in+the+Cornea&doi=10.1097%2FICO.0000000000001934"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea</span></div><div class="casAuthors">Murataeva Natalia; Daily Laura; Taylor Xavier; Dhopeshwarkar Amey; Miller Sally; Oehler Olivia; Mackie Ken; Straiker Alex; Hu Sherry Shu-Jung; McHugh Douglas; Li Shimin; Bonanno Joseph A</div><div class="citationInfo"><span class="NLM_cas:title">Cornea</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">905-913</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We previously showed that cannabinoid-related GPR18 receptors are present in the murine corneal epithelium, but their function remains unknown.  The related CB1 receptors regulate corneal healing, possibly via chemotaxis.  We therefore examined a potential role for GPR18 in corneal epithelial chemotaxis and wound healing.  METHODS:  We examined GPR18 messenger RNA (mRNA) and protein expression in the cornea.  We additionally examined GPR18 action in cultured bovine corneal epithelial cells (bCECs) using Boyden and tracking assays, as well as proliferation and signaling.  Finally, we examined wound closure in murine corneal explants.  RESULTS:  GPR18 mRNA was upregulated with injury in the mouse cornea.  GPR18 protein was present in basal epithelial cells of the mouse and cow and redistributed to the wound site upon injury.  GPR18 ligand N-arachidonoylglycine induced bCEC chemotaxis.  The endocannabinoid arachidonoylethanolamine also induced chemotaxis via fatty acid amide hydrolase-mediated metabolism to N-arachidonoylglycine.  GPR18 receptor activation additionally induced bCEC proliferation.  In an explant model, the GPR18 antagonist O-1918 slowed corneal epithelial cell migration and the rate of corneal wound closure.  CONCLUSIONS:  Corneal GPR18 activation induced both chemotaxis and proliferation in corneal epithelial cells in vitro and impacted wound healing.  GPR18 may contribute to the maintenance of corneal integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLYJ8o9kd5ca__Jf7-eMvJfW6udTcc2eahoHm4AU4GQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3M%252FjvVyqug%253D%253D&md5=ff28c96f32b3c4a6ef996c95267f6b45</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1097%2FICO.0000000000001934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FICO.0000000000001934%26sid%3Dliteratum%253Aachs%26aulast%3DMurataeva%26aufirst%3DN.%26aulast%3DDaily%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DX.%26aulast%3DDhopeshwarkar%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DS.%2BS.%2BJ.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DOehler%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DBonanno%26aufirst%3DJ.%2BA.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DStraiker%26aufirst%3DA.%26atitle%3DEvidence%2520for%2520a%2520GPR18%2520Role%2520in%2520Chemotaxis%252C%2520Proliferation%252C%2520and%2520the%2520Course%2520of%2520Wound%2520Closure%2520in%2520the%2520Cornea%26jtitle%3DCornea%26date%3D2019%26volume%3D38%26issue%3D7%26spage%3D905%26epage%3D913%26doi%3D10.1097%2FICO.0000000000001934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansbury, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prenner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conklin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatnagar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creager, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spite, M.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">666</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.116.021894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1161%2FCIRCULATIONAHA.116.021894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27507404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCns7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2016&pages=666-680&issue=9&author=M.+J.+Zhangauthor=B.+E.+Sansburyauthor=J.+Hellmannauthor=J.+F.+Bakerauthor=L.+Guoauthor=C.+M.+Parmerauthor=J.+C.+Prennerauthor=D.+J.+Conklinauthor=A.+Bhatnagarauthor=M.+A.+Creagerauthor=M.+Spite&title=Resolvin+D2+Enhances+Postischemic+Revascularization+While+Resolving+Inflammation&doi=10.1161%2FCIRCULATIONAHA.116.021894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation</span></div><div class="casAuthors">Zhang, Michael J.; Sansbury, Brian E.; Hellmann, Jason; Baker, James F.; Guo, Luping; Parmer, Caitlin M.; Prenner, Joshua C.; Conklin, Daniel J.; Bhatnagar, Aruni; Creager, Mark A.; Spite, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">666-680</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Resolvins are lipid mediators generated by leukocytes during the resoln. phase of inflammation.  They have been shown to regulate the transition from inflammation to tissue repair; however, it is unknown whether resolvins play a role in tissue revascularization following ischemia.  Methods: We used a murine model of hind limb ischemia (HLI), coupled with laser Doppler perfusion imaging, microcomputed tomog., and targeted mass spectrometry, to assess the role of resolvins in revascularization and inflammation resoln.  Results: In mice undergoing HLI, we identified resolvin D2 (RvD2) in bone marrow and skeletal muscle by mass spectrometry (n=4-7 per group).  We also identified RvD2 in skeletal muscle biopsies from humans with peripheral artery disease.  Monocytes were recruited to skeletal muscle during HLI and isolated monocytes produced RvD2 in a lipoxygenase-dependent manner.  Exogenous RvD2 enhanced perfusion recovery in HLI and microcomputed tomog. of limb vasculature revealed greater vol., with evidence of tortuous arterioles indicative of arteriogenesis (n=6-8 per group).  Unlike other treatment strategies for therapeutic revascularization that exacerbate inflammation, RvD2 did not increase vascular permeability, but reduced neutrophil accumulation and the plasma levels of tumor necrosis factor-α and granulocyte macrophage colony-stimulating factor.  In mice treated with RvD2, histopathol. anal. of skeletal muscle of ischemic limbs showed more regenerating myocytes with centrally located nuclei.  RvD2 enhanced endothelial cell migration in a Rac-dependent manner, via its receptor, GPR18, and Gpr18-deficient mice had an endogenous defect in perfusion recovery following HLI.  Importantly, RvD2 rescued defective revascularization in diabetic mice.  Conclusions: RvD2 stimulates arteriogenic revascularization during HLI, suggesting that resolvins may be a novel class of mediators that both resolve inflammation and promote arteriogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUwu_dNEWKZ7Vg90H21EOLACvtfcHk0ljTCUlw2qMLgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCns7fN&md5=2edf6653421d2f8c08f58d0ccc38dd34</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.116.021894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.116.021894%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BJ.%26aulast%3DSansbury%26aufirst%3DB.%2BE.%26aulast%3DHellmann%26aufirst%3DJ.%26aulast%3DBaker%26aufirst%3DJ.%2BF.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DParmer%26aufirst%3DC.%2BM.%26aulast%3DPrenner%26aufirst%3DJ.%2BC.%26aulast%3DConklin%26aufirst%3DD.%2BJ.%26aulast%3DBhatnagar%26aufirst%3DA.%26aulast%3DCreager%26aufirst%3DM.%2BA.%26aulast%3DSpite%26aufirst%3DM.%26atitle%3DResolvin%2520D2%2520Enhances%2520Postischemic%2520Revascularization%2520While%2520Resolving%2520Inflammation%26jtitle%3DCirculation%26date%3D2016%26volume%3D134%26issue%3D9%26spage%3D666%26epage%3D680%26doi%3D10.1161%2FCIRCULATIONAHA.116.021894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddy, D. M.</span></span> <span> </span><span class="NLM_article-title">New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery</span>. <i>ACS Pharmacol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.9b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.9b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1Cqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=88-106&issue=1&author=J.+Parkauthor=C.+J.+Langmeadauthor=D.+M.+Riddy&title=New+Advances+in+Targeting+the+Resolution+of+Inflammation%3A+Implications+for+Specialized+Pro-Resolving+Mediator+GPCR+Drug+Discovery&doi=10.1021%2Facsptsci.9b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery</span></div><div class="casAuthors">Park, Julia; Langmead, Christopher J.; Riddy, Darren M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Pharmacology & Translational Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">88-106</span>CODEN:
                <span class="NLM_cas:coden">APTSFN</span>;
        ISSN:<span class="NLM_cas:issn">2575-9108</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Chronic inflammation is a component of numerous diseases including autoimmune, metabolic, neurodegenerative, and cancer.  The discovery and characterization of specialized pro-resolving mediators (SPMs) crit. to the resoln. of inflammation, and their cognate G protein-coupled receptors (GPCRs) has led to a significant increase in the understanding of this physiol. process.  Approx. 20 ligands, including lipoxins, resolvins, maresins, and protectins, and 6 receptors (FPR2/ALX, GPR32, GPR18, chemerin1, BLT1, and GPR37) have been identified highlighting the complex and multilayered nature of resoln.  Therapeutic efforts in targeting these receptors have proved challenging, with very few ligands apparently progressing through to preclin. or clin. development.  To date, some knowledge gaps remain in the understanding of how the activation of these receptors, and their downstream signaling, results in efficient resoln. via apoptosis, phagocytosis, and efferocytosis of polymorphonuclear leukocytes (mainly neutrophils) and macrophages.  SPMs bind and activate multiple receptors (ligand poly-pharmacol.), while most receptors are activated by multiple ligands (receptor pleiotropy).  In addn., allosteric binding sites have been identified s.ignifying the capacity of more than one ligand to bind simultaneously.  These fundamental characteristics of SPM receptors enable alternative targeting strategies to be considered, including biased signaling and allosteric modulation.  This review describes those ligands and receptors involved in the resoln. of inflammation, and highlights the most recent clin. trial results.  Furthermore, we describe alternative mechanisms by which these SPM receptors could be targeted, paving the way for the identification of new therapeutics, perhaps with greater efficacy and fidelity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohpzw25BnY-LVg90H21EOLACvtfcHk0ljr4QcstYVqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1Cqtb0%253D&md5=9d3bc680260a3f593b2b16bf37488724</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.9b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.9b00075%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DRiddy%26aufirst%3DD.%2BM.%26atitle%3DNew%2520Advances%2520in%2520Targeting%2520the%2520Resolution%2520of%2520Inflammation%253A%2520Implications%2520for%2520Specialized%2520Pro-Resolving%2520Mediator%2520GPCR%2520Drug%2520Discovery%26jtitle%3DACS%2520Pharmacol.%2520Transl.%2520Sci.%26date%3D2020%26volume%3D3%26issue%3D1%26spage%3D88%26epage%3D106%26doi%3D10.1021%2Facsptsci.9b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">GPR18 Expression on PMNs as Biomarker for Outcome in Patient with Sepsis</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>217</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2018.11.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.lfs.2018.11.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30503722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCiur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=2019&pages=49-56&author=L.+Zhangauthor=C.+Qiuauthor=L.+Yangauthor=Z.+Zhangauthor=Q.+Zhangauthor=B.+Wangauthor=X.+Wang&title=GPR18+Expression+on+PMNs+as+Biomarker+for+Outcome+in+Patient+with+Sepsis&doi=10.1016%2Fj.lfs.2018.11.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">GPR18 expression on PMNs as biomarker for outcome in patient with sepsis</span></div><div class="casAuthors">Zhang, Lanqiu; Qiu, Chongyang; Yang, Lei; Zhang, Zhen; Zhang, Qi; Wang, Botao; Wang, Ximo</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">GPR18, a G protein-coupled receptor (GPCR), is involved in bacterial clearance and survival in microbial sepsis.  In this study, we examine GPR18 expression on polymorphonuclear neutrophils (PMNs) of patients with sepsis and to det. the potential assocn. with disease severity and outcomes.  We enrolled 81 patients admitted at the intensive care unit (ICU) with the diagnosis of sepsis.  PMNs GPR18 expression was measured by flow cytometry at admission.  Sequential Organ Failure Assessment (SOFA) and Acute Physiol. and Chronic Health Evaluation (APACHEII) as well as other biomarker were measured at admission.  Cox regression anal. was used to det. the influence of PMNs GPR18 expression on 28-day mortality.  Patients with sepsis had a decreased percentage of PMNs bearing GPR18 in comparison with healthy subjects (P < 0.001).  Compared with survivors, non-survivors had lower percentage of GPR18-pos. PMNs, but higher SOFA, APACHEIIscores, and WBC count.  There were inverse correlations between the percentage of GPR18-pos. PMNs and APACHEII, SOFA score and C-recreative protein (CRP).  Using Kaplan-Meier anal., high percentage of PMNs expressing GPR18 (≥43.7%) was assocd. with a preferable 28-day survival (P = 0.004).  High percentage of PMNs expressing GPR18 (≥43.7%) was significantly and independently assocd. with 28-day mortality, with a hazard ratio of 0.36 (P = 0.37).  Moreover, LPS-Toll-like receptor (TLR)4 signaling mediated the GPR18 expression on PMNs.  These results indicate that decreased percentage GPR18-pos. PMNs is assocd. with increased severity and poorer outcome of sepsis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprAonXHCQnr7Vg90H21EOLACvtfcHk0ljr4QcstYVqzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCiur7J&md5=f831af203d6f2c4b003ad32cf9014c22</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2018.11.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2018.11.061%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DGPR18%2520Expression%2520on%2520PMNs%2520as%2520Biomarker%2520for%2520Outcome%2520in%2520Patient%2520with%2520Sepsis%26jtitle%3DLife%2520Sci.%26date%3D2019%26volume%3D217%26spage%3D49%26epage%3D56%26doi%3D10.1016%2Fj.lfs.2018.11.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Protects against Cerebral Ischemia/Reperfusion Injury in Rats</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi"> DOI: 10.1186/s13041-018-0351-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2Fs13041-018-0351-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29439730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyjsLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2018&pages=9&author=G.+Zuoauthor=D.+Zhangauthor=R.+Muauthor=H.+Shenauthor=X.+Liauthor=Z.+Wangauthor=H.+Liauthor=G.+Chen&title=Resolvin+D2+Protects+against+Cerebral+Ischemia%2FReperfusion+Injury+in+Rats&doi=10.1186%2Fs13041-018-0351-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats</span></div><div class="casAuthors">Zuo, Gang; Zhang, Dongping; Mu, Rutao; Shen, Haitao; Li, Xiang; Wang, Zhong; Li, Haiying; Chen, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9/1-9/13</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Cerebral ischemia/reperfusion (I/R) injury is a crit. factor leading to a poor prognosis for ischemic stroke patients. ω-3 fatty acid supplements taken as part of a daily diet have been shown to improve the prognosis of patients with ischemic stroke.  In this study, we aimed to investigate the potential effects of resolvin D2 (RvD2), a deriv. of ω-3 fatty acids, and its possible advantage on cerebral I/R injury in rats.  Cerebral I/R caused by middle cerebral artery occlusion and reperfusion (MCAO/R) was established in Sprague-Dawley rats.  First, in rats fed a regular diet, the MCAO/R stimulus led to a significant decrease in endogenous prodn. of RvD2.  Exogenous supply of RvD2 via i.p. injection reversed MCAO/R-induced brain injury, including infarction, inflammatory response, brain edema, and neurol. dysfunction.  Meanwhile, RvD2 reversed the MCAO/R-induced decrease in the protein level of GPR18, which has been identified as a receptor for RvD2, esp. in neurons and brain microvascular endothelial cells (BMVECs).  Furthermore, RvD2 exerted rescue effects on MCAO/R-induced neuron and BMVEC death.  Moreover, GPR18 antagonist O-1918 could block the rescue effects of RvD2, possibly at least partially though the GPR18-ERK1/2- NOS signaling pathway.  Finally, compared with ω-3 fatty acid supplements, RvD2 treatment had a better rescue effect on cerebral infarction, which may be due to the MCAO/R-induced decrease in 5-lipoxygense phosphorylation and subsequent RvD2 generation.  In conclusion, compared with ω-3 fatty acids, RvD2 may be an optimal alternative and complementary treatment for ischemic stroke patients with recanalization treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSmVzM7cyIOrVg90H21EOLACvtfcHk0li_YdfyQhbcgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyjsLzJ&md5=4d2ae56d03dc07202bb9b26a63888f5d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs13041-018-0351-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-018-0351-1%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMu%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DResolvin%2520D2%2520Protects%2520against%2520Cerebral%2520Ischemia%252FReperfusion%2520Injury%2520in%2520Rats%26jtitle%3DMol.%2520Brain%26date%3D2018%26volume%3D11%26spage%3D9%26doi%3D10.1186%2Fs13041-018-0351-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macedo-De la Concha, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantoja-Meléndez, C. A.</span></span> <span> </span><span class="NLM_article-title">Low-Grade Inflammation and Its Relation to Obesity and Chronic Degenerative Diseases</span>. <i>Rev. Médica del Hosp. Gen. México</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1016/j.hgmx.2016.06.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.hgmx.2016.06.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=101-105&issue=2&author=A.+M.+Castroauthor=L.+E.+Macedo-De+la+Conchaauthor=C.+A.+Pantoja-Mel%C3%A9ndez&title=Low-Grade+Inflammation+and+Its+Relation+to+Obesity+and+Chronic+Degenerative+Diseases&doi=10.1016%2Fj.hgmx.2016.06.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.hgmx.2016.06.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.hgmx.2016.06.011%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%2BM.%26aulast%3DMacedo-De%2Bla%2BConcha%26aufirst%3DL.%2BE.%26aulast%3DPantoja-Mel%25C3%25A9ndez%26aufirst%3DC.%2BA.%26atitle%3DLow-Grade%2520Inflammation%2520and%2520Its%2520Relation%2520to%2520Obesity%2520and%2520Chronic%2520Degenerative%2520Diseases%26jtitle%3DRev.%2520M%25C3%25A9dica%2520del%2520Hosp.%2520Gen.%2520M%25C3%25A9xico%26date%3D2017%26volume%3D80%26issue%3D2%26spage%3D101%26epage%3D105%26doi%3D10.1016%2Fj.hgmx.2016.06.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pascoal, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bombassaro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramalho, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coope, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moura, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correa-Da-Silva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignacio-Souza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razolli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catharino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velloso, L. A.</span></span> <span> </span><span class="NLM_article-title">Resolvin RvD2 Reduces Hypothalamic Inflammation and Rescues Mice from Diet-Induced Obesity</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/s12974-016-0777-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2Fs12974-016-0777-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=28086928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=5&author=L.+B.+Pascoalauthor=B.+Bombassaroauthor=A.+F.+Ramalhoauthor=A.+Coopeauthor=R.+F.+Mouraauthor=F.+Correa-Da-Silvaauthor=L.+Ignacio-Souzaauthor=D.+Razolliauthor=D.+de+Oliveiraauthor=R.+Catharinoauthor=L.+A.+Velloso&title=Resolvin+RvD2+Reduces+Hypothalamic+Inflammation+and+Rescues+Mice+from+Diet-Induced+Obesity&doi=10.1186%2Fs12974-016-0777-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity</span></div><div class="casAuthors">Pascoal, Livia B.; Bombassaro, Bruna; Ramalho, Albina F.; Coope, Andressa; Moura, Rodrigo F.; Correa-da-Silva, Felipe; Ignacio-Souza, Leticia; Razolli, Daniela; de Oliveira, Diogo; Catharino, Rodrigo; Velloso, Licio A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5/1-5/12</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Diet-induced hypothalamic inflammation is an important mechanism leading to dysfunction of neurons involved in controlling body mass.  Studies have shown that polyunsatd. fats can reduce hypothalamic inflammation.  Here, we evaluated the presence and function of RvD2, a resolvin produced from docosahexaenoic acid, in the hypothalamus of mice.  Methods: Male Swiss mice were fed either chow or a high-fat diet.  RvD2 receptor and synthetic enzymes were evaluated by real-time PCR and immunofluorescence.  RvD2 was detd. by mass spectrometry.  Dietary and pharmacol. approaches were used to modulate the RvD2 system in the hypothalamus, and metabolic phenotype consequences were detd.  Results: All enzymes involved in the synthesis of RvD2 were detected in the hypothalamus and were modulated in response to the consumption of dietary satd. fats, leading to a redn. of hypothalamic RvD2.  GPR18, the receptor for RvD2, which was detected in POMC and NPY neurons, was also modulated by dietary fats.  The substitution of satd. by polyunsatd. fats in the diet resulted in increased hypothalamic RvD2, which was accompanied by reduced body mass and improved glucose tolerance.  The intracerebroventricular treatment with docosahexaenoic acid resulted in increased expression of the RvD2 synthetic enzymes, increased expression of anti-inflammatory cytokines and improved metabolic phenotype.  Finally, intracerebroventricular treatment with RvD2 resulted in reduced adiposity, improved glucose tolerance and increased hypothalamic expression of anti-inflammatory cytokines.  Conclusions: Thus, RvD2 is produced in the hypothalamus, and its receptor and synthetic enzymes are modulated by dietary fats.  The improved metabolic outcomes of RvD2 make this substance an attractive approach to treat obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2hr-c2S8EDLVg90H21EOLACvtfcHk0li_YdfyQhbcgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqt74%253D&md5=829de17df4e133456329bc78c35acf6b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs12974-016-0777-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-016-0777-2%26sid%3Dliteratum%253Aachs%26aulast%3DPascoal%26aufirst%3DL.%2BB.%26aulast%3DBombassaro%26aufirst%3DB.%26aulast%3DRamalho%26aufirst%3DA.%2BF.%26aulast%3DCoope%26aufirst%3DA.%26aulast%3DMoura%26aufirst%3DR.%2BF.%26aulast%3DCorrea-Da-Silva%26aufirst%3DF.%26aulast%3DIgnacio-Souza%26aufirst%3DL.%26aulast%3DRazolli%26aufirst%3DD.%26aulast%3Dde%2BOliveira%26aufirst%3DD.%26aulast%3DCatharino%26aufirst%3DR.%26aulast%3DVelloso%26aufirst%3DL.%2BA.%26atitle%3DResolvin%2520RvD2%2520Reduces%2520Hypothalamic%2520Inflammation%2520and%2520Rescues%2520Mice%2520from%2520Diet-Induced%2520Obesity%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2017%26volume%3D14%26spage%3D5%26doi%3D10.1186%2Fs12974-016-0777-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matouk, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Moselhy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeba, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. A.</span></span> <span> </span><span class="NLM_article-title">Abnormal Cannabidiol Confers Cardioprotection in Diabetic Rats Independent of Glycemic Control</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>820</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2017.12.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejphar.2017.12.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29274332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1yksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=820&publication_year=2018&pages=256-264&author=A.+I.+Matoukauthor=A.+Tayeauthor=M.+A.+El-Moselhyauthor=G.+H.+Heebaauthor=A.+A.+Abdel-Rahman&title=Abnormal+Cannabidiol+Confers+Cardioprotection+in+Diabetic+Rats+Independent+of+Glycemic+Control&doi=10.1016%2Fj.ejphar.2017.12.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control</span></div><div class="casAuthors">Matouk, Asmaa I.; Taye, Ashraf; El-Moselhy, Mohamed A.; Heeba, Gehan H.; Abdel-Rahman, Abdel A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">820</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">256-264</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Chronic GPR18 activation by its agonist abnormal cannabidiol (trans-4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; abn-cbd) improves myocardial redox status and function in healthy rats.  Here, we investigated the ability of abn-cbd to alleviate diabetes-evoked cardiovascular pathol. and the contribution of GPR18 to this effect.  Four weeks after diabetes induction by streptozotocin (STZ, 55 mg/kg; i.p), male Wistar rats received abn-cbd, the GPR18 antagonist (1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-,cyclohexen-1-yl]benzene;O-1918), their combination (100μg/kg/day, i.p, each) or their vehicle for 2 wk.  Abn-cbd had no effect on diabetes-evoked cardiac hypertrophy or impaired glycemic control (hyperglycemia and hypoinsulinemia), but alleviated the assocd. redns. in left ventricular (LV) contractility (dP/dtmax) and relaxation (dP/dtmin) indexes, and the increases in LV end diastolic pressure (LVEDP) and cardiac vagal dominance.  Abn-cbd also reversed myocardial oxidative stress by restoring circulating and cardiac nitric oxide (NO) and adiponectin (ADN) levels and enhancing GPR18 expression and phosphorylation of Akt, ERK1/2 and eNOS in diabetic rats' hearts.  Concurrent GPR18 blockade (O-1918) abrogated all favorable effects of abn-cbd in diabetic rats.  Collectively, the current findings present evidence for abn-cbd alleviation of diabetes-evoked cardiovascular anomalies likely via GPR18 dependent restoration of cardiac adiponectin-Akt-eNOS signaling and the diminution of myocardial oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyVjdb6KSAPLVg90H21EOLACvtfcHk0li_YdfyQhbcgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1yksA%253D%253D&md5=96ecf995a5cb551f6ca28313e5d5a226</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.12.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.12.039%26sid%3Dliteratum%253Aachs%26aulast%3DMatouk%26aufirst%3DA.%2BI.%26aulast%3DTaye%26aufirst%3DA.%26aulast%3DEl-Moselhy%26aufirst%3DM.%2BA.%26aulast%3DHeeba%26aufirst%3DG.%2BH.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BA.%26atitle%3DAbnormal%2520Cannabidiol%2520Confers%2520Cardioprotection%2520in%2520Diabetic%2520Rats%2520Independent%2520of%2520Glycemic%2520Control%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D820%26spage%3D256%26epage%3D264%26doi%3D10.1016%2Fj.ejphar.2017.12.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denovan-Wright, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. E. M.</span></span> <span> </span><span class="NLM_article-title">Cannabinoid and Lipid-Mediated Vasorelaxation in Retinal Microvasculature</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>735</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2014.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejphar.2014.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24751709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFSrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=735&publication_year=2014&pages=105-114&issue=1&author=J.+Macintyreauthor=A.+Dongauthor=A.+Straikerauthor=J.+Zhuauthor=S.+E.+Howlettauthor=A.+Bagherauthor=E.+Denovan-Wrightauthor=D.+Y.+Yuauthor=M.+E.+M.+Kelly&title=Cannabinoid+and+Lipid-Mediated+Vasorelaxation+in+Retinal+Microvasculature&doi=10.1016%2Fj.ejphar.2014.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature</span></div><div class="casAuthors">MacIntyre, Jessica; Dong, Alex; Straiker, Alex; Zhu, Jiequan; Howlett, Susan E.; Bagher, Amina; Denovan-Wright, Eileen; Yu, Dao-Yi; Kelly, Melanie E. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">735</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-114</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The endocannabinoid system plays a role in regulation of vasoactivity in the peripheral vasculature; however, little is known about its role in regulation of the CNS microvasculature.  This study investigated the pharmacol. of cannabinoids and cannabimimetic lipids in the retinal microvasculature, a CNS vascular bed that is autoregulated.  Vessel diam. (edge detector) and calcium transients (fura-2) were recorded from segments of retinal microvasculature isolated from adult, male Fischer 344 rats.  Results showed that abnormal cannabidiol (Abn-CBD), an agonist at the putative endothelial cannabinoid receptor, CBe, inhibited endothelin 1 (ET-1) induced vasoconstriction in retinal arterioles.  These actions of Abn-CBD were independent of CB1/CB2 receptors and were not mediated by agonists for GPR55 or affected by nitric oxide synthase (NOS) inhibition.  However, the vasorelaxant effects of Abn-CBD were abolished when the endothelium was removed and were inhibited by the small Ca2+-sensitive K channel (SKCa) blocker, apamin.  The effects of the endogenous endocannabinoid metabolite, N-arachidonoyl glycine (NAGly), a putative agonist for GPR18, were virtually identical to those of Abn-CBD.  GPR18 mRNA and protein were present in the retina, and immunohistochem. demonstrated that GPR18 was localized to the endothelium of retinal vessels.  These findings demonstrate that Abn-CBD and NAGly inhibit ET-1 induced vasoconstriction in retinal arterioles by an endothelium-dependent signaling mechanism that involves SKCa channels.  The endothelial localization of GPR18 suggests that GPR18 could contribute to cannabinoid and lipid-mediated retinal vasoactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp66MSsoYTxLbVg90H21EOLACvtfcHk0lhrLCLgdQbEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFSrt7w%253D&md5=e32c54d01a9aa7bd745bc3869b6cbace</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2014.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2014.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DMacintyre%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DA.%26aulast%3DStraiker%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHowlett%26aufirst%3DS.%2BE.%26aulast%3DBagher%26aufirst%3DA.%26aulast%3DDenovan-Wright%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DD.%2BY.%26aulast%3DKelly%26aufirst%3DM.%2BE.%2BM.%26atitle%3DCannabinoid%2520and%2520Lipid-Mediated%2520Vasorelaxation%2520in%2520Retinal%2520Microvasculature%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D735%26issue%3D1%26spage%3D105%26epage%3D114%26doi%3D10.1016%2Fj.ejphar.2014.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Penumarti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. A.</span></span> <span> </span><span class="NLM_article-title">The Novel Endocannabinoid Receptor GPR18 Is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>349</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.209213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1124%2Fjpet.113.209213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24431468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2014&pages=29-38&issue=4&author=A.+Penumartiauthor=A.+A.+Abdel-Rahman&title=The+Novel+Endocannabinoid+Receptor+GPR18+Is+Expressed+in+the+Rostral+Ventrolateral+Medulla+and+Exerts+Tonic+Restraining+Influence+on+Blood+Pressure&doi=10.1124%2Fjpet.113.209213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure</span></div><div class="casAuthors">Penumarti, Anusha; Abdel-Rahman, Abdel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Systemic administration of the G-protein-coupled receptor 18 (GPR18) agonist abnormal cannabidiol (Abn CBD) lowers blood pressure (BP).  Whether GPR18 is expressed in the central nervous system (CNS) and plays a role in BP control is not known despite the abundance of the GPR18 ligand N-arachidonoyl glycine (NAGly) in the CNS.  Therefore, we first detd. whether GPR18 is expressed in the presympathetic tyrosine hydroxylase (TH) immunoreactive (ir) neurons of the brainstem cardiovascular regulatory nuclei.  Second, we investigated the impact of GPR18 activation and blockade on BP and heart rate (HR) and neurochem. modulators of sympathetic activity and BP.  Immunofluorescence findings revealed GPR18 expression in TH-ir neurons in the rostral ventrolateral medulla (RVLM).  Intra-RVLM GPR18 activation (Abn CBD) and blockade (O-1918, 1,3-dimethoxy-5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-,cyclohexen-1-yl]benzene) elicited dose-dependent redns. and elevations in BP, resp., along with resp. increases and decreases in HR in conscious male Sprague-Dawley rats.  RVLM GPR18 activation increased neuronal adiponectin (ADN) and NO and reduced reactive oxygen species (ROS) levels, and GPR18 blockade reduced neuronal ADN and increased oxidative stress (i.e., ROS) in the RVLM.  Finally, we hypothesized that the negligible hypotensive effect caused by the endogenous GPR18 ligand NAGly could be due to concurrent activation of CB1R in the RVLM.  Our findings support this hypothesis because NAGly-evoked hypotension was doubled after RVLM CB1R blockade (SR 141716, rimonabant).  These findings are the first to demonstrate GPR18 expression in the RVLM and to suggest a sympathoinhibitory role for this receptor.  The findings yield new insight into the role of a novel cannabinoid receptor (GPR18) in central BP control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh8-1H3Unzl7Vg90H21EOLACvtfcHk0lhrLCLgdQbEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFGmtbs%253D&md5=a488b1086ec613d4552a113f2f4132d6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.209213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.209213%26sid%3Dliteratum%253Aachs%26aulast%3DPenumarti%26aufirst%3DA.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BA.%26atitle%3DThe%2520Novel%2520Endocannabinoid%2520Receptor%2520GPR18%2520Is%2520Expressed%2520in%2520the%2520Rostral%2520Ventrolateral%2520Medulla%2520and%2520Exerts%2520Tonic%2520Restraining%2520Influence%2520on%2520Blood%2520Pressure%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D349%26issue%3D4%26spage%3D29%26epage%3D38%26doi%3D10.1124%2Fjpet.113.209213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al
Suleimani, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mahruqi, A. S.</span></span> <span> </span><span class="NLM_article-title">The Endogenous Lipid N-Arachidonoyl Glycine Is Hypotensive and Nitric Oxide-CGMP-Dependent Vasorelaxant</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>794</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejphar.2016.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27890711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvF2gt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=794&publication_year=2017&pages=209-215&author=Y.+M.+Al%0ASuleimaniauthor=A.+S.+Al+Mahruqi&title=The+Endogenous+Lipid+N-Arachidonoyl+Glycine+Is+Hypotensive+and+Nitric+Oxide-CGMP-Dependent+Vasorelaxant&doi=10.1016%2Fj.ejphar.2016.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant</span></div><div class="casAuthors">Al Suleimani, Yousuf M.; Al Mahruqi, Ahmed S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">794</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-215</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-arachidonoyl glycine (NAGLY), is the endogenous lipid that activates the G protein-couple receptor 18 (GPR18) with vasodilatory activity in resistance arteries.  This study investigates its hemodynamic effects and mechanisms of vasorelaxation.  Hemodynamic effects of NAGLY in rats were assessed using a Biopac system and its vascular responses were assessed using a wire myograph.  NAGLY (1 mg/kg) decreased blood pressure by 69.4±5.5% and reduced renal blood flow by 88±12% and the effects were not sensitive to inhibition by O-1918 (3 mg/kg).  In resistant vessels, NAGLY (1-30 μM) induced concn.- and endothelium-dependent vasorelaxation and the effect was inhibited by the nitric oxide synthase inhibitor, L-NAME (300 μM), a cGMP synthase inhibitor, ODQ (10 μM), the antagonists of "endothelial anandamide" receptor, rimonabant (3 μM) and O-1918 (10 μM) and the inhibitor of Na+/Ca2+ exchanger (NCX), KB-R7943 (10 μM).  On the other hand, NAGLY-induced vasorelaxation was not affected by CID 16020046 (GPR55 antagonist), AM 251 (cannabinoid CB1 receptor antagonist), AM 630 (cannabinoid CB2 receptor antagonist), capsazepine (TRPV1 antagonist), indomethacin (cyclooxygenase inhibitor), TRAM34 (IKCa channel blocker), iberiotoxin (BKCa channel blocker) and GW9662 (PPARγ antagonist).  At low concns. of carbachol, NAGLY potentiated carbachol-induced vasorelaxation.  NAGLY is an endothelium-dependent vasodilator and hypotensive lipid.  The vasorelaxation is predominantly via activation of nitric oxide-cGMP pathway and NCX and probably mediated by the "endothelial anandamide" receptor, while the hypotensive effect of NAGLY appears not to involve the anandamide receptor.  NAGLY also potentiates carbachol-induced vasorelaxation, the mechanism of which might involve stimulation of NO release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUHSpSD0qiWLVg90H21EOLACvtfcHk0lhrLCLgdQbEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvF2gt73J&md5=d27f191d65e5b22533724331f0e1807e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DAl%2BSuleimani%26aufirst%3DY.%2BM.%26aulast%3DAl%2BMahruqi%26aufirst%3DA.%2BS.%26atitle%3DThe%2520Endogenous%2520Lipid%2520N-Arachidonoyl%2520Glycine%2520Is%2520Hypotensive%2520and%2520Nitric%2520Oxide-CGMP-Dependent%2520Vasorelaxant%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D794%26spage%3D209%26epage%3D215%26doi%3D10.1016%2Fj.ejphar.2016.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matouk, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Moselhy, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heeba, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Rahman, A. A.</span></span> <span> </span><span class="NLM_article-title">The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats</span>. <i>J. Cardiovasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1097/FJC.0000000000000438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1097%2FFJC.0000000000000438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27676325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps12i" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2017&pages=23-33&issue=1&author=A.+I.+Matoukauthor=A.+Tayeauthor=M.+A.+El-Moselhyauthor=G.+H.+Heebaauthor=A.+A.+Abdel-Rahman&title=The+Effect+of+Chronic+Activation+of+the+Novel+Endocannabinoid+Receptor+GPR18+on+Myocardial+Function+and+Blood+Pressure+in+Conscious+Rats&doi=10.1097%2FFJC.0000000000000438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats</span></div><div class="casAuthors">Matouk, Asmaa I.; Taye, Ashraf; El-Moselhy, Mohamed A.; Heeba, Gehan H.; Abdel-Rahman, Abdel A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">JCPCDT</span>;
        ISSN:<span class="NLM_cas:issn">0160-2446</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Although acute activation of the novel endocannabinoid receptor GPR18 causes hypotension, there are no reports on GPR18 expression in the heart or its chronic modulation of cardiovascular function.  In this study, after demonstrating GPR18 expression in the heart, we show that chronic (2 wk) GPR18 activation with its agonist abnormal cannabidiol (abn-cbd; 100 μg·kg·d; i.p) produced hypotension, suppressed the cardiac sympathetic dominance, and improved left ventricular (LV) function (increased the contractility index dp/dtmax and reduced LV end-diastolic pressure, LVEDP) in conscious rats.  Ex vivo studies revealed increased: (1) cardiac and plasma adiponectin (ADN) levels; (2) vascular (aortic) endothelial nitric oxide synthase (eNOS) expression, (3) vascular and serum nitric oxide (NO) levels; (4) myocardial and plasma cyclic guanosine monophosphate (cGMP) levels; (5) phosphorylation of myocardial protein kinase B (Akt) and extracellular signal regulated kinase 1/2 (ERK1/2) along with reduced myocardial reactive oxygen species (ROS) in abn-cbd treated rats.  These biochem. responses contributed to the hemodynamic responses and were GPR18-mediated because concurrent treatment with the competitive GPR18 antagonist (O-1918) abrogated the abn-cbd-evoked hemodynamic and biochem. responses.  The current findings present new evidence for a salutary cardiovascular role for GPR18, mediated, at least partly, via elevation in the levels of adiponectin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRWCRTzCTBMLVg90H21EOLACvtfcHk0ljH9XORerwH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps12i&md5=85b4c421f70654ad6eb9f5d2fddf4feb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1097%2FFJC.0000000000000438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFJC.0000000000000438%26sid%3Dliteratum%253Aachs%26aulast%3DMatouk%26aufirst%3DA.%2BI.%26aulast%3DTaye%26aufirst%3DA.%26aulast%3DEl-Moselhy%26aufirst%3DM.%2BA.%26aulast%3DHeeba%26aufirst%3DG.%2BH.%26aulast%3DAbdel-Rahman%26aufirst%3DA.%2BA.%26atitle%3DThe%2520Effect%2520of%2520Chronic%2520Activation%2520of%2520the%2520Novel%2520Endocannabinoid%2520Receptor%2520GPR18%2520on%2520Myocardial%2520Function%2520and%2520Blood%2520Pressure%2520in%2520Conscious%2520Rats%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2017%26volume%3D69%26issue%3D1%26spage%3D23%26epage%3D33%26doi%3D10.1097%2FFJC.0000000000000438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leishman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehler, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murataeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager-Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span> <span> </span><span class="NLM_article-title">Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">6419</span>– <span class="NLM_lpage">6426</span>, <span class="refDoi"> DOI: 10.1167/iovs.16-19437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1167%2Fiovs.16-19437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27893106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFKrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=6419-6426&issue=14&author=S.+Millerauthor=E.+Leishmanauthor=O.+Oehlerauthor=L.+Dailyauthor=N.+Murataevaauthor=J.+Wager-Millerauthor=H.+Bradshawauthor=A.+Straiker&title=Evidence+for+a+GPR18+Role+in+Diurnal+Regulation+of+Intraocular+Pressure&doi=10.1167%2Fiovs.16-19437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a GPR18 role in diurnal regulation of intraocular pressure</span></div><div class="casAuthors">Miller, Sally; Leishman, Emma; Oehler, Olivia; Daily, Laura; Murataeva, Natalia; Wager-Miller, Jim; Bradshaw, Heather; Straiker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6419-6425</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">PURPOSE.  The diurnal cycling of intraocular pressure (IOP) was first described in humans more than a century ago.  This cycling is preserved in other species.  The physiol. underpinning of this diurnal variation in IOP remains a mystery, even though elevated pressure is indicated in most forms of glaucoma, a common cause of blindness.  Once identified, the system that underlies diurnal variation would represent a natural target for therapeutic intervention.  METHODS.  Using normotensive mice, we measured the regulation of ocular lipid species by the enzymes fatty acid amide hydrolase (FAAH) and N-arachidonoyl phosphatidylethanolamine phospholipase (NAPE-PLD), mRNA expression of these enzymes, and their functional role in diurnal regulation of IOP.  RESULTS.  We now report that NAPE-PLD and FAAH mice do not exhibit a diurnal cycling of IOP.  These enzymes produce and break down acylethanolamines, including the endogenous cannabinoid anandamide.  The diurnal lipid profile in mice shows that levels of most N-acyl ethanolamines and, intriguingly, N-arachidonoyl glycine (NAGly), decline at night: NAGly is a metabolite of arachidonoyl ethanolamine and a potent agonist at GPR18 that lowers intraocular pressure.  The GPR18 blocker O1918 raises IOP during the day when pressure is low, but not at night.  Quant. PCR anal. shows that FAAH mRNA levels rise with pressure, suggesting that FAAH mediates the changes in pressure.  CONCLUSIONS.  Our results support FAAH-dependent NAGly action at GPR18 as the physiol. basis of the diurnal variation of intraocular pressure in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr8-FhpMpQrbVg90H21EOLACvtfcHk0ljH9XORerwH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFKrs7w%253D&md5=0171f0ae960f2796b190ceced467b043</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1167%2Fiovs.16-19437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.16-19437%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DLeishman%26aufirst%3DE.%26aulast%3DOehler%26aufirst%3DO.%26aulast%3DDaily%26aufirst%3DL.%26aulast%3DMurataeva%26aufirst%3DN.%26aulast%3DWager-Miller%26aufirst%3DJ.%26aulast%3DBradshaw%26aufirst%3DH.%26aulast%3DStraiker%26aufirst%3DA.%26atitle%3DEvidence%2520for%2520a%2520GPR18%2520Role%2520in%2520Diurnal%2520Regulation%2520of%2520Intraocular%2520Pressure%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2016%26volume%3D57%26issue%3D14%26spage%3D6419%26epage%3D6426%26doi%3D10.1167%2Fiovs.16-19437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daily, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leishman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straiker, A.</span></span> <span> </span><span class="NLM_article-title">Δ 9 -Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5904</span>– <span class="NLM_lpage">5911</span>, <span class="refDoi"> DOI: 10.1167/iovs.18-24838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1167%2Fiovs.18-24838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30550613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWiur7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=5904-5911&issue=15&author=S.+Millerauthor=L.+Dailyauthor=E.+Leishmanauthor=H.+Bradshawauthor=A.+Straiker&title=%CE%94+9+-Tetrahydrocannabinol+and+Cannabidiol+Differentially+Regulate+Intraocular+Pressure&doi=10.1167%2Fiovs.18-24838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">D9-tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure</span></div><div class="casAuthors">Miller, Sally; Daily, Laura; Leishman, Emma; Bradshaw, Heather; Straiker, Alex</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5904-5911</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">Purpose: It has been known for nearly 50 years that cannabis and the psychoactive constituent D9-tetrahydrocannabinol (THC) reduce intraocular pressure (IOP).  Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a major cause of blindness.  THC likely acts via one of the known cannabinoid-related receptors (CB1, CB2, GPR18, GPR119, GPR55) but this has never been detd. explicitly.  Cannabidiol (CBD) is a second major constituent of cannabis that has been found to be without effect on IOP in most studies.  Methods: Effects of topically applied THC and CBD were tested in living mice by using tonometry and measurements of mRNA levels.  In addn. the lipidomic consequences of CBD treatment were tested by using lipid anal.  Results: We now report that a single topical application of THC lowered IOP substantially (∼28%) for 8 h in male mice.  This effect is due to combined activation of CB1 and GPR18 receptors each of which has been shown to lower ocular pressure when activated.  We also found that the effect was sex-dependent, being stronger in male mice, and that mRNA levels of CB1 and GPR18 were higher in males.  Far from inactive, CBD was found to have two opposing effects on ocular pressure, one of which involved antagonism of tonic signaling.  CBD prevents THC from lowering ocular pressure.  Conclusions: We conclude that THC lowers IOP by activating two receptors-CB1 and GPR18-but in a sex-dependent manner.  CBD, contrary to expectation, has two opposing effects on IOP and can interfere with the effects of THC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFU0ff5TSO4bVg90H21EOLACvtfcHk0ljH9XORerwH0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWiur7O&md5=7c7bc1116a1e9686d450cf8cf3c1f775</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1167%2Fiovs.18-24838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.18-24838%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DDaily%26aufirst%3DL.%26aulast%3DLeishman%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DH.%26aulast%3DStraiker%26aufirst%3DA.%26atitle%3D%25CE%2594%25209%2520-Tetrahydrocannabinol%2520and%2520Cannabidiol%2520Differentially%2520Regulate%2520Intraocular%2520Pressure%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2018%26volume%3D59%26issue%3D15%26spage%3D5904%26epage%3D5911%26doi%3D10.1167%2Fiovs.18-24838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greten, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grivennikov, S. I.</span></span> <span> </span><span class="NLM_article-title">Inflammation and Cancer: Triggers, Mechanisms, and Consequences</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2019.06.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.immuni.2019.06.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31315034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlyls7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2019&pages=27-41&issue=1&author=F.+R.+Gretenauthor=S.+I.+Grivennikov&title=Inflammation+and+Cancer%3A+Triggers%2C+Mechanisms%2C+and+Consequences&doi=10.1016%2Fj.immuni.2019.06.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and Cancer: Triggers, Mechanisms, and Consequences</span></div><div class="casAuthors">Greten, Florian R.; Grivennikov, Sergei I.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-41</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis.  Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME).  Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics.  Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis.  We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations.  Defining the cornerstone rules of engagement governing mol. and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-8xulWOP50bVg90H21EOLACvtfcHk0liMhiWHmWr_KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlyls7jP&md5=0d39409f4a26c18100163b7b49367d46</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2019.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2019.06.025%26sid%3Dliteratum%253Aachs%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DGrivennikov%26aufirst%3DS.%2BI.%26atitle%3DInflammation%2520and%2520Cancer%253A%2520Triggers%252C%2520Mechanisms%252C%2520and%2520Consequences%26jtitle%3DImmunity%26date%3D2019%26volume%3D51%26issue%3D1%26spage%3D27%26epage%3D41%26doi%3D10.1016%2Fj.immuni.2019.06.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.-R.</span></span> <span> </span><span class="NLM_article-title">Identification of an Eight-Gene Signature for Survival Prediction for Patients with Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis</span>. <i>PeerJ</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e6548</span> <span class="refDoi"> DOI: 10.7717/peerj.6548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.7717%2Fpeerj.6548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30918751" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&author=G.-J.+Qiaoauthor=L.+Chenauthor=J.-C.+Wuauthor=Z.-R.+Li&title=Identification+of+an+Eight-Gene+Signature+for+Survival+Prediction+for+Patients+with+Hepatocellular+Carcinoma+Based+on+Integrated+Bioinformatics+Analysis&doi=10.7717%2Fpeerj.6548"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.7717%2Fpeerj.6548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7717%252Fpeerj.6548%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DG.-J.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DJ.-C.%26aulast%3DLi%26aufirst%3DZ.-R.%26atitle%3DIdentification%2520of%2520an%2520Eight-Gene%2520Signature%2520for%2520Survival%2520Prediction%2520for%2520Patients%2520with%2520Hepatocellular%2520Carcinoma%2520Based%2520on%2520Integrated%2520Bioinformatics%2520Analysis%26jtitle%3DPeerJ%26date%3D2019%26volume%3D7%26doi%3D10.7717%2Fpeerj.6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span> <span> </span><span class="NLM_article-title">Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">e920212</span> <span class="refDoi"> DOI: 10.12659/MSM.920212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.12659%2FMSM.920212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32251269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1Kls7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&author=H.+Renauthor=D.+Huauthor=Y.+Maoauthor=X.+Su&title=Identification+of+Genes+with+Prognostic+Value+in+the+Breast+Cancer+Microenvironment+Using+Bioinformatics+Analysis&doi=10.12659%2FMSM.920212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of genes with prognostic value in the breast cancer microenvironment using bioinformatics analysis</span></div><div class="casAuthors">Ren, Haoyu; Hu, Daixing; Mao, Yu; Su, Xinliang</div><div class="citationInfo"><span class="NLM_cas:title">Medical Science Monitor</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e920212</span>CODEN:
                <span class="NLM_cas:coden">MSMOFR</span>;
        ISSN:<span class="NLM_cas:issn">1643-3750</span>.
    
            (<span class="NLM_cas:orgname">International Scientific Information, Inc.</span>)
        </div><div class="casAbstract">Background: Stromal and immune cells play essential roles in the development of breast cancer (BC).  This study was conducted to identify prognosis-related genes from the tumor microenvironment.  Material/Methods: The gene expression profiles of 622 BC samples were downloaded from TCGA (The Cancer Genome Atlas) database.  Stromal and immune scores were calcd. by using the Est. (Estn. of STromal and Immune cells in MAlignant Tumors using Expression data) algorithm.  Then, differentially expressed genes (DEGs) between the high score group and the low score group were screened.  The intersecting DEGs were selected through Venn diagrams, and survival anal. was conducted.  Functional and pathway enrichment analyses were performed using the DAVID (Database for Annotation, Visualization and Integrated Discovery), and a protein-protein interaction (PPI) network was constructed with the STRING database and Cytoscape.  These genes were validated for prognostic value by use of the KM (Kaplan-Meier) plotter tool.  Results: The low immune score group was assocd. with a poor prognosis.  However, there was no difference in the prognosis between the high and low stromal score groups.  A total of 248 intersecting DEGs were found in BC, and 61 genes were significantly assocd. with the prognosis of BC patients in the TCGA database.  These genes were enriched in the immune response, components of the plasma membrane, and receptor activity.  Furthermore, in the validation group, 31 of 61 genes were significantly assocd. with prognosis.  Conclusions: Our bioinformatics anal. identified 31 tumor microenvironment-related genes as potential prognostic predictors for breast cancer patients.  Some of these genes that have not been widely investigated previously, such as CXCL9, GPR18, S1PR4, SASH3, and PYH1N1, might be addnl. predictive factors for BC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAQAkEbi1KuLVg90H21EOLACvtfcHk0liMhiWHmWr_KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1Kls7jK&md5=47bf4866b81236136cbbd2062a0841f8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.12659%2FMSM.920212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.920212%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DSu%26aufirst%3DX.%26atitle%3DIdentification%2520of%2520Genes%2520with%2520Prognostic%2520Value%2520in%2520the%2520Breast%2520Cancer%2520Microenvironment%2520Using%2520Bioinformatics%2520Analysis%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2020%26volume%3D26%26doi%3D10.12659%2FMSM.920212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nourbakhsh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atabaki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roohbakhsh, A.</span></span> <span> </span><span class="NLM_article-title">The Role of Orphan G Protein-Coupled Receptors in the Modulation of Pain: A Review</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>212</i></span> (<span class="NLM_issue">April</span>),  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2018.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.lfs.2018.09.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30236869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVejsb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2018&pages=59-69&issue=April&author=F.+Nourbakhshauthor=R.+Atabakiauthor=A.+Roohbakhsh&title=The+Role+of+Orphan+G+Protein-Coupled+Receptors+in+the+Modulation+of+Pain%3A+A+Review&doi=10.1016%2Fj.lfs.2018.09.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The role of orphan G protein-coupled receptors in the modulation of pain: A review</span></div><div class="casAuthors">Nourbakhsh, Fahimeh; Atabaki, Rabi; Roohbakhsh, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">59-69</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) comprise a large no. of receptors.  Orphan GPCRs are divided into six families.  These groups contain orphan receptors for which the endogenous ligands are unclear.  They have various physiol. effects in the body and have the potential to be used in the treatment of different diseases.  Considering their important role in the central and peripheral nervous system, their role in the treatment of pain has been the subject of some recent studies.  At present, there are effective therapeutics for the treatment of pain including opioid medications and non-steroidal anti-inflammatory drugs.  However, the side effects of these drugs and the risks of tolerance and dependence remain a major problem.  In addn., neuropathic pain is a condition that does not respond to currently available analgesic medications well.  In the present review article, we aimed to review the most recent findings regarding the role of orphan GPCRs in the treatment of pain.  Accordingly, based on the preclin. findings, the role of GPR3, GPR7, GPR8, GPR18, GPR30, GPR35, GPR40, GPR55, GPR74, and GPR147 in the treatment of pain was discussed.  The present study highlights the role of orphan GPCRs in the modulation of pain and implies that these receptors are potential new targets for finding better and more efficient therapeutics for the management of pain particularly neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeLh8oJ6vxmbVg90H21EOLACvtfcHk0liEquWpi95Tig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVejsb7M&md5=dece17ced834a6217fbb2f446400eb82</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2018.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2018.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DNourbakhsh%26aufirst%3DF.%26aulast%3DAtabaki%26aufirst%3DR.%26aulast%3DRoohbakhsh%26aufirst%3DA.%26atitle%3DThe%2520Role%2520of%2520Orphan%2520G%2520Protein-Coupled%2520Receptors%2520in%2520the%2520Modulation%2520of%2520Pain%253A%2520A%2520Review%26jtitle%3DLife%2520Sci.%26date%3D2018%26volume%3D212%26issue%3DApril%26spage%3D59%26epage%3D69%26doi%3D10.1016%2Fj.lfs.2018.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-h.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-x.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.-j.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, T.</span></span> <span> </span><span class="NLM_article-title">Resolvin D2 Relieving Radicular Pain Is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2384</span>– <span class="NLM_lpage">2392</span>, <span class="refDoi"> DOI: 10.1007/s11064-018-2666-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1007%2Fs11064-018-2666-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30443715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1eisbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=2384-2392&issue=12&author=L.-y.+Zhangauthor=Z.-h.+Liuauthor=Q.+Zhuauthor=S.+Wenauthor=C.-x.+Yangauthor=Z.-j.+Fuauthor=T.+Sun&title=Resolvin+D2+Relieving+Radicular+Pain+Is+Associated+with+Regulation+of+Inflammatory+Mediators%2C+Akt%2FGSK-3%CE%B2+Signal+Pathway+and+GPR18&doi=10.1007%2Fs11064-018-2666-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18</span></div><div class="casAuthors">Zhang, Lan-yu; Liu, Zhi-hua; Zhu, Qing; Wen, Shuang; Yang, Cong-xian; Fu, Zhi-jian; Sun, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2384-2392</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuroinflammation induced by protruded nucleus pulposus (NP) has been shown to play a significant role in facilitation of radicular pain.  Resolvin D2 (RvD2), a novel member of resolvin family, exhibits potent anti-inflammatory, pro-resolving and antinociceptive effects.  But the effect of RvD2 in radicular pain remains unknown.  The radicular pain rat models were induced by application of NP to L5 dorsal root ganglion.  Each animal received intrathecal injections of vehicle or RvD2 (10 ng μl-1 or 100 ng μl-1).  Mech. thresholds were detd. by measuring the paw withdrawal threshold for 7 days.  The expressions of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and transforming growth factor-β1 (TGF-β1) in ipsilateral lumbar segment of rat spinal dorsal horns were measured by using ELISA and real time-PCR.  Western blot was used to measure the expressions of phosphorylated Akt (p-Akt) and phosphorylated glycogen synthase kinase 3 beta (p-GSK-3β).  The expressions and distributions of RvD2 receptor, G-protein-coupled receptor 18 (GPR18), were also explored in the spinal cord of rats by using double-label immunofluorescence.  RvD2 treatment caused significant redns. in the intensity of mech. hypersensitivity and spinal expressions of TNF-α and IL-6.  Meanwhile, RvD2 increased the expressions of TGF-β1 and regulated Akt/GSK-3β signaling.  Furthermore, immunofluorescence showed that GPR18 colocalized with neurons and astrocytes in spinal cord.  The results suggested that RvD2 might attenuate mech. allodynia via regulating the expressions of inflammatory mediators and activation of Akt/GSK-3β signal pathway.  RvD2 might offer a hopeful method for radicular pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk2iA5SsdarLVg90H21EOLACvtfcHk0liEquWpi95Tig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1eisbzN&md5=5ce4fc174906734b09220a8655a2b5ac</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs11064-018-2666-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-018-2666-9%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-y.%26aulast%3DLiu%26aufirst%3DZ.-h.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DWen%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-x.%26aulast%3DFu%26aufirst%3DZ.-j.%26aulast%3DSun%26aufirst%3DT.%26atitle%3DResolvin%2520D2%2520Relieving%2520Radicular%2520Pain%2520Is%2520Associated%2520with%2520Regulation%2520of%2520Inflammatory%2520Mediators%252C%2520Akt%252FGSK-3%25CE%25B2%2520Signal%2520Pathway%2520and%2520GPR18%26jtitle%3DNeurochem.%2520Res.%26date%3D2018%26volume%3D43%26issue%3D12%26spage%3D2384%26epage%3D2392%26doi%3D10.1007%2Fs11064-018-2666-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero-Alba, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barragán-Iglesias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Hernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdez-Moráles, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granados-Soto, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condés-Lara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marichal-Cancino, B. A.</span></span> <span> </span><span class="NLM_article-title">Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1496</span>, <span class="refDoi"> DOI: 10.3389/fphar.2018.01496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3389%2Ffphar.2018.01496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30670965" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1496&author=R.+Guerrero-Albaauthor=P.+Barrag%C3%A1n-Iglesiasauthor=A.+Gonz%C3%A1lez-Hern%C3%A1ndezauthor=E.+E.+Valdez-Mor%C3%A1lesauthor=V.+Granados-Sotoauthor=M.+Cond%C3%A9s-Laraauthor=M.+G.+Rodr%C3%ADguezauthor=B.+A.+Marichal-Cancino&title=Some+Prospective+Alternatives+for+Treating+Pain%3A+The+Endocannabinoid+System+and+Its+Putative+Receptors+GPR18+and+GPR55&doi=10.3389%2Ffphar.2018.01496"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2018.01496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2018.01496%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrero-Alba%26aufirst%3DR.%26aulast%3DBarrag%25C3%25A1n-Iglesias%26aufirst%3DP.%26aulast%3DGonz%25C3%25A1lez-Hern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DValdez-Mor%25C3%25A1les%26aufirst%3DE.%2BE.%26aulast%3DGranados-Soto%26aufirst%3DV.%26aulast%3DCond%25C3%25A9s-Lara%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DM.%2BG.%26aulast%3DMarichal-Cancino%26aufirst%3DB.%2BA.%26atitle%3DSome%2520Prospective%2520Alternatives%2520for%2520Treating%2520Pain%253A%2520The%2520Endocannabinoid%2520System%2520and%2520Its%2520Putative%2520Receptors%2520GPR18%2520and%2520GPR55%26jtitle%3DFront.%2520Pharmacol.%26date%3D2019%26volume%3D9%26spage%3D1496%26doi%3D10.3389%2Ffphar.2018.01496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morsett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Khoury, J.</span></span> <span> </span><span class="NLM_article-title">Microglia in Neurodegeneration</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1359</span>– <span class="NLM_lpage">1369</span>, <span class="refDoi"> DOI: 10.1038/s41593-018-0242-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fs41593-018-0242-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30258234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVSmsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2018&pages=1359-1369&issue=10&author=S.+Hickmanauthor=S.+Izzyauthor=P.+Senauthor=L.+Morsettauthor=J.+El+Khoury&title=Microglia+in+Neurodegeneration&doi=10.1038%2Fs41593-018-0242-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia in neurodegeneration</span></div><div class="casAuthors">Hickman, Suzanne; Izzy, Saef; Sen, Pritha; Morsett, Liza; El Khoury, Joseph</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1359-1369</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The neuroimmune system is involved in development, normal functioning, aging, and injury of the central nervous system.  Microglia, first described a century ago, are the main neuroimmune cells and have three essential functions: a sentinel function involved in const. sensing of changes in their environment, a housekeeping function that promotes neuronal well-being and normal operation, and a defense function necessary for responding to such changes and providing neuroprotection.  Microglia use a defined armamentarium of genes to perform these tasks.  In response to specific stimuli, or with neuroinflammation, microglia also have the capacity to damage and kill neurons.  Injury to neurons in Alzheimer's, Parkinson's, Huntington's, and prion diseases, as well as in amyotrophic lateral sclerosis, frontotemporal dementia, and chronic traumatic encephalopathy, results from disruption of the sentinel or housekeeping functions and dysregulation of the defense function and neuroinflammation.  Pathways assocd. with such injury include several sensing and housekeeping pathways, such as the Trem2, Cx3cr1 and progranulin pathways, which act as immune checkpoints to keep the microglial inflammatory response under control, and the scavenger receptor pathways, which promote clearance of injurious stimuli.  Peripheral interference from systemic inflammation or the gut microbiome can also alter progression of such injury.  Initiation or exacerbation of neurodegeneration results from an imbalance between these microglial functions; correcting such imbalance may be a potential mode for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot-4F88NHuQbVg90H21EOLACvtfcHk0lgQzCaViB-H2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVSmsbrI&md5=2a00c64af74e7e3229e1edab9963ae7d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fs41593-018-0242-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41593-018-0242-x%26sid%3Dliteratum%253Aachs%26aulast%3DHickman%26aufirst%3DS.%26aulast%3DIzzy%26aufirst%3DS.%26aulast%3DSen%26aufirst%3DP.%26aulast%3DMorsett%26aufirst%3DL.%26aulast%3DEl%2BKhoury%26aufirst%3DJ.%26atitle%3DMicroglia%2520in%2520Neurodegeneration%26jtitle%3DNat.%2520Neurosci.%26date%3D2018%26volume%3D21%26issue%3D10%26spage%3D1359%26epage%3D1369%26doi%3D10.1038%2Fs41593-018-0242-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roskowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span> <span> </span><span class="NLM_article-title">Δ9-THC and N-Arachidonoyl Glycine Regulate BV-2 Microglial Morphology and Cytokine Release Plasticity: Implications for Signaling at GPR18</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">162</span>, <span class="refDoi"> DOI: 10.3389/fphar.2013.00162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3389%2Ffphar.2013.00162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=24427137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BC2czls1SjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=162&author=D.+McHughauthor=D.+Roskowskiauthor=S.+Xieauthor=H.+B.+Bradshaw&title=%CE%949-THC+and+N-Arachidonoyl+Glycine+Regulate+BV-2+Microglial+Morphology+and+Cytokine+Release+Plasticity%3A+Implications+for+Signaling+at+GPR18&doi=10.3389%2Ffphar.2013.00162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18</span></div><div class="casAuthors">McHugh Douglas; Roskowski Daniel; Xie Sisi; Bradshaw Heather B</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">162</span>
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    </div><div class="casAbstract">Microglial cells are extremely plastic and undergo a variety of CNS-prompted shape changes relative to their location and current role.  Signaling molecules from neurons also regulate microglial cytokine production.  Neurons are known to employ the endogenous cannabinoid system to communicate with other cells of the CNS.  N-arachidonoyl glycine (NAGly) and Δ(9)-tetrahydrocannabinol (Δ(9)-THC) signaling via GPR18 has been introduced as an important new target in microglial-neuronal communication.  Our hypothesis is that endogenous NAGly-GPR18 signaling regulates phenotypic shape and cytokine production in microglia, and is mimicked by Δ(9)-THC in the BV-2 microglia model system.  BV-2 microglia were exposed to NAGly and Δ(9)-THC or Vh for 12 h, which resulted in significant differences in the cell morphologies expressed.  Cannabidiol (CBD) was effective at antagonizing the effects of both NAGly and Δ(9)-THC.  Using ELISA-based microarrays, BV-2 microglia were exposed to NAGly and Δ(9)-THC or Vh for 3 h and the presence of 40 cytokines in the culture media quantified.  Production of Axl, CD40, IGF-I, OPN, and Pro-MMP-9 were significantly altered by NAGly and Δ(9)-THC, and antagonized by CBD.  These data add to an emerging profile that emphasizes NAGly as a component of an endogenous system present in the CNS that tightly integrates microglial proliferation, recruitment, and adhesion with neuron-glia interactivity and tissue remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9ZHjvbyki-EwlCcfExbvbfW6udTcc2ealYQRQGUqPv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czls1SjtA%253D%253D&md5=932bc29aa961119c6670e9300a57bd61</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2013.00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2013.00162%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DD.%26aulast%3DRoskowski%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26atitle%3D%25CE%25949-THC%2520and%2520N-Arachidonoyl%2520Glycine%2520Regulate%2520BV-2%2520Microglial%2520Morphology%2520and%2520Cytokine%2520Release%2520Plasticity%253A%2520Implications%2520for%2520Signaling%2520at%2520GPR18%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D4%26spage%3D162%26doi%3D10.3389%2Ffphar.2013.00162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabiec, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghadban, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothgänger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonietti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehghani, F.</span></span> <span> </span><span class="NLM_article-title">Protective Effect of N-Arachidonoyl Glycine-GPR18 Signaling after Excitotoxical Lesion in Murine Organotypic Hippocampal Slice Cultures</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1266</span>, <span class="refDoi"> DOI: 10.3390/ijms20061266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3390%2Fijms20061266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtFWntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=1266&issue=6&author=U.+Grabiecauthor=T.+Hohmannauthor=C.+Ghadbanauthor=C.+Rothg%C3%A4ngerauthor=D.+Wongauthor=A.+Antoniettiauthor=T.+Grothauthor=K.+Mackieauthor=F.+Dehghani&title=Protective+Effect+of+N-Arachidonoyl+Glycine-GPR18+Signaling+after+Excitotoxical+Lesion+in+Murine+Organotypic+Hippocampal+Slice+Cultures&doi=10.3390%2Fijms20061266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of N-arachidonoyl glycine-GPR18 signaling after excitotoxical lesion in murine organotypic hippocampal slice cultures</span></div><div class="casAuthors">Grabiec, Urszula; Hohmann, Tim; Ghadban, Chal; Rothgaenger, Candy; Wong, Daniel; Antonietti, Alexandra; Groth, Thomas; Mackie, Ken; Dehghani, Faramarz</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1266</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">N-arachidonoyl glycine (NAGly) is an endocannabinoid involved in the regulation of different immune cells.  It was shown to activate the GPR18 receptor, which was postulated to switch macrophages from cytotoxic to reparative.  To study GPR18 expression and neuroprotection after NAGly treatment we used excitotoxically lesioned organotypic hippocampal slice cultures (OHSC).  The effect of NAGly was also tested in isolated microglia and astrocytes as these cells play a crucial role during neuronal injury.  In the present study, the GPR18 receptor was found in OHSC at mRNA level and was downregulated after N-Methyl-D-aspartate (NMDA) treatment at a single time point.  Furthermore, treatment with NAGly reduced neuronal damage and this effect was abolished by GPR18 and cannabinoid receptor (CB)2 receptor antagonists.  The activation but not motility of primary microglia and astrocytes was influenced when incubated with NAGly.  However, NAGly alone reduced the phosphorylation of Akt but no changes in activation of the p44/42 and p38 MAPK and CREB pathways in BV2 cells could be obsd.  Given NAGly mediated actions we speculate that GPR18 and its ligand NAGly are modulators of glial and neuronal cells during neuronal damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdJHLl12_4CLVg90H21EOLACvtfcHk0lhAsjQzLl-hmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtFWntb0%253D&md5=e45cac1dafd085b272e69d577df5ab8c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fijms20061266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20061266%26sid%3Dliteratum%253Aachs%26aulast%3DGrabiec%26aufirst%3DU.%26aulast%3DHohmann%26aufirst%3DT.%26aulast%3DGhadban%26aufirst%3DC.%26aulast%3DRothg%25C3%25A4nger%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DD.%26aulast%3DAntonietti%26aufirst%3DA.%26aulast%3DGroth%26aufirst%3DT.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DDehghani%26aufirst%3DF.%26atitle%3DProtective%2520Effect%2520of%2520N-Arachidonoyl%2520Glycine-GPR18%2520Signaling%2520after%2520Excitotoxical%2520Lesion%2520in%2520Murine%2520Organotypic%2520Hippocampal%2520Slice%2520Cultures%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26issue%3D6%26spage%3D1266%26doi%3D10.3390%2Fijms20061266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weimar, C. H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macklon, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post
Uiterweer, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosens, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellersen, B.</span></span> <span> </span><span class="NLM_article-title">The Motile and Invasive Capacity of Human Endometrial Stromal Cells: Implications for Normal and Impaired Reproductive Function</span>. <i>Hum. Reprod. Update</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">542</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1093/humupd/dmt025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1093%2Fhumupd%2Fdmt025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23827985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=542-557&issue=5&author=C.+H.+E.+Weimarauthor=N.+S.+Macklonauthor=E.+D.+Post%0AUiterweerauthor=J.+J.+Brosensauthor=B.+Gellersen&title=The+Motile+and+Invasive+Capacity+of+Human+Endometrial+Stromal+Cells%3A+Implications+for+Normal+and+Impaired+Reproductive+Function&doi=10.1093%2Fhumupd%2Fdmt025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function</span></div><div class="casAuthors">Weimar, Charlotte H. E.; Macklon, Nick S.; Post Uiterweer, Emiel D.; Brosens, Jan J.; Gellersen, Birgit</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction Update</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-557</span>CODEN:
                <span class="NLM_cas:coden">HRUPF8</span>;
        ISSN:<span class="NLM_cas:issn">1355-4786</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  BACKGROUND Mechanisms underlying early reproductive loss in the human are beginning to be elucidated.  The migratory and invasive capacity of human endometrial stromal cells (ESCs) is increasingly recognized to contribute to the intense tissue remodelling assocd. with embryo implantation, trophoblast invasion and endometrial regeneration.  In this review, we examine the signals and mechanisms that control ESC migration and invasion and assess how deregulation of these cell functions contributes to common reproductive disorders.  METHODS The PubMed database was searched for publications on motility and invasiveness of human ESCs in normal endometrial function and in reproductive disorders including implantation failure, recurrent pregnancy loss (RPL), endometriosis and adenomyosis, covering the period 2000-2012.  RESULTS Increasing evidence suggests that implantation failure and RPL involve abnormal migratory responses of decidualizing ESCs to embryo and trophoblast signals.  Numerous reports indicate that endometriosis, as well as adenomyosis, is assocd. with increased basal and stimulated invasiveness of ESCs and their progenitor cells, suggesting a link between a heightened menstrual repair response and the formation of ectopic implants.  Migration and invasiveness of ESCs are controlled by a complex array of hormones, growth factors, chemokines and inflammatory mediators, and involve signalling through Rho GTPases, phosphatidylinositol-3-kinase and mitogen-activated protein kinase pathways.  CONCLUSIONS Novel concepts are extending our understanding of the key functions of ESCs in effecting tissue repair imposed by cyclic menstruation and parturition.  Migration of decidualizing ESCs also serves to support blastocyst implantation and embryo selection through discriminate motile responses directed by embryo quality.  Targeting regulatory mols. holds promise for developing new strategies for the treatment of reproductive disorders such as endometriosis and recurrent miscarriage; and harnessing the migratory capacity of progenitor mesenchymal stem cells in the endometrium may offer new opportunities in regenerative medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolsTOGNu9eAbVg90H21EOLACvtfcHk0lhAsjQzLl-hmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yrs7nJ&md5=ed835adc1b943b4b7c362dc85a8286c9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Fhumupd%2Fdmt025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumupd%252Fdmt025%26sid%3Dliteratum%253Aachs%26aulast%3DWeimar%26aufirst%3DC.%2BH.%2BE.%26aulast%3DMacklon%26aufirst%3DN.%2BS.%26aulast%3DPost%2BUiterweer%26aufirst%3DE.%2BD.%26aulast%3DBrosens%26aufirst%3DJ.%2BJ.%26aulast%3DGellersen%26aufirst%3DB.%26atitle%3DThe%2520Motile%2520and%2520Invasive%2520Capacity%2520of%2520Human%2520Endometrial%2520Stromal%2520Cells%253A%2520Implications%2520for%2520Normal%2520and%2520Impaired%2520Reproductive%2520Function%26jtitle%3DHum.%2520Reprod.%2520Update%26date%3D2013%26volume%3D19%26issue%3D5%26spage%3D542%26epage%3D557%26doi%3D10.1093%2Fhumupd%2Fdmt025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelton, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. A.</span></span> <span> </span><span class="NLM_article-title">Lipid G Protein-Coupled Receptor Ligand Identification Using Beta-Arrestin Path Hunter Assay</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">12328</span>– <span class="NLM_lpage">12338</span>, <span class="refDoi"> DOI: 10.1074/jbc.M806516200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1074%2Fjbc.M806516200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=19286662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=12328-12338&issue=18&author=H.+Yinauthor=A.+Chuauthor=W.+Liauthor=B.+Wangauthor=F.+Sheltonauthor=F.+Oteroauthor=D.+G.+Nguyenauthor=J.+S.+Caldwellauthor=Y.+A.+Chen&title=Lipid+G+Protein-Coupled+Receptor+Ligand+Identification+Using+Beta-Arrestin+Path+Hunter+Assay&doi=10.1074%2Fjbc.M806516200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter Assay</span></div><div class="casAuthors">Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">12328-12338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A growing no. of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors.  These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports.  We used the β-arrestin PathHunter assay system, a newly developed, generic GPCR assay format that measures β-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing.  This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation.  We screened a large no. of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of ∼400 lipid mols. to try to identify the receptor ligand in an unbiased fashion.  GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate.  The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids.  G2A receptor was confirmed to be an oxidized free fatty acid receptor.  In addn., we discovered that 3,3'-diindolylmethane, a dietary mol. from cruciferous vegetables, which has known anti-cancer properties, to be a CB2 receptor partial agonist, with binding affinity around 1 μM.  The anti-inflammatory effect of 3,3'-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQnRS1OGXeVrVg90H21EOLACvtfcHk0lj88P-ZnrWHfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltVClsrw%253D&md5=beb6f1fe11d9dab29329d2a2a85ab051</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806516200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806516200%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DShelton%26aufirst%3DF.%26aulast%3DOtero%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DD.%2BG.%26aulast%3DCaldwell%26aufirst%3DJ.%2BS.%26aulast%3DChen%26aufirst%3DY.%2BA.%26atitle%3DLipid%2520G%2520Protein-Coupled%2520Receptor%2520Ligand%2520Identification%2520Using%2520Beta-Arrestin%2520Path%2520Hunter%2520Assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D18%26spage%3D12328%26epage%3D12338%26doi%3D10.1074%2Fjbc.M806516200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berjukow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döring, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froschmayr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hering, S.</span></span> <span> </span><span class="NLM_article-title">Endogenous Calcium Channels in Human Embryonic Kidney (HEK293) Cells</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.1996.tb15463.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1476-5381.1996.tb15463.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=8762103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Git7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=748-754&issue=3&author=S.+Berjukowauthor=F.+D%C3%B6ringauthor=M.+Froschmayrauthor=M.+Grabnerauthor=H.+Glossmannauthor=S.+Hering&title=Endogenous+Calcium+Channels+in+Human+Embryonic+Kidney+%28HEK293%29+Cells&doi=10.1111%2Fj.1476-5381.1996.tb15463.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous calcium channels in human embryonic kidney (HEK293) cells</span></div><div class="casAuthors">Berjukow, Stanislav; Doering, Frank; Froschmayr, Monika; Grabner, Manfred; Glossmann, Hartmut; Hering, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">748-754</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">We have identified endogenous calcium channel currents in HEK293 cells.  Whole cell endogenous current (ISr -HEK) were studied in single HEK293 cells with 10 mM strontium as the charge carrier by the patch clamp technique.  The kinetic properties and pharmacol. features of ISr-HEK were characterized and compared with the properties of a heterologously expressed chimeric L-type calcium channel construct.  ISr-HEK activated on depolarization to voltage pos. of -40 mV.  It had transient current kinetics with a time to peak of 16 ± 1.4 ms (n = 7) and an activation times const. of 52 ± 5 ms (n = 7) at a test potential of 0 mV.  The voltage for half maximal activation was -19.0 U 1.5 mV (n = 7) and the voltage for half maximal steady-state inactivation was -39.7 ± 2.3 mV (n = 7).  Block of Isr-HEK by the dihydropyridine isradipine was not selective: 1 μM (+) and (-)- isradipine inhibited the current by 30 ± 4% (n = 3) and 29 ± 2% (n = 4) resp.  (+)-Isradipine and (=)-isradipine (10 μM) inhibited ISr-HEK by 89-4% (n = 5) and 88 ± 8% (n = 3) resp.  The 7-bromo substituted (±)-isradipine (VO2605, 10 μM) which is almost inactive on L-type calcium channels also inhibited ISr-HEK (83 ± 9%, n = 3) as was obsd. for 10 μM (-)-nimodipine (78 ± 6%, n =).  Interestingly, 10 μM (±)-Bay K 8644 (n = 5) had no effect on the current.  ISr-HEK was only slightly inhibited by the cone snail toxins ω-CTx GVIA (1 μM, inhibition by 17 ± 3%, n = 4) and ω-CTx MVIIC (1 μM, inhibition by 20 ± 3%, n = 4).  The funnel web spider toxin ω-Aga IVA (200 nM) inhibited ISr-HEK by 19 ± 2%, (n = 4).  In cells expressing ISr-HEK, max. inward current densities of 0.24 ± 0.03 pA/pF and 0.39 ± 0.7 pA/pF (at a test potential of -10 mV) were estd. in two different batches of HEK293 cells.  The c.d. increased to 0.88 ± 0.18 pA/pF or 1.11 ± 0.2 pA/pF resp., if the cells were cultured for 4 days in serum-free medium.  Co-expression of a chimeric L-type calcium channel construct revealed that ISr-HEK and L-type calcium channel currents could be distinguished by their different voltage-dependencies and current kinetics.  The c.d. after heterologous expression of the L-type α1 subunit chimera was estd. to be about ten times higher in serum contg. medium (2.14 ± 0.45 pA/pF) than that of ISr-HEK under the same conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGvxkIfqTGM7Vg90H21EOLACvtfcHk0ljXUA1tp_RhaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Git7g%253D&md5=1e619ff0d1cc315b804b7b6645786da7</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15463.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15463.x%26sid%3Dliteratum%253Aachs%26aulast%3DBerjukow%26aufirst%3DS.%26aulast%3DD%25C3%25B6ring%26aufirst%3DF.%26aulast%3DFroschmayr%26aufirst%3DM.%26aulast%3DGrabner%26aufirst%3DM.%26aulast%3DGlossmann%26aufirst%3DH.%26aulast%3DHering%26aufirst%3DS.%26atitle%3DEndogenous%2520Calcium%2520Channels%2520in%2520Human%2520Embryonic%2520Kidney%2520%2528HEK293%2529%2520Cells%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D118%26issue%3D3%26spage%3D748%26epage%3D754%26doi%3D10.1111%2Fj.1476-5381.1996.tb15463.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aoyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furuzono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsubara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimokata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imaizumi, Y.</span></span> <span> </span><span class="NLM_article-title">Requirement of Ryanodine Receptors for Pacemaker Ca2+ Activity in ICC and HEK293 Cells</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2813</span>– <span class="NLM_lpage">2825</span>, <span class="refDoi"> DOI: 10.1242/jcs.01136</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1242%2Fjcs.01136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=15169838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFehtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=2813-2825&issue=13&author=M.+Aoyamaauthor=A.+Yamadaauthor=J.+Wangauthor=S.+Ohyaauthor=S.+Furuzonoauthor=T.+Gotoauthor=S.+Hottaauthor=Y.+Itoauthor=T.+Matsubaraauthor=K.+Shimokataauthor=W.+Chenauthor=Y.+Imaizumi&title=Requirement+of+Ryanodine+Receptors+for+Pacemaker+Ca2%2B+Activity+in+ICC+and+HEK293+Cells&doi=10.1242%2Fjcs.01136"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of ryanodine receptors for pacemaker Ca2+ activity in ICC and HEK293 cells</span></div><div class="casAuthors">Aoyama, Masahiro; Yamada, Aki; Wang, Jing; Ohya, Susumu; Furuzono, Shinji; Goto, Takayo; Hotta, Shingo; Ito, Yasushi; Matsubara, Tatsuaki; Shimokata, Kaoru; Chen, S. R. Wayne; Imaizumi, Yuji; Nakayama, Shinsuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2813-2825</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Intracellular Ca2+ ([Ca2+]i) oscillations seen in interstitial cells of Cajal (ICCs) are considered to be the primary pacemaker activity in the gut.  Here, we show evidence that periodic Ca2+ release from intracellular Ca2+ stores produces [Ca2+]i oscillations in ICCs, using cell cluster prepns. isolated from mouse ileum.  The pacemaker [Ca2+]i oscillations in ICCs are preserved in the presence of dihydropyridine Ca2+ antagonists, which suppress Ca2+ activity in smooth muscle cells.  However, applications of drugs affecting either ryanodine receptors or inositol 1,4,5-trisphosphate receptors terminated [Ca2+]i oscillations at relatively low concns.  RT-PCR analyses revealed a predominant expression of type 3 RyR (RyR3) in isolated c-Kit-immunopos. cells (ICCs).  Furthermore, we demonstrate that pacemaker-like global [Ca2+]i oscillation activity is endowed by introducing RyR3 into HEK293 cells, which originally express only IP3Rs.  The reconstituted [Ca2+]i oscillations in HEK293 cells possess essentially the same pharmacol. characteristics as seen in ICCs.  The results support the functional role of RyR3 in ICCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNUVQVYlZx47Vg90H21EOLACvtfcHk0ljHpkOBqSN57A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFehtL8%253D&md5=4605d072330942aec0f97fa009c87287</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1242%2Fjcs.01136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.01136%26sid%3Dliteratum%253Aachs%26aulast%3DAoyama%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DOhya%26aufirst%3DS.%26aulast%3DFuruzono%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DMatsubara%26aufirst%3DT.%26aulast%3DShimokata%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DImaizumi%26aufirst%3DY.%26atitle%3DRequirement%2520of%2520Ryanodine%2520Receptors%2520for%2520Pacemaker%2520Ca2%252B%2520Activity%2520in%2520ICC%2520and%2520HEK293%2520Cells%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2004%26volume%3D117%26issue%3D13%26spage%3D2813%26epage%3D2825%26doi%3D10.1242%2Fjcs.01136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Console-Bram, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciuciu, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zipkin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brailoiu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abood, M. E.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine, Another Endogenous Agonist of GPR55</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>490</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1389</span>– <span class="NLM_lpage">1393</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2017.07.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.bbrc.2017.07.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=28698140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2017&pages=1389-1393&issue=4&author=L.+Console-Bramauthor=S.+M.+Ciuciuauthor=P.+Zhaoauthor=R.+E.+Zipkinauthor=E.+Brailoiuauthor=M.+E.+Abood&title=N-Arachidonoyl+Glycine%2C+Another+Endogenous+Agonist+of+GPR55&doi=10.1016%2Fj.bbrc.2017.07.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine, another endogenous agonist of GPR55</span></div><div class="casAuthors">Console-Bram, Linda; Ciuciu, Sandra M.; Zhao, Pingwei; Zipkin, Robert E.; Brailoiu, Eugen; Abood, Mary E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1389-1393</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Interest in lipoamino acids as endogenous modulators of G-protein coupled receptors has escalated due to their involvement in a variety of physiol. processes.  In particular, a role for these amino acid conjugates has emerged in the endocannabinoid system.  The study presented herein investigated the effects of N-arachidonoyl glycine (NAGly) on a candidate endocannabinoid receptor, GPR55.  Our novel findings reveal that NAGly induces concn. dependent increases in calcium mobilization and mitogen-activated protein kinase activities in HAGPR55/CHO cells.  These increases were attenuated by the selective GPR55 antagonist ML193 (N-[4-[[(3,4-Dimethyl-5-isoxazolyl)amino]sulfonyl]phenyl]-6,8-dimethyl-2-(2-pyridinyl)-4-quinolinecarboxamide), supporting receptor mediated signaling.  To our knowledge this is the first report identifying GPR55 as a target of the endogenous lipoamino acid, NAGly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx8GQEqbQziLVg90H21EOLACvtfcHk0ljHpkOBqSN57A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKht7zL&md5=4590520db0b526edae7ee95c52651315</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2017.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2017.07.038%26sid%3Dliteratum%253Aachs%26aulast%3DConsole-Bram%26aufirst%3DL.%26aulast%3DCiuciu%26aufirst%3DS.%2BM.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DZipkin%26aufirst%3DR.%2BE.%26aulast%3DBrailoiu%26aufirst%3DE.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26atitle%3DN-Arachidonoyl%2520Glycine%252C%2520Another%2520Endogenous%2520Agonist%2520of%2520GPR55%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2017%26volume%3D490%26issue%3D4%26spage%3D1389%26epage%3D1393%26doi%3D10.1016%2Fj.bbrc.2017.07.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deak, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groschner, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seles, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondarenko, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graier, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malli, R.</span></span> <span> </span><span class="NLM_article-title">The Endocannabinoid N-Arachidonoyl Glycine (NAGly) Inhibits Store-Operated Ca2+ Entry by Preventing STIM1-Orai1 Interaction</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>126</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">888</span>, <span class="refDoi"> DOI: 10.1242/jcs.118075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1242%2Fjcs.118075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23239024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFaitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2013&pages=879-888&issue=4&author=A.+T.+Deakauthor=L.+N.+Groschnerauthor=M.+R.+Alamauthor=E.+Selesauthor=A.+I.+Bondarenkoauthor=W.+F.+Graierauthor=R.+Malli&title=The+Endocannabinoid+N-Arachidonoyl+Glycine+%28NAGly%29+Inhibits+Store-Operated+Ca2%2B+Entry+by+Preventing+STIM1-Orai1+Interaction&doi=10.1242%2Fjcs.118075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid N-arachidonoyl glycine (NAGly) inhibits store-operated Ca2+ entry by preventing STIM1-Orai1 interaction</span></div><div class="casAuthors">Deak, Andras T.; Groschner, Lukas N.; Alam, Muhammad Rizwan; Seles, Elisabeth; Bondarenko, Alexander I.; Graier, Wolfgang F.; Malli, Roland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-888</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The endocannabinoid anandamide (AEA) and its derivate N-arachidonoyl glycine (NAGly) have a broad spectrum of physiol. effects, which are induced by both binding to receptors and receptor-independent modulations of ion channels and transporters.  The impact of AEA and NAGly on store-operated Ca2+ entry (SOCE), a ubiquitous Ca2+ entry pathway regulating many cellular functions, is unknown.  Here we show that NAGly, but not AEA reversibly hinders SOCE in a time- and concn.-dependent manner.  The inhibitory effect of NAGly on SOCE was found in the human endothelial cell line EA.hy926, the rat pancreatic β-cell line INS-1 832/13, and the rat basophilic leukemia cell line RBL-2H3.  NAGly diminished SOCE independently from the mode of Ca2+ depletion of the endoplasmic reticulum, whereas it had no effect on Ca2+ entry through L-type voltage-gated Ca2+ channels.  Enhanced Ca2+ entry was effectively hampered by NAGly in cells overexpressing the key mol. constituents of SOCE, stromal interacting mol. 1 (STIM1) and the pore-forming subunit of SOCE channels, Orai1.  Fluorescence microscopy revealed that NAGly did not affect STIM1 oligomerization, STIM1 clustering, or the colocalization of STIM1 with Orai1, which were induced by Ca2+ depletion of the endoplasmic reticulum.  In contrast, independently from its slow depolarizing effect on mitochondria, NAGly instantly and strongly diminished the interaction of STIM1 with Orai1, indicating that NAGly inhibits SOCE primarily by uncoupling STIM1 from Orai1.  In summary, our findings revealed the STIM1-Orai1-mediated SOCE machinery as a mol. target of NAGly, which might have many implications in cell physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptf1swH4VvWbVg90H21EOLACvtfcHk0ljN7XKzroXBkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFaitb8%253D&md5=744da2d1fe0bc08d7231f77c993b661b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1242%2Fjcs.118075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.118075%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DA.%2BT.%26aulast%3DGroschner%26aufirst%3DL.%2BN.%26aulast%3DAlam%26aufirst%3DM.%2BR.%26aulast%3DSeles%26aufirst%3DE.%26aulast%3DBondarenko%26aufirst%3DA.%2BI.%26aulast%3DGraier%26aufirst%3DW.%2BF.%26aulast%3DMalli%26aufirst%3DR.%26atitle%3DThe%2520Endocannabinoid%2520N-Arachidonoyl%2520Glycine%2520%2528NAGly%2529%2520Inhibits%2520Store-Operated%2520Ca2%252B%2520Entry%2520by%2520Preventing%2520STIM1-Orai1%2520Interaction%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2013%26volume%3D126%26issue%3D4%26spage%3D879%26epage%3D888%26doi%3D10.1242%2Fjcs.118075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondarenko, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panasiuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drachuk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montecucco, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, F.</span></span> <span> </span><span class="NLM_article-title">The Quest for Endothelial Atypical Cannabinoid Receptor: BKCa Channels Act as Cellular Sensors for Cannabinoids in in Vitro and in Situ Endothelial Cells</span>. <i>Vasc. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">55</span>, <span class="refDoi"> DOI: 10.1016/j.vph.2018.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.vph.2018.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29355732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitl2qtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2018&pages=44-55&author=A.+I.+Bondarenkoauthor=O.+Panasiukauthor=K.+Drachukauthor=F.+Montecuccoauthor=K.+J.+Brandtauthor=F.+Mach&title=The+Quest+for+Endothelial+Atypical+Cannabinoid+Receptor%3A+BKCa+Channels+Act+as+Cellular+Sensors+for+Cannabinoids+in+in+Vitro+and+in+Situ+Endothelial+Cells&doi=10.1016%2Fj.vph.2018.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells</span></div><div class="casAuthors">Bondarenko, Alexander I.; Panasiuk, Olga; Drachuk, Konstantin; Montecucco, Fabrizio; Brandt, Karim J.; Mach, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Vascular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-55</span>CODEN:
                <span class="NLM_cas:coden">VPAHAJ</span>;
        ISSN:<span class="NLM_cas:issn">1537-1891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Endothelium-dependent component of cannabinoid-induced vasodilation has been postulated to require G-protein-coupled non-CB1/CB2 endothelial cannabinoid (eCB) receptor.  GPR18 was proposed as a candidate for eCBR.  To address the hypothesis that the effects attributed to eCBR are mediated by G-protein-coupled receptor (GPCR)-independent targets, we studied the elec. responses in endothelial cells, focusing on BKCa channels.  In patches excised from endothelial-derived EA.hy926 cells, N-arachidonoyl glycine (NAGly) and abnormal cannabidiol (abn-cbd), prototypical agonists for eCB receptor, stimulate single BKCa activity in a concn.- and Ca2+-dependent manner.  The postulated eCB receptor inhibitors rimonabant and AM251 were found to inhibit basal and stimulated by NAGly- and abn-cbd BKCa activity in cell-free patches.  In isolated mice aortas, abn-cbd and NAGly produced endothelial cell hyperpolarization that was sensitive to paxilline, a selective BKCa inhibitor, but not to GPR18 antibody, and mimicked by NS1619, a direct BKCa opener.  In excised patches from mice aortic endothelium, single channel activity with characteristics similar to BKCa was established by the addn. of abn-cbd and NAGly.  In this paper conclude that the two cannabinoids abn-cbd and NAGly initiate a GPR18-independent activation of BKCa channels in mice aortic endothelial cells that might contribute to vasodilation to cannabinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQFA0rT5e9ErVg90H21EOLACvtfcHk0lhyRXJxpRiWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitl2qtrY%253D&md5=0433bec6bf4dc31832d14641f07bf4da</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.vph.2018.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vph.2018.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DBondarenko%26aufirst%3DA.%2BI.%26aulast%3DPanasiuk%26aufirst%3DO.%26aulast%3DDrachuk%26aufirst%3DK.%26aulast%3DMontecucco%26aufirst%3DF.%26aulast%3DBrandt%26aufirst%3DK.%2BJ.%26aulast%3DMach%26aufirst%3DF.%26atitle%3DThe%2520Quest%2520for%2520Endothelial%2520Atypical%2520Cannabinoid%2520Receptor%253A%2520BKCa%2520Channels%2520Act%2520as%2520Cellular%2520Sensors%2520for%2520Cannabinoids%2520in%2520in%2520Vitro%2520and%2520in%2520Situ%2520Endothelial%2520Cells%26jtitle%3DVasc.%2520Pharmacol.%26date%3D2018%26volume%3D102%26spage%3D44%26epage%3D55%26doi%3D10.1016%2Fj.vph.2018.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bondarenko, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drachuk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panasiuk, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagach, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deak, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graier, W. F.</span></span> <span> </span><span class="NLM_article-title">N-Arachidonoyl Glycine Suppresses Na+/Ca2+ Exchanger-Mediated Ca2+ Entry into Endothelial Cells and Activates BKCa Channels Independently of GPCRs</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>169</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">933</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1111/bph.12180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fbph.12180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=23517055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptlOhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2013&pages=933-948&issue=4&author=A.+I.+Bondarenkoauthor=K.+Drachukauthor=O.+Panasiukauthor=V.+Sagachauthor=A.+T.+Deakauthor=R.+Malliauthor=W.+F.+Graier&title=N-Arachidonoyl+Glycine+Suppresses+Na%2B%2FCa2%2B+Exchanger-Mediated+Ca2%2B+Entry+into+Endothelial+Cells+and+Activates+BKCa+Channels+Independently+of+GPCRs&doi=10.1111%2Fbph.12180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">N-arachidonoyl glycine suppresses Na+/Ca2+ exchanger-mediated Ca2+ entry into endothelial cells and activates BKCa channels independently of GPCRs</span></div><div class="casAuthors">Bondarenko, Alexander I.; Drachuk, Konstantin; Panasiuk, Olga; Sagach, Vadim; Deak, Andras T.; Malli, Roland; Graier, Wolfgang F.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">933-948</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose: N-arachidonoyl glycine (NAGly) is a lipoamino acid with vasorelaxant properties.  We aimed to explore the mechanisms of NAGly's action on unstimulated and agonist-stimulated endothelial cells.  Exptl. Approach: The effects of NAGly on endothelial elec. signaling were studied in combination with vascular reactivity.  Key Results: In EA.hy926 cells, the sustained hyperpolarization to histamine was inhibited by the non-selective Na+/Ca2+ exchanger (NCX) inhibitor bepridil and by an inhibitor of reversed mode NCX, KB-R 7943.  In cells dialyzed with Cs+-based Na+-contg. soln., the outwardly rectifying current with typical characteristics of NCX was augmented following histamine exposure, further increased upon external Na+ withdrawal and inhibited by bepridil.  NAGly (0.3-30 μM) suppressed NCX currents in a URB 597- and guanosine 5'-O-(2-thiodiphosphate) (GDPβS)-insensitive manner, [Ca2+]i elevation evoked by Na+ removal and the hyperpolarization to histamine.  In rat aorta, NAGly opposed the endothelial hyperpolarization and relaxation response to ACh.  In unstimulated EA.hy926 cells, NAGly potentiated the whole-cell current attributable to large-conductance Ca2+-activated K+ (BKCa) channels in a GDPβS-insensitive, paxilline-sensitive manner and produced a sustained hyperpolarization.  In cell-free inside-out patches, NAGly stimulated single BKCa channel activity.  Conclusion and Implications: Our data showed that NCX is a Ca2+ entry pathway in endothelial cells and that NAGly is a potent G-protein-independent modulator of endothelial elec. signaling and has a dual effect on endothelial elec. responses.  In agonist pre-stimulated cells, NAGly opposes hyperpolarization and relaxation via inhibition of NCX-mediated Ca2+ entry, while in unstimulated cells, it promotes hyperpolarization via receptor-independent activation of BKCa channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOyiZb5Eb6KbVg90H21EOLACvtfcHk0lhyRXJxpRiWDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptlOhsrc%253D&md5=f48651d9a5d66a6bc84f741f4d6fd663</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fbph.12180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12180%26sid%3Dliteratum%253Aachs%26aulast%3DBondarenko%26aufirst%3DA.%2BI.%26aulast%3DDrachuk%26aufirst%3DK.%26aulast%3DPanasiuk%26aufirst%3DO.%26aulast%3DSagach%26aufirst%3DV.%26aulast%3DDeak%26aufirst%3DA.%2BT.%26aulast%3DMalli%26aufirst%3DR.%26aulast%3DGraier%26aufirst%3DW.%2BF.%26atitle%3DN-Arachidonoyl%2520Glycine%2520Suppresses%2520Na%252B%252FCa2%252B%2520Exchanger-Mediated%2520Ca2%252B%2520Entry%2520into%2520Endothelial%2520Cells%2520and%2520Activates%2520BKCa%2520Channels%2520Independently%2520of%2520GPCRs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D169%26issue%3D4%26spage%3D933%26epage%3D948%26doi%3D10.1111%2Fbph.12180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maor, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groopman, J. E.</span></span> <span> </span><span class="NLM_article-title">Endocannabinoid-like N-Arachidonoyl Serine Is a Novel pro-Angiogenic Mediator</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>160</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1583</span>– <span class="NLM_lpage">1594</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.00841.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1111%2Fj.1476-5381.2010.00841.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=20649563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1583-1594&issue=7&author=X.+Zhangauthor=Y.+Maorauthor=J.+F.+Wangauthor=G.+Kunosauthor=J.+E.+Groopman&title=Endocannabinoid-like+N-Arachidonoyl+Serine+Is+a+Novel+pro-Angiogenic+Mediator&doi=10.1111%2Fj.1476-5381.2010.00841.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator</span></div><div class="casAuthors">Zhang, X.; Maor, Y.; Wang, J. F.; Kunos, G.; Groopman, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1583-1594</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">N-arachidonoyl serine (ARA-S) is a recently identified endocannabinoid-like lipid with weak affinity for the fully characterized cannabinoid receptors (CB1 and CB2) and the transient receptor potential vanilloid receptor 1 (TRPV-1).  ARA-S induces vasodilatation and shows vasoprotective potential via activation of key signaling pathways in endothelial cells.  Based on these findings, the effect of ARA-S on endothelial functions was further studied.  Primary human dermal microvascular endothelial cells (HMVEC) were used to investigate effects of ARA-S (0-10 mM) on certain endothelial functions, using cell proliferation, migration and wound repair models in vitro, and angiogenesis assays in vitro and ex vivo.  Selective CB receptor antagonists and specific siRNAs were deployed to block individual CB receptors.  Results showed that ARA-S stimulated angiogenesis and endothelial wound healing through induction of vascular endothelial growth factor C and its cognate receptor expression in primary HMVEC.  Moreover, knock-down of G protein-coupled receptor 55 (GPR55) partly inhibited ARA-S-induced signal transduction and endothelial functions.  Thus, our results indicate that ARA-S is a pro-angiogenic factor in addn. to a vessel dilator.  The GPR55 receptor may serve as one target of ARA-S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfC28ICw33KLVg90H21EOLACvtfcHk0liyZjIv7JtZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgurzN&md5=9019355944c5dc68c7945ee6dfb649c2</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00841.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00841.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMaor%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%2BF.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DGroopman%26aufirst%3DJ.%2BE.%26atitle%3DEndocannabinoid-like%2520N-Arachidonoyl%2520Serine%2520Is%2520a%2520Novel%2520pro-Angiogenic%2520Mediator%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26issue%3D7%26spage%3D1583%26epage%3D1594%26doi%3D10.1111%2Fj.1476-5381.2010.00841.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Milman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maor, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Lafi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horowitz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallily, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batkai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Offertaler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mechoulam, R.</span></span> <span> </span><span class="NLM_article-title">Brain Constituent with Vasodilatory Properties</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2428</span>– <span class="NLM_lpage">2433</span>, <span class="refDoi"> DOI: 10.1073/pnas.0510676103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1073%2Fpnas.0510676103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=16467152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=2428-2433&issue=7&author=G.+Milmanauthor=Y.+Maorauthor=S.+Abu-Lafiauthor=M.+Horowitzauthor=R.+Gallilyauthor=S.+Batkaiauthor=F.+Moauthor=L.+Offertalerauthor=P.+Pacherauthor=G.+Kunosauthor=R.+Mechoulam&title=Brain+Constituent+with+Vasodilatory+Properties&doi=10.1073%2Fpnas.0510676103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">N-Arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties</span></div><div class="casAuthors">Milman, Garry; Maor, Yehoshua; Abu-Lafi, Saleh; Horowitz, Michal; Gallily, Ruth; Batkai, Sandor; Mo, Fong-Ming; Offertaler, Laszlo; Pacher, Pal; Kunos, George; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2428-2433</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The endocannabinoid N-arachidonoyl ethanolamine (anandamide), found both in the CNS and in the periphery, plays a role in numerous physiol. systems.  One might expect that the chem. related N-arachidonoyl-L-serine (ARA-S) could also be formed alongside anandamide.  We have now isolated ARA-S from bovine brain and elucidated its structure by comparison with synthetic ARA-S.  Contrary to anandamide, ARA-S binds very weakly to cannabinoid CB1 and CB2 or vanilloid TRPV1 (transient receptor potential vanilloid 1) receptors.  However, it produces endothelium-dependent vasodilation of rat isolated mesenteric arteries and abdominal aorta and stimulates phosphorylation of p44/42 mitogen-activated protein (MAP) kinase and protein kinase B/Akt in cultured endothelial cells.  ARA-S also suppresses LPS-induced formation of TNF-α in a murine macrophage cell line and in wild-type mice, as well as in mice deficient in CB1 or CB2 receptors.  Many of these effects parallel those reported for abnormal cannabidiol (Abn-CBD), a synthetic agonist of a putative novel cannabinoid-type receptor.  Hence, ARA-S may represent an endogenous agonist for this receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKfjaFnck3_LVg90H21EOLACvtfcHk0liyZjIv7JtZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslGjtLs%253D&md5=3742d1ab2d54bd4cdcac0ee8cb3035f6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0510676103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0510676103%26sid%3Dliteratum%253Aachs%26aulast%3DMilman%26aufirst%3DG.%26aulast%3DMaor%26aufirst%3DY.%26aulast%3DAbu-Lafi%26aufirst%3DS.%26aulast%3DHorowitz%26aufirst%3DM.%26aulast%3DGallily%26aufirst%3DR.%26aulast%3DBatkai%26aufirst%3DS.%26aulast%3DMo%26aufirst%3DF.%26aulast%3DOffertaler%26aufirst%3DL.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DBrain%2520Constituent%2520with%2520Vasodilatory%2520Properties%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D7%26spage%3D2428%26epage%3D2433%26doi%3D10.1073%2Fpnas.0510676103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atzler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrenswerth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaleta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Imidazole-4-One Derivatives: A New Class of Antagonists for the Orphan G Protein-Coupled Receptors GPR18 and GPR55</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">632</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1039/C3MD00394A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1039%2FC3MD00394A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXms1Wqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=632-649&issue=5&author=V.+Rempelauthor=K.+Atzlerauthor=A.+Behrenswerthauthor=T.+Karczauthor=C.+Schoederauthor=S.+Hinzauthor=M.+Kaletaauthor=D.+Thimmauthor=K.+Kiec-Kononowiczauthor=C.+E.+M%C3%BCller&title=Bicyclic+Imidazole-4-One+Derivatives%3A+A+New+Class+of+Antagonists+for+the+Orphan+G+Protein-Coupled+Receptors+GPR18+and+GPR55&doi=10.1039%2FC3MD00394A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic imidazole-4-one derivatives: a new class of antagonists for the orphan G protein-coupled receptors GPR18 and GPR55</span></div><div class="casAuthors">Rempel, V.; Atzler, K.; Behrenswerth, A.; Karcz, T.; Schoeder, C.; Hinz, S.; Kaleta, M.; Thimm, D.; Kiec-Kononowicz, K.; Mueller, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">632-649</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">GPR18 and GPR55 are orphan G protein-coupled receptors (GPCRs) that interact with certain cannabinoid (CB) receptor ligands.  In the present study bicyclic imidazole-4-one derivs. were discovered as new scaffolds for the development of antagonists for GPR18 and GPR55.  Interaction with CB1 and CB2 receptors was also studied to assess selectivity.  The presented extensive structure-activity relationship study of 49 derivs. investigated at all four GPCRs revealed structural requirements for the development of potent and selective GPR18 and GPR55 antagonists. (Z)-(2,3-Difluorobenzylidene)-6,7-dihydro-2H-imidazo[2,1b][1,3]thiazin-3(5H)-one (18) was identified as a selective GPR55 antagonist (IC50 3.15 μM).  The most potent GPR18 antagonist was (Z)-2-(3-(4-chlorobenzyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1b][1,3]-thiazin-3(5H)-one (32, IC50 0.279 μM, >36-fold selective vs. CB1 and GPR55, 14-fold selective vs. CB2) representing the first selective GPR18 antagonist.  The new compds. may serve as lead structures and as tools to explore the (patho-)physiol. roles of these orphan GPCRs and their potential as drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7qHijbZ4H97Vg90H21EOLACvtfcHk0ljbyzxcS4i7Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXms1Wqs7g%253D&md5=6cd5f3bd0f5915369dfb7885bff24728</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1039%2FC3MD00394A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MD00394A%26sid%3Dliteratum%253Aachs%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DAtzler%26aufirst%3DK.%26aulast%3DBehrenswerth%26aufirst%3DA.%26aulast%3DKarcz%26aufirst%3DT.%26aulast%3DSchoeder%26aufirst%3DC.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DKaleta%26aufirst%3DM.%26aulast%3DThimm%26aufirst%3DD.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DBicyclic%2520Imidazole-4-One%2520Derivatives%253A%2520A%2520New%2520Class%2520of%2520Antagonists%2520for%2520the%2520Orphan%2520G%2520Protein-Coupled%2520Receptors%2520GPR18%2520and%2520GPR55%26jtitle%3DMedChemComm%26date%3D2014%26volume%3D5%26issue%3D5%26spage%3D632%26epage%3D649%26doi%3D10.1039%2FC3MD00394A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimmerman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benton, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dell, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span> <span> </span><span class="NLM_article-title">The Endocannabinoid Anandamide Is a Precursor for the Signaling Lipid N-Arachidonoyl Glycine by Two Distinct Pathways</span>. <i>BMC Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">14</span>, <span class="refDoi"> DOI: 10.1186/1471-2091-10-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1186%2F1471-2091-10-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=19460156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BD1MzotFKquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=14&author=H.+B.+Bradshawauthor=N.+Rimmermanauthor=S.+J.+Huauthor=V.+M.+Bentonauthor=J.+M.+Stuartauthor=K.+Masudaauthor=B.+F.+Cravattauthor=D.+K.+O%E2%80%99Dellauthor=J.+M.+Walker&title=The+Endocannabinoid+Anandamide+Is+a+Precursor+for+the+Signaling+Lipid+N-Arachidonoyl+Glycine+by+Two+Distinct+Pathways&doi=10.1186%2F1471-2091-10-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways</span></div><div class="casAuthors">Bradshaw Heather B; Rimmerman Neta; Hu Sherry Shu-Jung; Benton Valery M; Stuart Jordyn M; Masuda Kim; Cravatt Benjamin F; O'Dell David K; Walker J Michael</div><div class="citationInfo"><span class="NLM_cas:title">BMC biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  N-arachidonoyl glycine (NAGly) is an endogenous signaling lipid with a wide variety of biological activity whose biosynthesis is poorly understood.  Two primary biosynthetic pathways have been proposed.  One suggests that NAGly is formed via an enzymatically regulated conjugation of arachidonic acid (AA) and glycine.  The other suggests that NAGly is an oxidative metabolite of the endogenous cannabinoid, anandamide (AEA), through an alcohol dehydrogenase.  Here using both in vitro and in vivo assays measuring metabolites with LC/MS/MS we test the hypothesis that both pathways are present in mammalian cells.  RESULTS:  The metabolic products of deuterium-labeled AEA, D4AEA (deuterium on ethanolamine), indicated that NAGly is formed by the oxidation of the ethanolamine creating a D2NAGly product in both RAW 264.7 and C6 glioma cells.  Significantly, D4AEA produced a D0NAGly product only in C6 glioma cells suggesting that the hydrolysis of AEA yielded AA that was used preferentially in a conjugation reaction.  Addition of the fatty acid amide (FAAH) inhibitor URB 597 blocked the production of D0NAGly in these cells.  Incubation with D8AA in C6 glioma cells likewise produced D8NAGly; however, with significantly less efficacy leading to the hypothesis that FAAH-initiated AEA-released AA conjugation with glycine predominates in these cells.  Furthermore, the levels of AEA in the brain were significantly increased, whereas those of NAGly were significantly decreased after systemic injection of URB 597 in rats and in FAAH KO mice further supporting a role for FAAH in endogenous NAGly biosynthesis.  Incubations of NAGly and recombinant FAAH demonstrated that NAGly is a significantly less efficacious substrate for FAAH with only ~50% hydrolysis at 30 minutes compared to 100% hydrolysis of AEA.  Co-incubations of AEA and glycine with recombinant FAAH did not, however, produce NAGly.  CONCLUSION:  These data support the hypothesis that the signaling lipid NAGly is a metabolic product of AEA by both oxidative metabolism of the AEA ethanolamine moiety and through the conjugation of glycine to AA that is released during AEA hydrolysis by FAAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbc0zcJk3XZ6e0F5ixvZgXfW6udTcc2eZ9FwPgO04lzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzotFKquw%253D%253D&md5=d3df8125eb32445776bc0f74502fb1a9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1186%2F1471-2091-10-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2091-10-14%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DH.%2BB.%26aulast%3DRimmerman%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DS.%2BJ.%26aulast%3DBenton%26aufirst%3DV.%2BM.%26aulast%3DStuart%26aufirst%3DJ.%2BM.%26aulast%3DMasuda%26aufirst%3DK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DD.%2BK.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Endocannabinoid%2520Anandamide%2520Is%2520a%2520Precursor%2520for%2520the%2520Signaling%2520Lipid%2520N-Arachidonoyl%2520Glycine%2520by%2520Two%2520Distinct%2520Pathways%26jtitle%3DBMC%2520Biochem.%26date%3D2009%26volume%3D10%26spage%3D14%26doi%3D10.1186%2F1471-2091-10-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gläser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bräse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4798</span>– <span class="NLM_lpage">4810</span>, <span class="refDoi"> DOI: 10.1021/jm4005175</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4005175" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVCrt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4798-4810&issue=11&author=V.+Rempelauthor=N.+Volzauthor=F.+Gl%C3%A4serauthor=M.+Niegerauthor=S.+Br%C3%A4seauthor=C.+E.+M%C3%BCller&title=Antagonists+for+the+Orphan+G-Protein-Coupled+Receptor+GPR55+Based+on+a+Coumarin+Scaffold&doi=10.1021%2Fjm4005175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists for the Orphan G-Protein-Coupled Receptor GPR55 Based on a Coumarin Scaffold</span></div><div class="casAuthors">Rempel, Viktor; Volz, Nicole; Glaeser, Franziska; Nieger, Martin; Brase, Stefan; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4798-4810</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The orphan G-protein-coupled receptor GPR55, which is activated by 1-lysophosphatidylinositol and interacts with cannabinoid (CB) receptor ligands, has been proposed as a new potential drug target for the treatment of diabetes, Parkinson's disease, neuropathic pain, and cancer.  The authors applied β-arrestin assays to identify 3-substituted coumarins as a novel class of antagonists and performed an extensive structure-activity relationship study for GPR55.  Selectivity vs. the related receptors CB1, CB2, and GPR18 was assessed.  Among the 7-unsubstituted coumarins selective, competitive GPR55 antagonists were identified, such as 3-(2-hydroxybenzyl)-5-isopropyl-8-methyl-2H-chromen-2-one (12, PSB-SB-489, IC50 = 1.77 μM, pA2 = 0.547 μM).  Derivs. with long alkyl chains in position 7 were potent, possibly allosteric GPR55 antagonists which showed ancillary CB receptor affinity. 7-(1,1-Dimethyloctyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one (69, PSB-SB-487, IC50 = 0.113 μM, KB = 0.561 μM) and 7-(1,1-dimethylheptyl)-5-hydroxy-3-(2-hydroxybenzyl)-2H-chromen-2-one (67, PSB-SB-1203, IC50 = 0.261 μM) were the most potent GPR55 antagonists of the present series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1c2tlkbeBlLVg90H21EOLACvtfcHk0ljwsgHkboWtgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVCrt7k%253D&md5=399b24223430db4307a74604ef37ca2d</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm4005175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4005175%26sid%3Dliteratum%253Aachs%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DVolz%26aufirst%3DN.%26aulast%3DGl%25C3%25A4ser%26aufirst%3DF.%26aulast%3DNieger%26aufirst%3DM.%26aulast%3DBr%25C3%25A4se%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DAntagonists%2520for%2520the%2520Orphan%2520G-Protein-Coupled%2520Receptor%2520GPR55%2520Based%2520on%2520a%2520Coumarin%2520Scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D11%26spage%3D4798%26epage%3D4810%26doi%3D10.1021%2Fjm4005175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stella, N.</span></span> <span> </span><span class="NLM_article-title">Arachidonylcyclopropylamide Increases Microglial Cell Migration through Cannabinoid CB2 and Abnormal-Cannabidiol-Sensitive Receptors</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>474</i></span> (<span class="NLM_issue">2–3</span>),  <span class="NLM_fpage">195</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1016/S0014-2999(03)02074-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2FS0014-2999%2803%2902074-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=12921861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1Kjurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2003&pages=195-198&issue=2%E2%80%933&author=A.+Franklinauthor=N.+Stella&title=Arachidonylcyclopropylamide+Increases+Microglial+Cell+Migration+through+Cannabinoid+CB2+and+Abnormal-Cannabidiol-Sensitive+Receptors&doi=10.1016%2FS0014-2999%2803%2902074-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors</span></div><div class="casAuthors">Franklin, Allyn; Stella, Nephi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">195-198</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Microglial cells, the macrophages of the brain, express low, yet detectable levels of cannabinoid CB1 receptors, which are known to modulate cell migration.  To det. if cannabinoid CB1 receptors expressed by microglial cells modulate their migration, we assessed whether arachidonylcyclopropylamide (ACPA, an agonist shown to selectively activate CB1 receptors) affects the migration of BV-2 cells, a mouse microglial cell line.  We found that ACPA induced a dose-dependent increase in BV-2 cell migration (EC50=2.2 nM).  This ACPA response was blocked by pertussis toxin pretreatment, suggesting the involvement of Gi/o protein-coupled receptors.  However, the cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride (SR141716A) did not prevent ACPA-induced BV-2 cell migration.  Two antagonists of cannabinoid CB2 receptors N-(1,S)-endo-1,3,3-trimethyl bicyclo(2,2,1)heptan-2-yl-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3-carboxamide (SR144528) and cannabinol, as well as two antagonists of the newly identified "abnormal-cannabidiol-sensitive" (abn-CBD) receptors (O-1918 and cannabidiol) prevented this response.  Our results suggest that cannabinoid CB2 receptors and abn-CBD receptors, rather than cannabinoid CB1 receptors, regulate microglial cell migration, and that ACPA is a broad cannabinoid receptor agonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zHj8AYgkq7Vg90H21EOLACvtfcHk0liCPmjXwLugwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1Kjurc%253D&md5=17d2d107eacd2eb588d33b1e9fcc9d56</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2803%2902074-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252803%252902074-0%26sid%3Dliteratum%253Aachs%26aulast%3DFranklin%26aufirst%3DA.%26aulast%3DStella%26aufirst%3DN.%26atitle%3DArachidonylcyclopropylamide%2520Increases%2520Microglial%2520Cell%2520Migration%2520through%2520Cannabinoid%2520CB2%2520and%2520Abnormal-Cannabidiol-Sensitive%2520Receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2003%26volume%3D474%26issue%3D2%25E2%2580%25933%26spage%3D195%26epage%3D198%26doi%3D10.1016%2FS0014-2999%2803%2902074-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nazir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loef, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehraus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Maddah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arslan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, G. M.</span></span> <span> </span><span class="NLM_article-title">GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron Reticulatum</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">12–13</span>),  <span class="NLM_fpage">1141</span>– <span class="NLM_lpage">1145</span>, <span class="refDoi"> DOI: 10.1055/s-0035-1545979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1055%2Fs-0035-1545979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=26287693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlKksLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2015&pages=1141-1145&issue=12%E2%80%9313&author=M.+Nazirauthor=H.+Harmsauthor=I.+Loefauthor=S.+Kehrausauthor=F.+El+Maddahauthor=I.+Arslanauthor=V.+Rempelauthor=C.+E.+M%C3%BCllerauthor=G.+M.+K%C3%B6nig&title=GPR18+Inhibiting+Amauromine+and+the+Novel+Triterpene+Glycoside+Auxarthonoside+from+the+Sponge-Derived+Fungus+Auxarthron+Reticulatum&doi=10.1055%2Fs-0035-1545979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum *</span></div><div class="casAuthors">Nazir, Mamona; Harms, Henrik; Loef, Irene; Kehraus, Stefan; El Maddah, Fayrouz; Arslan, Idris; Rempel, Viktor; Mueller, Christa E.; Koenig, Gabriele M.</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">12/13</span>),
    <span class="NLM_cas:pages">1141-1145</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The marine sponge-derived fungus Auxarthron reticulatum produces the cannabinoid receptor antagonist amauromine (1).  Recultivation of the fungus to obtain further amts. for more detailed pharmacol. evaluation of 1 addnl. yielded the novel triterpene glycoside auxarthonoside (2), bearing, in nature, a rather rare sugar moiety, i.e., N-acetyl-6-methoxy-glucosamine.  Amauromine (1), which inhibited cannabinoid CB1 receptors (Ki 0.178 μM) also showed antagonistic activity at the cannabinoid-like orphan receptor GPR18 (IC50 3.74 μM).  The diketopiperazine 1 may thus serve as a lead structure for the development of more potent and selective GPR18 antagonists, which are required to study the orphan receptor's potential as a new drug target.  Despite the execution of many biol. assays, to date, no bioactivity could be found for auxarthonoside (2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj0Qyf9MIt9LVg90H21EOLACvtfcHk0liCPmjXwLugwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlKksLnK&md5=7c69eac23721159e0576a71218c1ac91</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1545979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1545979%26sid%3Dliteratum%253Aachs%26aulast%3DNazir%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DH.%26aulast%3DLoef%26aufirst%3DI.%26aulast%3DKehraus%26aufirst%3DS.%26aulast%3DEl%2BMaddah%26aufirst%3DF.%26aulast%3DArslan%26aufirst%3DI.%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DK%25C3%25B6nig%26aufirst%3DG.%2BM.%26atitle%3DGPR18%2520Inhibiting%2520Amauromine%2520and%2520the%2520Novel%2520Triterpene%2520Glycoside%2520Auxarthonoside%2520from%2520the%2520Sponge-Derived%2520Fungus%2520Auxarthron%2520Reticulatum%26jtitle%3DPlanta%2520Med.%26date%3D2015%26volume%3D81%26issue%3D12%25E2%2580%259313%26spage%3D1141%26epage%3D1145%26doi%3D10.1055%2Fs-0035-1545979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harms, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rempel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehraus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hufendiek, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">König, G. M.</span></span> <span> </span><span class="NLM_article-title">Indoloditerpenes from a Marine-Derived Fungal Strain of Dichotomomyces Cejpii with Antagonistic Activity at GPR18 and Cannabinoid Receptors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">673</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1021/np400850g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np400850g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2014&pages=673-677&issue=3&author=H.+Harmsauthor=V.+Rempelauthor=S.+Kehrausauthor=M.+Kaiserauthor=P.+Hufendiekauthor=C.+E.+M%C3%BCllerauthor=G.+M.+K%C3%B6nig&title=Indoloditerpenes+from+a+Marine-Derived+Fungal+Strain+of+Dichotomomyces+Cejpii+with+Antagonistic+Activity+at+GPR18+and+Cannabinoid+Receptors&doi=10.1021%2Fnp400850g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors</span></div><div class="casAuthors">Harms, Henrik; Rempel, Viktor; Kehraus, Stefan; Kaiser, Marcel; Hufendiek, Peter; Mueller, Christa E.; Koenig, Gabriele M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">673-677</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A marine-derived strain of Dichotomomyces cejpii produces the new compds. emindole SB beta-mannoside (1) and 27-O-methylasporyzin C (2), as well as the known indoloditerpenes JBIR-03 (3) and emindole SB (4).  Indole deriv. 1 was found to be a CB2 antagonist, while 2 was identified as the first selective GPR18 antagonist with an indole structure.  Compd. 4 was found to be a nonselective CB1/CB2 antagonist.  The new natural indole derivs. may serve as lead structures for the development of GPR18- and CB receptor-blocking drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJWAD4tAxharVg90H21EOLACvtfcHk0lgduBHntzyYdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCntbo%253D&md5=bbbab2b5b0843b41d02b896e3a02b56a</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fnp400850g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp400850g%26sid%3Dliteratum%253Aachs%26aulast%3DHarms%26aufirst%3DH.%26aulast%3DRempel%26aufirst%3DV.%26aulast%3DKehraus%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DHufendiek%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DK%25C3%25B6nig%26aufirst%3DG.%2BM.%26atitle%3DIndoloditerpenes%2520from%2520a%2520Marine-Derived%2520Fungal%2520Strain%2520of%2520Dichotomomyces%2520Cejpii%2520with%2520Antagonistic%2520Activity%2520at%2520GPR18%2520and%2520Cannabinoid%2520Receptors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2014%26volume%3D77%26issue%3D3%26spage%3D673%26epage%3D677%26doi%3D10.1021%2Fnp400850g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaleta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejarz-Maciej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łażewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Structure-Activity Relationships of Imidazothiazinones and Analogs as Antagonists of the Cannabinoid-Activated Orphan G Protein-Coupled Receptor GPR18</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>155</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">397</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.05.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.ejmech.2018.05.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29902723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFemsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=2018&pages=381-397&author=C.+T.+Schoederauthor=M.+Kaletaauthor=A.+B.+Mahardhikaauthor=A.+Olejarz-Maciejauthor=D.+%C5%81a%C5%BCewskaauthor=K.+Kie%C4%87-Kononowiczauthor=C.+E.+M%C3%BCller&title=Structure-Activity+Relationships+of+Imidazothiazinones+and+Analogs+as+Antagonists+of+the+Cannabinoid-Activated+Orphan+G+Protein-Coupled+Receptor+GPR18&doi=10.1016%2Fj.ejmech.2018.05.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18</span></div><div class="casAuthors">Schoeder, Clara T.; Kaleta, Maria; Mahardhika, Andhika B.; Olejarz-Maciej, Agnieszka; Lazewska, Dorota; Kiec-Kononowicz, Katarzyna; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">381-397</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">GPR18 is a cannabinoid-activated orphan G protein-coupled receptor (GPCR) that is selectively expressed on immune cells.  Despite its significant potential as a drug target for inflammatory diseases and cancer immunotherapy, only very few GPR18 ligands have been described to date.  In the present study we investigated the structure-activity relationships (SARs) of (Z)-2-(3-(4-chlorobenzyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1-b][1,3]thiazin-3(5H)-one (PSB-CB5, 5), the most potent GPR18 antagonist described to date.  Analogs were synthesized that exhibit broad modifications of the heterocyclic core and/or variation of substituents at the benzylidene moiety.  The compds. were investigated in β-arrestin recruitment assays as inhibitors of human GPR18 activation by tetrahydrocannabinol (THC).  Selectivity was assessed vs. the cannabinoid receptors (CB1 and CB2) and vs. GPR55, another orphan GPCR that interacts with cannabinoids.  Phenyloxyalkyloxy-substituted benzylidenethiazinones with long alkyl chains (optimal length: hexamethylene) efficiently blocked GPR18 with similarly high potency as lead structure 5.  (Z)-2-(3-(6-(4-Chlorophenoxy)hexyloxy)benzylidene)-6,7-dihydro-2H-imidazo[2,1-b][1,3]thiazin-3(5H)-one (PSB-CB-27, 23) exhibited the best profile: it displayed an IC50 value of 650 nM at GPR18 and showed improved selectivity vs. CB receptors as compared to lead structure 5.  Importantly, in contrast to 5, which showed only partial inhibition (60%), 23 led to a complete blockade of THC-induced GPR18 activation and is thus a superior tool for target validation.  In addn., several compds. were identified as dual GPR18/GPR55 antagonists with similar potency at both targets, and selectivity vs. CB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqW1W8TE9bQLVg90H21EOLACvtfcHk0lgduBHntzyYdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFemsbzJ&md5=f972f1e05e4080dd6165899d6d1acbaf</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.05.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.05.050%26sid%3Dliteratum%253Aachs%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DKaleta%26aufirst%3DM.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DOlejarz-Maciej%26aufirst%3DA.%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DD.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DStructure-Activity%2520Relationships%2520of%2520Imidazothiazinones%2520and%2520Analogs%2520as%2520Antagonists%2520of%2520the%2520Cannabinoid-Activated%2520Orphan%2520G%2520Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D155%26spage%3D381%26epage%3D397%26doi%3D10.1016%2Fj.ejmech.2018.05.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaschke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Development of Chromen-4-One Derivatives as (Ant)Agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">4276</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1021/acsomega.8b03695</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b03695" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1KmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=4276-4295&issue=2&author=C.+T.+Schoederauthor=A.+Meyerauthor=A.+B.+Mahardhikaauthor=D.+Thimmauthor=T.+Blaschkeauthor=M.+Funkeauthor=C.+E.+M%C3%BCller&title=Development+of+Chromen-4-One+Derivatives+as+%28Ant%29Agonists+for+the+Lipid-Activated+G+Protein-Coupled+Receptor+GPR55+with+Tunable+Efficacy&doi=10.1021%2Facsomega.8b03695"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Chromen-4-one Derivatives as (Ant)agonists for the Lipid-Activated G Protein-Coupled Receptor GPR55 with Tunable Efficacy</span></div><div class="casAuthors">Schoeder, Clara T.; Meyer, Anne; Mahardhika, Andhika B.; Thimm, Dominik; Blaschke, Thomas; Funke, Mario; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">4276-4295</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lipid-activated G protein-coupled receptor (GPCR) GPR55 has been proposed as a drug target for the treatment of chronic diseases including inflammation, neurodegeneration, neuropathic pain, metabolic diseases, and cancer.  A series of chromen-4-one-2-carboxylic derivs. was synthesized with the aim to obtain potent and selective ligands for GPR55 by (i) attachment of a variety of substituted 8-benzamido residues, (ii) substitution in position 6 by halogen atoms, and (iii) thioation of the 4-oxo function.  The compds. were investigated in β-arrestin recruitment assays using enzyme complementation.  Depending on the substitution pattern, a spectrum of efficacies was obtained ranging from (partial) agonists to antagonists.  6-Chloro-8-(3-((5-cyclohexylpentyl)oxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (PSB-18251) displayed the highest efficacy of the series combined with high potency (EC50 0.196 μM).  6-Chloro-8-(3-(heptyloxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (PSB-18337) exhibited higher affinity (EC50 0.0400 μM) but lower efficacy (39%).  Several GPR55 antagonists were discovered including 8-(3-(cyclohexylmethoxy)benzamido)-4-oxo-4H-chromene-2-carboxylic acid (PSB-18263) (IC50 8.23 μM) and 4-oxo-8-(3-phenethoxybenzamido)-4H-chromene-2-carboxylic acid (PSB-18270) (IC50 3.96 μM).  These potent GPR55 agonists and antagonists showed high selectivity vs. the related GPCRs GPR18 and GPR35 tested in the same assay system, while 8-(4-(4-cyclohexylbutoxy)benzamido)-6-fluoro-4-oxo-4H-chromene-2-carboxylic acid (PSB-18177) represents a dual GPR35/GPR55 antagonist (IC50 GPR55: 3.26 μM, GPR35: 2.57 μM).  Binding studies of selected compds. at CB1 and CB2 receptors indicated GPR55 selectivity also vs. CB receptors.  The newly developed GPR55 (partial) agonists and antagonists will be useful tools for evaluating the suitability of GPR55 as a drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoukMaZwtl17Vg90H21EOLACvtfcHk0lh_D-DHnP66lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1KmtLs%253D&md5=b4e6f5152c174e175fb8d578fd2c300f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b03695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b03695%26sid%3Dliteratum%253Aachs%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DThimm%26aufirst%3DD.%26aulast%3DBlaschke%26aufirst%3DT.%26aulast%3DFunke%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDevelopment%2520of%2520Chromen-4-One%2520Derivatives%2520as%2520%2528Ant%2529Agonists%2520for%2520the%2520Lipid-Activated%2520G%2520Protein-Coupled%2520Receptor%2520GPR55%2520with%2520Tunable%2520Efficacy%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26issue%3D2%26spage%3D4276%26epage%3D4295%26doi%3D10.1021%2Facsomega.8b03695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jagerovic, N.</span>; <span class="NLM_string-name">Lago-Fernandez, A.</span>; <span class="NLM_string-name">Morales, P.</span>; <span class="NLM_string-name">Abood, M. E.</span>; <span class="NLM_string-name">Brailoiu, E.</span>; <span class="NLM_string-name">Leo, L. M.</span>; <span class="NLM_string-name">Zhao, P.</span>; <span class="NLM_string-name">Reggio, P. H.</span>; <span class="NLM_string-name">Hurst, D. P.</span>; <span class="NLM_string-name">Chafi, N.</span></span> <span> </span><span class="NLM_article-title">Pyrazolylbenzene-1,3-Diols for Diseases Associated with G Protein-Coupled Receptor 18 and in Combination with Transient Receptor Potential Vanilloid 1</span>. European Patent <span class="NLM_patent">EP 20382324</span>, Apr 22, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=N.+Jagerovic&author=A.+Lago-Fernandez&author=P.+Morales&author=M.+E.+Abood&author=E.+Brailoiu&author=L.+M.+Leo&author=P.+Zhao&author=P.+H.+Reggio&author=D.+P.+Hurst&author=N.+Chafi&title=Pyrazolylbenzene-1%2C3-Diols+for+Diseases+Associated+with+G+Protein-Coupled+Receptor+18+and+in+Combination+with+Transient+Receptor+Potential+Vanilloid+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJagerovic%26aufirst%3DN.%26atitle%3DPyrazolylbenzene-1%252C3-Diols%2520for%2520Diseases%2520Associated%2520with%2520G%2520Protein-Coupled%2520Receptor%252018%2520and%2520in%2520Combination%2520with%2520Transient%2520Receptor%2520Potential%2520Vanilloid%25201%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drabczyńska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00208</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00208" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+T.+Schoederauthor=A.+B.+Mahardhikaauthor=A.+Drabczy%C5%84skaauthor=K.+Kie%C4%87-Kononowiczauthor=C.+E.+M%C3%BCller&title=Discovery+of+Tricyclic+Xanthines+as+Agonists+of+the+Cannabinoid-Activated+Orphan+G-Protein-Coupled+Receptor+GPR18&doi=10.1021%2Facsmedchemlett.0c00208"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00208%26sid%3Dliteratum%253Aachs%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DDrabczy%25C5%2584ska%26aufirst%3DA.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DDiscovery%2520of%2520Tricyclic%2520Xanthines%2520as%2520Agonists%2520of%2520the%2520Cannabinoid-Activated%2520Orphan%2520G-Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26doi%3D10.1021%2Facsmedchemlett.0c00208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sotudeh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reggio, P. H.</span></span> <span> </span><span class="NLM_article-title">Towards A Molecular Understanding of The Cannabinoid Related Orphan Receptor GPR18: A Focus on Its Constitutive Activity</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2300</span>, <span class="refDoi"> DOI: 10.3390/ijms20092300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3390%2Fijms20092300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=2300&author=N.+Sotudehauthor=P.+Moralesauthor=D.+P.+Hurstauthor=D.+L.+Lynchauthor=P.+H.+Reggio&title=Towards+A+Molecular+Understanding+of+The+Cannabinoid+Related+Orphan+Receptor+GPR18%3A+A+Focus+on+Its+Constitutive+Activity&doi=10.3390%2Fijms20092300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a molecular understanding of the cannabinoid related orphan receptor GPR18: a focus on its constitutive activity</span></div><div class="casAuthors">Sotudeh, Noori; Morales, Paula; Hurst, Dow P.; Lynch, Diane L.; Reggio, Patricia H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2300</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The orphan G-protein coupled receptor (GPCR), GPR18, has been recently proposed as a potential member of the cannabinoid family as it recognizes several endogenous, phytogenic, and synthetic cannabinoids.  Potential therapeutic applications for GPR18 include intraocular pressure, metabolic disorders, and cancer.  GPR18 has been reported to have high constitutive activity, i.e., activation/signaling occurs in the absence of an agonist.  This activity can be reduced significantly by the A3.39N mutation.  At the intracellular (IC) ends of (transmembrane helixes) TMH3 and TMH6 in GPCRs, typically, a pair of oppositely charged amino acids form a salt bridge called the "ionic lock".  Breaking of this salt bridge creates an IC opening for coupling with G protein.  The GPR18 "ionic lock" residues (R3.50/S6.33) can form only a hydrogen bond.  In this paper, we test the hypothesis that the high constitutive activity of GPR18 is due to the weakness of its "ionic lock" and that the A3.39N mutation strengthens this lock.  To this end, we report mol. dynamics simulations of wild-type (WT) GPR18 and the A3.39N mutant in fully hydrated (POPC) phophatidylcholine lipid bilayers.  Results suggest that in the A3.39N mutant, TMH6 rotates and brings R3.50 and S6.33 closer together, thus strengthening the GPR18 "ionic lock".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9HRytw-tD8LVg90H21EOLACvtfcHk0liNsG_tKQ7JQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWlsLo%253D&md5=bb957e136dc3e939906b478102dbfe9b</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.3390%2Fijms20092300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20092300%26sid%3Dliteratum%253Aachs%26aulast%3DSotudeh%26aufirst%3DN.%26aulast%3DMorales%26aufirst%3DP.%26aulast%3DHurst%26aufirst%3DD.%2BP.%26aulast%3DLynch%26aufirst%3DD.%2BL.%26aulast%3DReggio%26aufirst%3DP.%2BH.%26atitle%3DTowards%2520A%2520Molecular%2520Understanding%2520of%2520The%2520Cannabinoid%2520Related%2520Orphan%2520Receptor%2520GPR18%253A%2520A%2520Focus%2520on%2520Its%2520Constitutive%2520Activity%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26spage%3D2300%26doi%3D10.3390%2Fijms20092300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, J.</span>; <span class="NLM_string-name">Weinstein, H.</span></span> <span> </span><span class="NLM_article-title">Integrated Methods for the Construction of Three-Dimensional Models and Computational Probing of Structure-Function Relations in G Protein-Coupled Receptors</span>. In  <i>Methods in Neurosciences</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, C. S.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">San Diego, CA</span>, <span class="NLM_year">1995</span>; Vol.  <span class="NLM_volume">25</span>, pp  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">428</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=366-428&author=J.+Ballesteros&author=H.+Weinsteinauthor=C.+S.+Stuart&title=Methods+in+Neurosciences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%26atitle%3DIntegrated%2520Methods%2520for%2520the%2520Construction%2520of%2520Three-Dimensional%2520Models%2520and%2520Computational%2520Probing%2520of%2520Structure-Function%2520Relations%2520in%2520G%2520Protein-Coupled%2520Receptors%26btitle%3DMethods%2520in%2520Neurosciences%26aulast%3DStuart%26aufirst%3DC.%2BS.%26pub%3DElsevier%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakhnovich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span> <span> </span><span class="NLM_article-title">Common Activation Mechanism of Class a GPCRs</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e50279</span> <span class="refDoi"> DOI: 10.7554/eLife.50279</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.7554%2FeLife.50279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31855179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlertLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&author=Q.+Zhouauthor=D.+Yangauthor=M.+Wuauthor=Y.+Guoauthor=W.+Guoauthor=L.+Zhongauthor=X.+Caiauthor=A.+Daiauthor=W.+Jangauthor=E.+Shakhnovichauthor=Z.+Liuauthor=R.+Stevensauthor=N.+A.+Lambertauthor=M.+M.+Babuauthor=M.+Wangauthor=S.+Zhao&title=Common+Activation+Mechanism+of+Class+a+GPCRs&doi=10.7554%2FeLife.50279"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Common activation mechanism of class A GPCRs</span></div><div class="casAuthors">Zhou, Qingtong; Yang, Dehua; Wu, Meng; Guo, Yu; Guo, Wanjing; Zhong, Li; Cai, Xiaoqing; Dai, Antao; Jang, Wonjo; Shakhnovich, Eugene I.; Liu, Zhi-Jie; Stevens, Raymond C.; Lambert, Nevin A.; Madan Babu, M.; Wang, Ming-Wei; Zhao, Suwen</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e50279/1-e50279/31</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">Class A G-protein-coupled receptors (GPCRs) influence virtually every aspect of human physiol.  Understanding receptor activation mechanism is crit. for discovering novel therapeutics since about one-third of all marketed drugs target members of this family.  GPCR activation is an allosteric process that couples agonist binding to G-protein recruitment, with the hallmark outward movement of transmembrane helix 6 (TM6).  However, what leads to TM6 movement and the key residue level changes of this movement remain less well understood.  Here, we report a framework to quantify conformational changes.  By analyzing the conformational changes in 234 structures from 45 class A GPCRs, we discovered a common GPCR activation pathway comprising of 34 residue pairs and 35 residues.  The pathway unifies previous findings into a common activation mechanism and strings together the scattered key motifs such as CWxP, DRY, Na+ pocket, NPxxY and PIF, thereby directly linking the bottom of ligand-binding pocket with G-protein coupling region.  Site-directed mutagenesis expts. support this proposition and reveal that rational mutations of residues in this pathway can be used to obtain receptors that are constitutively active or inactive.  The common activation pathway provides the mechanistic interpretation of constitutively activating, inactivating and disease mutations.  As a module responsible for activation, the common pathway allows for decoupling of the evolution of the ligand binding site and G-protein-binding region.  Such an architecture might have facilitated GPCRs to emerge as a highly successful family of proteins for signal transduction in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGqDzu0ZVRbVg90H21EOLACvtfcHk0lhRTF-d4ey2-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlertLfI&md5=1bc80278e242ff048b07492ea1f10ff9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.7554%2FeLife.50279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.50279%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DA.%26aulast%3DJang%26aufirst%3DW.%26aulast%3DShakhnovich%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DN.%2BA.%26aulast%3DBabu%26aufirst%3DM.%2BM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26atitle%3DCommon%2520Activation%2520Mechanism%2520of%2520Class%2520a%2520GPCRs%26jtitle%3DeLife%26date%3D2019%26volume%3D8%26doi%3D10.7554%2FeLife.50279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span> <span> </span><span class="NLM_article-title">The Molecular Basis of G Protein–Coupled Receptor Activation</span>. <i>Annu. Rev. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1146/annurev-biochem-060614-033910</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1146%2Fannurev-biochem-060614-033910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=29925258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=897-919&issue=1&author=W.+I.+Weisauthor=B.+K.+Kobilka&title=The+Molecular+Basis+of+G+Protein%E2%80%93Coupled+Receptor+Activation&doi=10.1146%2Fannurev-biochem-060614-033910"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Basis of G Protein-Coupled Receptor Activation</span></div><div class="casAuthors">Weis, William I.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">897-919</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) mediate the majority of cellular responses to external stimuli.  Upon activation by a ligand, the receptor binds to a partner heterotrimeric G protein and promotes exchange of GTP for GDP, leading to dissocn. of the G protein into α and βγ subunits that mediate downstream signals.  GPCRs can also activate distinct signaling pathways through arrestins.  Active states of GPCRs form by small rearrangements of the ligand-binding, or orthosteric, site that are amplified into larger conformational changes.  Mol. understanding of the allosteric coupling between ligand binding and G protein or arrestin interaction is emerging from structures of several GPCRs crystd. in inactive and active states, spectroscopic data, and computer simulations.  The coupling is loose, rather than concerted, and agonist binding does not fully stabilize the receptor in an active conformation.  Distinct intermediates whose populations are shifted by ligands of different efficacies underlie the complex pharmacol. of GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfSIylPxq7yLVg90H21EOLACvtfcHk0lhRTF-d4ey2-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOrsrvM&md5=71f1f2d3c1d9be27da70dd472d7d44f2</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-060614-033910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-060614-033910%26sid%3Dliteratum%253Aachs%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Molecular%2520Basis%2520of%2520G%2520Protein%25E2%2580%2593Coupled%2520Receptor%2520Activation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2018%26volume%3D87%26issue%3D1%26spage%3D897%26epage%3D919%26doi%3D10.1146%2Fannurev-biochem-060614-033910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahardhika, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoeder, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18</span>. <i>Biomolecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">686</span>, <span class="refDoi"> DOI: 10.3390/biom10050686</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.3390%2Fbiom10050686" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvVOltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=686&issue=5&author=A.+Neumannauthor=V.+Engelauthor=A.+B.+Mahardhikaauthor=C.+T.+Schoederauthor=V.+Namasivayamauthor=K.+Kie%C4%87-Kononowiczauthor=C.+E.+M%C3%BCller&title=Computational+Investigations+on+the+Binding+Mode+of+Ligands+for+the+Cannabinoid-Activated+G+Protein-Coupled+Receptor+GPR18&doi=10.3390%2Fbiom10050686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Computational investigations on the binding mode of ligands for the cannabinoid-activated G protein-coupled receptor GPR18</span></div><div class="casAuthors">Neumann, Alexander; Engel, Viktor; Mahardhika, Andhika B.; Schoeder, Clara T.; Namasivayam, Vigneshwaran; Kiec-Kononowicz, Katarzyna; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Biomolecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">686</span>CODEN:
                <span class="NLM_cas:coden">BIOMHC</span>;
        ISSN:<span class="NLM_cas:issn">2218-273X</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">GPR18 is an orphan G protein-coupled receptor (GPCR) expressed in cells of the immune system.  It is activated by the cannabinoid receptor (CB) agonist Δ9-tetrahydrocannabinol (THC).  Several further lipids have been proposed to act as GPR18 agonists, but these results still require unambiguous confirmation.  In the present study, we constructed a homol. model of the human GPR18 based on an ensemble of three GPCR crystal structures to investigate the binding modes of the agonist THC and the recently reported antagonists which feature an imidazothiazinone core to which a (substituted) Ph ring is connected via a lipophilic linker.  Docking and mol. dynamics simulation studies were performed.  As a result, a hydrophobic binding pocket is predicted to accommodate the imidazothiazinone core, while the terminal Ph ring projects towards an arom. pocket.  Hydrophobic interaction of Cys251 with substituents on the Ph ring could explain the high potency of the most potent derivs.  Mol. dynamics simulation studies suggest that the binding of imidazothiazinone antagonists stabilizes transmembrane regions TM1, TM6 and TM7 of the receptor through a salt bridge between Asp118 and Lys133.  The agonist THC is presumed to bind differently to GPR18 than to the distantly related CB receptors.  This study provides insights into the binding mode of GPR18 agonists and antagonists which will facilitate future drug design for this promising potential drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ZcOlmh2vZLVg90H21EOLACvtfcHk0lirOtHExHEc9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvVOltb0%253D&md5=c5eab5ec9c4d3b73cf56ddd12dbe91f1</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.3390%2Fbiom10050686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fbiom10050686%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DV.%26aulast%3DMahardhika%26aufirst%3DA.%2BB.%26aulast%3DSchoeder%26aufirst%3DC.%2BT.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DComputational%2520Investigations%2520on%2520the%2520Binding%2520Mode%2520of%2520Ligands%2520for%2520the%2520Cannabinoid-Activated%2520G%2520Protein-Coupled%2520Receptor%2520GPR18%26jtitle%3DBiomolecules%26date%3D2020%26volume%3D10%26issue%3D5%26spage%3D686%26doi%3D10.3390%2Fbiom10050686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karcz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaleta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiec-Kononowicz, K.</span></span> <span> </span><span class="NLM_article-title">Molecular Modeling of an Orphan GPR18 Receptor</span>. <i>Lett. Drug Des. Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1167</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.2174/1570180815666180810114847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.2174%2F1570180815666180810114847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2isb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=1167-1174&issue=10&author=K.+J.+Kuderauthor=T.+Karczauthor=M.+Kaletaauthor=K.+Kiec-Kononowicz&title=Molecular+Modeling+of+an+Orphan+GPR18+Receptor&doi=10.2174%2F1570180815666180810114847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Modeling of an Orphan GPR18 Receptor</span></div><div class="casAuthors">Kuder, Kamil J.; Karcz, Tadeusz; Kaleta, Maria; Kiec-Kononowicz, Katarzyna</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Drug Design & Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1167-1174</span>CODEN:
                <span class="NLM_cas:coden">LDDDAW</span>;
        ISSN:<span class="NLM_cas:issn">1875-628X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Background: One of the best known to date GPCR class A (Rhodopsin) includes more than 100 orphan receptors for which the endogenous ligand is not known or is unclear.  One of them is N-arachidonyl glycine receptor, named GPR18, a receptor that has been reported to be activated by Δ9-THC, endogenous cannabinoid receptors agonist anandamide and other cannabinoid receptor ligands suggesting it could be considered as third cannabinoid receptor.  GPR18 activity, as well as its distribution might suggest usage of GPR18 ligands in treatment of endometriosis, cancer, and neurodegenerative disorders.  Yet, so far only few GPR18 antagonists have been described, thus only ligand-based design approaches appear to be most useful to identify new ligands for this orphan receptor.  Methods: Main goal of this study, GPR18 inactive form homol. model was built on the basis of the evolutionary closest homologous template: Human P2Y1 Receptor crystal structure.  Results: Obtained model was further evaluated and showed active/nonactive ligands differentiating properties with acceptable confidence.  Moreover, it allowed for preliminary assessment of proteinligand interactions for a set of previously described ligands.  Conclusion: Thus collected data might serve as a starting point for a discovery of novel, active GPR18 blocking ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFm5NNB5gparVg90H21EOLACvtfcHk0lirOtHExHEc9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2isb3F&md5=a1de6bdec48204b89a0b0c06768d5cb4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F1570180815666180810114847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1570180815666180810114847%26sid%3Dliteratum%253Aachs%26aulast%3DKuder%26aufirst%3DK.%2BJ.%26aulast%3DKarcz%26aufirst%3DT.%26aulast%3DKaleta%26aufirst%3DM.%26aulast%3DKiec-Kononowicz%26aufirst%3DK.%26atitle%3DMolecular%2520Modeling%2520of%2520an%2520Orphan%2520GPR18%2520Receptor%26jtitle%3DLett.%2520Drug%2520Des.%2520Discovery%26date%3D2019%26volume%3D16%26issue%3D10%26spage%3D1167%26epage%3D1174%26doi%3D10.2174%2F1570180815666180810114847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, V. W. Y.</span></span> <span> </span><span class="NLM_article-title">Omics-Wide Quantitative B-Cell Infiltration Analyses Identify GPR18 for Human Cancer Prognosis with Superiority over CD20</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">234</span>, <span class="refDoi"> DOI: 10.1038/s42003-020-0964-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fs42003-020-0964-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32398659" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A280%3ADC%252BB38vmtVSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=234&author=Y.+Liuauthor=L.+Wangauthor=K.-W.+Loauthor=V.+W.+Y.+Lui&title=Omics-Wide+Quantitative+B-Cell+Infiltration+Analyses+Identify+GPR18+for+Human+Cancer+Prognosis+with+Superiority+over+CD20&doi=10.1038%2Fs42003-020-0964-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Omics-wide quantitative B-cell infiltration analyses identify GPR18 for human cancer prognosis with superiority over CD20</span></div><div class="casAuthors">Liu Yuchen; Wang Li; Lui Vivian Wai Yan; Lo Kwok-Wai</div><div class="citationInfo"><span class="NLM_cas:title">Communications biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">234</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor-infiltrating B lymphocyte (TIL-B), and TIL-B-related biomarkers have clinical prognostic values for human cancers.  CD20 (encoded by MS4A1) is a widely used TIL-B biomarker.  Using TCGA-quantitative multiomics datasets, we first cross-compare prognostic powers of intratumoral CD20 protein, mRNA and TIL-B levels in pan-cancers.  Here, we show that MS4A1 and TIL-B are consistently prognostic in 5 cancers (head and neck, lung, cervical, kidney and low-grade glioma), while unexpectedly, CD20 protein levels lack quantitative correlations with MS4A1/TIL-B levels and demonstrate limited prognosticity.  Subsequent bioinformatics discovery for TIL-B prognostic gene identifies a single gene, GPR18 with stand-alone prognosticity across 9 cancers (superior over CD20), with further validations in multiple non-TCGA cohorts.  GPR18's immune signature denotes major B-cell-T-cell interactions, with its intratumoral expression strongly tied to a "T-cell active", likely cytolytic, status across human cancers, suggesting its functional link to cytolytic T-cell activity in cancer.  GPR18 merits biological and clinical utility assessments over CD20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRekrVMksnQDkodMGTatQ7LfW6udTcc2eah94FVD3uTsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38vmtVSitA%253D%253D&md5=029349acbf5e22193d0d37ca198b6ac7</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fs42003-020-0964-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-020-0964-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLo%26aufirst%3DK.-W.%26aulast%3DLui%26aufirst%3DV.%2BW.%2BY.%26atitle%3DOmics-Wide%2520Quantitative%2520B-Cell%2520Infiltration%2520Analyses%2520Identify%2520GPR18%2520for%2520Human%2520Cancer%2520Prognosis%2520with%2520Superiority%2520over%2520CD20%26jtitle%3DCommun.%2520Biol.%26date%3D2020%26volume%3D3%26spage%3D234%26doi%3D10.1038%2Fs42003-020-0964-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span> <span> </span><span class="NLM_article-title">Identification of Biomarkers for Sarcoidosis and Tuberculosis of the Lung Using Systematic and Integrated Analysis</span>. <i>Med. Sci. Monit.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">e925438</span> <span class="refDoi"> DOI: 10.12659/MSM.925438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.12659%2FMSM.925438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32701935" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2020&author=M.+Zhaoauthor=X.+Diauthor=X.+Jinauthor=C.+Tianauthor=S.+Congauthor=J.+Liuauthor=K.+Wang&title=Identification+of+Biomarkers+for+Sarcoidosis+and+Tuberculosis+of+the+Lung+Using+Systematic+and+Integrated+Analysis&doi=10.12659%2FMSM.925438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.12659%2FMSM.925438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.12659%252FMSM.925438%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DDi%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DC.%26aulast%3DCong%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Biomarkers%2520for%2520Sarcoidosis%2520and%2520Tuberculosis%2520of%2520the%2520Lung%2520Using%2520Systematic%2520and%2520Integrated%2520Analysis%26jtitle%3DMed.%2520Sci.%2520Monit.%26date%3D2020%26volume%3D26%26doi%3D10.12659%2FMSM.925438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iliopoulos-Tsoutsouvas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchama, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>180</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.01.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2020.01.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32004463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFeqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2020&pages=655-665&issue=4&author=T.+Huaauthor=X.+Liauthor=L.+Wuauthor=C.+Iliopoulos-Tsoutsouvasauthor=Y.+Wangauthor=M.+Wuauthor=L.+Shenauthor=C.+A.+Johnstonauthor=S.+P.+Nikasauthor=F.+Songauthor=X.+Songauthor=S.+Yuanauthor=Q.+Sunauthor=Y.+Wuauthor=S.+Jiangauthor=T.+Grimauthor=O.+Benchamaauthor=E.+L.+Stahlauthor=N.+Zvonokauthor=S.+Zhaoauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=Z.+Liu&title=Activation+and+Signaling+Mechanism+Revealed+by+Cannabinoid+Receptor-Gi+Complex+Structures&doi=10.1016%2Fj.cell.2020.01.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures</span></div><div class="casAuthors">Hua, Tian; Li, Xiaoting; Wu, Lijie; Iliopoulos-Tsoutsouvas, Christos; Wang, Yuxia; Wu, Meng; Shen, Ling; Johnston, Christina A.; Nikas, Spyros P.; Song, Feng; Song, Xiyong; Yuan, Shuguang; Sun, Qianqian; Wu, Yiran; Jiang, Shan; Grim, Travis W.; Benchama, Othman; Stahl, Edward L.; Zvonok, Nikolai; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">655-665.e18</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human endocannabinoid systems modulate multiple physiol. processes mainly through the activation of cannabinoid receptors CB1 and CB2.  Their high sequence similarity, low agonist selectivity, and lack of activation and G protein-coupling knowledge have hindered the development of therapeutic applications.  Importantly, missing structural information has significantly held back the development of promising CB2-selective agonist drugs for treating inflammatory and neuropathic pain without the psychoactivity of CB1.  Here, we report the cryoelectron microscopy structures of synthetic cannabinoid-bound CB2 and CB1 in complex with Gi, as well as agonist-bound CB2 crystal structure.  Of important scientific and therapeutic benefit, our results reveal a diverse activation and signaling mechanism, the structural basis of CB2-selective agonists design, and the unexpected interaction of cholesterol with CB1, suggestive of its endogenous allosteric modulating role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgy9tDrt9HArVg90H21EOLACvtfcHk0lhLjd2oAUNzbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFeqtbc%253D&md5=b9d4dd05094f3bae76b315a41a11c21b</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.01.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.01.008%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DIliopoulos-Tsoutsouvas%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DC.%2BA.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DSong%26aufirst%3DF.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DGrim%26aufirst%3DT.%26aulast%3DBenchama%26aufirst%3DO.%26aulast%3DStahl%26aufirst%3DE.%2BL.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DActivation%2520and%2520Signaling%2520Mechanism%2520Revealed%2520by%2520Cannabinoid%2520Receptor-Gi%2520Complex%2520Structures%26jtitle%3DCell%26date%3D2020%26volume%3D180%26issue%3D4%26spage%3D655%26epage%3D665%26doi%3D10.1016%2Fj.cell.2020.01.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrell, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span> <span> </span><span class="NLM_article-title">Structure of an Allosteric Modulator Bound to the CB1 Cannabinoid Receptor</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1205</span>, <span class="refDoi"> DOI: 10.1038/s41589-019-0387-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fs41589-019-0387-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=31659318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVCksLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=1199-1205&issue=12&author=Z.+Shaoauthor=W.+Yanauthor=K.+Chapmanauthor=K.+Rameshauthor=A.+J.+Ferrellauthor=J.+Yinauthor=X.+Wangauthor=Q.+Xuauthor=D.+M.+Rosenbaum&title=Structure+of+an+Allosteric+Modulator+Bound+to+the+CB1+Cannabinoid+Receptor&doi=10.1038%2Fs41589-019-0387-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an allosteric modulator bound to the CB1 cannabinoid receptor</span></div><div class="casAuthors">Shao, Zhenhua; Yan, Wei; Chapman, Karen; Ramesh, Karthik; Ferrell, Aaron J.; Yin, Jie; Wang, Xuehui; Xu, Qingping; Rosenbaum, Daniel M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1199-1205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">The CB1 receptor mediates the central nervous system response to cannabinoids, and is a drug target for pain, anxiety and seizures.  CB1 also responds to allosteric modulators, which influence cannabinoid binding and efficacy.  To understand the mechanism of these compds., we solved the crystal structure of CB1 with the neg. allosteric modulator (NAM) ORG27569 and the agonist CP55940.  The structure reveals that the NAM binds to an extrahelical site within the inner leaflet of the membrane, which overlaps with a conserved site of cholesterol interaction in many G protein-coupled receptors (GPCRs).  The ternary structure with ORG27569 and CP55940 captures an intermediate state of the receptor, in which arom. residues at the base of the agonist-binding pocket adopt an inactive conformation despite the large contraction of the orthosteric pocket.  The structure illustrates a potential strategy for drug modulation of CB1 and other class A GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz52KMEDfkTbVg90H21EOLACvtfcHk0lhLjd2oAUNzbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVCksLnM&md5=58150bc1805c874c5dce7ed13fcf7c68</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fs41589-019-0387-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-019-0387-2%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DRamesh%26aufirst%3DK.%26aulast%3DFerrell%26aufirst%3DA.%2BJ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26atitle%3DStructure%2520of%2520an%2520Allosteric%2520Modulator%2520Bound%2520to%2520the%2520CB1%2520Cannabinoid%2520Receptor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26issue%3D12%26spage%3D1199%26epage%3D1205%26doi%3D10.1038%2Fs41589-019-0387-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishna
Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shalev-Benami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banister, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorraca, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilger, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weis, W. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrens, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malhotra, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span> <span> </span><span class="NLM_article-title">Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.11.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2018.11.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30639101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFKkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=448-458&issue=3&author=K.+Krishna%0AKumarauthor=M.+Shalev-Benamiauthor=M.+J.+Robertsonauthor=H.+Huauthor=S.+D.+Banisterauthor=S.+A.+Hollingsworthauthor=N.+R.+Latorracaauthor=H.+E.+Katoauthor=D.+Hilgerauthor=S.+Maedaauthor=W.+I.+Weisauthor=D.+L.+Farrensauthor=R.+Drorauthor=S.+V.+Malhotraauthor=B.+Kobilkaauthor=G.+Skiniotis&title=Structure+of+a+Signaling+Cannabinoid+Receptor+1-G+Protein+Complex&doi=10.1016%2Fj.cell.2018.11.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex</span></div><div class="casAuthors">Krishna Kumar, Kaavya; Shalev-Benami, Moran; Robertson, Michael J.; Hu, Hongli; Banister, Samuel D.; Hollingsworth, Scott A.; Latorraca, Naomi R.; Kato, Hideaki E.; Hilger, Daniel; Maeda, Shoji; Weis, William I.; Farrens, David L.; Dror, Ron O.; Malhotra, Sanjay V.; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">448-458.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cannabis elicits its mood-enhancing and analgesic effects through the cannabinoid receptor 1 (CB1), a G protein-coupled receptor (GPCR) that signals primarily through the adenylyl cyclase-inhibiting heterotrimeric G protein Gi.  Activation of CB1-Gi signaling pathways holds potential for treating a no. of neurol. disorders and is thus crucial to understand the mechanism of Gi activation by CB1.  Here, we present the structure of the CB1-Gi signaling complex bound to the highly potent agonist MDMB-Fubinaca (FUB), a recently emerged illicit synthetic cannabinoid infused in street drugs that have been assocd. with numerous overdoses and fatalities.  The structure illustrates how FUB stabilizes the receptor in an active state to facilitate nucleotide exchange in Gi.  The results compose the structural framework to explain CB1 activation by different classes of ligands and provide insights into the G protein coupling and selectivity mechanisms adopted by the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovBXFMO5ZXtrVg90H21EOLACvtfcHk0ljyw76FvRvz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFKkuw%253D%253D&md5=de5d2da4a5fd3b4a1c8f7e9b2ac08f6f</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.11.040%26sid%3Dliteratum%253Aachs%26aulast%3DKrishna%2BKumar%26aufirst%3DK.%26aulast%3DShalev-Benami%26aufirst%3DM.%26aulast%3DRobertson%26aufirst%3DM.%2BJ.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DHollingsworth%26aufirst%3DS.%2BA.%26aulast%3DLatorraca%26aufirst%3DN.%2BR.%26aulast%3DKato%26aufirst%3DH.%2BE.%26aulast%3DHilger%26aufirst%3DD.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DWeis%26aufirst%3DW.%2BI.%26aulast%3DFarrens%26aufirst%3DD.%2BL.%26aulast%3DDror%26aufirst%3DR.%26aulast%3DMalhotra%26aufirst%3DS.%2BV.%26aulast%3DKobilka%26aufirst%3DB.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DStructure%2520of%2520a%2520Signaling%2520Cannabinoid%2520Receptor%25201-G%2520Protein%2520Complex%26jtitle%3DCell%26date%3D2019%26volume%3D176%26issue%3D3%26spage%3D448%26epage%3D458%26doi%3D10.1016%2Fj.cell.2018.11.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzemska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbaum, D. M.</span></span> <span> </span><span class="NLM_article-title">High-Resolution Crystal Structure of the Human CB1 Cannabinoid Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>540</i></span> (<span class="NLM_issue">7634</span>),  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1038/nature20613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fnature20613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27851727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCgtL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=540&publication_year=2016&pages=602-606&issue=7634&author=Z.+Shaoauthor=J.+Yinauthor=K.+Chapmanauthor=M.+Grzemskaauthor=L.+Clarkauthor=J.+Wangauthor=D.+M.+Rosenbaum&title=High-Resolution+Crystal+Structure+of+the+Human+CB1+Cannabinoid+Receptor&doi=10.1038%2Fnature20613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution crystal structure of the human CB1 cannabinoid receptor</span></div><div class="casAuthors">Shao, Zhenhua; Yin, Jie; Chapman, Karen; Grzemska, Magdalena; Clark, Lindsay; Wang, Junmei; Rosenbaum, Daniel M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">540</span>
        (<span class="NLM_cas:issue">7634</span>),
    <span class="NLM_cas:pages">602-606</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human cannabinoid G-protein-coupled receptors (GPCRs) CB1 and CB2 mediate the functional responses to the endocannabinoids anandamide and 2-arachidonyl glycerol (2-AG) and to the widely consumed plant phytocannabinoid Δ9-tetrahydrocannabinol (THC).  The cannabinoid receptors have been the targets of intensive drug discovery efforts, because modulation of these receptors has therapeutic potential to control pain, epilepsy, obesity, and other disorders.  Although much progress in understanding the biophys. properties of GPCRs has recently been made, investigations of the mol. mechanisms of the cannabinoids and their receptors have lacked high-resoln. structural data.  Here we report the use of GPCR engineering and lipidic cubic phase crystn. to det. the structure of the human CB1 receptor bound to the inhibitor taranabant at 2.6-Å resoln.  We found that the extracellular surface of CB1, including the highly conserved membrane-proximal N-terminal region, is distinct from those of other lipid-activated GPCRs, forming a crit. part of the ligand-binding pocket.  Docking studies further demonstrate how this same pocket may accommodate the cannabinoid agonist THC.  Our CB1 structure provides an at. framework for studying cannabinoid receptor function and will aid the design and optimization of therapeutic modulators of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrry3sr0ztbEbVg90H21EOLACvtfcHk0ljyw76FvRvz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCgtL3L&md5=cccd3a0e0d0ccf9795777e4b9e722102</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1038%2Fnature20613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature20613%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DGrzemska%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26atitle%3DHigh-Resolution%2520Crystal%2520Structure%2520of%2520the%2520Human%2520CB1%2520Cannabinoid%2520Receptor%26jtitle%3DNature%26date%3D2016%26volume%3D540%26issue%3D7634%26spage%3D602%26epage%3D606%26doi%3D10.1038%2Fnature20613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikas, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laprairie, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Agonist-Bound Human Cannabinoid Receptor CB1</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>547</i></span> (<span class="NLM_issue">7664</span>),  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">471</span>, <span class="refDoi"> DOI: 10.1038/nature23272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1038%2Fnature23272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=28678776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=547&publication_year=2017&pages=468-471&issue=7664&author=T.+Huaauthor=K.+Vemuriauthor=S.+P.+Nikasauthor=R.+B.+Laprairieauthor=Y.+Wuauthor=L.+Quauthor=M.+Puauthor=A.+Kordeauthor=S.+Jiangauthor=J.-H.+Hoauthor=G.+W.+Hanauthor=K.+Dingauthor=X.+Liauthor=H.+Liuauthor=M.+H.+Hansonauthor=S.+Zhaoauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+Stevensauthor=Z.-J.+Liu&title=Crystal+Structures+of+Agonist-Bound+Human+Cannabinoid+Receptor+CB1&doi=10.1038%2Fnature23272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of agonist-bound human cannabinoid receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Nikas, Spyros P.; Laprairie, Robert B.; Wu, Yiran; Qu, Lu; Pu, Mengchen; Korde, Anisha; Jiang, Shan; Ho, Jo-Hao; Han, Gye Won; Ding, Kang; Li, Xuanxuan; Liu, Haiguang; Hanson, Michael A.; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">547</span>
        (<span class="NLM_cas:issue">7664</span>),
    <span class="NLM_cas:pages">468-471</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).  Here the authors report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 Å and 2.95 Å resoln., resp.  The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state, including a 53% redn. in the vol. of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region.  In addn., a 'twin toggle switch' of Phe 2003.36 and Trp 3566.48 (superscripts denote Ballesteros-Weinstein numbering) is exptl. obsd. and appears to be essential for receptor activation.  The structures reveal important insights into the activation mechanism of CB1 and provide a mol. basis for predicting the binding modes of Δ9-THC, and endogenous and synthetic cannabinoids.  The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors.  These findings should inspire the design of chem. diverse ligands with distinct pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6XE4Hx5gDrVg90H21EOLACvtfcHk0ljyw76FvRvz2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFaqt73E&md5=f77fcc823e5856ece0bb5730ac00ea07</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fnature23272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23272%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DNikas%26aufirst%3DS.%2BP.%26aulast%3DLaprairie%26aufirst%3DR.%2BB.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DKorde%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DJ.-H.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHanson%26aufirst%3DM.%2BH.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520Structures%2520of%2520Agonist-Bound%2520Human%2520Cannabinoid%2520Receptor%2520CB1%26jtitle%3DNature%26date%3D2017%26volume%3D547%26issue%3D7664%26spage%3D468%26epage%3D471%26doi%3D10.1038%2Fnature23272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Cannabinoid CB 1</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">762</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2016.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=27768894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=750-762&author=T.+Huaauthor=K.+Vemuriauthor=M.+Puauthor=A.+Makriyannisauthor=R.+C.+Stevensauthor=Z.+Liu&title=Crystal+Structure+of+the+Human+Cannabinoid+CB+1&doi=10.1016%2Fj.cell.2016.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB1</span></div><div class="casAuthors">Hua, Tian; Vemuri, Kiran; Pu, Mengchen; Qu, Lu; Han, Gye Won; Wu, Yiran; Zhao, Suwen; Shui, Wenqing; Li, Shanshan; Korde, Anisha; Laprairie, Robert B.; Stahl, Edward L.; Ho, Jo-Hao; Zvonok, Nikolai; Zhou, Han; Kufareva, Irina; Wu, Beili; Zhao, Qiang; Hanson, Michael A.; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">750-762.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chem. from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use.  CB1 is activated by endocannabinoids and is a promising therapeutic target for pain management, inflammation, obesity, and substance abuse disorders.  Here, the authors present the 2.8 Å crystal structure of human CB1 in complex with AM6538, a stabilizing antagonist, synthesized and characterized for this structural study.  The structure of the CB1-AM6538 complex reveals key features of the receptor and crit. interactions for antagonist binding.  In combination with functional studies and mol. modeling, the structure provides insight into the binding mode of naturally occurring CB1 ligands, such as THC, and synthetic cannabinoids.  This enhances the understanding of the mol. basis for the physiol. functions of CB1 and provides new opportunities for the design of next-generation CB1-targeting pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAuMgAfmO22bVg90H21EOLACvtfcHk0lhpjmzyKVBcCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCrsrbI&md5=f4862c31391550ee2b83ef198c9c7b17</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Cannabinoid%2520CB%25201%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D750%26epage%3D762%26doi%3D10.1016%2Fj.cell.2016.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemuri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchama, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvonok, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makriyannis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Human Cannabinoid Receptor CB2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2018.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=30639103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=459-467&issue=3&author=X.+Liauthor=T.+Huaauthor=K.+Vemuriauthor=J.+H.+Hoauthor=Y.+Wuauthor=L.+Wuauthor=P.+Popovauthor=O.+Benchamaauthor=N.+Zvonokauthor=K.+Lockeauthor=L.+Quauthor=G.+W.+Hanauthor=M.+R.+Iyerauthor=R.+Cinarauthor=N.+J.+Coffeyauthor=J.+Wangauthor=M.+Wuauthor=V.+Katritchauthor=S.+Zhaoauthor=G.+Kunosauthor=L.+M.+Bohnauthor=A.+Makriyannisauthor=R.+Stevensauthor=Z.-J.+Liu&title=Crystal+Structure+of+the+Human+Cannabinoid+Receptor+CB2&doi=10.1016%2Fj.cell.2018.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of the Human Cannabinoid Receptor CB2</span></div><div class="casAuthors">Li, Xiaoting; Hua, Tian; Vemuri, Kiran; Ho, Jo-Hao; Wu, Yiran; Wu, Lijie; Popov, Petr; Benchama, Othman; Zvonok, Nikolai; Locke, K'ara; Qu, Lu; Han, Gye Won; Iyer, Malliga R.; Cinar, Resat; Coffey, Nathan J.; Wang, Jingjing; Wu, Meng; Katritch, Vsevolod; Zhao, Suwen; Kunos, George; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-467.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The cannabinoid receptor CB2 is predominately expressed in the immune system, and selective modulation of CB2 without the psychoactivity of CB1 has therapeutic potential in inflammatory, fibrotic, and neurodegenerative diseases.  Here, we report the crystal structure of human CB2 in complex with a rationally designed antagonist, AM10257, at 2.8 Å resoln.  The CB2-AM10257 structure reveals a distinctly different binding pose compared with CB1.  However, the extracellular portion of the antagonist-bound CB2 shares a high degree of conformational similarity with the agonist-bound CB1, which led to the discovery of AM10257's unexpected opposing functional profile of CB2 antagonism vs. CB1 agonism.  Further structural anal. using mutagenesis studies and mol. docking revealed the mol. basis of their function and selectivity for CB2 and CB1.  Addnl. analyses of our designed antagonist and agonist pairs provide important insight into the activation mechanism of CB2.  The present findings should facilitate rational drug design toward precise modulation of the endocannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFwNUEO0q03LVg90H21EOLACvtfcHk0lhpjmzyKVBcCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFKktw%253D%253D&md5=90ee72a6dc13b74b84fb6799c3aa0471</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DT.%26aulast%3DVemuri%26aufirst%3DK.%26aulast%3DHo%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DPopov%26aufirst%3DP.%26aulast%3DBenchama%26aufirst%3DO.%26aulast%3DZvonok%26aufirst%3DN.%26aulast%3DLocke%26aufirst%3DK.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DIyer%26aufirst%3DM.%2BR.%26aulast%3DCinar%26aufirst%3DR.%26aulast%3DCoffey%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DKunos%26aufirst%3DG.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DMakriyannis%26aufirst%3DA.%26aulast%3DStevens%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Human%2520Cannabinoid%2520Receptor%2520CB2%26jtitle%3DCell%26date%3D2019%26volume%3D176%26issue%3D3%26spage%3D459%26epage%3D467%26doi%3D10.1016%2Fj.cell.2018.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.-Q.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM Structure of the Human Cannabinoid Receptor CB2-G i Signaling Complex</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">654</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2020.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1016%2Fj.cell.2020.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32004460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFequr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2020&pages=645-654&author=C.+Xingauthor=Y.+Zhuangauthor=T.-H.+Xuauthor=Z.+Fengauthor=X.+E.+Zhouauthor=M.+Chenauthor=L.+Wangauthor=X.+Mengauthor=Y.+Xueauthor=J.+Wangauthor=H.+Liuauthor=T.+F.+McGuireauthor=G.+Zhaoauthor=K.+Melcherauthor=C.+Zhangauthor=H.+E.+Xuauthor=X.-Q.+Xie&title=Cryo-EM+Structure+of+the+Human+Cannabinoid+Receptor+CB2-G+i+Signaling+Complex&doi=10.1016%2Fj.cell.2020.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex</span></div><div class="casAuthors">Xing, Changrui; Zhuang, Youwen; Xu, Ting-Hai; Feng, Zhiwei; Zhou, X. Edward; Chen, Maozi; Wang, Lei; Meng, Xing; Xue, Ying; Wang, Junmei; Liu, Heng; McGuire, Terence Francis; Zhao, Gongpu; Melcher, Karsten; Zhang, Cheng; Xu, H. Eric; Xie, Xiang-Qun</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">645-654.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Drugs selectively targeting CB2 hold promise for treating neurodegenerative disorders, inflammation, and pain while avoiding psychotropic side effects mediated by CB1.  The mechanisms underlying CB2 activation and signaling are poorly understood but crit. for drug design.  Here we report the cryo-EM structure of the human CB2-Gi signaling complex bound to the agonist WIN 55,212-2.  The 3D structure reveals the binding mode of WIN 55,212-2 and structural determinants for distinguishing CB2 agonists from antagonists, which are supported by a pair of rationally designed agonist and antagonist.  Further structural analyses with computational docking results uncover the differences between CB2 and CB1 in receptor activation, ligand recognition, and Gi coupling.  These findings are expected to facilitate rational structure-based discovery of drugs targeting the cannabinoid system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxe6yMtfE8RbVg90H21EOLACvtfcHk0liGBmoS8UWqHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFequr8%253D&md5=2c54b7bd90e2f9b33b141adb36e57688</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2020.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2020.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DT.-H.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DX.%2BE.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMcGuire%26aufirst%3DT.%2BF.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DMelcher%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DXie%26aufirst%3DX.-Q.%26atitle%3DCryo-EM%2520Structure%2520of%2520the%2520Human%2520Cannabinoid%2520Receptor%2520CB2-G%2520i%2520Signaling%2520Complex%26jtitle%3DCell%26date%3D2020%26volume%3D180%26spage%3D645%26epage%3D654%26doi%3D10.1016%2Fj.cell.2020.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maria, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobingier, B. T.</span></span> <span> </span><span class="NLM_article-title">A Cellular Perspective of Bias at G Protein-Coupled Receptors</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1354</span>, <span class="refDoi"> DOI: 10.1002/pro.3872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=10.1002%2Fpro.3872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=32297394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVOqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2020&pages=1345-1354&author=T.+J.+Fernandezauthor=M.+De+Mariaauthor=B.+T.+Lobingier&title=A+Cellular+Perspective+of+Bias+at+G+Protein-Coupled+Receptors&doi=10.1002%2Fpro.3872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">A cellular perspective of bias at G protein-coupled receptors</span></div><div class="casAuthors">Fernandez, Thomas J.; De Maria, Monica; Lobingier, Braden T.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1345-1354</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) modulate cell function over short- and long-term timescales.  GPCR signaling depends on biochem. parameters that define the what, when, and where of receptor function: what proteins mediate and regulate receptor signaling, where within the cell these interactions occur, and how long these interactions persist.  These parameters can vary significantly depending on the activating ligand.  Collectivity, differential agonist activity at a GPCR is called bias or functional selectivity.  Here we review agonist bias at GPCRs with a focus on ligands that show dramatically different cellular responses from their unbiased counterparts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXtcFevqvi2bVg90H21EOLACvtfcHk0liGBmoS8UWqHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVOqs74%253D&md5=9ef6e3cebf44a073d7cd156f9b1b65d4</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1002%2Fpro.3872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3872%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DT.%2BJ.%26aulast%3DDe%2BMaria%26aufirst%3DM.%26aulast%3DLobingier%26aufirst%3DB.%2BT.%26atitle%3DA%2520Cellular%2520Perspective%2520of%2520Bias%2520at%2520G%2520Protein-Coupled%2520Receptors%26jtitle%3DProtein%2520Sci.%26date%3D2020%26volume%3D29%26spage%3D1345%26epage%3D1354%26doi%3D10.1002%2Fpro.3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N6H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4N6H','PDB','4N6H'); return false;">PDB: 4N6H</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00926&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00926%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00926" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679972c2ca803d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
